data_2l2g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l2g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.752 0.311 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.435 ' HB2' HD13 ' A' 1542 ' ' LEU . 2.5 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.647 ' HB3' HD23 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.704 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.574 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.574 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1551 ' ' ASP . . . . . 0.681 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1555 ' ' SER . . . . . . . . . . . . . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.442 ' HE3' HD22 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.513 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.589 HD11 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.749 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.527 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.533 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.591 ' HB3' HG13 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.442 HD22 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.414 ' OG1' HD12 ' A' 1588 ' ' ILE . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.509 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.425 ' OD1' HG11 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1592 ' ' SER . . . . . 0.455 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' 1604 ' ' LEU . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.577 ' HD1' HD13 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.521 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.553 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.783 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.472 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.7 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1611 ' ' GLY . . . . . 0.439 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.633 ' HZ1' ' HB3' ' A' 1623 ' ' LYS . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.557 HD11 ' HE2' ' A' 1608 ' ' TYR . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.553 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1629 ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.737 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.679 ' HB3' HD23 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.741 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.547 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.772 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.772 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' 1651 ' ' THR . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.589 HD12 HD11 ' A' 1564 ' ' ILE . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.512 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.516 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.737 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.445 0.641 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' 1533 ' ' GLN . 2.5 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1543 ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.659 HD23 HD11 ' A' 1660 ' ' LEU . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.598 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.902 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.517 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.538 ' HB3' HD11 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.509 HG22 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.525 ' HB2' ' SG ' ' A' 1582 ' ' CYS . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.463 HG12 HG23 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.517 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.902 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.554 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.659 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.429 HD13 HG21 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.429 HG21 HD13 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.822 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.554 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 32.1 mm-40 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1598 ' ' MET . . . . . . . . . . . . . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.592 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.592 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.778 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.644 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.465 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.424 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.5 t . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1649 ' ' THR . 5.1 mp . . . . . 0 CA--C 1.489 -1.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.469 ' N ' ' HE2' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.577 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.644 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.61 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.778 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' 1659 ' ' PRO . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.648 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.479 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.514 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.467 ' HB2' HG23 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.421 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.818 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.818 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.484 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.404 ' HG2' HD11 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1648 ' ' GLN . . . . . 0.424 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 6.9 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.604 HG22 HG23 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' 1622 ' ' TYR . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.617 ' HA ' HG22 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.509 ' HZ ' HG22 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.723 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.539 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.723 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.648 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.659 HD11 HD23 ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.429 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1536 ' ' ASN . . . . . 0.484 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.432 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.878 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1555 ' ' SER . . . . . . . . . . . . . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.612 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.536 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.519 HG12 HG21 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.498 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.878 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 10.3 m120 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1580 ' ' GLY . . . . . 0.689 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.829 HG11 ' HB2' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.506 ' HB3' HG13 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.403 HD12 ' HE3' ' A' 1561 ' ' LYS . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.829 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.689 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.784 HD13 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' 1604 ' ' LEU . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.569 ' HD1' HD11 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.837 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.9 tp-100 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.773 HG21 HG11 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' 1620 ' ' LEU . 73.4 m . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' 1649 ' ' THR . 9.5 mp . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.605 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.773 HG11 HG21 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.429 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.483 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.1 p-10 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.613 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.569 ' HA ' HD21 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.47 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.653 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.528 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.613 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.591 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.793 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.515 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.793 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 120.666 0.269 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.727 ' HG3' HD22 ' A' 1542 ' ' LEU . 2.7 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.415 HG13 ' CD2' ' A' 1597 ' ' LEU . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.727 HD22 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1547 ' ' SER . . . . . 0.419 ' HB3' HD22 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1550 ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' 1552 ' ' SER . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.445 ' HB2' ' OD1' ' A' 1550 ' ' ASN . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.526 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.524 ' HB3' HD11 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.901 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.479 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.513 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.513 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1562 ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.535 HD11 HD11 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.504 HG12 HG21 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.526 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.578 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.9 m120 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.404 ' SG ' HG11 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.492 ' HB3' HG12 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.446 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.448 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.489 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' 1604 ' ' LEU . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.59 ' HD1' HD11 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.523 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.792 HG21 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.489 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p . . . . . 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' 1649 ' ' THR . 9.1 mp . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.792 HG12 HG21 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.52 ' HB3' HG12 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1629 ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' 1657 ' ' HIS . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' 1631 ' ' THR . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.453 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.9 p-10 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.901 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.752 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.752 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.584 HG23 ' OG1' ' A' 1651 ' ' THR . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.584 ' OG1' HG23 ' A' 1649 ' ' THR . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.535 HD11 HD11 ' A' 1564 ' ' ILE . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG21 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.636 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.519 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.519 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.516 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' 1659 ' ' PRO . 79.0 m . . . . . 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.773 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.773 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 2.8 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.449 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.591 HD22 ' HG3' ' A' 1533 ' ' GLN . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.688 ' HB3' HD23 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.658 HD23 HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.549 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.404 HD11 HD22 ' A' 1660 ' ' LEU . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.573 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1555 ' ' SER . . . . . . . . . . . . . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.898 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.435 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.545 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.832 HG11 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.589 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.441 HD13 HG22 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.441 HG22 HD13 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.51 ' HB3' ' HB1' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.832 ' HB3' HG11 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.43 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.513 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.443 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.562 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.448 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1626 ' ' ILE . 21.7 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.432 HD12 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.709 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.453 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t . . . . . 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.738 ' HG ' HG23 ' A' 1581 ' ' VAL . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.709 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.686 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.48 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1639 ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.898 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1644 ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.782 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.576 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' 1646 ' ' ASP . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.782 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.491 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.686 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.658 HD11 HD23 ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' 1659 ' ' PRO . 89.5 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.424 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.535 ' HB2' HD23 ' A' 1542 ' ' LEU . 3.0 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.426 ' C ' HD22 ' A' 1542 ' ' LEU . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.549 ' HB3' HD22 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.619 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.413 HD11 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.408 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.483 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.587 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.778 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.778 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.483 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.439 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.528 HG12 HG21 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.441 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 13.0 m120 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.538 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.76 HG12 ' HB1' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.541 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.76 ' HB1' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.439 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.43 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.602 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.0 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.614 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.898 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.0 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.748 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p . . . . . 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' 1649 ' ' THR . 6.1 mp . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.748 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.614 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.898 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.486 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.835 ' HB2' HG23 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.542 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.795 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.795 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.416 ' HG2' HD11 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.579 ' HA ' HD23 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.682 ' HA ' HG21 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.542 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.655 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.539 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.486 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' 1659 ' ' PRO . 72.7 m . . . . . 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.876 0.369 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.501 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.2 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.508 HG12 ' HG ' ' A' 1597 ' ' LEU . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.678 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.634 ' HA ' HD21 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1547 ' ' SER . . . . . 0.711 ' HB2' HD23 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.41 HD13 HD23 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.419 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.521 ' HB3' HD11 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.446 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.57 ' HE2' HD12 ' A' 1585 ' ' LEU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.503 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.473 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.503 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.419 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.506 HG11 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG13 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.57 HD12 ' HE2' ' A' 1561 ' ' LYS . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.506 ' OD1' HG11 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1592 ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.472 ' HA ' ' NE2' ' A' 1596 ' ' GLN . 11.2 mm-40 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.508 ' HG ' HG12 ' A' 1534 ' ' VAL . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD13 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.93 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' 1598 ' ' MET . 0.0 OUTLIER -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.529 HG21 HG21 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.84 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.429 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 18.0 p . . . . . 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.84 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.445 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.529 HG21 HG21 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.502 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.93 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' 1633 ' ' ASP . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' 1631 ' ' THR . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.574 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.7 p-10 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.726 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.612 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.642 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.618 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.503 HD12 HD13 ' A' 1564 ' ' ILE . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.456 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.561 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.53 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.51 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 CA--C 1.523 -0.069 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' 1543 ' ' PHE . 2.8 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1539 ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' 1541 ' ' HIS . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1541 ' ' HIS . . . . . 0.483 ' HD2' ' HB ' ' A' 1539 ' ' THR . 31.1 m-70 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.655 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1551 ' ' ASP . . . . . 0.661 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.498 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.456 ' HB2' HD11 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' 1564 ' ' ILE . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.559 HD12 HD11 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.44 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.661 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.462 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.403 ' HA ' ' HD3' ' A' 1576 ' ' PRO . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.685 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1592 ' ' SER . . . . . 0.426 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.491 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.467 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 30.1 mm-40 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.456 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.466 ' HB3' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.459 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 23.4 p . . . . . 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' 1649 ' ' THR . 7.3 mp . . . . . 0 CA--C 1.506 -0.729 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.621 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.673 HG22 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.535 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.926 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1630 ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.2 p-10 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1639 ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.69 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.753 HG11 ' HG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.908 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.908 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.46 ' N ' HD12 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.465 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.559 HD11 HD12 ' A' 1564 ' ' ILE . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.673 ' HA ' HG22 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.753 ' HG ' HG11 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' 1658 ' ' THR . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m . . . . . 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.563 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.562 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.421 ' C ' HD23 ' A' 1542 ' ' LEU . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1536 ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1537 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.563 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.518 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1555 ' ' SER . . . . . . . . . . . . . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.439 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.559 HD13 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.528 HG12 HG21 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.513 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.4 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.476 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.575 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.45 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.528 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' 1582 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.809 HG11 ' HB2' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.491 ' HB3' HG13 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.554 HD13 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.554 HG23 HD13 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.481 ' HB3' ' HB1' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.809 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.528 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.575 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.417 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 1.066 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.407 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.717 HG22 HG13 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.567 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.539 ' CE2' HG23 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.717 HG13 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.567 HD12 ' HE2' ' A' 1608 ' ' TYR . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.594 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 1.066 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.655 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1639 ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.745 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.503 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.58 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.58 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.462 ' HG2' HD13 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.463 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.462 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.613 ' HA ' HG21 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.503 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.553 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.643 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.643 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD11 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.438 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' 1543 ' ' PHE . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.601 ' HG1' HD23 ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.601 HD23 ' HG1' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.518 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.446 ' HB2' HD11 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.431 ' H ' ' HA ' ' A' 1563 ' ' LEU . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.635 HG22 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1566 ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.813 HG13 ' HB1' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.489 HG22 HD11 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.442 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD13 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.536 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.876 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.772 HG21 HG13 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD11 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.809 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.772 HG13 HG21 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.583 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.419 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.857 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.857 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.61 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' 1646 ' ' ASP . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.635 ' HZ ' HG22 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.623 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.438 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' 1543 ' ' PHE . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.601 ' HG1' HD23 ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.601 HD23 ' HG1' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.518 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.446 ' HB2' HD11 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.431 ' H ' ' HA ' ' A' 1563 ' ' LEU . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.635 HG22 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1566 ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.813 HG13 ' HB1' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.489 HG22 HD11 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.442 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD13 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.536 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.876 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.772 HG21 HG13 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD11 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.809 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.772 HG13 HG21 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.583 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.419 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.857 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.857 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.61 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' 1646 ' ' ASP . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.635 ' HZ ' HG22 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.623 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.459 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' 1597 ' ' LEU . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1536 ' ' ASN . . . . . 0.4 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.688 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.677 HD22 HD13 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.506 HD13 HD23 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' 1549 ' ' LYS . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.477 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.496 ' CD1' HD13 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.896 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.896 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.503 HD11 HD13 ' A' 1652 ' ' LEU . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.466 HG12 HG23 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.574 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.477 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.414 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.544 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.77 HG12 ' HB2' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.484 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.566 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.77 ' HB2' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1592 ' ' SER . . . . . 0.419 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.414 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.512 ' HE3' ' HB3' ' A' 1605 ' ' GLN . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.611 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.439 HG12 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.512 ' HB3' ' HE3' ' A' 1598 ' ' MET . 0.0 OUTLIER -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.495 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.608 HG22 HG23 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.581 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.176 0.513 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1621 ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.41 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.608 HG23 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.581 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG12 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.417 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.859 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.859 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' 1650 ' ' CYS . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.501 HG21 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.501 ' OG1' HG21 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.503 HD13 HD11 ' A' 1564 ' ' ILE . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.733 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.677 HD13 HD22 ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.594 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 2.9 m-20 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 3.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' 1599 ' ' TYR . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.456 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.633 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.557 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.787 HG23 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.592 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.624 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.592 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' 1563 ' ' LEU . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.557 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.835 HG13 ' HB1' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.515 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.702 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.427 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.573 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.59 ' HD1' HD13 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.477 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.61 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.651 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.248 0.976 0 CA-C-O 121.868 0.842 . . . . 0.0 112.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.541 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.651 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.562 ' HB3' HG12 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.825 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.583 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.787 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.493 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.694 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.694 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.584 HG21 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.7 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.684 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.621 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.684 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.663 ' CD1' HD21 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m . . . . . 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.629 ' HB2' HD13 ' A' 1542 ' ' LEU . 4.1 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.591 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.566 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1547 ' ' SER . . . . . 0.477 ' HB2' HD22 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1551 ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.505 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.584 HD22 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.584 ' CD1' HD22 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.513 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.528 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1587 ' ' LYS . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.455 ' OG1' HD12 ' A' 1588 ' ' ILE . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.532 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.795 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.552 HD22 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.552 ' HB2' HD22 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' 1604 ' ' LEU . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.542 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.4 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.922 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG23 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.495 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' 1649 ' ' THR . 5.2 mp . . . . . 0 CA--C 1.495 -1.148 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.933 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.811 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.683 HG23 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.487 HD13 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.526 ' HB3' HG13 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.922 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.402 ' HB2' HG22 ' A' 1631 ' ' THR . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.424 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.504 ' ND2' ' HD3' ' A' 1640 ' ' PRO . 2.0 p-10 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.529 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.675 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.468 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.443 ' HG2' HD11 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.648 ' HA ' HD21 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.933 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.468 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.414 ' HE2' ' HG ' ' A' 1624 ' ' SER . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.547 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.597 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m . . . . . 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 35.5 t-20 . . . . . 0 C--O 1.218 -0.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.596 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 3.9 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1536 ' ' ASN . . . . . 0.5 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1537 ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.606 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.405 HD13 HD23 ' A' 1660 ' ' LEU . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.506 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.48 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.51 ' HB3' HD11 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.52 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.421 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.52 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.525 HD12 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.435 ' CE1' HD13 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.525 HG12 HG23 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.439 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.458 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.655 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.74 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.449 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.579 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' 1604 ' ' LEU . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' 1604 ' ' LEU . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.68 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.68 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.975 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.9 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.687 HG23 HG21 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.579 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' 1620 ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.687 HG21 HG23 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.975 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.734 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.415 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.736 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.806 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.806 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1650 ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.525 HD12 HD12 ' A' 1564 ' ' ILE . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.589 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' 1638 ' ' ASN . 33.9 m170 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.65 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.734 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.65 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.458 ' N ' HD11 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.858 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 63.9 t30 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.858 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 4.0 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.521 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1552 ' ' SER . . . . . 0.482 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1556 ' ' VAL . . . . . . . . . . . . . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.422 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.706 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1562 ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.456 ' N ' HD11 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.518 ' CE1' HD12 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.588 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1570 ' ' GLY . . . . . 0.452 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1573 ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.525 ' HB3' HG12 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1584 ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.706 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.751 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.516 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.452 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.721 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' 1604 ' ' LEU . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.526 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.477 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.7 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.5 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1606 ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.791 HG22 HG23 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.588 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.452 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 CA--C 1.498 -1.035 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.439 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.791 HG23 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1630 ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.798 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.509 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.636 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.485 HG13 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.578 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1644 ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' 1653 ' ' TYR . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.578 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.695 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.532 HG21 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.423 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.485 ' OG ' HG13 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' 1660 ' ' LEU . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.798 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.653 ' CD2' HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t . . . . . 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1533 ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.49 ' HB ' ' HG ' ' A' 1597 ' ' LEU . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.517 ' HB3' HD22 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.59 ' HA ' HD22 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.575 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1555 ' ' SER . . . . . . . . . . . . . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' 1560 ' ' GLU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.42 ' HG3' ' CD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.489 HG22 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.468 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.516 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.575 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.805 HG11 ' HB1' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' 1587 ' ' LYS . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 0.9 OUTLIER -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.805 ' HB1' HG11 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1592 ' ' SER . . . . . 0.489 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.56 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.482 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.75 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.655 ' HE2' HD13 ' A' 1626 ' ' ILE . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t . . . . . 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' 1649 ' ' THR . 5.3 mp . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.75 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.655 HD13 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.596 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.552 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.596 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1644 ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.596 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.672 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.408 ' HG2' HD11 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.606 HG21 ' OG1' ' A' 1651 ' ' THR . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.537 HD13 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.679 ' HA ' HG21 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.489 ' HZ ' HG22 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1658 ' ' THR . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.9 m . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.488 ' HB2' HD13 ' A' 1542 ' ' LEU . 2.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' 1543 ' ' PHE . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1536 ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1537 ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.642 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.533 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.481 HD11 HD23 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.575 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.508 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.63 HD11 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.51 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.483 HG12 HG21 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.443 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 0.9 OUTLIER -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.55 HG12 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.848 HG13 ' HB2' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.55 ' HB3' HG12 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.848 ' HB2' HG13 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' 1569 ' ' CYS . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' 1604 ' ' LEU . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.587 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.553 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.661 HG21 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' 1620 ' ' LEU . 23.4 t . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' 1649 ' ' THR . 7.5 mp . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.661 HG12 HG21 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.509 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG23 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.901 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1644 ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' 1653 ' ' TYR . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.901 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1647 ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' 1645 ' ' LEU . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.598 ' HA ' HD23 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.63 HD12 HD11 ' A' 1564 ' ' ILE . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.557 ' HA ' HG22 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.592 ' HZ ' HG23 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.496 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.701 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.701 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1661 ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' 1604 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.51 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 3.2 m-20 . . . . . 0 C--O 1.243 0.728 0 CA-C-O 120.267 0.08 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1532 ' ' CYS . . . . . 0.527 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.51 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 4.0 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' 1598 ' ' MET . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1535 ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.526 ' HB3' HD23 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.57 ' HA ' HD11 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1546 ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1548 ' ' LEU . . . . . 0.6 HD12 HG22 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1558 ' ' TYR . . . . . 0.491 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1560 ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.552 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.487 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.6 HG22 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1569 ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.439 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.52 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' 1582 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1585 ' ' LEU . . . . . 0.568 HD13 HG22 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1586 ' ' THR . . . . . 0.568 HG22 HD13 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.722 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.52 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.718 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.829 ' HA ' HE21 ' A' 1596 ' ' GLN . 0.0 OUTLIER -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' 1604 ' ' LEU . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' A' 1598 ' ' MET . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD13 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.451 HE21 ' HB2' ' A' 1605 ' ' GLN . 4.2 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.469 HG21 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.476 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1614 ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' 1620 ' ' LEU . 96.4 m . . . . . 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.596 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.455 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.469 HG22 HG21 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.492 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.508 ' HB3' HG12 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1629 ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1630 ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1636 ' ' ALA . . . . . 0.462 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.491 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1639 ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.405 ' HB3' ' CZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.586 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.541 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.541 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.481 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.549 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.528 ' OG1' HG22 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1652 ' ' LEU . . . . . 0.552 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.481 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.669 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.586 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.828 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.651 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.828 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.506 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.792 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1531 ' ' ASN . . . . . 0.672 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1533 ' ' GLN . . . . . 0.423 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1542 ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1543 ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1545 ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1549 ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.453 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1554 ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1555 ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1556 ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1557 ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1561 ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1563 ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1564 ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1565 ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1566 ' ' ILE . . . . . 0.517 HG12 HG23 ' A' 1581 ' ' VAL . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1568 ' ' ILE . . . . . 0.54 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1572 ' ' THR . . . . . 0.453 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1574 ' ' ASN . . . . . 0.476 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1575 ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1576 ' ' PRO . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1576 ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1578 ' ' GLY . . . . . 0.548 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1579 ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1581 ' ' VAL . . . . . 0.813 HG12 ' HB1' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG12 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1583 ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1587 ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1589 ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1593 ' ' TRP . . . . . 0.548 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1595 ' ' SER . . . . . 0.672 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1596 ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1597 ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1598 ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1599 ' ' TYR . . . . . 0.552 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1602 ' ' GLN . . . . . 0.443 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1603 ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.897 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1605 ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG13 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1608 ' ' TYR . . . . . 0.54 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1609 ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1612 ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1613 ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1620 ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' 1649 ' ' THR . 4.7 mp . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.224 0.535 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1622 ' ' TYR . . . . . 0.489 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1623 ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1624 ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1625 ' ' VAL . . . . . 0.718 HG13 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1626 ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1627 ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1628 ' ' PHE . . . . . 0.897 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1631 ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1635 ' ' GLY . . . . . 0.512 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1637 ' ' ASN . . . . . 0.53 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1638 ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1640 ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1641 ' ' VAL . . . . . 0.451 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1642 ' ' PHE . . . . . 0.619 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1644 ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' 1653 ' ' TYR . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1645 ' ' LEU . . . . . 0.619 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1646 ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1651 ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1652 ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1653 ' ' TYR . . . . . 0.678 ' HA ' HG21 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1654 ' ' PHE . . . . . 0.516 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1655 ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1656 ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1657 ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1658 ' ' THR . . . . . 0.507 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1659 ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' 1658 ' ' THR . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1660 ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1662 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 60.3 mtm . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 22.5 tptm 69.96 157.81 0.16 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.371 1.068 . . . . 0.0 111.119 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 38.7 t -52.76 150.25 5.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.226 1.01 . . . . 0.0 112.381 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.422 ' HB3' ' H ' ' A' 1535 ' ' THR . 39.7 t30 -105.36 88.6 2.89 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.587 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.97 HG12 ' HG2' ' A' 1598 ' ' MET . 11.5 mt -72.42 85.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 C-N-CA 124.325 1.05 . . . . 0.0 109.559 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -101.88 159.79 15.04 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.22 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -95.33 15.97 17.99 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.428 0.691 . . . . 0.0 111.034 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -108.29 19.92 19.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.1 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.435 ' HB2' HD13 ' A' 1542 ' ' LEU . 2.5 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.694 HG23 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.647 ' HB3' HD23 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.704 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.574 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.574 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1551 ' ' ASP . . . . . 0.681 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1555 ' ' SER . . . . . . . . . . . . . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.442 ' HE3' HD22 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.513 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.589 HD11 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.749 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.527 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.533 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.591 ' HB3' HG13 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.442 HD22 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.414 ' OG1' HD12 ' A' 1588 ' ' ILE . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.509 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.425 ' OD1' HG11 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1592 ' ' SER . . . . . 0.455 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' 1528 ' ' ILE . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.97 ' HG2' HG12 ' A' 1528 ' ' ILE . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.577 ' HD1' HD13 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.521 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.553 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.783 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.472 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.7 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1611 ' ' GLY . . . . . 0.439 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' 1615 ' ' PRO . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t -96.44 107.18 34.29 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' 1613 ' ' PRO . 72.4 Cg_endo -102.19 8.9 0.45 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.123 2.549 . . . . 0.0 112.108 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.7 m -62.16 -62.52 1.71 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.413 1.085 . . . . 0.0 113.569 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.94 -60.35 0.97 Allowed 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.176 0.512 . . . . 0.0 109.792 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.6 167.92 9.81 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -104.8 32.39 4.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp -86.36 -171.79 3.73 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.633 ' HZ1' ' HB3' ' A' 1623 ' ' LYS . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.557 HD11 ' HE2' ' A' 1608 ' ' TYR . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.553 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1629 ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.737 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.679 ' HB3' HD23 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.741 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.547 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.772 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.772 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.413 HG21 ' OG1' ' A' 1651 ' ' THR . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.589 HD12 HD11 ' A' 1564 ' ' ILE . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.547 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.512 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.516 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.737 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t -102.12 141.76 34.46 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.53 119.3 38.67 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-O 121.996 0.903 . . . . 0.0 112.775 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.29 -17.53 42.21 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.456 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.96 125.73 28.89 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -74.59 133.37 77.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 123.458 0.474 . . . . 0.0 111.132 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.74 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 61.6 Cg_endo -80.27 -168.76 0.67 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 123.311 2.674 . . . . 0.0 111.978 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -65.86 -50.42 64.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.097 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.93 93.32 4.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.74 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 2.3 p80 . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.342 0.115 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -119.46 141.28 49.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.104 0.478 . . . . 0.0 110.188 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 51.3 m -132.54 -173.43 3.17 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.171 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.437 ' HB2' ' H ' ' A' 1599 ' ' TYR . 3.8 p-10 -71.85 97.85 1.89 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.955 0.883 . . . . 0.0 111.371 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1528 ' ' ILE . . . . . . . . . . . . . 25.8 pt -139.49 -176.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 C-N-CA 125.2 1.4 . . . . 0.0 109.268 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.05 151.27 40.24 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -164.52 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 -175.41 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.353 0.661 . . . . 0.0 110.113 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' 1533 ' ' GLN . 2.5 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1543 ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.659 HD23 HD11 ' A' 1660 ' ' LEU . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.598 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.902 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.517 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.538 ' HB3' HD11 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.509 HG22 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.525 ' HB2' ' SG ' ' A' 1582 ' ' CYS . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.463 HG12 HG23 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.517 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.902 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.554 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.659 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.429 HD13 HG21 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.429 HG21 HD13 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.822 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.712 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.554 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 32.1 mm-40 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1598 ' ' MET . . . . . . . . . . . . . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.592 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.592 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.778 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.644 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.465 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' 1616 ' ' SER . 10.5 t -89.28 108.09 22.25 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' 1613 ' ' PRO . 3.8 Cg_exo -75.48 -9.67 20.18 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.286 2.657 . . . . 0.0 112.001 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1616 ' ' SER . . . . . 0.534 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 6.8 m -67.42 -43.65 80.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' 1617 ' ' LYS . 32.0 mmmt -119.87 3.6 11.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.949 0.88 . . . . 0.0 111.343 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 11.0 t30 73.5 -66.57 0.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 126.772 2.029 . . . . 0.0 114.389 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.78 57.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1649 ' ' THR . 5.1 mp -98.9 173.34 6.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.992 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.469 ' N ' ' HE2' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.577 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.644 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.61 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.778 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' 1659 ' ' PRO . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.648 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.479 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.514 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.467 ' HB2' HG23 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.421 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.818 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.818 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.484 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.404 ' HG2' HD11 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1648 ' ' GLN . . . . . 0.424 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 6.9 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.604 HG22 HG23 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' 1622 ' ' TYR . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.617 ' HA ' HG22 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.509 ' HZ ' HG22 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.723 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.539 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.723 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.648 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.659 HD11 HD23 ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m -90.77 116.47 28.64 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -102.15 136.69 41.55 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.2 mttm -67.61 -28.93 68.16 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.957 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -82.84 96.56 8.28 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 8.0 pt-20 -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.281 -2.385 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.984 -175.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 40.8 Cg_exo -63.53 -179.7 0.74 Allowed 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.375 2.717 . . . . 0.0 111.186 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -61.08 -40.53 94.06 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.8 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -126.31 98.32 5.4 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.488 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 53.7 t-80 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.766 ' HE3' ' HA ' ' A' 1524 ' ' MET . 3.9 mmt . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' 1537 ' ' PRO . 28.4 mmmt -74.21 141.59 45.44 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.313 0.577 . . . . 0.0 112.496 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' 1599 ' ' TYR . 44.2 m -80.94 109.26 15.35 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.785 ' O ' ' HA ' ' A' 1598 ' ' MET . 22.0 t-20 -83.39 122.99 29.23 Favored 'General case' 0 C--O 1.179 -2.633 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.606 HG12 ' HG2' ' A' 1598 ' ' MET . 31.2 mt -107.21 96.57 4.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 C-N-CA 125.432 1.493 . . . . 0.0 108.144 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.704 ' HB3' ' O ' ' A' 1533 ' ' GLN . 36.7 tt0 -109.36 157.32 19.01 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -130.68 28.78 4.85 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.686 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.704 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.484 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' 1525 ' ' LYS . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.432 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.878 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.46 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1555 ' ' SER . . . . . . . . . . . . . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.612 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.536 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.519 HG12 HG21 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.528 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.498 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.878 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 10.3 m120 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1580 ' ' GLY . . . . . 0.689 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.829 HG11 ' HB2' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.506 ' HB3' HG13 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.403 HD12 ' HE3' ' A' 1561 ' ' LYS . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.829 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.689 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.784 HD13 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.785 ' HA ' ' O ' ' A' 1527 ' ' ASN . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.569 ' HD1' HD11 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.837 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.9 tp-100 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.773 HG21 HG11 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' 1620 ' ' LEU . 73.4 m -74.14 107.56 3.78 Favored Pre-proline 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' 1613 ' ' PRO . 40.0 Cg_endo -91.64 -16.22 1.27 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.621 2.214 . . . . 0.0 114.481 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 32.2 t -146.09 -54.55 0.27 Allowed 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.835 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.64 -42.99 99.67 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.322 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1618 ' ' ASN . . . . . 0.433 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 64.1 m-20 -130.18 -178.91 4.94 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -118.84 -7.12 10.51 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' 1649 ' ' THR . 9.5 mp -100.32 -163.98 1.08 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.57 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.605 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.773 HG11 HG21 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.429 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.483 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.1 p-10 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.613 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.454 ' HG2' HD11 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.569 ' HA ' HD21 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.47 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.653 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.528 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.613 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.591 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.793 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.515 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.793 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m -89.42 126.81 35.71 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.1 135.72 49.49 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -52.53 -40.16 62.16 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.01 152.61 19.91 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.475 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' 1670 ' ' HIS . 11.1 pt-20 -74.43 136.79 74.83 Favored Pre-proline 0 C--O 1.251 1.145 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.59 -162.94 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.558 2.839 . . . . 0.0 110.957 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -53.42 -37.0 62.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -125.38 103.61 8.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.649 ' HB3' ' HB2' ' A' 1666 ' ' GLU . 52.4 p-80 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.457 -0.085 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -109.57 147.83 32.32 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' 1600 ' ' VAL . 9.0 m -66.63 122.26 17.22 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 123.349 0.66 . . . . 0.0 112.446 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' 1598 ' ' MET . 19.1 t-20 -85.23 125.31 32.76 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.609 HG12 ' HG2' ' A' 1598 ' ' MET . 21.7 mt -109.79 104.4 17.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 124.508 1.123 . . . . 0.0 108.797 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.559 ' HB3' ' O ' ' A' 1533 ' ' GLN . 9.1 tt0 -116.53 151.19 36.64 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.809 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.85 17.39 18.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.826 0.851 . . . . 0.0 111.564 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.441 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 -107.19 16.01 24.52 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.693 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.727 ' HG3' HD22 ' A' 1542 ' ' LEU . 2.7 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.415 HG13 ' CD2' ' A' 1597 ' ' LEU . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.727 HD22 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1547 ' ' SER . . . . . 0.419 ' HB3' HD22 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1550 ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' 1552 ' ' SER . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.445 ' HB2' ' OD1' ' A' 1550 ' ' ASN . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.526 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.524 ' HB3' HD11 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.901 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.479 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.513 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.513 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1562 ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.535 HD11 HD11 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.504 HG12 HG21 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.526 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.578 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.9 m120 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.404 ' SG ' HG11 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.448 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.797 HG11 ' HB1' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.492 ' HB3' HG12 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.446 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.797 ' HB1' HG11 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.448 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.489 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.609 ' HG2' HG12 ' A' 1528 ' ' ILE . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.59 ' HD1' HD11 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1600 ' ' VAL . . . . . 0.41 ' HB ' ' OG ' ' A' 1526 ' ' SER . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.523 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.792 HG21 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.489 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.478 ' HA ' ' CB ' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p -92.23 115.57 64.94 Favored Pre-proline 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' 1613 ' ' PRO . 50.6 Cg_endo -100.27 -4.84 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.638 2.225 . . . . 0.0 112.606 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 10.4 m -105.12 -58.05 1.94 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 64.9 mttm -78.14 -21.73 49.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.504 0.669 . . . . 0.0 111.69 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1618 ' ' ASN . . . . . 0.691 ' HB3' ' SG ' ' A' 1650 ' ' CYS . 3.3 t-20 -164.3 -167.02 1.21 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -175.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1619 ' ' ALA . . . . . 0.412 ' H ' ' ND2' ' A' 1618 ' ' ASN . . . -126.09 9.22 7.4 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.527 0.603 . . . . 0.0 110.86 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' 1649 ' ' THR . 9.1 mp -98.82 -165.34 1.23 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.792 HG12 HG21 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.52 ' HB3' HG12 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1629 ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' 1657 ' ' HIS . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' 1631 ' ' THR . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.453 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.9 p-10 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.901 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.752 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.752 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.584 HG23 ' OG1' ' A' 1651 ' ' THR . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' 1618 ' ' ASN . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.584 ' OG1' HG23 ' A' 1649 ' ' THR . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.535 HD11 HD11 ' A' 1564 ' ' ILE . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG21 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.636 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.519 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.519 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.516 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' 1659 ' ' PRO . 79.0 m -87.0 128.08 35.08 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.27 121.57 25.25 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -65.24 -22.49 66.88 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.35 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -90.23 124.65 35.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.95 124.85 78.74 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 42.7 Cg_endo -84.79 -163.45 0.2 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 123.458 2.772 . . . . 0.0 112.028 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -54.46 -43.35 71.61 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.601 0.563 . . . . 0.0 110.846 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 22.5 p80 -128.11 123.74 35.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.445 0.64 . . . . 0.0 109.785 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.67 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 11.6 t-160 . . . . . 0 C--N 1.284 -2.28 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -122.6 151.55 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.551 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 54.6 p -80.67 159.76 25.22 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.525 ' HB2' ' H ' ' A' 1535 ' ' THR . 18.7 m120 -78.11 87.82 4.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.428 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.571 ' HB ' ' HG3' ' A' 1598 ' ' MET . 4.4 tt -71.63 80.37 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.625 1.202 . . . . 0.0 109.843 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' 1531 ' ' ASN . 23.4 mt-30 -102.46 143.26 32.41 Favored 'General case' 0 N--CA 1.398 -3.026 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.143 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.1 33.64 0.8 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 123.023 1.392 . . . . 0.0 109.243 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.773 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 -101.04 -2.26 32.07 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.755 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.773 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 2.8 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.449 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' 1526 ' ' SER . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.591 HD22 ' HG3' ' A' 1533 ' ' GLN . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.688 ' HB3' HD23 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.658 HD23 HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.549 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.404 HD11 HD22 ' A' 1660 ' ' LEU . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.573 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1555 ' ' SER . . . . . . . . . . . . . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.898 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.435 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.545 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.832 HG11 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.589 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.441 HD13 HG22 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.441 HG22 HD13 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.487 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.51 ' HB3' ' HB1' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.832 ' HB3' HG11 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.43 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.513 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.571 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.562 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.448 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' 1626 ' ' ILE . 21.7 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.432 HD12 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.709 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.453 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t -95.92 106.56 28.71 Favored Pre-proline 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.9 Cg_endo -103.8 3.65 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.592 2.195 . . . . 0.0 111.052 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.9 t -95.26 -63.2 1.19 Allowed 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.668 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.516 ' HG3' HD13 ' A' 1645 ' ' LEU . 47.8 mmtm -85.62 -42.42 14.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.404 0.621 . . . . 0.0 110.777 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -150.17 -156.07 0.69 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.939 -2.986 . . . . 0.0 102.939 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1619 ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -123.44 39.19 4.02 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 119.226 0.921 . . . . 0.0 111.976 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp -102.02 -168.24 1.51 Allowed 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.738 ' HG ' HG23 ' A' 1581 ' ' VAL . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.709 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.686 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.48 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1639 ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.898 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1644 ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.782 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.576 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' 1646 ' ' ASP . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.782 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.624 ' HA ' HG22 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.491 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.686 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.658 HD11 HD23 ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' 1659 ' ' PRO . 89.5 m -87.75 144.51 26.59 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' 1665 ' ' GLU . 32.3 tt0 -135.92 139.86 43.6 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 87.1 mttt -86.47 -19.96 28.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1665 ' ' GLU . . . . . 0.451 ' H ' ' HG2' ' A' 1663 ' ' GLU . 60.6 mm-40 -82.87 165.96 19.34 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.652 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.73 143.18 39.32 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-O 120.672 0.272 . . . . 0.0 111.218 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.2 -163.31 0.22 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.703 2.936 . . . . 0.0 111.292 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -64.83 -37.68 88.43 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.141 0.496 . . . . 0.0 110.656 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -140.36 124.47 17.56 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.499 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.51 -0.59 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 4.7 tppp? 73.14 114.43 0.06 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.09 0.948 . . . . 0.0 109.149 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 3.2 t -88.55 159.58 17.85 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.095 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.489 ' HB3' ' H ' ' A' 1535 ' ' THR . 59.6 t30 -87.66 78.43 8.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.327 0.585 . . . . 0.0 110.679 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' 1597 ' ' LEU . 8.5 tt -72.87 82.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.721 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.76 168.65 11.58 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.378 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.14 22.12 16.48 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.057 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.424 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 -109.42 13.07 24.3 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.292 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.535 ' HB2' HD23 ' A' 1542 ' ' LEU . 3.0 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.426 ' C ' HD22 ' A' 1542 ' ' LEU . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1541 ' ' HIS . . . . . 0.445 ' ND1' ' HG3' ' A' 1663 ' ' GLU . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.549 ' HB3' HD22 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.619 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.413 HD11 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.408 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.483 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.587 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.778 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.778 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.483 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.587 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.439 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.528 HG12 HG21 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.441 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 13.0 m120 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.538 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.76 HG12 ' HB1' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.541 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.76 ' HB1' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.439 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.43 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.602 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.602 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.0 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.614 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.898 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.0 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.748 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.509 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.436 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p -96.36 104.62 18.15 Favored Pre-proline 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.5 Cg_endo -98.66 3.47 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.675 2.25 . . . . 0.0 109.659 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 41.7 t -57.55 -63.21 1.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.458 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 98.2 mttt -127.76 -17.36 4.52 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 0.0 111.014 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -126.33 -172.38 2.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.76 33.33 4.82 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.435 0.636 . . . . 0.0 109.745 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' 1649 ' ' THR . 6.1 mp -102.88 -163.52 1.0 Allowed 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.748 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.614 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.898 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.486 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.835 ' HB2' HG23 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.542 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.795 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.795 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.416 ' HG2' HD11 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.579 ' HA ' HD23 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.682 ' HA ' HG21 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.542 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.655 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.539 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.655 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.486 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' 1659 ' ' PRO . 72.7 m -86.1 128.9 34.96 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.445 ' HG3' ' ND1' ' A' 1541 ' ' HIS . 37.1 tt0 -104.2 135.88 44.84 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -78.31 -23.45 47.08 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.337 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1665 ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' 1663 ' ' GLU . 16.4 mm-40 -95.5 172.57 7.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -144.57 139.36 15.44 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 72.6 Cg_endo -74.37 172.61 15.74 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 122.707 2.272 . . . . 0.0 111.411 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.12 -19.99 64.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 69.4 t60 -136.27 89.62 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.525 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 14.2 p80 . . . . . 0 C--N 1.304 -1.386 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.792 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.635 ' O ' ' HB ' ' A' 1535 ' ' THR . 25.8 tptp -148.55 -177.65 5.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 10.6 m -93.36 -152.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.821 ' HB3' ' HG2' ' A' 1598 ' ' MET . 23.6 m-80 -45.37 114.98 0.83 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1528 ' ' ILE . . . . . . . . . . . . . 8.4 tt -143.84 156.46 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -97.99 134.44 41.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.97 -65.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.396 0.435 . . . . 0.0 109.829 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 -173.11 56.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.501 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.2 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.508 HG12 ' HG ' ' A' 1597 ' ' LEU . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.678 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.634 ' HA ' HD21 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1547 ' ' SER . . . . . 0.711 ' HB2' HD23 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.41 HD13 HD23 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.419 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.586 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.521 ' HB3' HD11 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.446 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.57 ' HE2' HD12 ' A' 1585 ' ' LEU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.503 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.473 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.503 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.419 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.506 HG11 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG13 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.57 HD12 ' HE2' ' A' 1561 ' ' LYS . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.506 ' OD1' HG11 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1592 ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.472 ' HA ' ' NE2' ' A' 1596 ' ' GLN . 11.2 mm-40 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.508 ' HG ' HG12 ' A' 1534 ' ' VAL . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.821 ' HG2' ' HB3' ' A' 1527 ' ' ASN . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD13 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.93 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' 1598 ' ' MET . 0.0 OUTLIER -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.529 HG21 HG21 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.593 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.84 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.436 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 18.0 p -90.2 118.02 68.51 Favored Pre-proline 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 19.2 Cg_endo -98.68 -11.3 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.963 2.442 . . . . 0.0 114.027 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 44.8 t -105.89 -51.63 2.95 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.998 -0.439 . . . . 0.0 112.05 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.99 -32.01 63.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.262 0.553 . . . . 0.0 110.885 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -162.97 -153.77 0.27 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.17 20.7 6.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 118.45 0.568 . . . . 0.0 112.399 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp -95.78 -168.62 1.8 Allowed 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.99 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.84 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.445 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.529 HG21 HG21 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.502 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.93 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' 1633 ' ' ASP . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' 1631 ' ' THR . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.574 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.7 p-10 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.726 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.612 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.642 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.618 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.503 HD12 HD13 ' A' 1564 ' ' ILE . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.456 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.574 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.561 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.53 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.51 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m -87.21 144.36 26.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -122.72 161.42 23.93 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -57.95 -34.97 70.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 118.82 0.737 . . . . 0.0 112.121 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.32 174.08 10.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.869 0.366 . . . . 0.0 110.334 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.52 154.09 87.68 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.01 -161.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 124.323 3.348 . . . . 0.0 111.508 172.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -59.93 -39.97 87.29 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.858 -0.526 . . . . 0.0 111.726 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -140.48 124.46 17.39 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 172.437 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 C--O 1.224 -0.244 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.3 151.44 45.28 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.807 0.337 . . . . 0.0 110.643 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 17.9 m -98.23 177.04 5.51 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.013 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 87.89 6.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.839 1.304 . . . . 0.0 111.906 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.476 HG13 ' HG2' ' A' 1529 ' ' GLN . 11.3 tp -145.67 173.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.476 ' HG2' HG13 ' A' 1528 ' ' ILE . 2.2 pt20 -60.27 159.66 9.6 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.691 1.196 . . . . 0.0 110.245 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 10.2 t0 -166.26 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.801 0.334 . . . . 0.0 110.289 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 178.31 65.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.24 0.616 . . . . 0.0 109.386 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' 1543 ' ' PHE . 2.8 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' 1541 ' ' HIS . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1541 ' ' HIS . . . . . 0.483 ' HD2' ' HB ' ' A' 1539 ' ' THR . 31.1 m-70 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.548 ' HB3' HD23 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.655 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1551 ' ' ASP . . . . . 0.661 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.498 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.456 ' HB2' HD11 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' 1564 ' ' ILE . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.559 HD12 HD11 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.44 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.661 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.462 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.403 ' HA ' ' HD3' ' A' 1576 ' ' PRO . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.685 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1592 ' ' SER . . . . . 0.426 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.491 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.467 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.467 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 30.1 mm-40 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.456 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.466 ' HB3' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.485 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 23.4 p -91.49 119.56 68.54 Favored Pre-proline 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 8.9 Cg_endo -96.63 -10.73 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.444 2.096 . . . . 0.0 112.575 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 29.0 t -103.5 -60.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -65.24 -37.87 88.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.791 0.805 . . . . 0.0 111.517 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -162.68 -159.39 0.56 Allowed 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -123.68 28.29 6.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 118.546 0.612 . . . . 0.0 111.691 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.655 HD21 ' HA ' ' A' 1649 ' ' THR . 7.3 mp -100.84 -167.44 1.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.558 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.547 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.621 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.673 HG22 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.535 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.926 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1630 ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.2 p-10 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1639 ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.69 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.753 HG11 ' HG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.908 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.908 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.46 ' N ' HD12 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.655 ' HA ' HD21 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.465 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.559 HD11 HD12 ' A' 1564 ' ' ILE . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.673 ' HA ' HG22 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.753 ' HG ' HG11 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' 1658 ' ' THR . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m -88.27 120.26 29.47 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.54 136.33 45.82 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -68.37 -15.67 63.65 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -90.03 114.25 26.1 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.56 ' HB3' ' CB ' ' A' 1670 ' ' HIS . 44.0 mt-10 -93.83 136.35 23.96 Favored Pre-proline 0 C--N 1.28 -2.45 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.022 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1666 ' ' GLU . 9.7 Cg_exo -72.37 -177.03 2.47 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 123.688 2.926 . . . . 0.0 112.937 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -55.02 -49.7 70.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.885 0.85 . . . . 0.0 108.771 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -106.95 100.78 10.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.56 ' CB ' ' HB3' ' A' 1666 ' ' GLU . 7.3 p80 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.288 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 25.8 tptp -137.9 134.66 35.28 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 49.7 m -89.37 128.32 35.9 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.925 ' HB3' ' H ' ' A' 1535 ' ' THR . 46.9 t30 -76.19 87.86 3.05 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' 1597 ' ' LEU . 4.9 tt -72.38 86.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 170.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -109.6 163.0 13.88 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.1 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -99.23 20.81 12.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 123.856 0.862 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -120.1 21.57 11.76 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.293 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.563 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.562 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.421 ' C ' HD23 ' A' 1542 ' ' LEU . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.925 ' H ' ' HB3' ' A' 1527 ' ' ASN . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.563 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.518 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1555 ' ' SER . . . . . . . . . . . . . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.745 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.559 ' CD1' HD13 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.439 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.559 HD13 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.528 HG12 HG21 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.513 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.4 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.476 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.575 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.45 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.528 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' 1582 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.809 HG11 ' HB2' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.491 ' HB3' HG13 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.66 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.554 HD13 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.554 HG23 HD13 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.481 ' HB3' ' HB1' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.809 ' HB2' HG11 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.528 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.575 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.417 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 1.066 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.407 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.717 HG22 HG13 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.567 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.598 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 41.3 t -96.1 112.74 60.56 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -100.36 3.59 0.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.374 2.716 . . . . 0.0 112.605 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 45.4 m -63.09 -62.94 1.37 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.05 -66.16 0.83 Allowed 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 120.804 0.335 . . . . 0.0 110.46 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1618 ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' 1648 ' ' GLN . 34.8 m-80 -97.87 165.75 11.79 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -102.95 34.07 3.01 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.129 0.49 . . . . 0.0 112.198 -170.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.92 -172.79 3.65 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.539 ' CE2' HG23 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.598 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.717 HG13 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.567 HD12 ' HE2' ' A' 1608 ' ' TYR . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.594 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 1.066 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.655 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.493 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1639 ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.745 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.503 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.58 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.58 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.462 ' HG2' HD13 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1648 ' ' GLN . . . . . 0.501 ' HA ' ' ND2' ' A' 1618 ' ' ASN . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.463 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.462 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.613 ' HA ' HG21 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.503 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.575 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.553 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.643 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.643 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD11 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m -93.28 133.94 35.99 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -110.96 137.42 48.61 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.11 -33.78 76.56 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 123.93 0.768 . . . . 0.0 111.041 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.57 144.17 26.49 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.77 149.9 67.0 Favored Pre-proline 0 C--N 1.279 -2.499 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.716 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.3 -162.6 0.16 Allowed 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.94 3.093 . . . . 0.0 110.043 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.52 -54.61 25.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -141.08 134.88 30.37 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 C--N 1.299 -1.589 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.6 177.432 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.44 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.44 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.536 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1530 ' ' ASP . . . . . 0.494 ' HB3' ' NE2' ' A' 1596 ' ' GLN . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.438 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.601 ' HG1' HD23 ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.601 HD23 ' HG1' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.518 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.446 ' HB2' HD11 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.431 ' H ' ' HA ' ' A' 1563 ' ' LEU . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.635 HG22 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1566 ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.813 HG13 ' HB1' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.489 HG22 HD11 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.442 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' 1530 ' ' ASP . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD13 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.536 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.876 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.772 HG21 HG13 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD11 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' 1613 ' ' PRO . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.809 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.772 HG13 HG21 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.583 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.419 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.857 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.857 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.61 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' 1646 ' ' ASP . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.635 ' HZ ' HG22 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.623 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.456 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.44 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.44 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.536 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1530 ' ' ASP . . . . . 0.494 ' HB3' ' NE2' ' A' 1596 ' ' GLN . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.438 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.618 HG21 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.601 ' HG1' HD23 ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.601 HD23 ' HG1' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.518 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.446 ' HB2' HD11 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.431 ' H ' ' HA ' ' A' 1563 ' ' LEU . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' 1561 ' ' LYS . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.635 HG22 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1566 ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.442 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.813 HG13 ' HB1' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.489 HG22 HD11 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.442 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' 1530 ' ' ASP . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.57 ' HD1' HD13 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.536 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.876 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.772 HG21 HG13 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD11 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' 1613 ' ' PRO . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.809 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.584 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.772 HG13 HG21 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.583 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.876 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.419 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.623 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.857 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.857 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.61 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' 1646 ' ' ASP . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.635 ' HZ ' HG22 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.716 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.623 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.716 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.456 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.467 ' HD2' HG23 ' A' 1600 ' ' VAL . 75.6 mmtt -129.35 179.83 5.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.691 ' HB2' ' HB3' ' A' 1599 ' ' TYR . 6.3 m -94.49 112.77 24.54 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 23.3 t30 -146.88 112.64 5.69 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.719 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.444 ' CG2' ' H ' ' A' 1535 ' ' THR . 7.5 tp -145.53 82.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.436 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' 1530 ' ' ASP . 27.8 pt20 -62.68 163.19 9.5 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.502 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1530 ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' 1529 ' ' GLN . 29.1 t70 167.4 -68.85 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.318 1.447 . . . . 0.0 110.219 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.56 71.57 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.459 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' 1597 ' ' LEU . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.4 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1541 ' ' HIS . . . . . 0.484 ' CG ' ' HG3' ' A' 1663 ' ' GLU . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.688 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.677 HD22 HD13 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.506 HD13 HD23 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' 1549 ' ' LYS . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.477 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.496 ' CD1' HD13 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.896 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.896 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.503 HD11 HD13 ' A' 1652 ' ' LEU . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.466 HG12 HG23 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.574 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.477 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.414 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.544 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.77 HG12 ' HB2' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.484 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.566 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.77 ' HB2' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1592 ' ' SER . . . . . 0.419 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.414 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.512 ' HE3' ' HB3' ' A' 1605 ' ' GLN . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.691 ' HB3' ' HB2' ' A' 1526 ' ' SER . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1600 ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' 1525 ' ' LYS . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.611 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.439 HG12 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.512 ' HB3' ' HE3' ' A' 1598 ' ' MET . 0.0 OUTLIER -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.495 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.608 HG22 HG23 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.581 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.416 ' HA ' ' CB ' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 24.7 p -95.76 114.36 63.87 Favored Pre-proline 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 30.3 Cg_endo -97.16 -0.04 1.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.863 2.376 . . . . 0.0 112.498 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.7 t -123.46 -51.12 1.86 Allowed 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.818 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -58.02 -46.94 84.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 0.0 110.321 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1618 ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' 1647 ' ' LYS . 8.1 t-20 -158.57 -144.56 0.12 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -126.49 18.81 7.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 118.131 0.423 . . . . 0.0 110.948 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp -98.98 -169.22 1.74 Allowed 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.88 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1621 ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.41 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.608 HG23 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.581 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG12 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.417 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.566 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.859 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.859 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' 1650 ' ' CYS . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' 1618 ' ' ASN . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.501 HG21 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.501 ' OG1' HG21 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.503 HD13 HD11 ' A' 1564 ' ' ILE . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.566 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.733 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.677 HD13 HD22 ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m -90.21 115.41 27.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.484 ' HG3' ' CG ' ' A' 1541 ' ' HIS . 36.8 tt0 -77.75 114.9 17.07 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.08 -29.02 70.02 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.584 -173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.5 119.6 24.9 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.47 128.86 49.36 Favored Pre-proline 0 C--N 1.29 -2.009 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.187 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 83.0 Cg_endo -76.17 -176.11 2.88 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.959 2.439 . . . . 0.0 111.789 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -66.38 -27.43 67.86 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 120.935 0.398 . . . . 0.0 111.735 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.4 m80 -137.17 105.9 5.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.634 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 28.6 t-80 . . . . . 0 C--N 1.31 -1.11 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.226 0.536 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -90.76 -175.42 4.38 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 41.2 m -116.89 -171.18 1.97 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.816 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' 1535 ' ' THR . 16.3 m120 -85.14 85.64 7.45 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' 1596 ' ' GLN . 8.2 tt -73.82 101.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.011 176.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -115.09 153.71 30.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1530 ' ' ASP . . . . . 0.409 ' HA ' ' HB2' ' A' 1595 ' ' SER . 10.0 p-10 -82.11 12.08 4.6 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.778 1.231 . . . . 0.0 111.341 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.594 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 2.9 m-20 -95.95 19.15 11.96 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 3.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' 1527 ' ' ASN . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' 1527 ' ' ASN . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.541 HD22 ' HG3' ' A' 1667 ' ' PRO . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.404 ' HG1' ' CD ' ' A' 1663 ' ' GLU . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.681 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.663 HD21 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.456 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.633 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.557 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.482 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.787 HG23 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.592 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.624 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.592 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' 1563 ' ' LEU . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.484 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.557 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.835 HG13 ' HB1' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.515 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.702 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB1' HG13 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.427 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.573 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.663 ' HB3' HD12 ' A' 1528 ' ' ILE . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.59 ' HD1' HD13 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.477 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.825 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.61 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.689 HG22 HG11 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.651 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 29.7 t -87.29 110.63 35.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 16.9 Cg_exo -70.03 -23.59 29.37 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 123.838 3.025 . . . . 0.0 112.574 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.0 m -61.28 -49.35 77.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.696 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 6.4 mmtt -92.36 -27.72 17.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.414 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 66.9 t30 74.92 -41.06 0.46 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.382 1.873 . . . . 0.0 112.009 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -77.46 -33.18 54.76 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.362 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.68 176.15 5.14 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.72 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.541 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.651 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.562 ' HB3' HG12 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.825 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.583 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.787 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.493 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.694 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.694 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.617 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.584 HG21 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.696 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.7 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.684 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.621 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.684 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.663 ' CD1' HD21 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.442 ' HA ' HD12 ' A' 1604 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m -91.32 126.62 36.46 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' 1665 ' ' GLU . 28.8 tt0 -88.79 153.04 21.4 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 174.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.22 -26.91 66.83 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.81 0.814 . . . . 0.0 109.649 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1665 ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' 1663 ' ' GLU . 66.6 mm-40 -116.49 179.15 4.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -129.11 152.16 78.89 Favored Pre-proline 0 C--N 1.286 -2.18 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.174 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 38.8 Cg_exo -67.42 -163.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.274 2.649 . . . . 0.0 110.858 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -66.23 -42.51 88.57 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -135.78 89.56 2.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.134 -0.354 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.65 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 46.2 t-80 . . . . . 0 C--N 1.303 -1.422 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.19 176.79 8.4 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 24.8 m -78.02 110.71 13.2 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.929 ' HB3' ' H ' ' A' 1535 ' ' THR . 51.0 t30 -67.32 85.04 0.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.945 HG12 ' HG2' ' A' 1598 ' ' MET . 9.7 mt -71.95 82.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.44 156.99 17.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 122.171 -0.331 . . . . 0.0 110.277 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -85.67 5.76 30.6 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.059 0.943 . . . . 0.0 112.05 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 -109.46 19.21 19.55 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.21 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.629 ' HB2' HD13 ' A' 1542 ' ' LEU . 4.1 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.929 ' H ' ' HB3' ' A' 1527 ' ' ASN . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.423 ' HG1' ' CD ' ' A' 1663 ' ' GLU . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.591 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.566 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1547 ' ' SER . . . . . 0.477 ' HB2' HD22 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1551 ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.505 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.782 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.489 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.501 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.584 HD22 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.584 ' CD1' HD22 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.537 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.513 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.795 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.528 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1587 ' ' LYS . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.455 ' OG1' HD12 ' A' 1588 ' ' ILE . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.532 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.795 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.552 HD22 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.552 ' HB2' HD22 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.945 ' HG2' HG12 ' A' 1528 ' ' ILE . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.542 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.533 ' NE2' ' HG3' ' A' 1667 ' ' PRO . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.922 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG23 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.811 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.495 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' 1616 ' ' SER . 34.1 t -85.98 108.48 17.18 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' 1613 ' ' PRO . 9.4 Cg_exo -72.83 -18.87 24.34 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.224 2.616 . . . . 0.0 111.654 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1616 ' ' SER . . . . . 0.513 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.4 m -62.7 -59.38 4.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.424 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.437 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 32.0 mmmt -101.32 -4.31 27.26 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.33 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 57.6 t30 71.65 -62.97 0.44 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.55 1.94 . . . . 0.0 113.836 172.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.85 68.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' 1649 ' ' THR . 5.2 mp -107.81 177.71 4.74 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.158 -173.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.407 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.933 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.811 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.683 HG23 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.487 HD13 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.526 ' HB3' HG13 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.922 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.402 ' HB2' HG22 ' A' 1631 ' ' THR . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.437 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.424 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.504 ' ND2' ' HD3' ' A' 1640 ' ' PRO . 2.0 p-10 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.529 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.782 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.675 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.675 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.468 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.443 ' HG2' HD11 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.648 ' HA ' HD21 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.933 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.468 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.414 ' HE2' ' HG ' ' A' 1624 ' ' SER . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.597 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.547 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.597 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m -90.83 120.35 31.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.423 ' CD ' ' HG1' ' A' 1539 ' ' THR . 26.1 tt0 -76.86 158.9 30.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1664 ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' 1664 ' ' LYS . 27.8 mmmt -59.99 -47.98 83.57 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -101.44 153.92 19.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' 1670 ' ' HIS . 53.2 mt-10 -92.56 139.99 23.86 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.533 ' HG3' ' NE2' ' A' 1602 ' ' GLN . 62.0 Cg_endo -78.78 -164.65 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 123.06 2.507 . . . . 0.0 112.141 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -47.42 -54.12 12.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.426 1.09 . . . . 0.0 111.27 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -128.73 99.05 5.19 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.672 ' HB3' ' HB3' ' A' 1666 ' ' GLU . 24.7 p80 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.642 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.539 ' HB2' ' O ' ' A' 1537 ' ' PRO . 60.3 mtt . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -131.39 172.5 12.11 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.8 m -71.36 115.85 11.01 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.841 ' HB3' ' H ' ' A' 1535 ' ' THR . 52.8 t30 -80.5 85.22 5.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.627 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.885 HG12 ' HG2' ' A' 1598 ' ' MET . 6.3 mt -72.31 79.54 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.37 140.59 46.96 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 -177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -85.83 35.83 0.64 Allowed 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.386 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 35.5 t-20 -115.51 17.67 16.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.596 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 3.9 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.841 ' H ' ' HB3' ' A' 1527 ' ' ASN . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.5 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' 1524 ' ' MET . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1539 ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.617 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.606 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.405 HD13 HD23 ' A' 1660 ' ' LEU . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.506 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.458 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.48 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.51 ' HB3' HD11 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.52 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.421 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.52 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.525 HD12 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.435 ' CE1' HD13 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.525 HG12 HG23 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.439 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.458 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.437 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.655 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.74 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.655 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.449 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.579 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' 1528 ' ' ILE . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.885 ' HG2' HG12 ' A' 1528 ' ' ILE . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.68 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.68 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.975 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.9 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.687 HG23 HG21 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.579 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.516 ' O ' ' HD3' ' A' 1615 ' ' PRO . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' 1616 ' ' SER . 49.8 t -95.7 109.55 46.62 Favored Pre-proline 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' 1613 ' ' PRO . 36.7 Cg_endo -96.42 0.02 1.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.682 2.255 . . . . 0.0 110.471 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1616 ' ' SER . . . . . 0.467 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.1 m -58.37 -62.45 1.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 125.3 1.44 . . . . 0.0 113.108 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -131.34 -69.36 0.63 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -100.64 159.62 15.02 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -97.63 35.85 1.6 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.761 0.791 . . . . 0.0 111.248 -169.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' 1620 ' ' LEU . 0.9 OUTLIER -92.45 -168.15 1.91 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.914 177.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.578 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.687 HG21 HG23 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.975 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.734 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.415 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.736 ' HB2' HG23 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.806 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.806 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.525 HD12 HD12 ' A' 1564 ' ' ILE . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.589 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' 1638 ' ' ASN . 33.9 m170 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.65 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.734 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.65 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.458 ' N ' HD11 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m -90.9 122.55 33.69 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -69.98 142.05 52.9 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -53.14 -49.28 66.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.578 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -104.93 178.29 4.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 12.9 pt-20 -81.89 136.38 47.7 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.177 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 26.2 Cg_exo -67.14 -172.43 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.154 2.569 . . . . 0.0 112.14 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -73.87 -34.62 64.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 -174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -123.05 85.13 2.37 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.827 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.728 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 72.1 t60 . . . . . 0 C--N 1.31 -1.15 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 66.0 mttp 64.45 -175.4 0.17 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.769 0.827 . . . . 0.0 110.367 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.5 m -85.14 158.46 20.39 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' 1598 ' ' MET . 46.3 t-20 -75.5 124.59 27.44 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.651 ' HA ' ' HG2' ' A' 1598 ' ' MET . 50.0 mt -123.35 94.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 128.133 2.573 . . . . 0.0 106.631 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1529 ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' 1533 ' ' GLN . 50.4 tt0 -114.43 155.8 25.68 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1530 ' ' ASP . . . . . 0.466 ' HB2' ' NE2' ' A' 1596 ' ' GLN . 20.1 t70 -123.99 80.79 1.85 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.663 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.858 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 63.9 t30 -166.95 20.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.858 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 4.0 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.521 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1552 ' ' SER . . . . . 0.482 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1556 ' ' VAL . . . . . . . . . . . . . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.422 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.706 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1562 ' ' GLY . . . . . 0.531 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.456 ' N ' HD11 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.518 ' CE1' HD12 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.588 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1570 ' ' GLY . . . . . 0.452 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1573 ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.525 ' HB3' HG12 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1584 ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.706 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.751 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.516 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.452 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' 1530 ' ' ASP . 20.7 mm-40 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.721 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.651 ' HG2' ' HA ' ' A' 1528 ' ' ILE . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.526 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.477 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.7 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.5 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1606 ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.791 HG22 HG23 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.588 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.452 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t -94.37 114.87 64.41 Favored Pre-proline 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' 1613 ' ' PRO . 57.5 Cg_endo -102.67 2.5 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.458 2.772 . . . . 0.0 111.847 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 20.4 t -59.81 -63.05 1.44 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.724 0.809 . . . . 0.0 111.937 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.56 ' HG3' ' HB3' ' A' 1647 ' ' LYS . 31.5 mmmt -134.47 -65.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -89.52 175.29 7.35 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -115.46 34.85 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.171 0.51 . . . . 0.0 112.278 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.02 -167.17 1.8 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.439 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.791 HG23 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1630 ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.798 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.537 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.509 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.636 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.485 HG13 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.578 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1644 ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' 1653 ' ' TYR . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.578 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.695 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.56 ' HB3' ' HG3' ' A' 1617 ' ' LYS . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.532 HG21 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.423 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.485 ' OG ' HG13 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' 1660 ' ' LEU . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.798 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.653 ' CD2' HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t -94.59 138.06 32.93 Favored 'General case' 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.62 115.3 26.05 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -83.26 -15.37 50.55 Favored 'General case' 0 C--N 1.265 -3.072 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.8 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -71.15 122.41 20.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.68 138.05 73.83 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.052 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.05 173.07 1.98 Allowed 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 124.044 3.163 . . . . 0.0 115.283 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -56.87 -34.73 68.13 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.047 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 53.7 t60 -126.57 87.77 2.72 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.518 -179.69 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.33 157.03 16.68 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.037 0.446 . . . . 0.0 110.004 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 13.9 m -95.22 -173.4 2.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.796 ' HB3' ' H ' ' A' 1535 ' ' THR . 7.6 t30 -81.38 73.25 8.43 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.032 0.444 . . . . 0.0 111.149 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.602 ' HB ' ' HG3' ' A' 1598 ' ' MET . 6.7 tt -72.32 84.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.054 0.931 . . . . 0.0 109.314 173.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -134.92 159.4 41.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -87.06 29.84 0.8 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -101.78 6.7 41.8 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.807 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1533 ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' 1527 ' ' ASN . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.796 ' H ' ' HB3' ' A' 1527 ' ' ASN . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.517 ' HB3' HD22 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.59 ' HA ' HD22 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.575 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1555 ' ' SER . . . . . . . . . . . . . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.42 ' CD1' ' HG3' ' A' 1560 ' ' GLU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.42 ' HG3' ' CD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.485 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.489 HG22 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.468 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.516 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.575 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.805 HG11 ' HB1' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' 1587 ' ' LYS . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 0.9 OUTLIER -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.805 ' HB1' HG11 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1592 ' ' SER . . . . . 0.489 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.602 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.56 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.482 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.75 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.655 ' HE2' HD13 ' A' 1626 ' ' ILE . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' 1615 ' ' PRO . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.503 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t -90.06 105.49 11.44 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' 1613 ' ' PRO . 6.2 Cg_exo -82.15 -4.15 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.176 2.584 . . . . 0.0 111.382 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 17.3 t -69.66 -50.68 41.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.406 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 31.9 mmmt -112.18 -7.34 14.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.624 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 74.32 -54.29 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.403 1.881 . . . . 0.0 113.793 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.39 90.1 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' 1649 ' ' THR . 5.3 mp -106.79 -177.46 3.37 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.25 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.75 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.655 HD13 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.596 ' HB3' HG13 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.552 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.596 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1644 ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.596 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.672 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.408 ' HG2' HD11 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.606 HG21 ' OG1' ' A' 1651 ' ' THR . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.537 HD13 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.679 ' HA ' HG21 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.489 ' HZ ' HG22 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.492 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' 1658 ' ' THR . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.9 m -84.78 124.84 32.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -106.24 139.42 40.77 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -94.2 -18.87 21.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -84.59 165.82 17.67 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.81 134.54 10.06 Favored Pre-proline 0 N--CA 1.412 -2.342 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.056 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 45.1 Cg_endo -87.56 -163.08 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 123.465 2.777 . . . . 0.0 109.801 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1668 ' ' ARG . . . . . 0.711 ' HG3' ' HD2' ' A' 1669 ' ' HIS . 24.1 ptt180 -64.82 -21.03 66.71 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1669 ' ' HIS . . . . . 0.711 ' HD2' ' HG3' ' A' 1668 ' ' ARG . 40.3 m-70 -131.14 102.52 6.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.686 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 43.4 t60 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 68.1 mttm -119.15 -175.86 3.01 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 15.1 m -70.29 105.05 2.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' 1534 ' ' VAL . 14.7 m120 -79.99 80.73 6.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.135 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.563 ' HB ' ' HG2' ' A' 1598 ' ' MET . 5.6 tt -72.66 107.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.242 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -126.36 153.85 44.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -79.73 19.62 0.65 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.333 0.653 . . . . 0.0 112.399 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -102.88 12.71 35.79 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.488 ' HB2' HD13 ' A' 1542 ' ' LEU . 2.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' 1527 ' ' ASN . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1536 ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1526 ' ' SER . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.642 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.533 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.481 HD11 HD23 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.575 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.508 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.63 HD11 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.51 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.483 HG12 HG21 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.443 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 0.9 OUTLIER -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.55 HG12 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.848 HG13 ' HB2' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.55 ' HB3' HG12 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.668 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.848 ' HB2' HG13 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' 1569 ' ' CYS . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.563 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.587 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.553 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.779 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.661 HG21 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.586 ' O ' ' HD3' ' A' 1615 ' ' PRO . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' 1619 ' ' ALA . 23.4 t -95.96 106.29 27.06 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' 1613 ' ' PRO . 61.1 Cg_endo -104.8 3.86 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.899 2.399 . . . . 0.0 109.626 170.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.0 m -88.44 -62.23 1.53 Allowed 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.778 -1.556 . . . . 0.0 113.177 -170.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.657 ' HG3' HD12 ' A' 1645 ' ' LEU . 72.5 mmtt -84.44 -41.79 16.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.713 0.768 . . . . 0.0 109.891 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.93 -157.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1619 ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.05 40.1 3.23 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 118.872 0.76 . . . . 0.0 111.421 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' 1649 ' ' THR . 7.5 mp -102.17 -166.18 1.26 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.615 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.661 HG12 HG21 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.509 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG23 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.496 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.901 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1644 ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' 1653 ' ' TYR . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.901 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.504 ' HA ' ' HB3' ' A' 1617 ' ' LYS . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.598 ' HA ' HD23 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.63 HD12 HD11 ' A' 1564 ' ' ILE . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.557 ' HA ' HG22 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.592 ' HZ ' HG23 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.496 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.701 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.701 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1661 ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' 1604 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m -73.34 133.67 43.9 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' 1665 ' ' GLU . 8.5 tp10 -128.54 162.15 27.92 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.448 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.06 -9.98 58.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.422 0.63 . . . . 0.0 110.633 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1665 ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' 1663 ' ' GLU . 43.4 mt-10 -77.77 145.99 36.12 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.23 138.71 30.44 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.514 ' HA ' ' OE1' ' A' 1602 ' ' GLN . 70.2 Cg_endo -68.65 -177.99 1.75 Allowed 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.179 2.586 . . . . 0.0 113.171 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -55.54 -49.73 71.87 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.135 0.493 . . . . 0.0 110.08 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -115.37 104.1 11.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.241 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' 1537 ' ' PRO . 53.6 ttm . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -95.38 161.82 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1526 ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 19.1 m -62.39 119.47 9.17 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.866 ' HB3' ' H ' ' A' 1535 ' ' THR . 3.7 t-20 -66.51 81.61 0.1 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' 1597 ' ' LEU . 9.8 tt -72.27 81.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 122.665 1.222 . . . . 0.0 109.217 171.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -93.28 163.92 13.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.712 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.74 16.79 23.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.648 1.213 . . . . 0.0 109.338 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.51 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 3.2 m-20 -105.71 21.2 17.66 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.851 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1532 ' ' CYS . . . . . 0.527 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.51 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 4.0 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' 1527 ' ' ASN . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.866 ' H ' ' HB3' ' A' 1527 ' ' ASN . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1537 ' ' PRO . . . . . 0.587 ' HA ' ' SD ' ' A' 1524 ' ' MET . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.526 ' HB3' HD23 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.57 ' HA ' HD11 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1546 ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1548 ' ' LEU . . . . . 0.6 HD12 HG22 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1558 ' ' TYR . . . . . 0.491 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1560 ' ' GLU . . . . . 0.613 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.552 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.487 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.6 HG22 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1569 ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.439 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.52 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' 1582 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.826 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.722 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1585 ' ' LEU . . . . . 0.568 HD13 HG22 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1586 ' ' THR . . . . . 0.568 HG22 HD13 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.722 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.52 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.718 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.829 ' HA ' HE21 ' A' 1596 ' ' GLN . 0.0 OUTLIER -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' 1528 ' ' ILE . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.626 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD13 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.508 HG12 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.451 HE21 ' HB2' ' A' 1605 ' ' GLN . 4.2 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.469 HG21 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.476 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.589 ' O ' ' HD3' ' A' 1615 ' ' PRO . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' 1619 ' ' ALA . 96.4 m -90.02 107.98 22.93 Favored Pre-proline 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' 1613 ' ' PRO . 47.3 Cg_endo -104.73 6.31 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.097 2.532 . . . . 0.0 108.907 167.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 19.8 m -87.14 -62.9 1.4 Allowed 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.767 -173.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.61 -65.33 1.11 Allowed 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1618 ' ' ASN . . . . . 0.612 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 19.0 m120 -92.67 -179.89 5.3 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1619 ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.6 23.22 11.62 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp -99.13 -171.6 2.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.596 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.455 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.469 HG22 HG21 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.492 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.508 ' HB3' HG12 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1629 ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1630 ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1636 ' ' ALA . . . . . 0.462 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.491 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1639 ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.405 ' HB3' ' CZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.586 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.541 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.541 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.481 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.549 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' 1618 ' ' ASN . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.528 ' OG1' HG22 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1652 ' ' LEU . . . . . 0.552 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.481 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.669 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.586 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.828 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.651 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.828 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.506 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.792 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m -86.02 122.97 30.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1663 ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' 1665 ' ' GLU . 39.4 tt0 -87.83 130.06 35.0 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.887 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -78.75 -12.12 60.01 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.382 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1665 ' ' GLU . . . . . 0.463 ' H ' ' HG2' ' A' 1663 ' ' GLU . 33.3 mt-10 -116.02 178.55 4.28 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 124.905 1.282 . . . . 0.0 107.648 -176.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.86 133.83 14.55 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 118.252 0.478 . . . . 0.0 111.455 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 86.8 Cg_endo -74.26 -178.38 3.9 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.373 2.715 . . . . 0.0 114.418 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -53.87 -33.34 56.1 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.449 1.5 . . . . 0.0 112.883 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 18.0 t60 -127.38 92.79 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.461 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 45.0 t-80 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1524 ' ' MET . . . . . 0.57 ' HB2' HG21 ' A' 1535 ' ' THR . 1.1 mpt? . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1525 ' ' LYS . . . . . 0.479 ' HD2' ' HB ' ' A' 1528 ' ' ILE . 37.0 ttpt -160.47 151.89 19.45 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 23.8 m -88.49 -162.08 0.81 Allowed 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.696 0.623 . . . . 0.0 109.495 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1527 ' ' ASN . . . . . 0.673 ' HB2' ' H ' ' A' 1599 ' ' TYR . 5.0 p-10 -74.94 85.37 2.26 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 122.458 1.123 . . . . 0.0 110.762 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1528 ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' 1525 ' ' LYS . 42.6 mm -137.36 154.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -60.03 165.69 3.19 Favored 'General case' 0 C--O 1.256 1.431 0 C-N-CA 124.438 1.095 . . . . 0.0 112.294 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.32 -93.2 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.147 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1531 ' ' ASN . . . . . 0.672 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 -161.33 76.56 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1533 ' ' GLN . . . . . 0.423 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1535 ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' 1524 ' ' MET . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1542 ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1543 ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1545 ' ' LEU . . . . . 0.619 ' HA ' HD22 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1549 ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.453 ' HA3' ' HG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1554 ' ' TYR . . . . . 0.507 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1555 ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1556 ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1557 ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1558 ' ' TYR . . . . . . . . . . . . . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1561 ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1563 ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1564 ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1565 ' ' TYR . . . . . 0.476 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1566 ' ' ILE . . . . . 0.517 HG12 HG23 ' A' 1581 ' ' VAL . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1568 ' ' ILE . . . . . 0.54 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1572 ' ' THR . . . . . 0.453 ' HG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1574 ' ' ASN . . . . . 0.476 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1575 ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1576 ' ' PRO . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1576 ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1578 ' ' GLY . . . . . 0.548 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1579 ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1581 ' ' VAL . . . . . 0.813 HG12 ' HB1' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG12 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1583 ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1587 ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1589 ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1590 ' ' ALA . . . . . 0.813 ' HB1' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1593 ' ' TRP . . . . . 0.548 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1595 ' ' SER . . . . . 0.672 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1596 ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1597 ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1598 ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1599 ' ' TYR . . . . . 0.673 ' H ' ' HB2' ' A' 1527 ' ' ASN . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1602 ' ' GLN . . . . . 0.443 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1603 ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.897 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1605 ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG13 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1608 ' ' TYR . . . . . 0.54 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1609 ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1612 ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1613 ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1614 ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' 1616 ' ' SER . 30.1 t -85.71 110.22 28.29 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1615 ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' 1613 ' ' PRO . 3.6 Cg_exo -78.49 -13.28 15.03 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.974 2.449 . . . . 0.0 112.071 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1616 ' ' SER . . . . . 0.427 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 18.9 m -66.18 -57.31 7.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.478 0.656 . . . . 0.0 110.948 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1617 ' ' LYS . . . . . 0.414 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 72.3 mmtt -104.19 -0.04 28.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.957 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 55.8 t30 73.16 -60.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.659 1.584 . . . . 0.0 114.548 169.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -67.08 -27.25 67.21 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1620 ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' 1649 ' ' THR . 4.7 mp -113.7 178.37 4.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 118.419 -1.313 . . . . 0.0 112.419 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1622 ' ' TYR . . . . . 0.489 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1623 ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1624 ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1625 ' ' VAL . . . . . 0.718 HG13 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1626 ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1627 ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1628 ' ' PHE . . . . . 0.897 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1631 ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1635 ' ' GLY . . . . . 0.512 ' HA2' HD12 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1637 ' ' ASN . . . . . 0.53 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1638 ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1640 ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1641 ' ' VAL . . . . . 0.451 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1642 ' ' PHE . . . . . 0.619 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1644 ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' 1653 ' ' TYR . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1645 ' ' LEU . . . . . 0.619 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1646 ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1647 ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' 1617 ' ' LYS . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1650 ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1651 ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1652 ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1653 ' ' TYR . . . . . 0.678 ' HA ' HG21 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1654 ' ' PHE . . . . . 0.516 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1655 ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1656 ' ' TRP . . . . . 0.53 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1657 ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1658 ' ' THR . . . . . 0.507 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1659 ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' 1658 ' ' THR . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1660 ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1662 ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m -86.02 127.86 34.74 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.99 149.07 43.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 60.2 mttm -55.44 -45.89 76.78 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.479 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.04 177.04 5.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1666 ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 40.7 mt-10 -77.59 139.1 62.84 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.948 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1667 ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 14.7 Cg_exo -71.61 -168.62 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.344 2.696 . . . . 0.0 111.856 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.83 -35.58 77.13 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -140.63 114.41 8.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1670 ' ' HIS . . . . . 0.628 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 51.7 t-80 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.752 0.311 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' 1542 ' ' LEU . 11.1 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.488 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.749 ' HB3' HD21 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.713 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1550 ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' 1552 ' ' SER . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' 1550 ' ' ASN . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' 1563 ' ' LEU . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.558 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.452 ' HE3' HD21 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.51 HD13 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.776 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.591 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' 1549 ' ' LYS . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.606 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.452 HD21 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.441 ' OD1' HG13 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1592 ' ' SER . . . . . 0.454 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' 1604 ' ' LEU . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.676 ' HD1' HD12 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.524 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' 1597 ' ' LEU . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1611 ' ' GLY . . . . . 0.442 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1649 ' ' THR . 6.4 mp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' 1651 ' ' THR . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.573 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1629 ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.707 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.553 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.773 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.773 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.451 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' 1623 ' ' LYS . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.566 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.553 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.546 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.524 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.449 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.445 0.641 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.434 ' HB2' HD21 ' A' 1542 ' ' LEU . 12.6 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.441 HG21 ' C ' ' A' 1598 ' ' MET . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.461 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1539 ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' 1536 ' ' ASN . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' 1536 ' ' ASN . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.916 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.58 ' HB3' HD13 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.434 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.523 HG21 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.916 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.563 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.824 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.44 HD12 HG23 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.44 HG23 HD12 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.446 ' H ' ' HB2' ' A' 1583 ' ' PHE . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.726 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.563 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.654 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.654 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 32.1 mm-40 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.441 ' C ' HG21 ' A' 1534 ' ' VAL . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.712 ' HB3' HD11 ' A' 1597 ' ' LEU . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.676 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.5 t . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.7 HD22 ' HA ' ' A' 1649 ' ' THR . 5.1 mp . . . . . 0 CA--C 1.489 -1.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.465 ' HE2' ' N ' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.601 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.676 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.699 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.695 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.532 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.524 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.478 ' HB2' HG22 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.824 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.824 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.516 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1648 ' ' GLN . . . . . 0.431 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 51.2 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.7 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.657 HG22 HG22 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.522 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.523 ' HZ ' HG21 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.751 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.751 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.478 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.574 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.696 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1544 ' ' ASP . . . . . 0.427 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.427 HD22 ' CG ' ' A' 1544 ' ' ASP . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.899 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.45 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.554 HG12 HG22 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 91.2 m-20 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' 1579 ' ' VAL . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.861 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' 1604 ' ' LEU . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.578 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.55 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.858 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' 1625 ' ' VAL . 47.4 tp60 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.82 HG22 HG12 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' 1649 ' ' THR . 9.5 mp . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.692 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.82 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.858 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.57 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.455 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.526 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 5.8 p30 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' 1657 ' ' HIS . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB2' ' CG2' ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.623 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.869 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.869 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.499 ' HG2' HD12 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.606 ' HA ' HD22 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.692 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.555 HD13 HD23 ' A' 1645 ' ' LEU . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.696 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.553 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' 1638 ' ' ASN . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.49 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 120.666 0.269 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.681 ' HG3' HD21 ' A' 1542 ' ' LEU . 12.5 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' 1599 ' ' TYR . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.422 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.754 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1547 ' ' SER . . . . . 0.446 ' HB3' HD21 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.533 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.512 HD13 HD12 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.53 HG12 HG22 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' 1573 ' ' LYS . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 81.2 m-20 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.445 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.538 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' 1604 ' ' LEU . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.701 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1600 ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' 1603 ' ' VAL . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' 1626 ' ' ILE . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.797 HG22 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.538 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p . . . . . 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' 1649 ' ' THR . 9.1 mp . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.797 HG12 HG22 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.776 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' 1658 ' ' THR . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.466 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 5.1 p30 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' 1655 ' ' SER . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.753 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.615 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.54 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.539 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.44 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 79.0 m . . . . . 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.826 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.826 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 12.0 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.832 ' HB3' HD21 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1544 ' ' ASP . . . . . 0.411 ' O ' HD22 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.632 ' CD2' HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.61 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.939 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' 1564 ' ' ILE . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1564 ' ' ILE . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' 1558 ' ' TYR . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.55 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.593 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.586 ' CZ ' HD11 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.481 HD12 HG23 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.481 HG23 HD12 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.5 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.486 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.638 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.446 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1626 ' ' ILE . 15.8 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.442 HD13 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.729 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.629 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t . . . . . 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.624 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.729 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.73 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.519 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1639 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.939 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' 1655 ' ' SER . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1644 ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.439 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.572 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.592 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.662 ' HA ' HG23 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' 1564 ' ' ILE . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.759 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.759 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.73 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.5 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.591 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.1 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.43 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.651 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1544 ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.654 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.616 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.425 HD13 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.608 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.559 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.608 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.444 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.581 HG12 HG22 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.403 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 91.9 m-20 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.57 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.474 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.757 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.458 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' 1596 ' ' GLN . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' 1594 ' ' ASN . 15.9 mm100 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.625 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.625 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 98.8 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' 1626 ' ' ILE . 38.5 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.789 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p . . . . . 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' 1649 ' ' THR . 6.1 mp . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' 1651 ' ' THR . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.789 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.671 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 6.2 t30 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.829 ' HB2' HG22 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.552 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.797 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.797 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.636 ' HA ' HD22 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.716 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.552 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.667 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.667 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 72.7 m . . . . . 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.876 0.369 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.8 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' 1543 ' ' PHE . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.768 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.681 ' HA ' HD23 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1547 ' ' SER . . . . . 0.714 ' HB2' HD21 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.452 HD12 HD22 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.467 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.41 ' CB ' ' HD3' ' A' 1561 ' ' LYS . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.41 ' HD3' ' CB ' ' A' 1560 ' ' GLU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.536 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1580 ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.467 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.491 ' OD1' HG13 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1592 ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.712 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' 1533 ' ' GLN . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.712 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.412 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.986 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' 1597 ' ' LEU . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.602 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.902 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 18.0 p . . . . . 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.986 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' 1658 ' ' THR . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.593 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 4.8 p30 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.715 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.62 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.571 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' 1564 ' ' ILE . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 CA--C 1.523 -0.069 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' 1543 ' ' PHE . 12.9 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' 1598 ' ' MET . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 46.5 m80 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.675 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 19.2 m120 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.477 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' 1555 ' ' SER . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.528 HD13 HD12 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.492 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.415 HG21 ' HE2' ' A' 1622 ' ' TYR . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.664 ' HB2' HG13 ' A' 1579 ' ' VAL . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.721 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1592 ' ' SER . . . . . 0.427 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.492 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.518 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.4 ' HB3' ' N ' ' A' 1532 ' ' CYS . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 30.1 mm-40 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.595 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.462 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.644 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.52 ' HB2' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.447 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 23.4 p . . . . . 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.723 HD22 ' HA ' ' A' 1649 ' ' THR . 7.3 mp . . . . . 0 CA--C 1.506 -0.729 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' 1651 ' ' THR . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.6 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 4.7 p30 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1639 ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.677 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.64 HG12 ' OG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.911 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.911 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.464 ' N ' HD13 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.723 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.515 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.713 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.64 ' OG ' HG12 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.6 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.55 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.526 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m . . . . . 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' 1531 ' ' ASN . 0.8 OUTLIER . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.569 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.608 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.7 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' 1598 ' ' MET . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.564 ' CD2' HD11 ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.569 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.53 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.439 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.481 ' HE2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.553 HG12 HG22 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.432 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.412 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.476 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.532 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.537 HG12 ' SG ' ' A' 1575 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.607 HD12 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.607 HG23 HD12 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.804 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.532 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.435 ' H ' ' HE1' ' A' 1608 ' ' TYR . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' 1594 ' ' ASN . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.843 HD11 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.407 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1604 ' ' LEU . . . . . 1.051 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.421 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.743 HG22 HG12 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.55 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' 1620 ' ' LEU . 41.3 t . . . . . 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.665 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.743 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.641 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1628 ' ' PHE . . . . . 1.051 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.708 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.643 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1639 ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.516 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.576 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.6 HD23 HD13 ' A' 1652 ' ' LEU . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.512 ' HG2' HD12 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.6 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.65 ' HA ' HG23 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.516 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.607 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.708 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1543 ' ' PHE . 14.0 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1543 ' ' PHE . 14.0 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' 1542 ' ' LEU . 14.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.751 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.424 HD12 HD22 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.488 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.504 ' CD1' HD11 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.922 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.922 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' 1558 ' ' TYR . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.467 HG12 HG22 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.512 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.488 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.466 ' H ' HG23 ' A' 1572 ' ' THR . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 1585 ' ' LEU . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.776 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1592 ' ' SER . . . . . 0.418 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.415 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.439 ' H ' ' HE1' ' A' 1608 ' ' TYR . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' 1604 ' ' LEU . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.692 ' HD1' HD12 ' A' 1604 ' ' LEU . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.624 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.984 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.497 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.576 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.176 0.513 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.984 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.775 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.422 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.45 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.497 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.497 ' OG1' HG23 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.483 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.402 ' CD1' HG11 ' A' 1556 ' ' VAL . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.765 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.512 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.765 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.775 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.628 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.628 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 11.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.468 HG21 ' N ' ' A' 1599 ' ' TYR . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.738 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.578 HD23 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.625 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.412 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.625 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.538 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.487 HG21 ' HZ ' ' A' 1654 ' ' PHE . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.538 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' 1572 ' ' THR . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.532 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.698 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.57 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.409 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.719 ' HD1' HD12 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.513 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.646 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG12 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' 1649 ' ' THR . 5.0 mp . . . . . 0 C--O 1.248 0.976 0 CA-C-O 121.868 0.842 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.56 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.74 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.568 ' HB3' HG11 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.641 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.505 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.803 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.702 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.579 HG23 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.583 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.74 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.719 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.719 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.421 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m . . . . . 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.675 ' HB2' HD11 ' A' 1542 ' ' LEU . 13.2 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1547 ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.491 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.476 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.509 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.607 HD21 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.607 ' CD1' HD21 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.814 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.537 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' 1564 ' ' ILE . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.509 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.814 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.617 HD21 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.617 ' HB2' HD21 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' 1604 ' ' LEU . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.557 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.419 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.938 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' 1649 ' ' THR . 5.2 mp . . . . . 0 CA--C 1.495 -1.148 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.963 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.588 ' HB3' HG11 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.938 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.445 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.498 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 6.8 p30 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.68 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.68 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.479 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.494 ' HG2' HD12 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.708 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.963 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.594 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.552 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m . . . . . 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 13.3 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.536 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1537 ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' 1599 ' ' TYR . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.539 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.526 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.548 ' HB3' HD13 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.44 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' 1555 ' ' SER . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.437 HD13 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.564 HG12 HG22 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.473 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' 1595 ' ' SER . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.475 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.669 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.455 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.578 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.401 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' 1604 ' ' LEU . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.671 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.671 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.981 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' 1626 ' ' ILE . 39.4 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.578 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1605 ' ' GLN . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.981 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.428 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 7.3 p30 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1639 ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' 1641 ' ' VAL . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.459 HG22 ' HE3' ' A' 1639 ' ' LYS . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.817 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.817 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.541 HD13 HD23 ' A' 1645 ' ' LEU . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.635 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 1638 ' ' ASN . 22.8 m-70 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.665 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.665 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.868 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 2.3 t-20 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.868 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 12.1 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' 1598 ' ' MET . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.727 HD23 HD22 ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' 1572 ' ' THR . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1552 ' ' SER . . . . . 0.517 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.639 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' 1654 ' ' PHE . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.458 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.73 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1562 ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.506 ' CE1' HD11 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1570 ' ' GLY . . . . . 0.441 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1573 ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG11 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1584 ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.53 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.441 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' 1596 ' ' GLN . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.416 ' H ' ' HB3' ' A' 1594 ' ' ASN . 20.7 mm-40 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' 1604 ' ' LEU . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.548 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.486 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1606 ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 CA--C 1.498 -1.035 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.453 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.554 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.953 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.848 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.537 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.62 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.471 HG12 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.593 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.527 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.586 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.51 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.447 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.471 ' OG ' HG12 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.62 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.506 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.848 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.727 HD22 HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' 1628 ' ' PHE . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t . . . . . 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 1542 ' ' LEU . 13.9 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.491 ' HB ' ' HG ' ' A' 1597 ' ' LEU . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.406 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.602 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.611 ' HA ' HD23 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.478 ' H ' ' HA ' ' A' 1563 ' ' LEU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.431 ' H ' ' HD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.511 HG21 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.495 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.498 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.401 ' H ' HG23 ' A' 1572 ' ' THR . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' 1652 ' ' LEU . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 4.8 t30 -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1592 ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.717 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.481 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.786 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1624 ' ' SER . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.509 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t . . . . . 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' 1649 ' ' THR . 5.3 mp . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.786 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.629 HD12 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.567 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.594 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1644 ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.594 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.436 ' HG2' HD12 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.554 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.726 ' HA ' HG23 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.575 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 83.9 m . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' 1542 ' ' LEU . 10.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' 1599 ' ' TYR . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1537 ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.755 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.519 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.441 HD12 HD22 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.57 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.618 HD13 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.511 HG12 HG22 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.463 HG23 ' H ' ' A' 1575 ' ' CYS . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 7.5 m-20 -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.862 HG12 ' HB3' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.565 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.862 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' 1596 ' ' GLN . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.486 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.417 ' H ' ' HB3' ' A' 1594 ' ' ASN . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.699 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.559 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.697 HG22 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1614 ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' 1620 ' ' LEU . 23.4 t . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' 1649 ' ' THR . 7.5 mp . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.536 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.697 HG12 HG22 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.54 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.6 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.845 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.505 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.906 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.906 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1647 ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' 1645 ' ' LEU . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.612 ' HA ' HD22 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.65 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.597 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.57 ' HZ ' HG21 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.721 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.721 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.845 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.64 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.543 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 0.7 OUTLIER . . . . . 0 C--O 1.243 0.728 0 CA-C-O 120.267 0.08 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.536 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 13.4 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' 1598 ' ' MET . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1535 ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.58 ' HA ' HD13 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1548 ' ' LEU . . . . . 0.58 HD12 HG21 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.543 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1560 ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1561 ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.562 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.478 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.58 HG21 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.523 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' 1575 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1585 ' ' LEU . . . . . 0.627 HD12 HG23 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1586 ' ' THR . . . . . 0.627 HG23 HD12 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.822 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.523 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.502 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.721 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' 1604 ' ' LEU . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.476 ' C ' HG21 ' A' 1534 ' ' VAL . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.574 ' HD1' HD12 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.502 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.47 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1621 ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' 1621 ' ' LYS . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.596 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.602 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1629 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.474 ' HA2' HD21 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1636 ' ' ALA . . . . . 0.497 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.537 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1639 ' ' LYS . . . . . 0.462 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.415 ' HB3' ' HZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.534 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.54 HD23 HD13 ' A' 1652 ' ' LEU . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' 1651 ' ' THR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.568 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1650 ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.538 ' OG1' HG23 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.562 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.667 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.873 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.662 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.873 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.554 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1661 ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' 1658 ' ' THR . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1531 ' ' ASN . . . . . 0.656 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1532 ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' 1569 ' ' CYS . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1533 ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' 1542 ' ' LEU . 14.2 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1536 ' ' ASN . . . . . 0.429 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1542 ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1545 ' ' LEU . . . . . 0.645 ' HA ' HD23 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1549 ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1551 ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' 1571 ' ' GLY . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1554 ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1555 ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1556 ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1557 ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1558 ' ' TYR . . . . . 0.426 ' HD1' HD11 ' A' 1564 ' ' ILE . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1563 ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1564 ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1565 ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1566 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1568 ' ' ILE . . . . . 0.471 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1569 ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' 1532 ' ' CYS . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1571 ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1572 ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1574 ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1575 ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1576 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1578 ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1579 ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1581 ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1582 ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1583 ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1587 ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1589 ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1590 ' ' ALA . . . . . 0.811 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1593 ' ' TRP . . . . . 0.539 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A 1594 ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1595 ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1596 ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1597 ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1598 ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1599 ' ' TYR . . . . . 0.56 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1602 ' ' GLN . . . . . 0.445 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1605 ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' 1626 ' ' ILE . 42.4 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.747 HG22 HG12 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1608 ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1609 ' ' ASP . . . . . 0.648 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1612 ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1613 ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1620 ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' 1649 ' ' THR . 4.7 mp . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.224 0.535 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1622 ' ' TYR . . . . . 0.51 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1623 ' ' LYS . . . . . 0.648 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1624 ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1625 ' ' VAL . . . . . 0.747 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1626 ' ' ILE . . . . . 0.552 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1630 ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1633 ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1635 ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1637 ' ' ASN . . . . . 0.547 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 6.9 p30 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1638 ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1640 ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1641 ' ' VAL . . . . . 0.475 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1642 ' ' PHE . . . . . 0.621 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1645 ' ' LEU . . . . . 0.621 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1646 ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1651 ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1652 ' ' LEU . . . . . 0.41 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1653 ' ' TYR . . . . . 0.718 ' HA ' HG23 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1654 ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1655 ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1656 ' ' TRP . . . . . 0.547 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1658 ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1659 ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' 1660 ' ' LEU . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1660 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1662 ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 60.3 mtm . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 22.5 tptm 69.96 157.81 0.16 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.371 1.068 . . . . 0.0 111.119 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 38.7 t -52.76 150.25 5.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.226 1.01 . . . . 0.0 112.381 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.473 ' HB3' ' H ' ' A' 1535 ' ' THR . 39.7 t30 -105.36 88.6 2.89 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.587 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.994 HG12 ' HG2' ' A' 1598 ' ' MET . 11.5 mt -72.42 85.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 C-N-CA 124.325 1.05 . . . . 0.0 109.559 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -101.88 159.79 15.04 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.22 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -95.33 15.97 17.99 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.428 0.691 . . . . 0.0 111.034 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -108.29 19.92 19.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.1 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' 1542 ' ' LEU . 11.1 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' 1527 ' ' ASN . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.488 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.749 ' HB3' HD21 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.713 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1550 ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' 1552 ' ' SER . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' 1550 ' ' ASN . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' 1563 ' ' LEU . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.558 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.452 ' HE3' HD21 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.51 HD13 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.776 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.591 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' 1549 ' ' LYS . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.606 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.452 HD21 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.441 ' OD1' HG13 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1592 ' ' SER . . . . . 0.454 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' 1604 ' ' LEU . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.994 ' HG2' HG12 ' A' 1528 ' ' ILE . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.676 ' HD1' HD12 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.524 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' 1597 ' ' LEU . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1611 ' ' GLY . . . . . 0.442 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.491 ' O ' ' HD3' ' A' 1615 ' ' PRO . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t -96.44 107.18 34.29 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' 1613 ' ' PRO . 72.4 Cg_endo -102.19 8.9 0.45 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.123 2.549 . . . . 0.0 112.108 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.7 m -62.16 -62.52 1.71 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.413 1.085 . . . . 0.0 113.569 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.94 -60.35 0.97 Allowed 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.176 0.512 . . . . 0.0 109.792 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.6 167.92 9.81 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -104.8 32.39 4.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1649 ' ' THR . 6.4 mp -86.36 -171.79 3.73 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' 1651 ' ' THR . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.573 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1629 ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.707 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.553 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.773 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.773 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.451 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' 1623 ' ' LYS . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.566 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.553 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.546 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.524 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.449 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t -102.12 141.76 34.46 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.53 119.3 38.67 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-O 121.996 0.903 . . . . 0.0 112.775 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.29 -17.53 42.21 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.456 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.96 125.73 28.89 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -74.59 133.37 77.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 123.458 0.474 . . . . 0.0 111.132 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 61.6 Cg_endo -80.27 -168.76 0.67 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 123.311 2.674 . . . . 0.0 111.978 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -65.86 -50.42 64.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.097 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.93 93.32 4.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.738 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 2.3 p80 . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.342 0.115 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -119.46 141.28 49.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.104 0.478 . . . . 0.0 110.188 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 51.3 m -132.54 -173.43 3.17 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.171 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.505 ' HB2' ' H ' ' A' 1599 ' ' TYR . 3.8 p-10 -71.85 97.85 1.89 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.955 0.883 . . . . 0.0 111.371 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1528 ' ' ILE . . . . . . . . . . . . . 25.8 pt -139.49 -176.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 C-N-CA 125.2 1.4 . . . . 0.0 109.268 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -74.05 151.27 40.24 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -164.52 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 -175.41 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.353 0.661 . . . . 0.0 110.113 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.434 ' HB2' HD21 ' A' 1542 ' ' LEU . 12.6 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.441 HG21 ' C ' ' A' 1598 ' ' MET . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.461 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' 1536 ' ' ASN . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' 1536 ' ' ASN . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.916 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.58 ' HB3' HD13 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.434 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.523 HG21 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.916 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.563 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.824 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.44 HD12 HG23 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.44 HG23 HD12 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.446 ' H ' ' HB2' ' A' 1583 ' ' PHE . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.726 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.563 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.654 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.654 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 16.4 mm100 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.441 ' C ' HG21 ' A' 1534 ' ' VAL . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.712 ' HB3' HD11 ' A' 1597 ' ' LEU . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.676 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' 1616 ' ' SER . 10.5 t -89.28 108.09 22.25 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' 1613 ' ' PRO . 3.8 Cg_exo -75.48 -9.67 20.18 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.286 2.657 . . . . 0.0 112.001 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1616 ' ' SER . . . . . 0.503 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 6.8 m -67.42 -43.65 80.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -119.87 3.6 11.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.949 0.88 . . . . 0.0 111.343 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 11.0 t30 73.5 -66.57 0.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 126.772 2.029 . . . . 0.0 114.389 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.78 57.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.7 HD22 ' HA ' ' A' 1649 ' ' THR . 5.1 mp -98.9 173.34 6.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.992 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.465 ' HE2' ' N ' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.601 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.676 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.699 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.695 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.532 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.524 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.478 ' HB2' HG22 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.824 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.824 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.516 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1648 ' ' GLN . . . . . 0.431 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 51.2 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.7 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.657 HG22 HG22 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.522 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.523 ' HZ ' HG21 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.751 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.751 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m -90.77 116.47 28.64 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -102.15 136.69 41.55 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.2 mttm -67.61 -28.93 68.16 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.957 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -82.84 96.56 8.28 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 8.0 pt-20 -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.281 -2.385 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.984 -175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 40.8 Cg_exo -63.53 -179.7 0.74 Allowed 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.375 2.717 . . . . 0.0 111.186 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -61.08 -40.53 94.06 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.8 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -126.31 98.32 5.4 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.477 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 53.7 t-80 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' 1524 ' ' MET . 3.9 mmt . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' 1537 ' ' PRO . 28.4 mmmt -74.21 141.59 45.44 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.313 0.577 . . . . 0.0 112.496 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' 1599 ' ' TYR . 44.2 m -80.94 109.26 15.35 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' 1598 ' ' MET . 22.0 t-20 -83.39 122.99 29.23 Favored 'General case' 0 C--O 1.179 -2.633 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.634 HG12 ' HG2' ' A' 1598 ' ' MET . 31.2 mt -107.21 96.57 4.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 C-N-CA 125.432 1.493 . . . . 0.0 108.144 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.72 ' HB3' ' O ' ' A' 1533 ' ' GLN . 36.7 tt0 -109.36 157.32 19.01 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -130.68 28.78 4.85 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.686 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.72 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.574 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1537 ' ' PRO . . . . . 0.481 ' HG3' ' O ' ' A' 1525 ' ' LYS . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.696 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1544 ' ' ASP . . . . . 0.427 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.427 HD22 ' CG ' ' A' 1544 ' ' ASP . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.899 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.45 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.554 HG12 HG22 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 91.2 m-20 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' 1579 ' ' VAL . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.861 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.802 ' HA ' ' O ' ' A' 1527 ' ' ASN . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.578 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.55 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.858 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.415 ' NE2' ' HB ' ' A' 1625 ' ' VAL . 47.4 tp60 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.82 HG22 HG12 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 73.4 m -74.14 107.56 3.78 Favored Pre-proline 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -91.64 -16.22 1.27 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.621 2.214 . . . . 0.0 114.481 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 32.2 t -146.09 -54.55 0.27 Allowed 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.835 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.64 -42.99 99.67 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.322 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.452 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 64.1 m-20 -130.18 -178.91 4.94 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -118.84 -7.12 10.51 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' 1649 ' ' THR . 9.5 mp -100.32 -163.98 1.08 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.57 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.692 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.82 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.858 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.57 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.455 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.526 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 5.8 p30 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' 1657 ' ' HIS . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB2' ' CG2' ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.623 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.869 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.869 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.499 ' HG2' HD12 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.606 ' HA ' HD22 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.692 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.555 HD13 HD23 ' A' 1645 ' ' LEU . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.696 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.553 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' 1638 ' ' ASN . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m -89.42 126.81 35.71 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.1 135.72 49.49 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -52.53 -40.16 62.16 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.01 152.61 19.91 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.475 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' 1670 ' ' HIS . 11.1 pt-20 -74.43 136.79 74.83 Favored Pre-proline 0 C--O 1.251 1.145 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.59 -162.94 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.558 2.839 . . . . 0.0 110.957 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -53.42 -37.0 62.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -125.38 103.61 8.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.669 ' HB3' ' HB2' ' A' 1666 ' ' GLU . 52.4 p-80 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.457 -0.085 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -109.57 147.83 32.32 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.426 ' OG ' ' HB ' ' A' 1600 ' ' VAL . 9.0 m -66.63 122.26 17.22 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 123.349 0.66 . . . . 0.0 112.446 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' 1598 ' ' MET . 19.1 t-20 -85.23 125.31 32.76 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.638 HG12 ' HG2' ' A' 1598 ' ' MET . 21.7 mt -109.79 104.4 17.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 124.508 1.123 . . . . 0.0 108.797 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' 1533 ' ' GLN . 54.0 tt0 -116.53 151.19 36.64 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.809 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.85 17.39 18.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.826 0.851 . . . . 0.0 111.564 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.49 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 -107.19 16.01 24.52 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.693 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.681 ' HG3' HD21 ' A' 1542 ' ' LEU . 12.5 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' 1599 ' ' TYR . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.422 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.754 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1547 ' ' SER . . . . . 0.446 ' HB3' HD21 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.533 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.512 HD13 HD12 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.53 HG12 HG22 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' 1573 ' ' LYS . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 81.2 m-20 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.445 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.538 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.638 ' HG2' HG12 ' A' 1528 ' ' ILE . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.701 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1600 ' ' VAL . . . . . 0.426 ' HB ' ' OG ' ' A' 1526 ' ' SER . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' 1626 ' ' ILE . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.797 HG22 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.538 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p -92.23 115.57 64.94 Favored Pre-proline 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 50.6 Cg_endo -100.27 -4.84 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.638 2.225 . . . . 0.0 112.606 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 10.4 m -105.12 -58.05 1.94 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 64.9 mttm -78.14 -21.73 49.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.504 0.669 . . . . 0.0 111.69 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.687 ' HB3' ' SG ' ' A' 1650 ' ' CYS . 3.3 t-20 -164.3 -167.02 1.21 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -175.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.402 ' H ' ' ND2' ' A' 1618 ' ' ASN . . . -126.09 9.22 7.4 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.527 0.603 . . . . 0.0 110.86 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' 1649 ' ' THR . 9.1 mp -98.82 -165.34 1.23 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.797 HG12 HG22 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.776 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' 1658 ' ' THR . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.466 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 5.1 p30 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' 1655 ' ' SER . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.753 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.615 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' 1618 ' ' ASN . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.54 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.539 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.44 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 79.0 m -87.0 128.08 35.08 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.27 121.57 25.25 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -65.24 -22.49 66.88 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.35 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -90.23 124.65 35.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.95 124.85 78.74 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 42.7 Cg_endo -84.79 -163.45 0.2 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 123.458 2.772 . . . . 0.0 112.028 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -54.46 -43.35 71.61 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.601 0.563 . . . . 0.0 110.846 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 22.5 p80 -128.11 123.74 35.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.445 0.64 . . . . 0.0 109.785 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.677 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 11.6 t-160 . . . . . 0 C--N 1.284 -2.28 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -122.6 151.55 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 54.6 p -80.67 159.76 25.22 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' 1535 ' ' THR . 18.7 m120 -78.11 87.82 4.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.428 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' 1598 ' ' MET . 4.4 tt -71.63 80.37 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.625 1.202 . . . . 0.0 109.843 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -102.46 143.26 32.41 Favored 'General case' 0 N--CA 1.398 -3.026 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.143 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.1 33.64 0.8 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 123.023 1.392 . . . . 0.0 109.243 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.826 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 -101.04 -2.26 32.07 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.755 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.826 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 12.0 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1537 ' ' PRO . . . . . 0.577 ' HD3' ' HA ' ' A' 1526 ' ' SER . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.832 ' HB3' HD21 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1544 ' ' ASP . . . . . 0.411 ' O ' HD22 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.632 ' CD2' HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.61 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.939 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' 1564 ' ' ILE . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1564 ' ' ILE . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' 1558 ' ' TYR . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.55 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.593 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.586 ' CZ ' HD11 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.481 HD12 HG23 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.481 HG23 HD12 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.5 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.486 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.599 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.638 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.446 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1626 ' ' ILE . 15.8 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.442 HD13 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.729 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.629 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t -95.92 106.56 28.71 Favored Pre-proline 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.9 Cg_endo -103.8 3.65 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.592 2.195 . . . . 0.0 111.052 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.9 t -95.26 -63.2 1.19 Allowed 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.668 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.561 ' HG3' HD11 ' A' 1645 ' ' LEU . 47.8 mmtm -85.62 -42.42 14.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.404 0.621 . . . . 0.0 110.777 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' 1618 ' ' ASN . 1.8 t-20 -150.17 -156.07 0.69 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.939 -2.986 . . . . 0.0 102.939 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -123.44 39.19 4.02 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 119.226 0.921 . . . . 0.0 111.976 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp -102.02 -168.24 1.51 Allowed 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.624 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.729 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.73 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.519 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1639 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.939 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' 1655 ' ' SER . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1644 ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.439 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.572 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.592 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.662 ' HA ' HG23 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' 1564 ' ' ILE . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.759 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.759 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.73 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.5 m -87.75 144.51 26.59 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' 1665 ' ' GLU . 32.3 tt0 -135.92 139.86 43.6 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 87.1 mttt -86.47 -19.96 28.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1665 ' ' GLU . . . . . 0.534 ' H ' ' HG2' ' A' 1663 ' ' GLU . 60.6 mm-40 -82.87 165.96 19.34 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.652 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.73 143.18 39.32 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-O 120.672 0.272 . . . . 0.0 111.218 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.2 -163.31 0.22 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.703 2.936 . . . . 0.0 111.292 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -64.83 -37.68 88.43 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.141 0.496 . . . . 0.0 110.656 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -140.36 124.47 17.56 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.499 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.51 -0.59 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 4.7 tppp? 73.14 114.43 0.06 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.09 0.948 . . . . 0.0 109.149 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 3.2 t -88.55 159.58 17.85 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.095 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.573 ' HB3' ' H ' ' A' 1535 ' ' THR . 59.6 t30 -87.66 78.43 8.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.327 0.585 . . . . 0.0 110.679 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' 1597 ' ' LEU . 8.5 tt -72.87 82.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.721 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.76 168.65 11.58 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.378 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.14 22.12 16.48 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.057 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 -109.42 13.07 24.3 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.292 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.591 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.1 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.43 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1541 ' ' HIS . . . . . 0.449 ' ND1' ' HG3' ' A' 1663 ' ' GLU . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.651 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1544 ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.654 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.616 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.425 HD13 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.608 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.559 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.608 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.444 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.581 HG12 HG22 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.403 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 91.9 m-20 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.57 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.474 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.757 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.458 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' 1596 ' ' GLN . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.6 mm-40 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.625 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.625 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.0 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' 1626 ' ' ILE . 38.5 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.789 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p -96.36 104.62 18.15 Favored Pre-proline 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.5 Cg_endo -98.66 3.47 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.675 2.25 . . . . 0.0 109.659 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 41.7 t -57.55 -63.21 1.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.458 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 98.2 mttt -127.76 -17.36 4.52 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 0.0 111.014 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.402 ' HB3' HD12 ' A' 1620 ' ' LEU . 90.1 m-20 -126.33 -172.38 2.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.76 33.33 4.82 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.435 0.636 . . . . 0.0 109.745 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' 1649 ' ' THR . 6.1 mp -102.88 -163.52 1.0 Allowed 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' 1651 ' ' THR . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.789 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.671 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 6.2 t30 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.829 ' HB2' HG22 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.552 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.797 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.797 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.636 ' HA ' HD22 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.716 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.552 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.667 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.667 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 72.7 m -86.1 128.9 34.96 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' 1665 ' ' GLU . 37.1 tt0 -104.2 135.88 44.84 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -78.31 -23.45 47.08 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.337 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1665 ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' 1663 ' ' GLU . 16.4 mm-40 -95.5 172.57 7.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -144.57 139.36 15.44 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 72.6 Cg_endo -74.37 172.61 15.74 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 122.707 2.272 . . . . 0.0 111.411 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.12 -19.99 64.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 69.4 t60 -136.27 89.62 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 14.2 p80 . . . . . 0 C--N 1.304 -1.386 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.792 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.647 ' O ' ' HB ' ' A' 1535 ' ' THR . 25.8 tptp -148.55 -177.65 5.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 10.6 m -93.36 -152.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.823 ' HB3' ' HG2' ' A' 1598 ' ' MET . 23.6 m-80 -45.37 114.98 0.83 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' 1529 ' ' GLN . 8.4 tt -143.84 156.46 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.404 ' O ' HG12 ' A' 1528 ' ' ILE . 7.5 tt0 -97.99 134.44 41.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.97 -65.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.396 0.435 . . . . 0.0 109.829 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 -173.11 56.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.8 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' 1527 ' ' ASN . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.768 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.681 ' HA ' HD23 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1547 ' ' SER . . . . . 0.714 ' HB2' HD21 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.452 HD12 HD22 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.467 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.41 ' CB ' ' HD3' ' A' 1561 ' ' LYS . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.41 ' HD3' ' CB ' ' A' 1560 ' ' GLU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.536 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1580 ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.467 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.491 ' OD1' HG13 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1592 ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.712 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' 1533 ' ' GLN . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.823 ' HG2' ' HB3' ' A' 1527 ' ' ASN . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.712 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.412 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.986 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' 1597 ' ' LEU . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.602 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.902 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 18.0 p -90.2 118.02 68.51 Favored Pre-proline 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 19.2 Cg_endo -98.68 -11.3 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.963 2.442 . . . . 0.0 114.027 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 44.8 t -105.89 -51.63 2.95 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.998 -0.439 . . . . 0.0 112.05 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.99 -32.01 63.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.262 0.553 . . . . 0.0 110.885 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -162.97 -153.77 0.27 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.17 20.7 6.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 118.45 0.568 . . . . 0.0 112.399 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp -95.78 -168.62 1.8 Allowed 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.99 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.986 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' 1658 ' ' THR . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.593 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 4.8 p30 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.715 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.62 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.571 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' 1564 ' ' ILE . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m -87.21 144.36 26.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -122.72 161.42 23.93 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -57.95 -34.97 70.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 118.82 0.737 . . . . 0.0 112.121 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.32 174.08 10.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.869 0.366 . . . . 0.0 110.334 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.52 154.09 87.68 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.01 -161.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 124.323 3.348 . . . . 0.0 111.508 172.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -59.93 -39.97 87.29 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.858 -0.526 . . . . 0.0 111.726 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -140.48 124.46 17.39 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 172.437 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 C--O 1.224 -0.244 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.3 151.44 45.28 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.807 0.337 . . . . 0.0 110.643 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 17.9 m -98.23 177.04 5.51 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.013 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 87.89 6.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.839 1.304 . . . . 0.0 111.906 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.503 HG13 ' HG2' ' A' 1529 ' ' GLN . 11.3 tp -145.67 173.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.503 ' HG2' HG13 ' A' 1528 ' ' ILE . 12.1 pt20 -60.27 159.66 9.6 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.691 1.196 . . . . 0.0 110.245 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 10.2 t0 -166.26 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.801 0.334 . . . . 0.0 110.289 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 178.31 65.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.24 0.616 . . . . 0.0 109.386 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' 1543 ' ' PHE . 12.9 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' 1598 ' ' MET . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 46.5 m80 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.675 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 19.2 m120 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.477 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' 1555 ' ' SER . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.528 HD13 HD12 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.492 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.415 HG21 ' HE2' ' A' 1622 ' ' TYR . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.664 ' HB2' HG13 ' A' 1579 ' ' VAL . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.721 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1592 ' ' SER . . . . . 0.427 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.492 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.518 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.4 ' HB3' ' N ' ' A' 1532 ' ' CYS . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 15.4 mm100 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.595 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.462 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.644 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.52 ' HB2' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.447 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 23.4 p -91.49 119.56 68.54 Favored Pre-proline 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 8.9 Cg_endo -96.63 -10.73 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.444 2.096 . . . . 0.0 112.575 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 29.0 t -103.5 -60.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -65.24 -37.87 88.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.791 0.805 . . . . 0.0 111.517 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -162.68 -159.39 0.56 Allowed 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -123.68 28.29 6.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 118.546 0.612 . . . . 0.0 111.691 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.723 HD22 ' HA ' ' A' 1649 ' ' THR . 7.3 mp -100.84 -167.44 1.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.558 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' 1651 ' ' THR . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.6 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 4.7 p30 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1639 ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.677 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.64 HG12 ' OG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.911 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.911 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.464 ' N ' HD13 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.723 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.515 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.713 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.64 ' OG ' HG12 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.6 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.55 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.526 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m -88.27 120.26 29.47 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.54 136.33 45.82 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1664 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1664 ' ' LYS . 72.2 mmtt -68.37 -15.67 63.65 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -90.03 114.25 26.1 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' 1670 ' ' HIS . 44.0 mt-10 -93.83 136.35 23.96 Favored Pre-proline 0 C--N 1.28 -2.45 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.022 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' 1666 ' ' GLU . 9.7 Cg_exo -72.37 -177.03 2.47 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 123.688 2.926 . . . . 0.0 112.937 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1668 ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' 1668 ' ' ARG . 72.7 mtt180 -55.02 -49.7 70.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.885 0.85 . . . . 0.0 108.771 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -106.95 100.78 10.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.569 ' CB ' ' HB3' ' A' 1666 ' ' GLU . 7.3 p80 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.288 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 25.8 tptp -137.9 134.66 35.28 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 49.7 m -89.37 128.32 35.9 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.99 ' HB3' ' H ' ' A' 1535 ' ' THR . 46.9 t30 -76.19 87.86 3.05 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' 1597 ' ' LEU . 4.9 tt -72.38 86.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 170.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -109.6 163.0 13.88 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.1 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -99.23 20.81 12.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 123.856 0.862 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -120.1 21.57 11.76 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.293 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.569 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.608 ' HB2' HD22 ' A' 1542 ' ' LEU . 13.7 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' 1598 ' ' MET . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.99 ' H ' ' HB3' ' A' 1527 ' ' ASN . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.564 ' CD2' HD11 ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.569 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.53 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.439 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.481 ' HE2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.553 HG12 HG22 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.432 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.412 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.476 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.532 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.537 HG12 ' SG ' ' A' 1575 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.607 HD12 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.607 HG23 HD12 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.804 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.532 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.435 ' H ' ' HE1' ' A' 1608 ' ' TYR . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' 1594 ' ' ASN . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.843 HD11 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.407 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1604 ' ' LEU . . . . . 1.051 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.421 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.743 HG22 HG12 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.55 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' 1620 ' ' LEU . 41.3 t -96.1 112.74 60.56 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -100.36 3.59 0.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.374 2.716 . . . . 0.0 112.605 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 45.4 m -63.09 -62.94 1.37 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.05 -66.16 0.83 Allowed 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 120.804 0.335 . . . . 0.0 110.46 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' 1648 ' ' GLN . 34.8 m-80 -97.87 165.75 11.79 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -102.95 34.07 3.01 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.129 0.49 . . . . 0.0 112.198 -170.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp -89.92 -172.79 3.65 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.665 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.743 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.641 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1628 ' ' PHE . . . . . 1.051 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.708 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.643 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1639 ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.516 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.576 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.6 HD23 HD13 ' A' 1652 ' ' LEU . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.512 ' HG2' HD12 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1648 ' ' GLN . . . . . 0.501 ' HA ' ' ND2' ' A' 1618 ' ' ASN . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.6 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.65 ' HA ' HG23 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.516 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.607 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.708 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m -93.28 133.94 35.99 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -110.96 137.42 48.61 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.11 -33.78 76.56 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 123.93 0.768 . . . . 0.0 111.041 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.57 144.17 26.49 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.77 149.9 67.0 Favored Pre-proline 0 C--N 1.279 -2.499 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.716 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.3 -162.6 0.16 Allowed 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.94 3.093 . . . . 0.0 110.043 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.52 -54.61 25.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -141.08 134.88 30.37 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 C--N 1.299 -1.589 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.6 177.432 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.448 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.739 ' HB2' HG23 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 16.1 mm100 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' 1528 ' ' ILE . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' 1619 ' ' ALA . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.446 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.448 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.739 ' HB2' HG23 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 16.1 mm100 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' 1528 ' ' ILE . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' 1619 ' ' ALA . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.446 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' 1600 ' ' VAL . 75.6 mmtt -129.35 179.83 5.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' 1599 ' ' TYR . 6.3 m -94.49 112.77 24.54 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 23.3 t30 -146.88 112.64 5.69 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.719 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.476 ' CG2' ' H ' ' A' 1535 ' ' THR . 7.5 tp -145.53 82.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.436 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' 1530 ' ' ASP . 27.8 pt20 -62.68 163.19 9.5 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.502 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1530 ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' 1529 ' ' GLN . 29.1 t70 167.4 -68.85 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.318 1.447 . . . . 0.0 110.219 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.56 71.57 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' 1542 ' ' LEU . 14.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1541 ' ' HIS . . . . . 0.503 ' CG ' ' HG3' ' A' 1663 ' ' GLU . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.751 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.424 HD12 HD22 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.488 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.504 ' CD1' HD11 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.922 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.922 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' 1558 ' ' TYR . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.467 HG12 HG22 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.512 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.488 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.466 ' H ' HG23 ' A' 1572 ' ' THR . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 1585 ' ' LEU . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.776 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1592 ' ' SER . . . . . 0.418 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.415 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.439 ' H ' ' HE1' ' A' 1608 ' ' TYR . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' 1604 ' ' LEU . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.72 ' HB3' ' HB2' ' A' 1526 ' ' SER . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1600 ' ' VAL . . . . . 0.454 HG23 ' HD2' ' A' 1525 ' ' LYS . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.624 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.984 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.497 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.576 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.422 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 24.7 p -95.76 114.36 63.87 Favored Pre-proline 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 30.3 Cg_endo -97.16 -0.04 1.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.863 2.376 . . . . 0.0 112.498 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.7 t -123.46 -51.12 1.86 Allowed 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.818 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -58.02 -46.94 84.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 0.0 110.321 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' 1647 ' ' LYS . 8.1 t-20 -158.57 -144.56 0.12 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -126.49 18.81 7.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 118.131 0.423 . . . . 0.0 110.948 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp -98.98 -169.22 1.74 Allowed 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.88 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.984 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.775 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.422 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.45 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1618 ' ' ASN . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.497 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.497 ' OG1' HG23 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.483 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.402 ' CD1' HG11 ' A' 1556 ' ' VAL . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.765 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.512 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.765 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.775 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m -90.21 115.41 27.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.503 ' HG3' ' CG ' ' A' 1541 ' ' HIS . 36.8 tt0 -77.75 114.9 17.07 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.08 -29.02 70.02 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.584 -173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.5 119.6 24.9 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.47 128.86 49.36 Favored Pre-proline 0 C--N 1.29 -2.009 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.187 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 83.0 Cg_endo -76.17 -176.11 2.88 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.959 2.439 . . . . 0.0 111.789 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -66.38 -27.43 67.86 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 120.935 0.398 . . . . 0.0 111.735 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.4 m80 -137.17 105.9 5.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.636 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 28.6 t-80 . . . . . 0 C--N 1.31 -1.11 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.226 0.536 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -90.76 -175.42 4.38 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 41.2 m -116.89 -171.18 1.97 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.816 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.551 ' HB2' ' HB ' ' A' 1535 ' ' THR . 16.3 m120 -85.14 85.64 7.45 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' 1596 ' ' GLN . 8.2 tt -73.82 101.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.011 176.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -115.09 153.71 30.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -82.11 12.08 4.6 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.778 1.231 . . . . 0.0 111.341 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.628 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 2.9 m-20 -95.95 19.15 11.96 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.628 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 11.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' 1527 ' ' ASN . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' 1527 ' ' ASN . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.565 HD21 ' HG3' ' A' 1667 ' ' PRO . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.738 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.578 HD23 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.625 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.412 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.625 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.538 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.487 HG21 ' HZ ' ' A' 1654 ' ' PHE . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.538 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' 1572 ' ' THR . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.532 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.698 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.57 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' 1528 ' ' ILE . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.719 ' HD1' HD12 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.513 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.646 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG12 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.402 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 29.7 t -87.29 110.63 35.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 16.9 Cg_exo -70.03 -23.59 29.37 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 123.838 3.025 . . . . 0.0 112.574 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.0 m -61.28 -49.35 77.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.706 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 6.4 mmtt -92.36 -27.72 17.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.414 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 66.9 t30 74.92 -41.06 0.46 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.382 1.873 . . . . 0.0 112.009 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -77.46 -33.18 54.76 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.362 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' 1649 ' ' THR . 5.0 mp -112.68 176.15 5.14 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.72 -175.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.56 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.74 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.568 ' HB3' HG11 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.641 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.505 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.803 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.702 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.579 HG23 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.583 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.74 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.719 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.719 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.421 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m -91.32 126.62 36.46 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' 1665 ' ' GLU . 28.8 tt0 -88.79 153.04 21.4 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 174.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.22 -26.91 66.83 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.81 0.814 . . . . 0.0 109.649 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1665 ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' 1663 ' ' GLU . 66.6 mm-40 -116.49 179.15 4.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -129.11 152.16 78.89 Favored Pre-proline 0 C--N 1.286 -2.18 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.174 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 38.8 Cg_exo -67.42 -163.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.274 2.649 . . . . 0.0 110.858 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -66.23 -42.51 88.57 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -135.78 89.56 2.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.134 -0.354 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.658 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 46.2 t-80 . . . . . 0 C--N 1.303 -1.422 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.19 176.79 8.4 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 24.8 m -78.02 110.71 13.2 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.985 ' HB3' ' H ' ' A' 1535 ' ' THR . 51.0 t30 -67.32 85.04 0.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.964 HG12 ' HG2' ' A' 1598 ' ' MET . 9.7 mt -71.95 82.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.44 156.99 17.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 122.171 -0.331 . . . . 0.0 110.277 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -85.67 5.76 30.6 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.059 0.943 . . . . 0.0 112.05 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 -109.46 19.21 19.55 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.21 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.675 ' HB2' HD11 ' A' 1542 ' ' LEU . 4.1 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.985 ' H ' ' HB3' ' A' 1527 ' ' ASN . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1547 ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.491 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.476 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.509 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.607 HD21 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.607 ' CD1' HD21 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.814 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.537 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' 1564 ' ' ILE . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.509 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.814 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.617 HD21 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.617 ' HB2' HD21 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.964 ' HG2' HG12 ' A' 1528 ' ' ILE . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.557 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.543 ' NE2' ' HG3' ' A' 1667 ' ' PRO . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.938 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' 1616 ' ' SER . 34.1 t -85.98 108.48 17.18 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' 1613 ' ' PRO . 9.4 Cg_exo -72.83 -18.87 24.34 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.224 2.616 . . . . 0.0 111.654 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1616 ' ' SER . . . . . 0.494 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.4 m -62.7 -59.38 4.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.424 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -101.32 -4.31 27.26 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 57.6 t30 71.65 -62.97 0.44 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.55 1.94 . . . . 0.0 113.836 172.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.85 68.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' 1649 ' ' THR . 5.2 mp -107.81 177.71 4.74 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.158 -173.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.963 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.588 ' HB3' HG11 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.938 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.445 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.498 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 6.8 p30 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.68 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.68 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.479 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.494 ' HG2' HD12 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.708 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.963 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.594 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.552 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m -90.83 120.35 31.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -76.86 158.9 30.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1664 ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' 1664 ' ' LYS . 27.8 mmmt -59.99 -47.98 83.57 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -101.44 153.92 19.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' 1670 ' ' HIS . 53.2 mt-10 -92.56 139.99 23.86 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.543 ' HG3' ' NE2' ' A' 1602 ' ' GLN . 62.0 Cg_endo -78.78 -164.65 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 123.06 2.507 . . . . 0.0 112.141 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -47.42 -54.12 12.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.426 1.09 . . . . 0.0 111.27 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -128.73 99.05 5.19 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.688 ' HB3' ' HB3' ' A' 1666 ' ' GLU . 24.7 p80 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.642 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' 1537 ' ' PRO . 60.3 mtt . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -131.39 172.5 12.11 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.8 m -71.36 115.85 11.01 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.907 ' HB3' ' H ' ' A' 1535 ' ' THR . 52.8 t30 -80.5 85.22 5.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.627 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.922 HG12 ' HG2' ' A' 1598 ' ' MET . 6.3 mt -72.31 79.54 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.37 140.59 46.96 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 -177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -85.83 35.83 0.64 Allowed 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.386 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 0.2 OUTLIER -115.51 17.67 16.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 3.9 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.907 ' H ' ' HB3' ' A' 1527 ' ' ASN . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.536 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1537 ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' 1524 ' ' MET . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1539 ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.539 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.526 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.548 ' HB3' HD13 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.44 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' 1555 ' ' SER . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.437 HD13 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.564 HG12 HG22 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.473 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' 1595 ' ' SER . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.475 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.669 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.455 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.578 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.401 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.922 ' HG2' HG12 ' A' 1528 ' ' ILE . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.671 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.671 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.981 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' 1626 ' ' ILE . 39.4 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.578 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' 1616 ' ' SER . 49.8 t -95.7 109.55 46.62 Favored Pre-proline 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' 1613 ' ' PRO . 36.7 Cg_endo -96.42 0.02 1.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.682 2.255 . . . . 0.0 110.471 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1616 ' ' SER . . . . . 0.435 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.1 m -58.37 -62.45 1.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 125.3 1.44 . . . . 0.0 113.108 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -131.34 -69.36 0.63 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -100.64 159.62 15.02 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -97.63 35.85 1.6 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.761 0.791 . . . . 0.0 111.248 -169.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.477 ' H ' ' HG ' ' A' 1620 ' ' LEU . 0.9 OUTLIER -92.45 -168.15 1.91 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.914 177.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1605 ' ' GLN . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.981 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.428 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 7.3 p30 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1639 ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' 1641 ' ' VAL . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.459 HG22 ' HE3' ' A' 1639 ' ' LYS . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.817 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.817 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.541 HD13 HD23 ' A' 1645 ' ' LEU . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.635 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 1638 ' ' ASN . 22.8 m-70 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.665 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.665 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m -90.9 122.55 33.69 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -69.98 142.05 52.9 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -53.14 -49.28 66.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.578 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -104.93 178.29 4.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 12.9 pt-20 -81.89 136.38 47.7 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.177 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.725 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 26.2 Cg_exo -67.14 -172.43 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.154 2.569 . . . . 0.0 112.14 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -73.87 -34.62 64.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 -174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -123.05 85.13 2.37 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.827 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.725 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 72.1 t60 . . . . . 0 C--N 1.31 -1.15 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 66.0 mttp 64.45 -175.4 0.17 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.769 0.827 . . . . 0.0 110.367 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.5 m -85.14 158.46 20.39 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' 1598 ' ' MET . 46.3 t-20 -75.5 124.59 27.44 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' 1598 ' ' MET . 50.0 mt -123.35 94.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 128.133 2.573 . . . . 0.0 106.631 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1529 ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' 1533 ' ' GLN . 50.4 tt0 -114.43 155.8 25.68 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.99 80.79 1.85 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.868 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 2.3 t-20 -166.95 20.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.868 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 12.1 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' 1598 ' ' MET . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.727 HD23 HD22 ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' 1572 ' ' THR . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1552 ' ' SER . . . . . 0.517 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.639 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' 1654 ' ' PHE . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.458 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.73 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1562 ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.506 ' CE1' HD11 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1570 ' ' GLY . . . . . 0.441 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1573 ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG11 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1584 ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.53 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.441 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' 1596 ' ' GLN . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.416 ' H ' ' HB3' ' A' 1594 ' ' ASN . 13.5 mm100 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' 1528 ' ' ILE . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.548 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.486 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1606 ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t -94.37 114.87 64.41 Favored Pre-proline 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' 1613 ' ' PRO . 57.5 Cg_endo -102.67 2.5 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.458 2.772 . . . . 0.0 111.847 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 20.4 t -59.81 -63.05 1.44 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.724 0.809 . . . . 0.0 111.937 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' 1647 ' ' LYS . 31.5 mmmt -134.47 -65.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -89.52 175.29 7.35 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -115.46 34.85 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.171 0.51 . . . . 0.0 112.278 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.02 -167.17 1.8 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.453 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.554 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.953 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.848 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.537 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.62 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.471 HG12 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.593 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' 1617 ' ' LYS . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.527 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.586 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.51 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.447 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.471 ' OG ' HG12 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.62 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.506 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.848 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.727 HD22 HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' 1628 ' ' PHE . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t -94.59 138.06 32.93 Favored 'General case' 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.62 115.3 26.05 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -83.26 -15.37 50.55 Favored 'General case' 0 C--N 1.265 -3.072 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.8 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -71.15 122.41 20.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.68 138.05 73.83 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.052 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.05 173.07 1.98 Allowed 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 124.044 3.163 . . . . 0.0 115.283 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -56.87 -34.73 68.13 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.047 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 53.7 t60 -126.57 87.77 2.72 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.518 -179.69 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.33 157.03 16.68 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.037 0.446 . . . . 0.0 110.004 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 13.9 m -95.22 -173.4 2.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.826 ' HB3' ' H ' ' A' 1535 ' ' THR . 7.6 t30 -81.38 73.25 8.43 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.032 0.444 . . . . 0.0 111.149 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.634 ' HB ' ' HG3' ' A' 1598 ' ' MET . 6.7 tt -72.32 84.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.054 0.931 . . . . 0.0 109.314 173.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -134.92 159.4 41.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -87.06 29.84 0.8 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -101.78 6.7 41.8 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.807 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 1542 ' ' LEU . 13.9 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' 1527 ' ' ASN . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.826 ' H ' ' HB3' ' A' 1527 ' ' ASN . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.406 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.602 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.611 ' HA ' HD23 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.478 ' H ' ' HA ' ' A' 1563 ' ' LEU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.431 ' H ' ' HD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.511 HG21 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.495 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.498 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.401 ' H ' HG23 ' A' 1572 ' ' THR . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' 1652 ' ' LEU . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 4.8 t30 -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1592 ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.717 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.634 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.481 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.786 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1624 ' ' SER . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' 1615 ' ' PRO . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.509 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t -90.06 105.49 11.44 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' 1613 ' ' PRO . 6.2 Cg_exo -82.15 -4.15 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.176 2.584 . . . . 0.0 111.382 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1616 ' ' SER . . . . . 0.406 ' HB3' ' SG ' ' A' 1614 ' ' CYS . 17.3 t -69.66 -50.68 41.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 31.9 mmmt -112.18 -7.34 14.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.624 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 74.32 -54.29 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.403 1.881 . . . . 0.0 113.793 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.39 90.1 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' 1649 ' ' THR . 5.3 mp -106.79 -177.46 3.37 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.25 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.786 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.629 HD12 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.567 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.594 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1644 ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.594 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.436 ' HG2' HD12 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.554 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.726 ' HA ' HG23 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.575 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 83.9 m -84.78 124.84 32.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -106.24 139.42 40.77 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -94.2 -18.87 21.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -84.59 165.82 17.67 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.81 134.54 10.06 Favored Pre-proline 0 N--CA 1.412 -2.342 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.056 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 45.1 Cg_endo -87.56 -163.08 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 123.465 2.777 . . . . 0.0 109.801 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -64.82 -21.03 66.71 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.14 102.52 6.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.702 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 59.3 t-80 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' 1537 ' ' PRO . 91.6 mmm . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 68.1 mttm -119.15 -175.86 3.01 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 15.1 m -70.29 105.05 2.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' 1534 ' ' VAL . 14.7 m120 -79.99 80.73 6.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.135 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.576 ' HB ' ' HG2' ' A' 1598 ' ' MET . 5.6 tt -72.66 107.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.242 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -126.36 153.85 44.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -79.73 19.62 0.65 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.333 0.653 . . . . 0.0 112.399 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -102.88 12.71 35.79 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' 1542 ' ' LEU . 2.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' 1527 ' ' ASN . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.574 ' H ' ' HB2' ' A' 1527 ' ' ASN . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1537 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1526 ' ' SER . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.755 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.519 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.441 HD12 HD22 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.57 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.618 HD13 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.511 HG12 HG22 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.463 HG23 ' H ' ' A' 1575 ' ' CYS . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 7.5 m-20 -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.862 HG12 ' HB3' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.565 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.862 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' 1596 ' ' GLN . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.486 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.417 ' H ' ' HB3' ' A' 1594 ' ' ASN . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.576 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.699 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' 1667 ' ' PRO . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.697 HG22 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' 1615 ' ' PRO . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' 1619 ' ' ALA . 23.4 t -95.96 106.29 27.06 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' 1613 ' ' PRO . 61.1 Cg_endo -104.8 3.86 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.899 2.399 . . . . 0.0 109.626 170.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.0 m -88.44 -62.23 1.53 Allowed 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.778 -1.556 . . . . 0.0 113.177 -170.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.697 ' HG3' HD11 ' A' 1645 ' ' LEU . 72.5 mmtt -84.44 -41.79 16.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.713 0.768 . . . . 0.0 109.891 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.93 -157.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.05 40.1 3.23 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 118.872 0.76 . . . . 0.0 111.421 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' 1649 ' ' THR . 7.5 mp -102.17 -166.18 1.26 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.615 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.536 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.697 HG12 HG22 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.54 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.6 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.845 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.505 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.906 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.906 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' 1617 ' ' LYS . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.612 ' HA ' HD22 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.65 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.597 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.57 ' HZ ' HG21 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.721 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.721 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.845 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.64 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m -73.34 133.67 43.9 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' 1665 ' ' GLU . 8.5 tp10 -128.54 162.15 27.92 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.448 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.06 -9.98 58.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.422 0.63 . . . . 0.0 110.633 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1665 ' ' GLU . . . . . 0.591 ' H ' ' HG3' ' A' 1663 ' ' GLU . 43.4 mt-10 -77.77 145.99 36.12 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.23 138.71 30.44 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.564 ' HA ' ' OE1' ' A' 1602 ' ' GLN . 70.2 Cg_endo -68.65 -177.99 1.75 Allowed 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.179 2.586 . . . . 0.0 113.171 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -55.54 -49.73 71.87 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.135 0.493 . . . . 0.0 110.08 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -115.37 104.1 11.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.241 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' 1537 ' ' PRO . 53.6 ttm . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -95.38 161.82 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1526 ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 19.1 m -62.39 119.47 9.17 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.938 ' HB3' ' H ' ' A' 1535 ' ' THR . 3.7 t-20 -66.51 81.61 0.1 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' 1597 ' ' LEU . 9.8 tt -72.27 81.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 122.665 1.222 . . . . 0.0 109.217 171.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -93.28 163.92 13.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.712 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.74 16.79 23.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.648 1.213 . . . . 0.0 109.338 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.543 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 3.2 m-20 -105.71 21.2 17.66 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.851 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.536 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 4.0 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1527 ' ' ASN . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.938 ' H ' ' HB3' ' A' 1527 ' ' ASN . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1537 ' ' PRO . . . . . 0.61 ' HA ' ' SD ' ' A' 1524 ' ' MET . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.58 ' HA ' HD13 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1548 ' ' LEU . . . . . 0.58 HD12 HG21 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.543 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1560 ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1561 ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.562 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.478 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.58 HG21 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.523 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' 1575 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1585 ' ' LEU . . . . . 0.627 HD12 HG23 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1586 ' ' THR . . . . . 0.627 HG23 HD12 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.822 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.523 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.502 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.721 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' 1528 ' ' ILE . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.657 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.574 ' HD1' HD12 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.502 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.47 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.601 ' O ' ' HD3' ' A' 1615 ' ' PRO . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' 1619 ' ' ALA . 96.4 m -90.02 107.98 22.93 Favored Pre-proline 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' 1613 ' ' PRO . 47.3 Cg_endo -104.73 6.31 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.097 2.532 . . . . 0.0 108.907 167.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 19.8 m -87.14 -62.9 1.4 Allowed 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.767 -173.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.61 -65.33 1.11 Allowed 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1618 ' ' ASN . . . . . 0.621 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 19.0 m120 -92.67 -179.89 5.3 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1619 ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.6 23.22 11.62 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp -99.13 -171.6 2.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1621 ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' 1621 ' ' LYS . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.596 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.602 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1629 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.474 ' HA2' HD21 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1636 ' ' ALA . . . . . 0.497 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.537 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1639 ' ' LYS . . . . . 0.462 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.415 ' HB3' ' HZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.534 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.54 HD23 HD13 ' A' 1652 ' ' LEU . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' 1651 ' ' THR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.568 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1650 ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' 1618 ' ' ASN . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.538 ' OG1' HG23 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.562 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.667 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.873 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.662 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.873 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.554 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1661 ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' 1658 ' ' THR . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m -86.02 122.97 30.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1663 ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' 1665 ' ' GLU . 39.4 tt0 -87.83 130.06 35.0 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.887 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -78.75 -12.12 60.01 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.382 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1665 ' ' GLU . . . . . 0.521 ' H ' ' HG2' ' A' 1663 ' ' GLU . 33.3 mt-10 -116.02 178.55 4.28 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 124.905 1.282 . . . . 0.0 107.648 -176.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.86 133.83 14.55 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 118.252 0.478 . . . . 0.0 111.455 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 86.8 Cg_endo -74.26 -178.38 3.9 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.373 2.715 . . . . 0.0 114.418 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -53.87 -33.34 56.1 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.449 1.5 . . . . 0.0 112.883 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 18.0 t60 -127.38 92.79 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.453 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 45.0 t-80 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1524 ' ' MET . . . . . 0.594 ' HB2' HG21 ' A' 1535 ' ' THR . 1.1 mpt? . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1525 ' ' LYS . . . . . 0.445 ' HD2' ' HB ' ' A' 1528 ' ' ILE . 37.0 ttpt -160.47 151.89 19.45 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 23.8 m -88.49 -162.08 0.81 Allowed 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.696 0.623 . . . . 0.0 109.495 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1527 ' ' ASN . . . . . 0.708 ' HB2' ' H ' ' A' 1599 ' ' TYR . 5.0 p-10 -74.94 85.37 2.26 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 122.458 1.123 . . . . 0.0 110.762 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1528 ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' 1525 ' ' LYS . 42.6 mm -137.36 154.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -60.03 165.69 3.19 Favored 'General case' 0 C--O 1.256 1.431 0 C-N-CA 124.438 1.095 . . . . 0.0 112.294 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.32 -93.2 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.147 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1531 ' ' ASN . . . . . 0.656 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 -161.33 76.56 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1532 ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' 1569 ' ' CYS . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1533 ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' 1542 ' ' LEU . 14.2 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1535 ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' 1524 ' ' MET . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1536 ' ' ASN . . . . . 0.429 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1542 ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1545 ' ' LEU . . . . . 0.645 ' HA ' HD23 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1549 ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1551 ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' 1571 ' ' GLY . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1554 ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1555 ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1556 ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1557 ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1558 ' ' TYR . . . . . 0.426 ' HD1' HD11 ' A' 1564 ' ' ILE . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1563 ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1564 ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1565 ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1566 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1568 ' ' ILE . . . . . 0.471 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1569 ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' 1532 ' ' CYS . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1571 ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1572 ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1574 ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1575 ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1576 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1578 ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1579 ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1581 ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1582 ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1583 ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1587 ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1589 ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1590 ' ' ALA . . . . . 0.811 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1593 ' ' TRP . . . . . 0.539 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A 1594 ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1595 ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1596 ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1597 ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1598 ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1599 ' ' TYR . . . . . 0.708 ' H ' ' HB2' ' A' 1527 ' ' ASN . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1602 ' ' GLN . . . . . 0.445 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1605 ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' 1626 ' ' ILE . 42.4 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.747 HG22 HG12 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1608 ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1609 ' ' ASP . . . . . 0.648 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1612 ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1613 ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1614 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 30.1 t -85.71 110.22 28.29 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1615 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 3.6 Cg_exo -78.49 -13.28 15.03 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.974 2.449 . . . . 0.0 112.071 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1616 ' ' SER . . . . . 0.404 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 18.9 m -66.18 -57.31 7.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.478 0.656 . . . . 0.0 110.948 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1617 ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' 1647 ' ' LYS . 72.3 mmtt -104.19 -0.04 28.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.957 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 55.8 t30 73.16 -60.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.659 1.584 . . . . 0.0 114.548 169.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -67.08 -27.25 67.21 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1620 ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' 1649 ' ' THR . 4.7 mp -113.7 178.37 4.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 118.419 -1.313 . . . . 0.0 112.419 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1622 ' ' TYR . . . . . 0.51 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1623 ' ' LYS . . . . . 0.648 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1624 ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1625 ' ' VAL . . . . . 0.747 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1626 ' ' ILE . . . . . 0.552 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1630 ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1633 ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1635 ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1637 ' ' ASN . . . . . 0.547 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 6.9 p30 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1638 ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1640 ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1641 ' ' VAL . . . . . 0.475 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1642 ' ' PHE . . . . . 0.621 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1645 ' ' LEU . . . . . 0.621 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1646 ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1647 ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' 1617 ' ' LYS . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1651 ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1652 ' ' LEU . . . . . 0.41 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1653 ' ' TYR . . . . . 0.718 ' HA ' HG23 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1654 ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1655 ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1656 ' ' TRP . . . . . 0.547 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1658 ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1659 ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' 1660 ' ' LEU . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1660 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1662 ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m -86.02 127.86 34.74 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.99 149.07 43.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 60.2 mttm -55.44 -45.89 76.78 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.479 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.04 177.04 5.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1666 ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 40.7 mt-10 -77.59 139.1 62.84 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.948 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1667 ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 14.7 Cg_exo -71.61 -168.62 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.344 2.696 . . . . 0.0 111.856 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.83 -35.58 77.13 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -140.63 114.41 8.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1670 ' ' HIS . . . . . 0.643 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 51.7 t-80 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 120.752 0.311 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' 1542 ' ' LEU . 2.5 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.403 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.488 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.749 ' HB3' HD21 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.713 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' 1552 ' ' SER . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' 1550 ' ' ASN . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' 1563 ' ' LEU . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.558 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.452 ' HE3' HD21 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.51 HD13 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.776 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.591 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' 1549 ' ' LYS . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.606 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.452 HD21 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.441 ' OD1' HG13 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . 0.454 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' 1604 ' ' LEU . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.676 ' HD1' HD12 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.524 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.7 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' 1597 ' ' LEU . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . 0.442 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1649 ' ' THR . 6.4 mp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' 1651 ' ' THR . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.573 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.707 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.553 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.773 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.773 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.451 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' 1623 ' ' LYS . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.566 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.553 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.546 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.524 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.449 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.445 0.641 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.473 HE21 ' HB3' ' A' 1533 ' ' GLN . 2.5 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.441 HG21 ' C ' ' A' 1598 ' ' MET . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.461 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' 1536 ' ' ASN . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' 1536 ' ' ASN . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.916 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.58 ' HB3' HD13 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.434 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.523 HG21 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.916 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.563 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.824 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.44 HD12 HG23 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.44 HG23 HD12 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.446 ' H ' ' HB2' ' A' 1583 ' ' PHE . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.726 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.563 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.654 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.654 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 32.1 mm-40 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.441 ' C ' HG21 ' A' 1534 ' ' VAL . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.712 ' HB3' HD11 ' A' 1597 ' ' LEU . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.676 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.5 t . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.7 HD22 ' HA ' ' A' 1649 ' ' THR . 5.1 mp . . . . . 0 CA--C 1.489 -1.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.601 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.676 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.699 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.695 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.532 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.524 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.478 ' HB2' HG22 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.824 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.824 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.516 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . 0.431 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 6.9 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.7 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.657 HG22 HG22 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.522 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.523 ' HZ ' HG21 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.751 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.751 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 121.018 0.437 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.478 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.574 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.696 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . 0.427 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.427 HD22 ' CG ' ' A' 1544 ' ' ASP . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.899 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.45 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.554 HG12 HG22 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 10.3 m120 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' 1579 ' ' VAL . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.861 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' 1604 ' ' LEU . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.578 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.55 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.858 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.9 tp-100 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.82 HG22 HG12 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' 1649 ' ' THR . 9.5 mp . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.692 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.82 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.858 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.57 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.455 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.526 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 2.1 p-10 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' 1657 ' ' HIS . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB2' ' CG2' ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.623 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.869 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.869 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.499 ' HG2' HD12 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.606 ' HA ' HD22 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.692 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.555 HD13 HD23 ' A' 1645 ' ' LEU . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.696 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.553 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' 1638 ' ' ASN . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.49 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 120.666 0.269 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.681 ' HG3' HD21 ' A' 1542 ' ' LEU . 2.7 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' 1599 ' ' TYR . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.422 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.754 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . 0.446 ' HB3' HD21 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.533 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.512 HD13 HD12 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.53 HG12 HG22 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' 1573 ' ' LYS . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.9 m120 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.445 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.538 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' 1604 ' ' LEU . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.701 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . 0.408 ' O ' ' HB ' ' A' 1603 ' ' VAL . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' 1626 ' ' ILE . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.797 HG22 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.538 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p . . . . . 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' 1649 ' ' THR . 9.1 mp . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.797 HG12 HG22 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.776 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' 1658 ' ' THR . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.466 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.9 p-10 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' 1655 ' ' SER . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.753 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.615 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.54 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.539 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.44 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 79.0 m . . . . . 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.826 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 . . . . . 0 CA--C 1.503 -0.835 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.826 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 2.8 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.832 ' HB3' HD21 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . 0.411 ' O ' HD22 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.632 ' CD2' HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.61 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.939 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' 1564 ' ' ILE . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1564 ' ' ILE . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' 1558 ' ' TYR . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.55 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.593 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.586 ' CZ ' HD11 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.481 HD12 HG23 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.481 HG23 HD12 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.5 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.486 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.638 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.446 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1626 ' ' ILE . 21.7 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.442 HD13 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.729 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.629 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t . . . . . 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.624 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.729 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.73 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.519 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.939 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' 1655 ' ' SER . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.439 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.572 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.592 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.662 ' HA ' HG23 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' 1564 ' ' ILE . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.759 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.759 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.73 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.5 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.591 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.0 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.43 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.651 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.654 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.616 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.425 HD13 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.608 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.559 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.608 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.444 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.581 HG12 HG22 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.403 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 13.0 m120 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.57 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.474 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.757 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.458 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' 1596 ' ' GLN . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.6 mm-40 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.625 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.625 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.0 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.0 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.789 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p . . . . . 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' 1649 ' ' THR . 6.1 mp . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' 1651 ' ' THR . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.789 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.671 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.829 ' HB2' HG22 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.552 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.797 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.797 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.636 ' HA ' HD22 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.716 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.552 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.667 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.667 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 72.7 m . . . . . 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 120.876 0.369 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.2 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' 1543 ' ' PHE . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.768 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.681 ' HA ' HD23 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . 0.714 ' HB2' HD21 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.452 HD12 HD22 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.467 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.41 ' CB ' ' HD3' ' A' 1561 ' ' LYS . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.41 ' HD3' ' CB ' ' A' 1560 ' ' GLU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.536 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.467 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.491 ' OD1' HG13 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.712 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.482 ' HA ' ' NE2' ' A' 1596 ' ' GLN . 11.2 mm-40 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' 1533 ' ' GLN . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' 1604 ' ' LEU . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.712 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.412 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.986 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' 1597 ' ' LEU . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.602 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.902 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.419 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 18.0 p . . . . . 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.986 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' 1658 ' ' THR . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.593 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.7 p-10 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.715 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.62 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.571 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' 1564 ' ' ILE . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 . . . . . 0 CA--C 1.523 -0.069 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' 1543 ' ' PHE . 2.8 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' 1598 ' ' MET . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' 1541 ' ' HIS . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . 0.49 ' HD2' ' HB ' ' A' 1539 ' ' THR . 31.1 m-70 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.675 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.477 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' 1555 ' ' SER . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.528 HD13 HD12 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.492 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.415 HG21 ' HE2' ' A' 1622 ' ' TYR . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.664 ' HB2' HG13 ' A' 1579 ' ' VAL . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.721 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . 0.427 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.492 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.518 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.4 ' HB3' ' N ' ' A' 1532 ' ' CYS . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 30.1 mm-40 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.595 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.462 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.644 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.52 ' HB2' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.447 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 23.4 p . . . . . 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.723 HD22 ' HA ' ' A' 1649 ' ' THR . 7.3 mp . . . . . 0 CA--C 1.506 -0.729 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' 1651 ' ' THR . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.6 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.2 p-10 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.677 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.64 HG12 ' OG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.911 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.911 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.464 ' N ' HD13 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.723 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.515 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.713 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.64 ' OG ' HG12 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.6 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.55 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.526 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m . . . . . 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.5 -0.973 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.569 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.608 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.6 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' 1598 ' ' MET . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.564 ' CD2' HD11 ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.569 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.53 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.439 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.481 ' HE2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.553 HG12 HG22 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.432 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.412 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.476 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.532 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.537 HG12 ' SG ' ' A' 1575 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.607 HD12 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.607 HG23 HD12 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.804 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.532 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.435 ' H ' ' HE1' ' A' 1608 ' ' TYR . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' 1594 ' ' ASN . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.843 HD11 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.407 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 1.051 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.421 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.743 HG22 HG12 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.55 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' 1620 ' ' LEU . 41.3 t . . . . . 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.665 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.743 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.641 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 1.051 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.708 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.643 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.516 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.576 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.6 HD23 HD13 ' A' 1652 ' ' LEU . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.512 ' HG2' HD12 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.6 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.65 ' HA ' HG23 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.516 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.607 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.708 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1543 ' ' PHE . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' 1543 ' ' PHE . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' 1594 ' ' ASN . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' 1604 ' ' LEU . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.4 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 13.5 p . . . . . 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp . . . . . 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m . . . . . 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.751 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.424 HD12 HD22 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.488 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.504 ' CD1' HD11 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.922 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.922 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' 1558 ' ' TYR . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.467 HG12 HG22 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.512 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.488 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.466 ' H ' HG23 ' A' 1572 ' ' THR . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 1585 ' ' LEU . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.776 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . 0.418 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.415 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.439 ' H ' ' HE1' ' A' 1608 ' ' TYR . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' 1604 ' ' LEU . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.692 ' HD1' HD12 ' A' 1604 ' ' LEU . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.624 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.984 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.497 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.576 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 121.176 0.513 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.984 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.775 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.422 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.45 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.497 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.497 ' OG1' HG23 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.483 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.402 ' CD1' HG11 ' A' 1556 ' ' VAL . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.765 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.512 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.765 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.775 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m . . . . . 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.628 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 2.9 m-20 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.628 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 3.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.468 HG21 ' N ' ' A' 1599 ' ' TYR . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.738 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.578 HD23 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.625 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.412 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.625 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.538 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.487 HG21 ' HZ ' ' A' 1654 ' ' PHE . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.538 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' 1572 ' ' THR . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.532 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.698 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.57 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.409 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.719 ' HD1' HD12 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.513 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.646 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG12 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' 1649 ' ' THR . 5.0 mp . . . . . 0 C--O 1.248 0.976 0 CA-C-O 121.868 0.842 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.56 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.74 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.568 ' HB3' HG11 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.641 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.505 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.803 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.702 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.579 HG23 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.583 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.74 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.719 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.719 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.421 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m . . . . . 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.675 ' HB2' HD11 ' A' 1542 ' ' LEU . 4.1 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.491 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.476 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.509 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.607 HD21 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.607 ' CD1' HD21 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.814 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.537 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' 1564 ' ' ILE . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.509 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.814 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.617 HD21 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.617 ' HB2' HD21 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' 1604 ' ' LEU . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.557 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.419 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.938 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 34.1 t . . . . . 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' 1649 ' ' THR . 5.2 mp . . . . . 0 CA--C 1.495 -1.148 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.963 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.588 ' HB3' HG11 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.938 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.445 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.502 ' ND2' ' HD3' ' A' 1640 ' ' PRO . 2.0 p-10 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.68 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.68 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.479 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.494 ' HG2' HD12 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.708 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.963 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.594 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.552 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m . . . . . 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 35.5 t-20 . . . . . 0 C--O 1.218 -0.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 3.9 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.536 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' 1599 ' ' TYR . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.539 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.526 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.548 ' HB3' HD13 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.44 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.468 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' 1555 ' ' SER . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.437 HD13 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.564 HG12 HG22 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.473 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' 1595 ' ' SER . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.475 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.669 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.455 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.578 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.401 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' 1604 ' ' LEU . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.671 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.671 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.981 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.9 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.578 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1605 ' ' GLN . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.981 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.428 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' 1641 ' ' VAL . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.459 HG22 ' HE3' ' A' 1639 ' ' LYS . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.817 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.817 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.541 HD13 HD23 ' A' 1645 ' ' LEU . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.635 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 1638 ' ' ASN . 33.9 m170 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.665 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.665 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.868 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 63.9 t30 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.868 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 4.0 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' 1598 ' ' MET . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.727 HD23 HD22 ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' 1572 ' ' THR . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . 0.517 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.639 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' 1654 ' ' PHE . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.458 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.73 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.506 ' CE1' HD11 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . 0.441 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG11 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.53 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.441 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' 1596 ' ' GLN . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.416 ' H ' ' HB3' ' A' 1594 ' ' ASN . 20.7 mm-40 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' 1604 ' ' LEU . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.548 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.486 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.7 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.495 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.5 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 CA--C 1.498 -1.035 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.453 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.554 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.953 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.848 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.537 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.62 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.471 HG12 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.593 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.527 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.586 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.51 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.447 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.471 ' OG ' HG12 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.62 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.506 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.848 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.727 HD22 HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' 1628 ' ' PHE . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t . . . . . 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.8 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.491 ' HB ' ' HG ' ' A' 1597 ' ' LEU . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.406 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.602 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.611 ' HA ' HD23 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.478 ' H ' ' HA ' ' A' 1563 ' ' LEU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.431 ' H ' ' HD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.511 HG21 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.495 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.498 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.401 ' H ' HG23 ' A' 1572 ' ' THR . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' 1652 ' ' LEU . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 0.9 OUTLIER -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.717 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.481 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.786 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1624 ' ' SER . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.509 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t . . . . . 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' 1649 ' ' THR . 5.3 mp . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.786 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.629 HD12 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.567 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.594 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.594 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.436 ' HG2' HD12 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.554 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.726 ' HA ' HG23 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.575 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 83.9 m . . . . . 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 . . . . . 0 C--O 1.223 -0.326 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' 1542 ' ' LEU . 2.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' 1599 ' ' TYR . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' 1536 ' ' ASN . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.755 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.519 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.441 HD12 HD22 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.57 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.618 HD13 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.511 HG12 HG22 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.463 HG23 ' H ' ' A' 1575 ' ' CYS . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 0.9 OUTLIER -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.862 HG12 ' HB3' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.565 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.862 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' 1596 ' ' GLN . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.486 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.417 ' H ' ' HB3' ' A' 1594 ' ' ASN . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.699 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.559 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.697 HG22 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' 1620 ' ' LEU . 23.4 t . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' 1649 ' ' THR . 7.5 mp . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.536 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.697 HG12 HG22 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.54 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.6 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.845 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.505 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.906 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.906 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . 0.449 ' HG2' HD12 ' A' 1645 ' ' LEU . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.612 ' HA ' HD22 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.65 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.597 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.57 ' HZ ' HG21 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.721 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.721 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.845 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.64 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m . . . . . 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.543 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 3.2 m-20 . . . . . 0 C--O 1.243 0.728 0 CA-C-O 120.267 0.08 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.536 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 4.0 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.476 HG21 ' C ' ' A' 1598 ' ' MET . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.58 ' HA ' HD13 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . 0.58 HD12 HG21 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.543 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.562 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.478 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.58 HG21 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.523 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' 1575 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . 0.627 HD12 HG23 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . 0.627 HG23 HD12 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.822 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.523 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.502 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.721 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.859 ' HA ' HE21 ' A' 1596 ' ' GLN . 0.0 OUTLIER -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' 1604 ' ' LEU . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.476 ' C ' HG21 ' A' 1534 ' ' VAL . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.574 ' HD1' HD12 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.507 HE21 ' HB2' ' A' 1605 ' ' GLN . 4.2 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.502 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.47 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' 1621 ' ' LYS . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.596 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.602 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.474 ' HA2' HD21 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . 0.497 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.537 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . 0.462 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.415 ' HB3' ' HZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.534 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.54 HD23 HD13 ' A' 1652 ' ' LEU . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' 1651 ' ' THR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.568 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.538 ' OG1' HG23 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.562 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.667 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.873 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.662 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.873 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.554 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' 1658 ' ' THR . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m . . . . . 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1531 ' ' ASN . . . . . 0.656 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1532 ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' 1569 ' ' CYS . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1533 ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1535 ' ' THR . . . . . . . . . . . . . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1536 ' ' ASN . . . . . 0.429 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1542 ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1545 ' ' LEU . . . . . 0.645 ' HA ' HD23 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1549 ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1551 ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' 1571 ' ' GLY . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1554 ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1555 ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1556 ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1557 ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1558 ' ' TYR . . . . . 0.426 ' HD1' HD11 ' A' 1564 ' ' ILE . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1563 ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1564 ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1565 ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1566 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1568 ' ' ILE . . . . . 0.471 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1569 ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' 1532 ' ' CYS . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1571 ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1572 ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1574 ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1575 ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1576 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1578 ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1579 ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1581 ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1582 ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1583 ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1587 ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1589 ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1590 ' ' ALA . . . . . 0.811 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1593 ' ' TRP . . . . . 0.539 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A 1594 ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1595 ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1596 ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1597 ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1598 ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1599 ' ' TYR . . . . . 0.56 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1602 ' ' GLN . . . . . 0.445 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1605 ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.8 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.747 HG22 HG12 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1608 ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1609 ' ' ASP . . . . . 0.648 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1612 ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1613 ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1620 ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' 1649 ' ' THR . 4.7 mp . . . . . 0 CA--C 1.501 -0.938 0 CA-C-O 121.224 0.535 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1622 ' ' TYR . . . . . 0.51 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1623 ' ' LYS . . . . . 0.648 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1624 ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1625 ' ' VAL . . . . . 0.747 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1626 ' ' ILE . . . . . 0.552 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1630 ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1633 ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1635 ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1637 ' ' ASN . . . . . 0.547 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1638 ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1640 ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1641 ' ' VAL . . . . . 0.475 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1642 ' ' PHE . . . . . 0.621 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1644 ' ' SER . . . . . . . . . . . . . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1645 ' ' LEU . . . . . 0.621 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1646 ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1651 ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1652 ' ' LEU . . . . . 0.41 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1653 ' ' TYR . . . . . 0.718 ' HA ' HG23 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1654 ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1655 ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1656 ' ' TRP . . . . . 0.547 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1658 ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1659 ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' 1660 ' ' LEU . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1660 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1662 ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 60.3 mtm . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 22.5 tptm 69.96 157.81 0.16 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.371 1.068 . . . . 0.0 111.119 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 38.7 t -52.76 150.25 5.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.226 1.01 . . . . 0.0 112.381 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.473 ' HB3' ' H ' ' A' 1535 ' ' THR . 39.7 t30 -105.36 88.6 2.89 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.587 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.994 HG12 ' HG2' ' A' 1598 ' ' MET . 11.5 mt -72.42 85.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 C-N-CA 124.325 1.05 . . . . 0.0 109.559 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -101.88 159.79 15.04 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.22 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -95.33 15.97 17.99 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.428 0.691 . . . . 0.0 111.034 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -108.29 19.92 19.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.1 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 6.9 t 64.66 41.41 5.3 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.857 0.863 . . . . 0.0 109.931 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' 1542 ' ' LEU . 2.5 pt20 -148.01 152.93 38.28 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' 1527 ' ' ASN . 2.6 p -144.58 129.81 14.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 1.7 m -92.05 126.21 37.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.488 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 43.8 t30 -66.48 120.05 67.53 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.155 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.02 -8.9 23.17 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.303 2.002 . . . . 0.0 112.828 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.72 14.81 Favored 'General case' 0 N--CA 1.428 -1.546 0 O-C-N 122.132 -0.355 . . . . 0.0 110.976 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.78 -27.96 4.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.36 0.6 . . . . 0.0 112.398 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.04 9.52 76.95 Favored Glycine 0 N--CA 1.409 -3.121 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.3 t60 -77.18 114.0 15.53 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.605 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -72.29 134.64 45.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.238 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.749 ' HB3' HD21 ' A' 1604 ' ' LEU . 72.0 m-85 -104.92 149.01 26.07 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.774 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.1 t70 -143.66 127.19 16.94 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.663 0.21 . . . . 0.0 111.485 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.713 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -109.92 3.77 20.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 48.0 m-80 -66.27 -20.49 66.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.651 0.739 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.9 m -70.24 -13.52 62.21 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.062 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' 1637 ' ' ASN . 69.1 mt -101.84 14.61 31.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.945 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 49.0 mtmt -91.73 102.55 15.16 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.953 0.882 . . . . 0.0 111.686 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' 1552 ' ' SER . 6.2 p30 -142.07 145.9 34.85 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.557 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' 1572 ' ' THR . 4.5 p-10 -78.54 -14.23 59.44 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.58 -177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' A' 1550 ' ' ASN . 13.7 t -51.18 -43.76 61.39 Favored 'General case' 0 C--O 1.246 0.872 0 O-C-N 124.187 0.929 . . . . 0.0 108.881 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 89.73 170.3 44.31 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.853 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 86.3 m-85 -129.65 160.98 31.66 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.601 -0.799 . . . . 0.0 110.783 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' 1563 ' ' LEU . 6.7 p -140.59 149.68 42.66 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 122.33 0.252 . . . . 0.0 110.444 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.751 HG22 ' HB2' ' A' 1640 ' ' PRO . 93.9 t -143.53 94.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -43.45 119.63 1.68 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.681 0.753 . . . . 0.0 112.333 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.558 ' H ' ' HA ' ' A' 1563 ' ' LEU . 43.4 t80 -88.1 145.74 25.79 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.833 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.0 p -54.7 -38.82 67.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.69 -89.22 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.452 ' HE3' HD21 ' A' 1585 ' ' LEU . 0.1 OUTLIER -147.49 32.73 0.87 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -174.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.33 -170.49 23.08 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.2 pp -129.46 173.97 10.07 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.51 HD13 HD12 ' A' 1652 ' ' LEU . 31.2 mt -125.94 119.53 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.776 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 52.7 m-85 -80.71 149.42 29.73 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.591 HG12 HG22 ' A' 1581 ' ' VAL . 22.6 mt -131.0 144.17 38.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.484 0.659 . . . . 0.0 112.424 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.81 137.29 10.14 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 107.319 -2.312 . . . . 0.0 107.319 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' 1549 ' ' LYS . 41.1 mm -105.3 100.44 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 118.068 0.934 . . . . 0.0 110.656 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.7 p 52.42 18.32 0.92 Allowed 'General case' 0 C--N 1.367 1.333 0 C-N-CA 125.073 1.349 . . . . 0.0 113.779 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.18 167.86 32.93 Favored Glycine 0 N--CA 1.417 -2.612 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.35 147.11 28.2 Favored Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.07 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.0 OUTLIER -128.35 165.01 21.41 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 17.2 pttp -92.89 -11.23 34.0 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.488 0.661 . . . . 0.0 109.9 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -91.0 -21.28 21.36 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.653 0.739 . . . . 0.0 111.336 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 3.3 m -131.02 143.83 51.05 Favored Pre-proline 0 C--N 1.286 -2.167 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.195 171.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.07 147.52 82.42 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.095 2.53 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.6 t -70.99 122.2 19.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 112.58 -13.49 25.21 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' 1582 ' ' CYS . 56.0 t -116.48 121.2 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.31 -39.47 7.83 Favored Glycine 0 C--N 1.293 -1.849 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' 1590 ' ' ALA . 42.3 t -139.23 134.83 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.606 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.3 p -147.39 135.75 21.66 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.373 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' 1587 ' ' LYS . 39.4 m-85 -65.48 149.87 49.31 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -96.46 -23.9 15.33 Favored Glycine 0 C--N 1.291 -1.944 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.799 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.452 HD21 ' HE3' ' A' 1561 ' ' LYS . 20.2 tp -56.55 -65.92 0.53 Allowed 'General case' 0 N--CA 1.425 -1.714 0 C-N-CA 124.329 1.052 . . . . 0.0 111.278 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 73.6 p -123.02 21.26 9.83 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.148 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.4 mmtp 52.78 69.02 0.74 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.539 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.521 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 18.5 mt -105.55 101.9 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.275 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.441 ' OD1' HG13 ' A' 1579 ' ' VAL . 20.3 t30 -52.11 108.35 0.28 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.977 0.894 . . . . 0.0 110.006 171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.69 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -94.66 5.45 51.82 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.101 -173.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 167.09 120.59 0.52 Allowed Glycine 0 C--N 1.287 -2.142 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . 0.454 ' O ' ' HD1' ' A' 1608 ' ' TYR . 49.9 m -76.56 156.26 32.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.992 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.5 124.71 1.65 Allowed 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.929 1.692 . . . . 0.0 112.931 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.97 156.95 42.63 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.7 m -127.86 17.58 6.78 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -72.61 89.24 1.3 Allowed 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 113.498 -1.683 . . . . 0.0 109.262 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' 1604 ' ' LEU . 60.2 tp -100.53 141.87 32.79 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.883 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.994 ' HG2' HG12 ' A' 1528 ' ' ILE . 30.0 mtm -138.73 165.53 26.72 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.676 ' HD1' HD12 ' A' 1604 ' ' LEU . 54.5 t80 -128.06 101.74 6.42 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.2 p -138.86 124.95 23.74 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.037 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 65.17 38.86 5.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 124.083 0.953 . . . . 0.0 111.214 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.524 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.8 mt-30 64.52 13.97 8.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.283 0.633 . . . . 0.0 111.616 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' 1627 ' ' SER . 24.9 t -123.59 134.63 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.357 1.063 . . . . 0.0 110.582 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -76.15 139.16 41.15 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.7 tt0 -140.39 132.16 27.42 Favored 'General case' 0 C--N 1.268 -2.967 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.798 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' 1597 ' ' LEU . 87.2 mt -112.18 127.12 55.85 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 6.3 p -111.64 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-O 122.586 1.184 . . . . 0.0 110.53 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' 1624 ' ' SER . 84.3 m-85 -78.48 93.74 4.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.923 -1.489 . . . . 0.0 107.777 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.0 168.99 9.01 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.718 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.07 50.56 4.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 125.13 1.372 . . . . 0.0 110.071 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . 0.442 ' HA2' ' OG ' ' A' 1592 ' ' SER . . . -85.08 -134.37 3.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.892 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -81.56 160.6 64.11 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.491 ' O ' ' HD3' ' A' 1615 ' ' PRO . 24.7 Cg_endo -72.65 128.67 13.67 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.072 1.848 . . . . 0.0 111.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' 1620 ' ' LEU . 44.6 t -96.44 107.18 34.29 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.075 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' 1613 ' ' PRO . 72.4 Cg_endo -102.19 8.9 0.45 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.123 2.549 . . . . 0.0 112.108 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.7 m -62.16 -62.52 1.71 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 124.413 1.085 . . . . 0.0 113.569 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.94 -60.35 0.97 Allowed 'General case' 0 CA--C 1.495 -1.161 0 CA-C-O 121.176 0.512 . . . . 0.0 109.792 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.6 167.92 9.81 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -104.8 32.39 4.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -171.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' 1649 ' ' THR . 6.4 mp -86.36 -171.79 3.73 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -107.1 162.14 14.13 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' 1590 ' ' ALA . 59.4 m-85 -69.5 139.9 53.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.156 0.503 . . . . 0.0 110.856 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' 1651 ' ' THR . 1.8 ttpm? -143.46 139.7 30.01 Favored 'General case' 0 N--CA 1.384 -3.749 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.842 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 53.4 m -116.09 130.03 56.62 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 123.975 0.797 . . . . 0.0 110.978 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.1 m -120.26 93.13 2.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 122.371 1.081 . . . . 0.0 110.531 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 47.8 mt -86.53 109.69 19.21 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.117 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.485 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.573 ' HB3' HG11 ' A' 1603 ' ' VAL . 13.9 m -91.01 115.32 27.92 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.038 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 69.3 m-85 -92.7 110.03 21.46 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 122.563 1.173 . . . . 0.0 109.725 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' 1657 ' ' HIS . 39.6 t -104.57 124.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.63 0 CA-C-N 112.908 -1.951 . . . . 0.0 110.167 -175.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.75 123.39 3.16 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 124.805 1.242 . . . . 0.0 112.85 175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.4 t -124.36 143.25 50.7 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -73.25 4.1 4.96 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 3.4 m-20 -63.6 178.69 0.55 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.645 0.778 . . . . 0.0 110.278 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 46.9 m -112.21 91.09 3.53 Favored 'General case' 0 N--CA 1.404 -2.76 0 O-C-N 121.313 -0.867 . . . . 0.0 112.528 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 61.42 61.14 7.17 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.331 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -134.06 -178.37 5.0 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 123.098 0.559 . . . . 0.0 109.509 -174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.707 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.5 p-10 -123.27 -18.45 6.28 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 6.2 m-20 65.7 -80.03 0.03 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 C-N-CA 125.315 1.446 . . . . 0.0 111.491 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -172.46 124.71 0.49 Allowed Pre-proline 0 C--N 1.269 -2.912 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.687 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.751 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -70.9 125.21 11.33 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.835 1.69 . . . . 0.0 110.045 167.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.553 ' HB ' ' OG ' ' A' 1655 ' ' SER . 10.8 t -114.52 134.13 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.773 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 56.8 t80 -79.69 114.72 18.83 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.93 -54.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.97 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 71.6 m -150.01 156.4 41.64 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.636 -173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.773 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -120.05 142.11 49.14 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' 1651 ' ' THR . 11.7 t70 -111.5 116.09 30.3 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 79.0 mttt -93.29 4.51 53.86 Favored 'General case' 0 C--N 1.283 -2.298 0 O-C-N 123.411 0.444 . . . . 0.0 110.991 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -93.25 -35.48 13.09 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.708 0.766 . . . . 0.0 109.7 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.451 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.0 t -132.43 18.26 4.38 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 122.124 0.964 . . . . 0.0 110.614 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 83.0 m 46.2 52.88 9.96 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' 1623 ' ' LYS . 30.9 m -109.48 113.46 26.28 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.039 -172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.566 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -77.09 103.51 7.06 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 125.692 1.597 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 65.9 m-85 -86.72 120.91 28.52 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 75.5 m-85 -115.88 142.35 46.89 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.39 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.553 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.7 p -109.18 118.57 37.08 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.546 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -122.35 116.53 24.2 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.524 ' HB3' ' HB ' ' A' 1631 ' ' THR . 20.3 m-70 -91.65 102.95 15.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.4 t -126.75 136.52 28.88 Favored Pre-proline 0 N--CA 1.417 -2.101 0 CA-C-O 121.533 0.683 . . . . 0.0 110.409 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.777 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.0 Cg_exo -66.42 -21.44 53.63 Favored 'Trans proline' 0 CA--C 1.488 -1.777 0 C-N-CA 124.048 3.166 . . . . 0.0 112.147 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.2 pp -78.03 -18.92 55.26 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.033 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.449 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.39 -2.39 52.9 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.601 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 1.7 t -102.12 141.76 34.46 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.726 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.53 119.3 38.67 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-O 121.996 0.903 . . . . 0.0 112.775 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.29 -17.53 42.21 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.456 165.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -73.96 125.73 28.89 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.682 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -74.59 133.37 77.04 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 123.458 0.474 . . . . 0.0 111.132 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 61.6 Cg_endo -80.27 -168.76 0.67 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 123.311 2.674 . . . . 0.0 111.978 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -65.86 -50.42 64.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.097 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -106.93 93.32 4.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.738 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 2.3 p80 . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.342 0.115 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -119.46 141.28 49.29 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.104 0.478 . . . . 0.0 110.188 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 51.3 m -132.54 -173.43 3.17 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.171 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.505 ' HB2' ' H ' ' A' 1599 ' ' TYR . 3.8 p-10 -71.85 97.85 1.89 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.955 0.883 . . . . 0.0 111.371 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . . . . . . . . . 25.8 pt -139.49 -176.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 C-N-CA 125.2 1.4 . . . . 0.0 109.268 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.05 151.27 40.24 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 13.4 t0 -164.52 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.9 t30 -175.41 70.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.353 0.661 . . . . 0.0 110.113 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 2.3 t 64.12 29.4 14.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.385 1.074 . . . . 0.0 109.981 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.473 HE21 ' HB3' ' A' 1533 ' ' GLN . 2.5 pt20 -152.08 146.35 25.46 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.865 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.441 HG21 ' C ' ' A' 1598 ' ' MET . 7.7 p -140.77 131.24 27.84 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.29 0 O-C-N 123.662 0.601 . . . . 0.0 110.291 -176.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 33.4 m -94.59 126.01 39.6 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.461 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.2 t-20 -64.69 122.95 81.75 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.608 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 -12.46 28.76 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.667 2.245 . . . . 0.0 113.469 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -97.6 -27.95 14.16 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 121.6 -0.687 . . . . 0.0 111.782 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' 1536 ' ' ASN . 43.1 p -117.89 -33.14 4.57 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 111.646 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.28 11.29 69.63 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -171.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -79.56 117.53 20.58 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.018 0.437 . . . . 0.0 111.421 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.5 tm? -73.44 133.14 43.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.37 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.461 ' HE2' ' HB2' ' A' 1536 ' ' ASN . 90.5 m-85 -107.78 146.53 32.07 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.51 130.53 18.32 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 118.615 0.643 . . . . 0.0 111.61 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 42.6 mt -109.71 6.54 23.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 44.2 m-80 -65.72 -22.31 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 7.1 m -67.04 -25.53 66.31 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.18 -5.03 55.53 Favored 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 122.023 -0.423 . . . . 0.0 111.741 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 40.0 mtmt -74.06 99.04 3.22 Favored 'General case' 0 N--CA 1.394 -3.235 0 C-N-CA 123.197 0.599 . . . . 0.0 110.272 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.4 150.84 50.91 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.95 -27.4 64.72 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 125.076 1.35 . . . . 0.0 112.574 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.916 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 19.3 m -58.79 -47.28 85.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 C-N-CA 123.111 0.564 . . . . 0.0 110.547 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 88.18 172.2 46.93 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.618 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 88.4 m-85 -119.42 169.82 9.69 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.442 -174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.58 ' HB3' HD13 ' A' 1563 ' ' LEU . 21.5 m -153.39 151.01 29.44 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 122.923 0.489 . . . . 0.0 110.188 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.2 t -142.85 93.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 124.075 0.95 . . . . 0.0 108.768 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.463 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.07 125.34 6.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.771 173.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.434 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.2 t80 -91.52 161.19 15.06 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -62.49 -14.43 41.5 Favored 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -98.03 -82.18 0.42 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.2 OUTLIER -146.21 4.17 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -148.58 172.95 28.69 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -107.63 179.66 4.17 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 123.971 0.908 . . . . 0.0 110.4 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.523 HG21 ' HZ ' ' A' 1654 ' ' PHE . 36.9 mt -126.21 117.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 95.4 m-85 -80.44 145.07 32.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.48 HG12 HG22 ' A' 1581 ' ' VAL . 63.0 mt -131.37 136.52 57.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.623 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.65 129.42 8.0 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 47.3 mm -96.03 97.14 6.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 117.772 0.786 . . . . 0.0 109.746 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' 1594 ' ' ASN . 20.9 m 59.54 13.77 3.52 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 112.118 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 165.24 32.11 Favored Glycine 0 N--CA 1.417 -2.609 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.585 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -80.0 146.85 28.45 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.035 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.0 OUTLIER -128.45 165.06 21.4 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.916 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.3 pttt -91.29 -10.3 41.91 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.492 0.663 . . . . 0.0 110.025 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.54 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.1 m-20 -94.34 -21.43 18.99 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.135 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . . . . . . . . . 8.3 t -136.3 142.0 38.09 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' 1579 ' ' VAL . 18.1 Cg_exo -60.64 154.1 57.03 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.071 2.514 . . . . 0.0 116.195 -172.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 45.1 p -66.15 130.51 43.5 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.684 172.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.563 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 91.97 -1.76 74.78 Favored Glycine 0 C--N 1.312 -0.779 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' 1589 ' ' ASN . 71.9 t -117.3 123.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.86 -38.29 8.78 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.114 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.726 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.5 t -145.33 142.7 22.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.824 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.7 p -151.83 138.37 18.67 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' 1587 ' ' LYS . 41.3 m-85 -64.03 145.88 55.12 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.5 -44.49 4.92 Favored Glycine 0 C--N 1.277 -2.73 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.211 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.44 HD12 HG23 ' A' 1586 ' ' THR . 0.5 OUTLIER -62.69 -61.36 2.48 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.609 0.764 . . . . 0.0 109.894 -176.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.44 HG23 HD12 ' A' 1585 ' ' LEU . 3.2 p -101.14 7.84 43.01 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.736 -173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' 1583 ' ' PHE . 33.3 mmtp 48.59 49.95 17.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.996 1.318 . . . . 0.0 113.974 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.446 ' H ' ' HB2' ' A' 1583 ' ' PHE . 21.9 mt -104.69 100.57 10.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.529 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 4.3 p-10 -55.15 109.78 0.58 Allowed 'General case' 0 C--O 1.203 -1.37 0 CA-C-O 122.761 1.267 . . . . 0.0 113.842 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.726 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.26 15.71 6.03 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.773 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 174.86 144.28 4.84 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 58.6 m -94.01 142.07 27.81 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.297 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.563 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.09 122.47 1.51 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.682 1.993 . . . . 0.0 111.402 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.654 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 78.7 m-20 -153.78 169.58 23.02 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 5.3 m -127.59 30.25 5.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.654 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 32.1 mm-40 -77.89 88.47 4.08 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.148 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.712 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.7 tp -112.07 137.16 50.5 Favored 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 123.456 0.472 . . . . 0.0 111.175 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.441 ' C ' HG21 ' A' 1534 ' ' VAL . 4.0 mtm -136.16 -177.79 4.86 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.365 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 52.9 t80 -139.84 103.93 4.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.9 p -135.7 123.62 36.87 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.575 -175.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.72 38.87 5.06 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 123.75 0.82 . . . . 0.0 112.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.594 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.1 mt-30 65.17 16.33 10.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.752 0.821 . . . . 0.0 110.882 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' 1627 ' ' SER . 37.2 t -123.82 133.85 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.919 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.712 ' HB3' HD11 ' A' 1597 ' ' LEU . 4.1 mt -76.09 141.76 41.91 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.75 121.38 31.83 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.723 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' 1625 ' ' VAL . 50.7 mt -101.06 124.85 47.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.676 HG22 HG12 ' A' 1625 ' ' VAL . 87.4 t -117.22 98.05 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.812 0.815 . . . . 0.0 109.756 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 35.6 m-85 -91.37 91.15 8.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.605 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 23.4 t70 -91.13 170.82 9.71 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.11 0.564 . . . . 0.0 111.037 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.51 61.26 2.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.0 1.72 . . . . 0.0 111.923 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.06 -142.4 6.61 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.978 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.52 166.88 32.07 Favored Pre-proline 0 C--N 1.295 -1.772 0 C-N-CA 123.078 0.551 . . . . 0.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 19.0 Cg_endo -65.53 127.97 19.19 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.98 1.787 . . . . 0.0 111.387 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' 1616 ' ' SER . 10.5 t -89.28 108.09 22.25 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.858 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' 1613 ' ' PRO . 3.8 Cg_exo -75.48 -9.67 20.18 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.286 2.657 . . . . 0.0 112.001 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . 0.503 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 6.8 m -67.42 -43.65 80.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -119.87 3.6 11.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.949 0.88 . . . . 0.0 111.343 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 11.0 t30 73.5 -66.57 0.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 126.772 2.029 . . . . 0.0 114.389 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.78 57.2 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.7 HD22 ' HA ' ' A' 1649 ' ' THR . 5.1 mp -98.9 173.34 6.9 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.992 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.465 ' N ' ' HE2' ' A' 1621 ' ' LYS . 0.4 OUTLIER -108.13 158.16 17.67 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.601 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 32.0 m-85 -79.5 144.98 33.47 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.263 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 14.7 ttpt -138.18 142.62 40.04 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 44.1 t -113.81 136.43 52.87 Favored 'General case' 0 C--N 1.272 -2.783 0 O-C-N 123.498 0.499 . . . . 0.0 110.532 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.676 HG12 HG22 ' A' 1607 ' ' VAL . 0.5 OUTLIER -125.69 92.62 2.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.509 1.147 . . . . 0.0 110.137 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.69 109.17 18.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.925 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.037 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.699 ' HB2' HG11 ' A' 1603 ' ' VAL . 30.6 p -90.48 118.55 30.04 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.566 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.71 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 88.4 m-85 -95.64 107.69 19.91 Favored 'General case' 0 CA--C 1.483 -1.629 0 CA-C-O 121.952 0.882 . . . . 0.0 110.251 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.4 t -103.33 124.27 57.4 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 CA-C-N 112.677 -2.056 . . . . 0.0 109.776 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.6 t -49.87 125.89 12.87 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 125.42 1.488 . . . . 0.0 113.665 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 7.4 t -130.69 143.78 50.98 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 33.2 m80 -64.15 2.59 0.54 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.695 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 15.3 m-20 -74.28 -164.0 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.475 0.71 . . . . 0.0 111.874 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.0 t -126.86 105.84 8.92 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.972 -0.455 . . . . 0.0 110.509 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 42.22 58.23 3.4 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.327 0.965 . . . . 0.0 113.706 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.532 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.09 179.29 4.58 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.524 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 26.1 p-10 -104.43 -22.09 13.37 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 22.8 t-20 65.05 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.356 0.891 0 C-N-CA 125.869 1.667 . . . . 0.0 108.474 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -173.59 106.7 0.31 Allowed Pre-proline 0 C--N 1.275 -2.637 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.262 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.478 ' HB2' HG22 ' A' 1556 ' ' VAL . 4.2 Cg_exo -75.19 134.7 17.82 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.583 2.189 . . . . 0.0 110.521 175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.0 t -120.15 155.46 23.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.824 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 92.4 t80 -95.51 106.88 19.0 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.7 p -77.27 -53.47 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 44.1 t -162.85 154.04 17.38 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.265 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.824 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -104.44 136.86 43.21 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.516 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 16.0 t70 -93.97 106.82 18.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' 1645 ' ' LEU . 78.0 mttt -86.73 10.91 14.36 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.166 -174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . 0.431 ' HB3' ' OD2' ' A' 1646 ' ' ASP . 6.9 tt0 -88.78 -46.81 8.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.7 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.1 t -139.41 19.61 2.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 74.4 m 62.13 53.23 2.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 112.032 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.657 HG22 HG22 ' A' 1625 ' ' VAL . 1.3 m -103.85 111.76 24.42 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.278 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.522 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -76.93 99.01 5.09 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.032 1.333 . . . . 0.0 110.093 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.645 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.0 m-85 -84.62 116.91 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.076 0.465 . . . . 0.0 110.176 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.523 ' HZ ' HG21 ' A' 1564 ' ' ILE . 58.2 m-85 -112.91 140.17 47.94 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.53 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 5.2 p -108.29 118.29 36.39 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.751 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -118.72 130.14 55.65 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 41.5 m-70 -98.01 101.58 13.1 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.751 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 6.8 t -125.01 134.96 26.18 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-O 122.082 0.944 . . . . 0.0 111.515 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 36.9 Cg_exo -68.93 -19.88 39.55 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.696 3.598 . . . . 0.0 112.985 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.61 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.1 pp -79.37 -17.63 54.03 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.98 -3.28 54.06 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' 1659 ' ' PRO . 73.5 m -90.77 116.47 28.64 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.094 176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -102.15 136.69 41.55 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.2 mttm -67.61 -28.93 68.16 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.957 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -82.84 96.56 8.28 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 8.0 pt-20 -98.94 146.22 31.3 Favored Pre-proline 0 C--N 1.281 -2.385 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.984 -175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 40.8 Cg_exo -63.53 -179.7 0.74 Allowed 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.375 2.717 . . . . 0.0 111.186 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -61.08 -40.53 94.06 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.8 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -126.31 98.32 5.4 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.477 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 53.7 t-80 . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' 1524 ' ' MET . 3.9 mmt . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' 1537 ' ' PRO . 28.4 mmmt -74.21 141.59 45.44 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.313 0.577 . . . . 0.0 112.496 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' 1599 ' ' TYR . 44.2 m -80.94 109.26 15.35 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.802 ' O ' ' HA ' ' A' 1598 ' ' MET . 22.0 t-20 -83.39 122.99 29.23 Favored 'General case' 0 C--O 1.179 -2.633 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.634 HG12 ' HG2' ' A' 1598 ' ' MET . 31.2 mt -107.21 96.57 4.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 C-N-CA 125.432 1.493 . . . . 0.0 108.144 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.72 ' HB3' ' O ' ' A' 1533 ' ' GLN . 36.7 tt0 -109.36 157.32 19.01 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -130.68 28.78 4.85 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.686 -174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 5.6 t 65.11 32.51 10.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.577 1.179 . . . . 0.0 108.985 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.72 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.6 pt20 -146.02 157.62 43.87 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.3 p -150.14 133.45 7.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 26.7 m -97.6 126.15 42.74 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.574 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 45.2 t-20 -61.44 120.83 59.16 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.404 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . 0.481 ' HG3' ' O ' ' A' 1525 ' ' LYS . 36.6 Cg_endo -67.44 -6.61 16.9 Favored 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 121.986 1.79 . . . . 0.0 112.906 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.9 -32.46 11.31 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.857 -0.527 . . . . 0.0 111.479 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.8 p -120.76 -22.49 6.27 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.312 0.577 . . . . 0.0 112.097 -175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.98 7.36 88.67 Favored Glycine 0 N--CA 1.414 -2.8 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 35.0 m170 -80.38 124.22 28.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.668 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.62 138.84 49.03 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.6 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.696 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.9 m-85 -115.19 144.96 42.89 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . 0.427 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.1 t70 -147.68 136.2 21.7 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.696 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 36.5 mt -115.27 9.31 15.69 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.227 0.211 . . . . 0.0 111.294 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.427 HD22 ' CG ' ' A' 1544 ' ' ASP . 47.0 m-80 -62.3 -17.8 59.65 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.3 m -67.84 -20.98 65.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.771 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.85 -0.11 55.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.326 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' 1568 ' ' ILE . 48.3 mtmt -79.07 97.61 6.19 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -136.01 145.84 46.53 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.73 -22.17 63.41 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 123.978 0.911 . . . . 0.0 111.347 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.899 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.1 t -61.89 -53.82 50.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.34 -177.91 36.65 Favored Glycine 0 N--CA 1.415 -2.761 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.167 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.511 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 84.4 m-85 -128.87 171.69 12.04 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 122.823 0.449 . . . . 0.0 110.666 -175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.45 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.6 p -150.61 147.86 27.93 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 123.603 0.761 . . . . 0.0 111.222 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' 1640 ' ' PRO . 60.9 t -143.08 94.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.61 120.26 1.24 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.983 0.913 . . . . 0.0 111.589 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' 1564 ' ' ILE . 33.6 t80 -88.78 149.93 23.19 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.556 -175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 4.5 m -60.14 -3.07 0.52 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 126.022 1.729 . . . . 0.0 115.528 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -110.6 -80.0 0.58 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.57 22.5 0.53 Allowed 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.585 0.707 . . . . 0.0 112.297 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.08 -169.51 21.76 Favored Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.615 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -127.34 175.29 8.3 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' 1558 ' ' TYR . 60.9 mt -121.31 119.07 58.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 75.7 m-85 -80.14 146.75 31.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.554 HG12 HG22 ' A' 1581 ' ' VAL . 42.3 mt -130.71 140.3 49.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.522 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.69 129.22 7.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' 1549 ' ' LYS . 43.5 mm -106.71 97.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 117.462 0.631 . . . . 0.0 110.388 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.1 m 65.67 8.6 5.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 0.0 111.623 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 159.83 29.29 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 121.169 -0.538 . . . . 0.0 112.071 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -76.9 138.58 22.33 Favored Glycine 0 N--CA 1.442 -0.932 0 O-C-N 124.064 0.508 . . . . 0.0 113.466 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.71 163.55 17.91 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 123.108 0.563 . . . . 0.0 110.444 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.899 ' HE2' ' HA ' ' A' 1552 ' ' SER . 25.8 pttt -92.43 -13.3 30.21 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.255 0.55 . . . . 0.0 110.886 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 10.3 m120 -93.43 -21.78 19.3 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.714 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' 1579 ' ' VAL . 8.3 t -136.62 142.74 40.23 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' 1579 ' ' VAL . 51.3 Cg_exo -56.28 149.77 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.906 2.404 . . . . 0.0 114.5 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 27.5 t -72.98 132.57 43.59 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 95.77 -6.24 67.19 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.3 t -118.37 118.44 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 C-N-CA 125.109 1.364 . . . . 0.0 107.61 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . 0.694 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -94.41 -22.53 24.19 Favored Glycine 0 CA--C 1.469 -2.83 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.679 -176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.861 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.9 t -145.82 133.85 16.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.48 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.4 p -152.81 136.57 16.16 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.835 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' 1587 ' ' LYS . 86.4 m-85 -65.01 134.49 54.0 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -83.98 -14.51 72.14 Favored Glycine 0 C--N 1.275 -2.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.443 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.27 -66.3 0.48 Allowed 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 122.055 0.931 . . . . 0.0 110.88 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 63.7 p -123.53 13.13 9.39 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.609 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.267 12.5 mptt 60.08 69.37 0.7 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.76 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 33.5 mt -100.8 98.41 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.684 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 19.2 t30 -49.74 109.29 0.27 Allowed 'General case' 0 C--O 1.201 -1.472 0 CA-C-O 122.243 1.021 . . . . 0.0 110.97 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.861 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 14.14 32.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.751 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.54 128.23 0.94 Allowed Glycine 0 C--N 1.3 -1.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 12.7 p -84.91 127.49 34.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.582 0.691 . . . . 0.0 110.286 -175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.694 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.365 0.7 OUTLIER -67.45 145.76 54.68 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.674 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -147.6 -175.36 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.456 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 15.4 m -118.21 21.01 12.96 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -79.7 92.74 5.43 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.369 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.3 tp -105.32 139.47 39.91 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.348 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.802 ' HA ' ' O ' ' A' 1527 ' ' ASN . 21.0 mtm -129.08 175.29 8.81 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.578 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.8 t80 -140.38 107.43 5.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -139.17 121.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 124.404 1.081 . . . . 0.0 110.123 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.77 38.72 11.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.253 1.021 . . . . 0.0 111.767 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.55 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 66.58 16.62 10.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 110.975 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' 1627 ' ' SER . 24.4 t -121.64 128.91 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.57 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.858 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.7 mp -75.18 133.0 41.54 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.9 tp-100 -124.42 125.3 44.05 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.07 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.19 123.64 47.67 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 169.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.82 HG22 HG12 ' A' 1625 ' ' VAL . 95.0 t -113.0 101.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.54 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 23.2 m-85 -92.23 90.84 7.46 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.407 -1.27 . . . . 0.0 107.86 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 16.6 p-10 -102.59 162.09 13.2 Favored 'General case' 0 CA--C 1.476 -1.874 0 O-C-N 122.2 -0.312 . . . . 0.0 110.944 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.92 61.83 1.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 O-C-N 124.646 1.216 . . . . 0.0 113.021 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -91.62 -134.47 6.3 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -81.52 155.45 71.35 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 31.8 Cg_endo -83.37 135.43 7.17 Favored 'Trans proline' 0 N--CA 1.426 -2.478 0 C-N-CA 121.314 1.343 . . . . 0.0 111.525 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 73.4 m -74.14 107.56 3.78 Favored Pre-proline 0 N--CA 1.426 -1.632 0 C-N-CA 125.049 1.34 . . . . 0.0 107.508 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -91.64 -16.22 1.27 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.621 2.214 . . . . 0.0 114.481 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 32.2 t -146.09 -54.55 0.27 Allowed 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.835 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.64 -42.99 99.67 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 111.322 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.452 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 64.1 m-20 -130.18 -178.91 4.94 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -118.84 -7.12 10.51 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' 1649 ' ' THR . 9.5 mp -100.32 -163.98 1.08 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.57 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 92.6 mttt -96.15 146.59 24.54 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 169.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.692 ' HA ' ' HB3' ' A' 1650 ' ' CYS . 96.0 m-85 -63.72 145.4 55.81 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.623 0.577 . . . . 0.0 110.931 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.1 pttt -146.7 162.29 38.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 35.9 t -132.09 144.57 50.82 Favored 'General case' 0 C--N 1.266 -3.065 0 CA-C-O 120.98 0.419 . . . . 0.0 110.691 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.82 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -129.69 91.78 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 124.355 1.062 . . . . 0.0 109.856 178.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.0 mt -90.28 107.0 17.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.145 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.5 m -90.42 120.83 31.87 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.651 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.858 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.0 m-85 -98.89 110.84 23.38 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.972 0.891 . . . . 0.0 109.83 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 46.8 t -101.99 126.43 56.0 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.647 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.2 t -56.33 124.74 19.09 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 124.332 1.02 . . . . 0.0 111.889 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 14.5 t -124.29 140.16 53.22 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -66.32 2.46 1.21 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.57 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.2 m-20 -66.96 -171.69 0.15 Allowed 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 123.862 0.865 . . . . 0.0 110.499 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.6 t -127.5 104.32 7.83 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.308 -0.87 . . . . 0.0 110.811 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 51.48 59.78 8.05 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.544 0.528 . . . . 0.0 113.904 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.455 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -127.46 179.31 5.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.526 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 2.1 p-10 -121.87 -15.77 7.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' 1657 ' ' HIS . 3.2 m-20 60.14 -82.85 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 126.231 1.812 . . . . 0.0 111.172 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.25 113.05 0.35 Allowed Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.602 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.534 ' HB2' ' CG2' ' A' 1556 ' ' VAL . 2.8 Cg_exo -73.57 136.46 23.63 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.432 2.088 . . . . 0.0 111.116 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.623 ' HB ' ' OG ' ' A' 1655 ' ' SER . 8.9 t -114.46 126.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.869 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.1 t80 -76.61 102.96 6.35 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -51.1 15.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.946 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.1 t -157.92 158.96 36.01 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.399 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.869 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -120.01 140.93 50.22 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.7 t70 -106.56 107.61 18.7 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.499 ' HG2' HD12 ' A' 1645 ' ' LEU . 3.9 mtpm? -86.85 2.15 50.05 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.723 -174.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.89 -36.57 13.4 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.606 ' HA ' HD22 ' A' 1620 ' ' LEU . 59.9 p -129.93 17.61 5.65 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.934 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.692 ' HB3' ' HA ' ' A' 1622 ' ' TYR . 84.9 m 53.93 41.37 32.06 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.307 1.043 . . . . 0.0 112.239 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 35.0 m -98.63 108.72 21.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.555 HD13 HD23 ' A' 1645 ' ' LEU . 3.2 mm? -76.27 101.3 5.4 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.717 1.607 . . . . 0.0 110.31 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.696 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.3 m-85 -85.83 120.82 27.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.955 0.407 . . . . 0.0 111.362 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.553 ' HZ ' HG21 ' A' 1564 ' ' ILE . 80.4 m-85 -119.95 144.96 47.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.6 p -117.5 119.16 34.2 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.7 t-105 -118.59 122.35 42.4 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' 1638 ' ' ASN . 20.5 m170 -92.51 103.1 15.55 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.787 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.3 t -134.85 138.75 30.36 Favored Pre-proline 0 N--CA 1.408 -2.555 0 CA-C-O 121.877 0.846 . . . . 0.0 112.321 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.57 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 32.6 Cg_exo -69.97 -10.77 29.17 Favored 'Trans proline' 0 CA--C 1.514 -0.49 0 C-N-CA 124.34 3.36 . . . . 0.0 111.448 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.787 ' HG ' ' OG1' ' A' 1658 ' ' THR . 6.6 mt -77.77 -20.7 52.9 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -84.93 -7.43 59.17 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.457 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 75.5 m -89.42 126.81 35.71 Favored 'General case' 0 CA--C 1.484 -1.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.807 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.1 135.72 49.49 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -52.53 -40.16 62.16 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -92.01 152.61 19.91 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.475 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' 1670 ' ' HIS . 11.1 pt-20 -74.43 136.79 74.83 Favored Pre-proline 0 C--O 1.251 1.145 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.59 -162.94 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.558 2.839 . . . . 0.0 110.957 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -53.42 -37.0 62.13 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -125.38 103.61 8.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.669 ' HB3' ' HB2' ' A' 1666 ' ' GLU . 52.4 p-80 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.457 -0.085 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -109.57 147.83 32.32 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.426 ' OG ' ' HB ' ' A' 1600 ' ' VAL . 9.0 m -66.63 122.26 17.22 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 123.349 0.66 . . . . 0.0 112.446 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' 1598 ' ' MET . 19.1 t-20 -85.23 125.31 32.76 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.638 HG12 ' HG2' ' A' 1598 ' ' MET . 21.7 mt -109.79 104.4 17.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 124.508 1.123 . . . . 0.0 108.797 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' 1533 ' ' GLN . 9.1 tt0 -116.53 151.19 36.64 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.809 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -97.85 17.39 18.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.826 0.851 . . . . 0.0 111.564 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.49 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 17.7 m120 -107.19 16.01 24.52 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.693 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 14.2 m 61.16 30.39 19.32 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 122.471 1.129 . . . . 0.0 108.705 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.681 ' HG3' HD21 ' A' 1542 ' ' LEU . 2.7 pt20 -155.1 148.67 25.26 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' 1599 ' ' TYR . 2.0 p -135.13 136.33 51.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 31.3 m -93.78 125.53 38.45 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.422 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.9 t-20 -59.51 119.31 38.75 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.86 -6.47 17.02 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.042 1.828 . . . . 0.0 113.278 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.58 -24.59 14.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.573 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.7 p -122.38 -32.83 3.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.508 0.671 . . . . 0.0 111.82 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.11 4.5 71.6 Favored Glycine 0 N--CA 1.417 -2.57 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.17 119.95 23.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.975 0.417 . . . . 0.0 110.352 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.681 HD21 ' HG3' ' A' 1533 ' ' GLN . 3.5 tm? -66.93 139.52 57.72 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.407 1.083 . . . . 0.0 111.645 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.754 ' HB3' HD21 ' A' 1604 ' ' LEU . 54.1 m-85 -112.0 146.96 36.95 Favored 'General case' 0 C--O 1.188 -2.159 0 C-N-CA 126.196 1.799 . . . . 0.0 107.337 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 14.5 t70 -144.28 136.97 26.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 119.066 0.848 . . . . 0.0 112.822 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' 1660 ' ' LEU . 84.0 mt -118.13 11.33 13.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -64.89 -14.33 59.34 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . 0.446 ' HB3' HD21 ' A' 1660 ' ' LEU . 26.8 t -69.45 -26.35 64.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 175.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.7 mt -87.09 9.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.067 0.461 . . . . 0.0 112.233 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -78.53 90.33 4.5 Favored 'General case' 0 N--CA 1.397 -3.096 0 CA-C-O 121.952 0.882 . . . . 0.0 109.279 175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -119.72 133.81 55.47 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.442 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -64.95 -42.22 94.81 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.648 -175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 59.7 m -58.23 -48.17 81.22 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.77 173.2 30.58 Favored Glycine 0 N--CA 1.411 -3.019 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.398 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -115.3 169.13 9.37 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.583 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.9 m -148.67 156.33 42.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.899 HG22 ' HB2' ' A' 1640 ' ' PRO . 95.4 t -143.63 93.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.455 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.2 119.49 2.07 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.613 0.721 . . . . 0.0 111.713 174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.533 ' H ' ' HA ' ' A' 1563 ' ' LEU . 41.0 t80 -97.04 140.18 31.94 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.823 -175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 14.9 m -45.33 -37.73 5.12 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 54.2 mt-10 -71.22 -89.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -176.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.577 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -146.86 22.2 1.25 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' 1558 ' ' TYR . . . -158.28 -175.66 29.46 Favored Glycine 0 CA--C 1.474 -2.496 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' 1555 ' ' SER . 4.0 pp -119.64 178.95 4.38 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 123.354 0.662 . . . . 0.0 109.43 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.512 HD13 HD12 ' A' 1652 ' ' LEU . 43.8 mt -124.42 116.8 48.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.5 m-85 -80.73 145.59 31.46 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 122.642 0.377 . . . . 0.0 110.184 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.53 HG12 HG22 ' A' 1581 ' ' VAL . 46.3 mt -131.31 137.87 54.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.877 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.58 129.01 7.53 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 170.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 32.3 mm -107.13 97.87 6.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.844 0.322 . . . . 0.0 110.244 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 41.9 t 66.42 9.93 6.88 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.986 0.898 . . . . 0.0 110.811 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.35 164.24 31.9 Favored Glycine 0 N--CA 1.421 -2.308 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.492 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.17 139.92 17.98 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 164.61 16.01 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 122.753 0.421 . . . . 0.0 109.891 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' 1573 ' ' LYS . 13.3 ptmm? -87.29 -17.82 31.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.9 m120 -85.88 -22.03 27.71 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.522 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -136.58 142.74 40.31 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 51.2 Cg_exo -59.07 147.91 88.01 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 123.079 2.52 . . . . 0.0 114.591 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 49.0 m -68.3 122.47 18.43 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.32 -9.31 45.56 Favored Glycine 0 C--N 1.308 -0.977 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.3 t -116.93 121.01 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.15 -36.05 8.52 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.97 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' 1590 ' ' ALA . 50.1 t -139.23 138.23 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.505 ' HB3' HG11 ' A' 1579 ' ' VAL . 25.9 p -153.78 138.18 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1587 ' ' LYS . 79.6 m-85 -65.29 142.62 58.2 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.68 -13.37 63.01 Favored Glycine 0 C--N 1.278 -2.692 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.615 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 42.3 mt -53.52 -66.05 0.46 Allowed 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 123.952 0.901 . . . . 0.0 110.419 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.6 p -131.82 18.7 4.64 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.419 -175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' 1583 ' ' PHE . 35.0 mmtp 60.95 69.43 0.68 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.947 0.88 . . . . 0.0 111.37 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 18.9 mt -103.81 99.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.522 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' 1579 ' ' VAL . 26.9 t30 -48.27 108.89 0.19 Allowed 'General case' 0 C--O 1.204 -1.322 0 CA-C-O 121.896 0.855 . . . . 0.0 111.135 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.78 8.35 44.85 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.521 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 165.95 121.2 0.55 Allowed Glycine 0 C--N 1.294 -1.775 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.354 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 71.2 m -76.1 145.9 39.7 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.445 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.252 0.0 OUTLIER -39.28 124.56 1.55 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.518 2.327 . . . . 0.0 111.679 178.682 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.538 ' H ' ' HE2' ' A' 1608 ' ' TYR . 96.8 m-20 -149.33 159.35 44.35 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 51.1 m -115.54 9.42 15.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.209 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -75.06 91.91 2.59 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.429 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.2 tp -107.41 141.2 39.18 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.638 ' HG2' HG12 ' A' 1528 ' ' ILE . 27.9 mtm -135.9 168.12 19.92 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.381 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.701 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.2 t80 -127.21 104.23 7.84 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . 0.426 ' HB ' ' OG ' ' A' 1526 ' ' SER . 1.5 p -136.55 121.72 26.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.668 -173.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.21 37.43 8.79 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.281 1.432 . . . . 0.0 109.381 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 87.3 mt-30 67.75 12.13 8.7 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.459 1.104 . . . . 0.0 110.428 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 22.6 t -115.66 130.15 70.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.776 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -75.48 134.99 40.7 Favored 'General case' 0 C--O 1.195 -1.781 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' 1626 ' ' ILE . 33.8 tt0 -140.35 130.09 24.42 Favored 'General case' 0 C--N 1.265 -3.082 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' 1597 ' ' LEU . 84.4 mt -106.2 125.2 50.71 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.797 HG22 HG12 ' A' 1625 ' ' VAL . 94.2 t -106.3 98.23 6.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.538 ' HE2' ' H ' ' A' 1594 ' ' ASN . 78.6 m-85 -86.31 90.55 8.21 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.306 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.481 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -100.46 176.99 5.16 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.13 0.491 . . . . 0.0 112.296 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.2 t70 53.75 53.09 11.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.214 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -86.71 -143.99 8.05 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.583 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -75.29 154.17 86.14 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 32.8 Cg_endo -83.44 121.96 3.1 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 121.954 1.77 . . . . 0.0 111.638 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 8.3 p -92.23 115.57 64.94 Favored Pre-proline 0 N--CA 1.408 -2.544 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 50.6 Cg_endo -100.27 -4.84 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.638 2.225 . . . . 0.0 112.606 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 10.4 m -105.12 -58.05 1.94 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 64.9 mttm -78.14 -21.73 49.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.504 0.669 . . . . 0.0 111.69 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.687 ' HB3' ' SG ' ' A' 1650 ' ' CYS . 3.3 t-20 -164.3 -167.02 1.21 Allowed 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -175.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.402 ' H ' ' ND2' ' A' 1618 ' ' ASN . . . -126.09 9.22 7.4 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.527 0.603 . . . . 0.0 110.86 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' 1649 ' ' THR . 9.1 mp -98.82 -165.34 1.23 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.963 0.411 . . . . 0.0 110.907 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 95.4 mttt -99.02 154.46 18.07 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' 1614 ' ' CYS . 94.5 m-85 -72.22 153.01 41.84 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.23 0.538 . . . . 0.0 111.135 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 60.6 pttt -149.63 154.43 38.63 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 61.2 m -124.69 137.02 54.38 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.449 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.797 HG12 HG22 ' A' 1607 ' ' VAL . 1.1 m -122.11 90.78 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-O 122.313 1.054 . . . . 0.0 109.566 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 24.3 mt -86.99 104.91 14.54 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.084 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 45.1 m -90.22 116.85 28.52 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.055 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.776 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.1 m-85 -93.04 109.54 21.01 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-O 122.482 1.134 . . . . 0.0 108.589 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 28.2 t -103.66 117.92 49.91 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.735 0 CA-C-N 112.64 -2.073 . . . . 0.0 109.15 -176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' 1658 ' ' THR . 15.4 t -47.78 126.77 10.82 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.537 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.8 t -125.69 143.9 50.84 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 64.7 m80 -67.15 1.73 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.59 -177.68 1.59 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.894 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 57.3 m -118.97 101.29 7.93 Favored 'General case' 0 N--CA 1.406 -2.638 0 O-C-N 122.033 -0.417 . . . . 0.0 111.453 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 51.11 60.69 6.88 Favored Glycine 0 N--CA 1.471 1.003 0 O-C-N 123.611 0.569 . . . . 0.0 113.653 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.411 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -126.92 179.05 5.59 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.78 0.324 . . . . 0.0 110.544 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.466 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.9 p-10 -121.08 -18.98 7.32 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.26 -82.58 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.706 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -173.24 124.22 0.44 Allowed Pre-proline 0 C--N 1.265 -3.089 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.702 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' 1556 ' ' VAL . 5.3 Cg_exo -74.3 124.39 8.94 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 122.002 1.801 . . . . 0.0 110.171 172.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' 1655 ' ' SER . 15.5 t -108.24 121.24 60.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 124.273 1.029 . . . . 0.0 109.309 -174.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.753 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -75.09 107.02 6.89 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 172.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.12 -49.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.78 -176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 58.1 p -154.58 163.17 40.61 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.564 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.753 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -122.42 142.94 50.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' 1651 ' ' THR . 14.3 t70 -109.64 114.42 28.0 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 75.8 mttt -93.25 7.28 44.98 Favored 'General case' 0 C--N 1.277 -2.563 0 C-N-CA 124.391 1.076 . . . . 0.0 110.046 -176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.31 -34.2 12.92 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.615 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.4 t -140.05 19.7 2.45 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.904 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' 1618 ' ' ASN . 12.5 m 49.66 58.54 5.32 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 122.009 0.909 . . . . 0.0 112.663 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.2 m -107.05 109.93 21.93 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.391 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.54 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -78.96 101.72 7.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.981 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.671 ' HA ' HG23 ' A' 1625 ' ' VAL . 71.3 m-85 -84.34 117.61 23.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.989 0.423 . . . . 0.0 111.12 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.666 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.21 139.74 49.13 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.068 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 14.1 m -108.89 118.79 37.71 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.539 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.5 t-105 -122.01 120.98 35.96 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.44 ' HB3' ' HB ' ' A' 1631 ' ' THR . 30.7 m80 -89.08 104.47 17.01 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.539 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.1 t -133.28 135.31 25.25 Favored Pre-proline 0 N--CA 1.414 -2.248 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.616 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' 1658 ' ' THR . 44.9 Cg_exo -68.14 -10.75 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 124.489 3.459 . . . . 0.0 111.342 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.2 mp -78.57 -21.03 49.25 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.059 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' 1604 ' ' LEU . . . -85.47 -6.37 59.2 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.629 -1.169 . . . . 0.0 107.887 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 79.0 m -87.0 128.08 35.08 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.34 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.27 121.57 25.25 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 92.1 mttt -65.24 -22.49 66.88 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.35 -174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -90.23 124.65 35.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.95 124.85 78.74 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 42.7 Cg_endo -84.79 -163.45 0.2 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 123.458 2.772 . . . . 0.0 112.028 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -54.46 -43.35 71.61 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.601 0.563 . . . . 0.0 110.846 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 22.5 p80 -128.11 123.74 35.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.445 0.64 . . . . 0.0 109.785 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.677 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 11.6 t-160 . . . . . 0 C--N 1.284 -2.28 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -122.6 151.55 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 54.6 p -80.67 159.76 25.22 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' 1535 ' ' THR . 18.7 m120 -78.11 87.82 4.23 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.428 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' 1598 ' ' MET . 4.4 tt -71.63 80.37 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.916 0 CA-C-O 122.625 1.202 . . . . 0.0 109.843 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -102.46 143.26 32.41 Favored 'General case' 0 N--CA 1.398 -3.026 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.143 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.1 33.64 0.8 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 123.023 1.392 . . . . 0.0 109.243 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.826 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 15.7 m120 -101.04 -2.26 32.07 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.018 -1.447 . . . . 0.0 107.755 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.7 t 66.67 42.33 2.74 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.807 1.289 . . . . 0.0 108.202 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.826 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 2.8 pt20 -154.6 147.28 24.27 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.252 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' 1597 ' ' LEU . 2.6 p -138.03 128.31 35.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.083 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 48.8 m -91.21 127.82 36.79 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -63.7 121.67 72.06 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.705 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . 0.577 ' HD3' ' HA ' ' A' 1526 ' ' SER . 36.1 Cg_endo -66.05 -10.02 25.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.276 1.984 . . . . 0.0 112.698 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.17 -30.53 13.45 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.63 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -125.97 -11.61 6.52 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.53 9.62 78.36 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.295 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -79.72 119.44 22.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.276 0.56 . . . . 0.0 111.009 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.3 tm? -77.74 136.25 38.13 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.584 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.832 ' HB3' HD21 ' A' 1604 ' ' LEU . 68.9 m-85 -109.33 143.81 38.35 Favored 'General case' 0 C--O 1.183 -2.396 0 C-N-CA 125.732 1.613 . . . . 0.0 107.129 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . 0.411 ' O ' HD22 ' A' 1660 ' ' LEU . 20.6 t70 -147.87 130.64 16.05 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 119.315 0.962 . . . . 0.0 110.866 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.632 ' CD2' HD11 ' A' 1660 ' ' LEU . 66.8 mt -107.1 3.45 25.83 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.268 0.355 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.536 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 56.8 m-80 -66.0 -23.53 66.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.352 0.596 . . . . 0.0 111.025 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 5.4 m -68.6 -19.31 64.44 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.737 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 64.8 mt -88.66 -27.39 21.3 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 122.053 -0.404 . . . . 0.0 111.001 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 47.8 mtmt -50.2 104.33 0.07 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 125.215 1.406 . . . . 0.0 112.559 -172.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -134.98 131.06 36.71 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 113.933 -1.485 . . . . 0.0 109.647 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.39 -23.99 66.41 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 125.054 1.341 . . . . 0.0 111.559 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.61 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 0.1 OUTLIER -60.47 -20.88 61.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 123.813 0.845 . . . . 0.0 112.872 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.79 163.08 28.99 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 115.914 1.125 . . . . 0.0 115.914 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 32.0 m-85 -125.68 161.12 28.0 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.5 p -155.18 145.31 21.78 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.939 HG22 ' HB2' ' A' 1640 ' ' PRO . 94.9 t -134.72 93.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -52.08 124.49 13.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.445 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' 1564 ' ' ILE . 4.3 t80 -95.0 139.22 31.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 31.0 m -64.38 0.01 1.16 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.06 -82.03 0.22 Allowed 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 110.618 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.75 14.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -150.81 -162.58 10.73 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' 1564 ' ' ILE . 3.6 pp -135.13 174.99 9.99 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.013 0.925 . . . . 0.0 109.213 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' 1558 ' ' TYR . 61.1 mt -118.68 116.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 77.2 m-85 -80.09 144.48 33.08 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.1 mt -130.54 155.46 41.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.45 128.08 4.73 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.5 mm -96.37 96.94 5.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 117.35 0.575 . . . . 0.0 110.272 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' 1595 ' ' SER . 57.1 m 61.02 15.83 6.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 0.0 111.774 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.8 172.41 33.82 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.71 152.46 21.46 Favored Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.731 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 164.8 23.43 Favored 'General case' 0 N--CA 1.405 -2.702 0 CA-C-N 114.712 -0.744 . . . . 0.0 109.162 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' 1552 ' ' SER . 45.9 pttt -87.55 -12.38 45.96 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.395 0.617 . . . . 0.0 110.07 176.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.55 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 74.9 m-20 -94.75 -19.32 20.47 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.329 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -131.77 143.0 47.28 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.66 150.7 59.81 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.034 2.489 . . . . 0.0 115.025 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 18.4 m -70.16 115.44 9.37 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 111.65 -10.45 27.98 Favored Glycine 0 C--N 1.311 -0.847 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.593 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.7 t -113.75 122.77 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -89.16 -33.32 9.65 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -141.11 136.41 33.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.593 ' HB3' HG11 ' A' 1579 ' ' VAL . 27.2 p -153.99 136.75 15.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.586 ' CZ ' HD11 ' A' 1652 ' ' LEU . 90.0 m-85 -67.88 134.96 51.76 Favored 'General case' 0 C--O 1.199 -1.556 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.87 -5.39 71.12 Favored Glycine 0 C--N 1.275 -2.822 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.481 HD12 HG23 ' A' 1586 ' ' THR . 0.9 OUTLIER -58.25 -59.18 5.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 124.54 1.136 . . . . 0.0 108.31 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.481 HG23 HD12 ' A' 1585 ' ' LEU . 40.8 p -134.96 23.38 3.57 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.528 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 55.41 68.51 0.85 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.377 1.084 . . . . 0.0 111.799 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.5 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 23.5 mt -104.36 98.82 7.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 113.602 -1.635 . . . . 0.0 108.586 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 21.6 t30 -50.86 112.38 0.7 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.201 1.001 . . . . 0.0 111.047 176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.835 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -103.3 15.29 29.54 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.896 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 160.45 121.91 0.61 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 67.8 m -80.71 151.56 28.83 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.48 -174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.61 122.99 1.18 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.872 1.669 . . . . 0.0 112.512 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.486 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -149.84 163.93 36.7 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 19.8 m -127.25 25.85 6.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.98 94.57 3.99 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.888 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.1 tp -112.29 135.02 53.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 123.757 0.661 . . . . 0.0 111.199 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.599 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.51 169.46 14.95 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.259 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.638 ' HD1' HD12 ' A' 1604 ' ' LEU . 52.9 t80 -127.61 100.79 6.13 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 122.97 34.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.031 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.1 37.49 6.65 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.201 1.0 . . . . 0.0 111.672 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.446 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 26.4 mm-40 67.43 14.9 9.77 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 122.082 0.944 . . . . 0.0 109.718 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' 1627 ' ' SER . 19.6 t -124.29 134.29 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.471 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 9.9 mp -78.6 139.48 38.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' 1626 ' ' ILE . 21.7 tt0 -136.72 129.66 30.89 Favored 'General case' 0 C--N 1.273 -2.731 0 C-N-CA 117.915 -1.514 . . . . 0.0 111.571 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.442 HD13 ' OH ' ' A' 1608 ' ' TYR . 86.4 mt -104.23 124.95 50.06 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.729 HG22 HG12 ' A' 1625 ' ' VAL . 98.3 t -112.05 104.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.629 ' HB2' ' HB3' ' A' 1624 ' ' SER . 86.2 m-85 -99.52 94.88 6.63 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -106.38 172.1 6.99 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.611 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.38 57.34 1.94 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 126.06 1.744 . . . . 0.0 109.976 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.6 -136.98 5.24 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.249 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -87.99 165.64 28.29 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 42.9 Cg_endo -70.77 131.98 20.84 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.766 1.644 . . . . 0.0 112.327 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' 1620 ' ' LEU . 38.5 t -95.92 106.56 28.71 Favored Pre-proline 0 C--N 1.285 -2.239 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.9 Cg_endo -103.8 3.65 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.592 2.195 . . . . 0.0 111.052 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.9 t -95.26 -63.2 1.19 Allowed 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.668 -170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.561 ' HG3' HD11 ' A' 1645 ' ' LEU . 47.8 mmtm -85.62 -42.42 14.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.404 0.621 . . . . 0.0 110.777 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.411 ' HA ' HD22 ' A' 1618 ' ' ASN . 1.8 t-20 -150.17 -156.07 0.69 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.939 -2.986 . . . . 0.0 102.939 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -123.44 39.19 4.02 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 119.226 0.921 . . . . 0.0 111.976 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.2 mp -102.02 -168.24 1.51 Allowed 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -98.17 160.53 14.24 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.624 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 81.3 m-85 -77.1 147.49 36.6 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.248 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -140.29 160.19 40.53 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 39.8 t -128.19 141.0 51.6 Favored 'General case' 0 C--N 1.271 -2.842 0 C-N-CA 122.914 0.485 . . . . 0.0 110.436 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.729 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -133.85 89.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 122.288 1.042 . . . . 0.0 111.089 178.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' 1605 ' ' GLN . 43.4 mt -87.36 110.08 20.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.452 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.669 ' HB2' HG11 ' A' 1603 ' ' VAL . 15.4 p -90.82 113.45 25.61 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.373 0.606 . . . . 0.0 111.396 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 83.1 m-85 -91.06 107.17 19.02 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 124.704 1.202 . . . . 0.0 109.802 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.9 t -101.26 134.17 42.32 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.52 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.442 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.61 126.94 28.92 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 123.903 0.881 . . . . 0.0 112.811 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' 1659 ' ' PRO . 15.3 t -130.58 141.4 50.46 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 29.1 m170 -69.87 4.49 1.99 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.73 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 22.7 m-20 -66.77 -168.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.446 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -125.28 108.37 11.65 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.548 -0.72 . . . . 0.0 110.244 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 44.84 59.7 4.23 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.107 0.861 . . . . 0.0 113.94 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.519 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -113.45 171.69 7.41 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.017 0.913 . . . . 0.0 113.154 -173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.0 -44.25 2.42 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 127.074 2.15 . . . . 0.0 105.506 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 66.31 -84.2 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.431 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.2 ttpt -173.31 117.65 0.38 Allowed Pre-proline 0 C--N 1.274 -2.715 0 C-N-CA 125.295 1.438 . . . . 0.0 109.531 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.939 ' HB2' HG22 ' A' 1556 ' ' VAL . 25.5 Cg_exo -68.0 139.99 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.659 2.239 . . . . 0.0 110.873 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' 1655 ' ' SER . 21.4 t -106.6 124.82 62.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 123.792 0.837 . . . . 0.0 109.984 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.587 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 46.3 t80 -75.23 104.88 5.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -52.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.621 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' 1653 ' ' TYR . 31.5 t -156.46 153.14 28.34 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.802 -176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.587 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -114.72 132.54 56.39 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.5 t70 -95.73 112.52 24.22 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.439 ' HG2' HD12 ' A' 1645 ' ' LEU . 39.7 mttp -94.27 6.46 48.59 Favored 'General case' 0 C--N 1.249 -3.772 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.486 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 -37.33 11.84 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.572 HG23 ' OG1' ' A' 1651 ' ' THR . 5.1 t -136.43 18.59 3.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.147 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 66.6 m 51.73 61.9 2.98 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.491 1.138 . . . . 0.0 111.99 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 53.7 m -110.61 116.4 31.29 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.703 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.592 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.8 mm? -80.75 101.05 9.07 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 125.254 1.422 . . . . 0.0 110.33 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.662 ' HA ' HG23 ' A' 1625 ' ' VAL . 70.7 m-85 -85.36 118.62 25.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.42 ' HZ ' HG21 ' A' 1564 ' ' ILE . 69.4 m-85 -118.37 140.68 49.47 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.544 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 9.6 m -110.98 129.08 56.0 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.759 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -128.16 130.34 47.92 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.487 ' HB3' ' HB ' ' A' 1631 ' ' THR . 76.4 m-70 -100.1 104.83 16.41 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.759 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 12.8 t -125.47 136.73 28.67 Favored Pre-proline 0 N--CA 1.418 -2.071 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.73 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 53.7 Cg_exo -65.19 -22.34 61.29 Favored 'Trans proline' 0 CA--C 1.501 -1.165 0 C-N-CA 124.648 3.565 . . . . 0.0 113.55 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -79.09 -17.43 55.17 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.378 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -82.13 -0.34 44.34 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.5 m -87.75 144.51 26.59 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.877 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' 1665 ' ' GLU . 32.3 tt0 -135.92 139.86 43.6 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 87.1 mttt -86.47 -19.96 28.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . 0.534 ' H ' ' HG2' ' A' 1663 ' ' GLU . 60.6 mm-40 -82.87 165.96 19.34 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.652 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.73 143.18 39.32 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-O 120.672 0.272 . . . . 0.0 111.218 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.2 -163.31 0.22 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.703 2.936 . . . . 0.0 111.292 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -64.83 -37.68 88.43 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.141 0.496 . . . . 0.0 110.656 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -140.36 124.47 17.56 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.298 -1.651 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.499 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.51 -0.59 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 4.7 tppp? 73.14 114.43 0.06 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.09 0.948 . . . . 0.0 109.149 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 3.2 t -88.55 159.58 17.85 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.095 -171.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.573 ' HB3' ' H ' ' A' 1535 ' ' THR . 59.6 t30 -87.66 78.43 8.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.327 0.585 . . . . 0.0 110.679 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' 1597 ' ' LEU . 8.5 tt -72.87 82.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.721 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -90.76 168.65 11.58 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.378 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -107.14 22.12 16.48 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.057 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 16.7 m120 -109.42 13.07 24.3 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.292 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' 1595 ' ' SER . 34.1 m 61.39 33.31 18.82 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.588 0.709 . . . . 0.0 110.442 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.591 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.0 pt20 -144.25 145.56 32.12 Favored 'General case' 0 N--CA 1.411 -2.402 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' 1599 ' ' TYR . 7.1 p -138.98 125.33 23.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.4 m -91.15 126.22 36.17 Favored 'General case' 0 C--N 1.261 -3.273 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.43 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.6 t-20 -59.45 121.4 56.45 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.391 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 -6.4 13.35 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.687 2.258 . . . . 0.0 113.456 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -104.52 -33.64 8.49 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.945 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 67.6 p -111.85 -27.68 8.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.589 0.709 . . . . 0.0 111.691 -173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 83.78 7.74 85.41 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . 0.449 ' ND1' ' HG3' ' A' 1663 ' ' GLU . 44.0 t-80 -79.97 121.13 25.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.479 0.18 . . . . 0.0 110.672 176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.9 OUTLIER -75.23 143.74 42.95 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.894 0.854 . . . . 0.0 111.214 176.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.651 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.32 145.5 43.14 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . 0.423 ' CG ' HD22 ' A' 1546 ' ' ASN . 12.7 t70 -148.28 137.68 22.09 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 118.762 0.71 . . . . 0.0 109.655 -173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.654 ' HA ' HD23 ' A' 1660 ' ' LEU . 56.2 mt -116.21 14.35 15.85 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.14 0.275 . . . . 0.0 111.615 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.616 ' O ' ' HG2' ' A' 1549 ' ' LYS . 51.8 m-80 -66.14 -13.74 60.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.408 0.623 . . . . 0.0 112.043 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 15.5 m -71.32 -23.71 61.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.425 HD13 ' CZ2' ' A' 1656 ' ' TRP . 89.5 mt -94.09 9.55 37.27 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.3 ptpt -85.13 92.42 8.38 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.211 1.005 . . . . 0.0 110.728 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -130.75 138.31 49.9 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' 1571 ' ' GLY . 3.5 p30 -76.08 -14.11 60.2 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 124.888 1.275 . . . . 0.0 112.19 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 47.4 p -55.54 -47.15 76.78 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 99.62 163.09 29.16 Favored Glycine 0 N--CA 1.414 -2.81 0 CA-C-N 114.673 -1.148 . . . . 0.0 113.202 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.4 m-85 -121.93 166.84 13.81 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' 1640 ' ' PRO . 5.1 p -151.22 152.56 33.45 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.363 0.414 . . . . 0.0 111.716 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.829 HG22 ' HB2' ' A' 1640 ' ' PRO . 70.5 t -144.31 94.23 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -39.91 119.99 1.08 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.23 0.612 . . . . 0.0 111.727 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.608 ' HB2' HG13 ' A' 1564 ' ' ILE . 64.5 t80 -97.61 156.97 16.28 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.138 -175.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 1.3 p -71.9 18.51 0.08 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 41.2 mt-10 -116.05 -91.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.307 -0.871 . . . . 0.0 112.451 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 6.1 mptt -135.2 8.6 3.44 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.121 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.55 -159.58 9.73 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.559 ' HA ' ' H ' ' A' 1558 ' ' TYR . 4.2 pp -124.28 -176.55 3.54 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 123.199 0.599 . . . . 0.0 111.436 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.608 HG13 ' HB2' ' A' 1558 ' ' TYR . 53.4 mt -123.14 122.98 66.8 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.135 0 C-N-CA 124.435 1.094 . . . . 0.0 108.175 175.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.444 ' CE1' HD11 ' A' 1563 ' ' LEU . 90.7 m-85 -85.34 145.86 27.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.765 0.317 . . . . 0.0 110.324 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.581 HG12 HG22 ' A' 1581 ' ' VAL . 51.4 mt -130.65 142.01 44.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.299 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.72 129.7 7.17 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 170.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.403 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 48.4 mm -102.84 97.85 6.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 117.528 0.664 . . . . 0.0 110.014 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 98.1 m 61.99 17.39 8.97 Favored 'General case' 0 C--N 1.366 1.29 0 O-C-N 123.683 0.614 . . . . 0.0 111.695 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.89 152.41 23.86 Favored Glycine 0 CA--C 1.472 -2.6 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.549 -171.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -78.81 146.18 29.46 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' 1575 ' ' CYS . 0.0 OUTLIER -122.06 164.75 17.16 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 120.81 0.338 . . . . 0.0 110.113 178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -83.39 -17.0 43.76 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.344 0.593 . . . . 0.0 109.931 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.424 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 13.0 m120 -95.44 -21.25 18.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.371 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.57 ' HB3' HG23 ' A' 1572 ' ' THR . 5.7 t -133.28 141.31 40.14 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.35 144.97 95.52 Favored 'Trans proline' 0 C--N 1.336 -0.092 0 C-N-CA 122.832 2.355 . . . . 0.0 115.413 -173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 p -63.94 113.13 3.27 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.651 172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 112.04 -7.0 27.24 Favored Glycine 0 C--N 1.308 -0.998 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' 1582 ' ' CYS . 50.4 t -116.56 124.43 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.62 -37.63 9.42 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.757 HG12 ' HB3' ' A' 1590 ' ' ALA . 26.3 t -142.98 139.98 27.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.474 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.0 p -152.07 136.64 16.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.794 0.33 . . . . 0.0 111.42 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' A' 1587 ' ' LYS . 67.0 m-85 -63.4 144.65 56.79 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -90.91 -17.66 50.58 Favored Glycine 0 C--N 1.277 -2.698 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.27 -67.56 0.25 Allowed 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.286 1.034 . . . . 0.0 111.568 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 42.0 p -125.63 18.98 8.03 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.357 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.3 mmtm 57.29 68.59 0.83 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.775 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.556 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 16.9 mt -104.65 100.21 10.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.338 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 8.6 t30 -51.08 111.57 0.58 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.936 0.874 . . . . 0.0 110.428 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.757 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.18 7.57 45.65 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.35 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 170.38 130.58 1.23 Allowed Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 89.5 p -74.82 147.14 41.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 117.339 0.569 . . . . 0.0 111.333 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.458 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.83 122.56 1.73 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.554 1.541 . . . . 0.0 110.8 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' 1596 ' ' GLN . 61.3 m-20 -148.12 170.22 18.29 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.459 ' HB3' ' SG ' ' A' 1532 ' ' CYS . 19.8 m -131.88 20.21 4.58 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.403 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.6 mm-40 -78.23 94.55 4.8 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.266 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.8 tp -107.37 139.87 41.19 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.7 mtm -133.1 174.64 10.15 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.721 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.625 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 65.1 t80 -139.6 94.9 2.83 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.4 p -120.75 115.63 47.52 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.324 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.55 55.71 6.99 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.09 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.625 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.0 mt-30 64.59 12.39 7.46 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.238 -1.347 . . . . 0.0 113.349 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' 1627 ' ' SER . 25.2 t -124.1 128.58 74.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.945 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -74.97 141.46 44.01 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.0 tt0 -143.7 131.11 20.97 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 118.099 -1.44 . . . . 0.0 111.477 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.99 124.5 46.8 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.789 HG22 HG12 ' A' 1625 ' ' VAL . 69.6 t -109.89 99.05 7.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 122.105 0.955 . . . . 0.0 109.569 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' 1624 ' ' SER . 41.6 m-85 -92.67 92.52 8.03 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.84 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.11 -176.52 3.7 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 20.6 t70 50.66 49.45 20.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.426 1.09 . . . . 0.0 111.432 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -79.59 -134.6 1.15 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.146 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -89.9 150.55 43.95 Favored Pre-proline 0 C--N 1.279 -2.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 19.0 Cg_endo -75.32 130.31 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 C-N-CA 121.894 1.729 . . . . 0.0 111.134 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.44 ' HB3' ' CE2' ' A' 1622 ' ' TYR . 14.2 p -96.36 104.62 18.15 Favored Pre-proline 0 N--CA 1.396 -3.143 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' 1613 ' ' PRO . 55.5 Cg_endo -98.66 3.47 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.675 2.25 . . . . 0.0 109.659 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 41.7 t -57.55 -63.21 1.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.458 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 98.2 mttt -127.76 -17.36 4.52 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 0.0 111.014 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.402 ' HB3' HD12 ' A' 1620 ' ' LEU . 90.1 m-20 -126.33 -172.38 2.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.76 33.33 4.82 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.435 0.636 . . . . 0.0 109.745 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' 1649 ' ' THR . 6.1 mp -102.88 -163.52 1.0 Allowed 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 54.6 mttp -115.09 159.69 20.55 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 70.3 m-85 -76.49 147.58 37.73 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.73 0.3 . . . . 0.0 111.036 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' 1651 ' ' THR . 27.8 ttpt -138.87 144.49 39.21 Favored 'General case' 0 N--CA 1.4 -2.94 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 54.1 m -116.45 135.12 54.11 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.656 0.598 . . . . 0.0 110.837 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.789 HG12 HG22 ' A' 1607 ' ' VAL . 0.9 OUTLIER -124.97 91.31 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.321 1.057 . . . . 0.0 110.419 178.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 42.7 mt -87.4 107.92 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.903 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.671 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.5 p -89.92 119.78 30.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.243 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 77.0 m-85 -97.18 114.86 26.61 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 122.16 0.981 . . . . 0.0 109.666 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.58 125.14 65.47 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.342 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.789 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 17.0 t -52.52 126.16 18.64 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 123.839 0.856 . . . . 0.0 112.431 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 6.7 t -125.63 143.73 50.9 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -70.79 2.2 4.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.847 0.859 . . . . 0.0 111.907 -172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.41 -170.05 0.75 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.934 0.894 . . . . 0.0 110.441 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.7 t -125.1 107.78 11.13 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 46.92 58.19 6.38 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.081 0.863 . . . . 0.0 113.936 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -107.72 175.91 5.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.89 0.852 . . . . 0.0 112.947 -175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -129.61 -44.3 1.23 Allowed 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 126.127 1.771 . . . . 0.0 106.263 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 7.9 m-20 70.2 -86.68 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 125.124 1.515 . . . . 0.0 108.007 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -174.11 129.87 0.49 Allowed Pre-proline 0 C--N 1.262 -3.201 0 C-N-CA 126.832 2.053 . . . . 0.0 105.952 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.829 ' HB2' HG22 ' A' 1556 ' ' VAL . 21.4 Cg_exo -69.56 144.02 53.7 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.513 1.475 . . . . 0.0 109.347 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.552 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.5 t -112.85 129.62 68.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.797 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 83.2 t80 -83.25 101.88 11.55 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.3 p -79.0 -52.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.779 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 30.3 t -156.11 159.04 38.7 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.405 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.797 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -118.52 140.25 50.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' 1651 ' ' THR . 9.8 t70 -99.45 109.21 21.79 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.415 ' HG2' HD12 ' A' 1645 ' ' LEU . 41.2 mttp -89.03 5.13 45.79 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.959 -172.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -93.92 -41.42 9.61 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.636 ' HA ' HD22 ' A' 1620 ' ' LEU . 8.0 t -132.47 19.21 4.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.02 -174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 98.1 m 56.8 45.32 21.88 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.14 0.976 . . . . 0.0 111.751 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 45.9 m -103.0 113.08 26.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.5 mm? -78.64 103.39 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 126.601 1.96 . . . . 0.0 110.248 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.716 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.8 m-85 -85.75 118.11 25.05 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 120.959 0.409 . . . . 0.0 110.344 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 77.1 m-85 -114.18 144.34 43.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.453 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.552 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.8 p -117.94 120.52 38.1 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.667 ' CD1' ' HB ' ' A' 1658 ' ' THR . 2.3 t-105 -123.13 125.72 45.68 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.529 ' HB3' ' HB ' ' A' 1631 ' ' THR . 67.2 m-70 -92.85 107.96 19.63 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.667 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.9 t -134.49 137.49 27.89 Favored Pre-proline 0 N--CA 1.411 -2.406 0 CA-C-O 122.021 0.915 . . . . 0.0 111.28 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' 1636 ' ' ALA . 46.7 Cg_exo -68.08 -10.31 28.5 Favored 'Trans proline' 0 N--CA 1.48 0.731 0 C-N-CA 124.683 3.589 . . . . 0.0 111.841 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.1 mp -78.0 -22.18 49.72 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.84 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.31 -4.31 59.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.423 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 72.7 m -86.1 128.9 34.96 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.515 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' 1665 ' ' GLU . 37.1 tt0 -104.2 135.88 44.84 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 93.2 mttt -78.31 -23.45 47.08 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.337 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' 1663 ' ' GLU . 16.4 mm-40 -95.5 172.57 7.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -144.57 139.36 15.44 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' 1670 ' ' HIS . 72.6 Cg_endo -74.37 172.61 15.74 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 122.707 2.272 . . . . 0.0 111.411 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.12 -19.99 64.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 69.4 t60 -136.27 89.62 2.49 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' A' 1667 ' ' PRO . 14.2 p80 . . . . . 0 C--N 1.304 -1.386 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.792 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.647 ' O ' ' HB ' ' A' 1535 ' ' THR . 25.8 tptp -148.55 -177.65 5.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 10.6 m -93.36 -152.98 0.34 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.823 ' HB3' ' HG2' ' A' 1598 ' ' MET . 23.6 m-80 -45.37 114.98 0.83 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' 1529 ' ' GLN . 8.4 tt -143.84 156.46 16.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -167.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.404 ' O ' HG12 ' A' 1528 ' ' ILE . 7.5 tt0 -97.99 134.44 41.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.97 -65.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.283 0 O-C-N 123.396 0.435 . . . . 0.0 109.829 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 53.1 t30 -173.11 56.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 7.6 t 57.9 44.62 19.63 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.558 0.694 . . . . 0.0 110.3 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.2 pt20 -145.49 143.31 29.92 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 -176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' 1527 ' ' ASN . 2.8 p -135.09 124.97 43.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 4.0 m -91.54 126.44 36.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -55.16 120.26 28.71 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.02 -7.01 15.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.443 2.096 . . . . 0.0 112.905 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -103.15 -33.89 9.05 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.805 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.4 p -122.82 -12.68 8.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 75.85 7.37 83.7 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.216 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -74.78 118.44 17.74 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.67 ' HA ' ' HA ' ' A' 1535 ' ' THR . 0.6 OUTLIER -75.43 145.43 41.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.623 0.725 . . . . 0.0 110.587 177.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.768 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.4 m-85 -117.4 141.44 48.33 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -147.95 134.04 19.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.681 ' HA ' HD23 ' A' 1660 ' ' LEU . 83.2 mt -109.76 12.45 24.05 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' 1549 ' ' LYS . 44.4 m-80 -66.08 -15.08 62.76 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.506 0.67 . . . . 0.0 110.914 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . 0.714 ' HB2' HD21 ' A' 1660 ' ' LEU . 11.0 m -67.97 -27.8 66.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.734 0.778 . . . . 0.0 109.08 175.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.452 HD12 HD22 ' A' 1545 ' ' LEU . 96.7 mt -94.77 1.38 55.43 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.879 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' 1546 ' ' ASN . 32.5 ttmt -88.51 102.93 15.4 Favored 'General case' 0 N--CA 1.383 -3.811 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -141.84 166.98 23.24 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.496 -2.039 . . . . 0.0 105.496 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 17.5 t70 -87.07 -28.34 22.62 Favored 'General case' 0 C--N 1.276 -2.597 0 C-N-CA 123.49 0.716 . . . . 0.0 111.342 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 22.9 t -55.03 -52.67 62.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 97.25 170.15 33.37 Favored Glycine 0 N--CA 1.422 -2.275 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.225 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.9 m-85 -121.35 168.62 11.45 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.303 -175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.61 ' HB3' HD13 ' A' 1563 ' ' LEU . 18.4 m -146.58 152.87 39.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' 1640 ' ' PRO . 89.4 t -144.57 93.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -40.4 125.02 2.06 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 123.748 0.819 . . . . 0.0 112.8 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.467 ' HB2' HG13 ' A' 1564 ' ' ILE . 66.3 t80 -107.63 117.76 34.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.41 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 35.8 m -49.34 -34.96 17.08 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.41 ' CB ' ' HD3' ' A' 1561 ' ' LYS . 52.5 mt-10 -61.34 -63.98 1.1 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.41 ' HD3' ' CB ' ' A' 1560 ' ' GLU . 0.0 OUTLIER -155.67 5.65 0.21 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -175.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.82 -142.36 3.38 Favored Glycine 0 C--O 1.215 -1.037 0 C-N-CA 118.981 -1.58 . . . . 0.0 112.042 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.61 HD13 ' HB3' ' A' 1555 ' ' SER . 3.9 pp -139.55 177.17 8.13 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.489 HD13 HD12 ' A' 1652 ' ' LEU . 45.5 mt -124.2 119.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 93.5 m-85 -81.37 149.19 28.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.9 mt -130.84 147.62 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 CA-C-O 121.122 0.487 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -134.65 138.2 9.86 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.536 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 47.7 mm -109.19 97.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 118.004 0.902 . . . . 0.0 112.091 -172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 66.3 m 65.46 7.71 4.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.344 1.058 . . . . 0.0 111.807 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.32 157.61 27.81 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -63.17 136.71 43.06 Favored Glycine 0 N--CA 1.428 -1.855 0 O-C-N 124.38 0.694 . . . . 0.0 113.353 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.77 166.15 13.14 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.2 -15.2 36.61 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-O 121.212 0.529 . . . . 0.0 109.664 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.33 -23.52 26.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.811 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 60.5 m -137.47 142.94 39.02 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.67 149.97 12.97 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.45 2.767 . . . . 0.0 114.067 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 56.8 m -65.68 112.18 3.55 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 113.51 -6.22 24.6 Favored Glycine 0 C--O 1.211 -1.324 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.491 HG13 ' OD1' ' A' 1589 ' ' ASN . 53.4 t -117.73 118.81 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . 0.712 ' CA ' ' HB3' ' A' 1593 ' ' TRP . . . -93.36 -25.68 18.09 Favored Glycine 0 CA--C 1.465 -3.084 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.52 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' 1590 ' ' ALA . 45.4 t -142.98 132.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.467 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.1 p -150.02 136.59 19.11 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.394 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -66.04 152.01 45.58 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.43 -13.67 50.59 Favored Glycine 0 CA--C 1.482 -1.986 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.652 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.09 -69.02 0.19 Allowed 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 123.862 0.865 . . . . 0.0 110.909 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.9 p -127.36 21.84 6.6 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.404 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' 1583 ' ' PHE . 14.7 mmmm 54.27 68.9 0.78 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.573 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 40.8 mt -99.42 101.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.128 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.491 ' OD1' HG13 ' A' 1579 ' ' VAL . 19.5 t30 -52.88 109.15 0.38 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.037 0.922 . . . . 0.0 110.118 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.68 8.31 45.09 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.626 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.74 121.62 0.57 Allowed Glycine 0 C--N 1.299 -1.5 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' 1579 ' ' VAL . 34.6 m -80.49 130.9 35.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.712 ' HB3' ' CA ' ' A' 1580 ' ' GLY 0.408 0.1 OUTLIER -66.26 153.48 42.45 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -173.037 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -153.34 -179.99 8.25 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.308 -2.478 . . . . 0.0 104.308 -174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 8.6 m -119.5 21.68 12.02 Favored 'General case' 0 C--N 1.271 -2.804 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.482 ' HA ' ' NE2' ' A' 1596 ' ' GLN . 11.2 mm-40 -74.09 79.63 1.74 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.679 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' 1533 ' ' GLN . 59.4 tp -97.14 137.8 35.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.272 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.823 ' HG2' ' HB3' ' A' 1527 ' ' ASN . 30.5 mtm -139.73 163.6 32.16 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.492 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.712 ' HD1' HD12 ' A' 1604 ' ' LEU . 44.5 t80 -127.86 90.81 3.16 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -126.34 122.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.608 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 65.1 37.94 6.4 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.846 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.412 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.2 mm-40 64.54 15.11 9.42 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.534 1.134 . . . . 0.0 111.224 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' 1627 ' ' SER . 72.8 t -123.71 138.76 52.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.631 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.986 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.2 mp -76.02 144.37 40.91 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.29 134.5 39.99 Favored 'General case' 0 C--N 1.274 -2.687 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.525 -175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' 1597 ' ' LEU . 76.1 mt -122.92 123.97 42.15 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 170.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1625 ' ' VAL . 59.0 t -114.13 98.02 6.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.604 ' CD1' ' HA ' ' A' 1593 ' ' TRP . 24.1 m-85 -85.09 100.92 12.03 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.602 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 4.2 p30 -102.14 174.97 5.69 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.1 t70 49.79 61.56 3.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 125.397 1.686 . . . . 0.0 111.453 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -88.47 -137.65 5.96 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.152 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -88.24 154.54 51.82 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.902 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.6 Cg_endo -82.68 138.16 9.33 Favored 'Trans proline' 0 N--CA 1.438 -1.74 0 C-N-CA 121.712 1.608 . . . . 0.0 113.417 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 18.0 p -90.2 118.02 68.51 Favored Pre-proline 0 N--CA 1.397 -3.124 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 19.2 Cg_endo -98.68 -11.3 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.963 2.442 . . . . 0.0 114.027 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 44.8 t -105.89 -51.63 2.95 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.998 -0.439 . . . . 0.0 112.05 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.99 -32.01 63.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.262 0.553 . . . . 0.0 110.885 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -162.97 -153.77 0.27 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -127.17 20.7 6.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 118.45 0.568 . . . . 0.0 112.399 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' 1649 ' ' THR . 6.5 mp -95.78 -168.62 1.8 Allowed 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.99 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.902 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.5 mttt -99.59 156.16 17.21 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 86.5 m-85 -75.36 154.24 37.36 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.289 0.566 . . . . 0.0 110.266 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.5 pttt -148.83 158.0 43.84 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 62.9 m -128.66 129.54 45.98 Favored 'General case' 0 C--N 1.266 -3.037 0 O-C-N 123.224 0.327 . . . . 0.0 110.817 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.516 HG22 HG22 ' A' 1607 ' ' VAL . 88.2 t -118.76 97.25 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 44.7 mt -89.64 114.75 28.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.221 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.8 m -93.78 122.4 36.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.109 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.986 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 76.9 m-85 -100.53 110.34 22.5 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-O 122.109 0.957 . . . . 0.0 110.02 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.3 t -100.24 128.96 51.69 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.926 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' 1658 ' ' THR . 11.6 t -57.42 130.4 46.09 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.878 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 10.6 t -131.55 124.56 30.31 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 170.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -61.22 4.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.63 -171.55 0.06 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.956 0.902 . . . . 0.0 111.366 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 22.6 t -113.63 100.56 8.58 Favored 'General case' 0 N--CA 1.428 -1.574 0 O-C-N 121.562 -0.711 . . . . 0.0 110.328 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 47.33 53.39 11.89 Favored Glycine 0 C--O 1.216 -1.019 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.855 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.552 ' H ' ' HG2' ' A' 1659 ' ' PRO . . . -108.27 176.61 5.07 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.593 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.7 p-10 -119.1 -21.48 7.62 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 47.8 t30 63.12 -77.4 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 126.239 1.816 . . . . 0.0 110.503 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -173.09 125.92 0.47 Allowed Pre-proline 0 C--N 1.27 -2.858 0 C-N-CA 124.816 1.247 . . . . 0.0 109.226 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_exo -74.5 129.5 12.87 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.887 1.724 . . . . 0.0 109.328 171.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.625 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.4 t -114.6 121.25 66.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -174.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.662 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 69.7 t80 -72.1 109.39 5.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.2 p -85.54 -51.04 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.65 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 69.3 m -156.68 155.66 32.11 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 122.207 -0.308 . . . . 0.0 111.648 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.662 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -116.97 142.84 46.43 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.4 t70 -112.64 115.37 28.47 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 36.1 mttp -93.42 4.17 54.4 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -85.44 -38.24 18.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.715 ' HA ' HD22 ' A' 1620 ' ' LEU . 4.5 t -131.45 18.59 4.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.176 177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' 1646 ' ' ASP . 85.2 m 49.76 62.2 2.77 Favored 'General case' 0 C--O 1.212 -0.892 0 CA-C-O 122.408 1.099 . . . . 0.0 112.384 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.62 ' OG1' HG23 ' A' 1649 ' ' THR . 25.7 m -111.86 113.77 26.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.048 -175.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.571 HD13 HD23 ' A' 1645 ' ' LEU . 2.3 mm? -79.5 107.62 12.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.337 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 81.1 m-85 -93.66 120.69 34.24 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 110.365 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' 1564 ' ' ILE . 89.6 m-85 -116.19 142.33 46.97 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.596 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.0 p -110.47 119.95 40.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.7 t-105 -118.85 128.47 54.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -97.79 104.58 16.62 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.0 t -135.42 140.71 35.05 Favored Pre-proline 0 N--CA 1.425 -1.682 0 CA-C-O 121.559 0.695 . . . . 0.0 112.001 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' 1636 ' ' ALA . 52.2 Cg_exo -68.12 -12.21 34.41 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 124.586 3.524 . . . . 0.0 111.401 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' 1547 ' ' SER . 3.0 mp -77.77 -20.58 53.11 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.855 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -88.15 -4.77 58.7 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.191 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 75.7 m -87.21 144.36 26.86 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.748 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -122.72 161.42 23.93 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -57.95 -34.97 70.48 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 118.82 0.737 . . . . 0.0 112.121 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.32 174.08 10.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.869 0.366 . . . . 0.0 110.334 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.52 154.09 87.68 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.01 -161.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 124.323 3.348 . . . . 0.0 111.508 172.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -59.93 -39.97 87.29 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.858 -0.526 . . . . 0.0 111.726 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -140.48 124.46 17.39 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--N 1.305 -1.348 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 172.437 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 C--O 1.224 -0.244 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -70.3 151.44 45.28 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.807 0.337 . . . . 0.0 110.643 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 17.9 m -98.23 177.04 5.51 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.013 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 87.89 6.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.839 1.304 . . . . 0.0 111.906 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.503 HG13 ' HG2' ' A' 1529 ' ' GLN . 11.3 tp -145.67 173.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.503 ' HG2' HG13 ' A' 1528 ' ' ILE . 2.2 pt20 -60.27 159.66 9.6 Favored 'General case' 0 C--O 1.252 1.219 0 C-N-CA 124.691 1.196 . . . . 0.0 110.245 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 10.2 t0 -166.26 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.801 0.334 . . . . 0.0 110.289 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 61.2 t30 178.31 65.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.24 0.616 . . . . 0.0 109.386 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.1 t 63.71 26.59 14.55 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.212 1.006 . . . . 0.0 110.126 176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' 1543 ' ' PHE . 2.8 pt20 -150.5 146.2 26.47 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.609 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' 1598 ' ' MET . 7.1 p -140.28 133.15 33.64 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.291 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 16.8 m -98.83 126.65 44.53 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.9 t-20 -63.56 119.58 55.08 Favored Pre-proline 0 CA--C 1.512 -0.492 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.84 -10.85 24.16 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 122.522 2.148 . . . . 0.0 113.147 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.96 -36.19 12.28 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 120.124 -0.631 . . . . 0.0 111.233 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' 1541 ' ' HIS . 68.5 p -113.33 -26.9 8.15 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.614 0.721 . . . . 0.0 112.399 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.45 13.35 78.73 Favored Glycine 0 N--CA 1.401 -3.671 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . 0.49 ' HD2' ' HB ' ' A' 1539 ' ' THR . 31.1 m-70 -79.77 113.28 17.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.267 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.1 tm? -74.58 134.41 42.14 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.425 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.675 ' HB3' HD21 ' A' 1604 ' ' LEU . 98.3 m-85 -107.74 138.05 44.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -138.18 126.15 22.65 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 118.308 0.504 . . . . 0.0 111.312 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' 1660 ' ' LEU . 31.1 mt -108.29 6.26 26.37 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.851 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 44.3 m-80 -64.97 -15.82 62.66 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.434 0.635 . . . . 0.0 111.342 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.7 p -73.79 -15.41 61.19 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.941 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 98.0 mt -90.3 4.79 49.72 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 122.718 0.407 . . . . 0.0 111.624 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -75.49 94.9 3.19 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -138.4 144.31 40.17 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.843 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' 1572 ' ' THR . 5.7 m-20 -82.91 -17.99 41.76 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.615 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 51.2 p -47.76 -47.21 30.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.646 1.216 . . . . 0.0 109.588 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 94.62 162.1 34.88 Favored Glycine 0 CA--C 1.483 -1.932 0 CA-C-N 114.997 -1.002 . . . . 0.0 114.405 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 62.7 m-85 -128.36 161.03 30.39 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.716 -0.742 . . . . 0.0 109.887 -178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' 1563 ' ' LEU . 5.8 p -150.7 152.58 34.13 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 123.853 0.861 . . . . 0.0 111.384 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.677 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.4 t -141.71 94.26 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -46.16 125.61 6.74 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 123.65 0.78 . . . . 0.0 112.031 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.477 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.6 t80 -90.6 149.37 22.15 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 13.5 m -71.7 -0.04 9.97 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -94.01 -86.94 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.29 25.64 0.53 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -157.66 -172.56 24.99 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' 1555 ' ' SER . 3.8 pp -131.62 178.36 6.81 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 123.701 0.8 . . . . 0.0 109.718 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.528 HD13 HD12 ' A' 1652 ' ' LEU . 34.8 mt -124.2 118.54 54.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 90.2 m-85 -81.56 146.04 30.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 59.5 mt -131.2 144.78 36.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.174 0.511 . . . . 0.0 111.465 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.61 137.5 10.31 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 107.367 -2.293 . . . . 0.0 107.367 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . . . . . . . . . 46.9 mm -108.71 98.88 7.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 117.947 0.873 . . . . 0.0 110.663 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.4 p 52.99 13.22 0.34 Allowed 'General case' 0 C--N 1.37 1.489 0 C-N-CA 125.279 1.432 . . . . 0.0 113.465 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.94 163.62 31.44 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -84.57 147.97 23.48 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 121.029 -0.605 . . . . 0.0 114.343 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 1.4 t -130.01 166.26 20.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 23.9 pttm -89.56 -15.68 32.32 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 2.8 m-20 -79.77 -23.7 42.01 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.681 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.6 t -137.26 142.68 38.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' A' 1579 ' ' VAL . 50.6 Cg_exo -59.93 149.99 80.73 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.985 2.457 . . . . 0.0 114.54 -175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 26.0 m -68.41 126.84 30.87 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.492 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.67 -6.48 57.28 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -173.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' 1589 ' ' ASN . 68.5 t -117.64 127.69 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 123.975 0.91 . . . . 0.0 108.753 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.24 -39.21 6.1 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.16 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' 1590 ' ' ALA . 52.6 t -142.2 142.91 27.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 23.2 p -154.79 136.33 14.26 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.689 ' O ' ' HA ' ' A' 1587 ' ' LYS . 70.9 m-85 -62.97 149.08 45.73 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -91.0 -29.95 11.96 Favored Glycine 0 C--N 1.294 -1.803 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.89 -73.73 0.13 Allowed 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.545 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 6.2 p -100.7 12.83 36.64 Favored 'General case' 0 N--CA 1.403 -2.786 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.909 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.7 mmtp 48.55 59.13 4.56 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.74 1.616 . . . . 0.0 113.427 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.415 HG21 ' HE2' ' A' 1622 ' ' TYR . 19.2 mt -103.61 102.31 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.934 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.664 ' HB2' HG13 ' A' 1579 ' ' VAL . 4.2 p-10 -56.71 107.09 0.36 Allowed 'General case' 0 C--O 1.198 -1.653 0 CA-C-O 122.802 1.287 . . . . 0.0 113.135 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.721 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.8 13.79 9.97 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.123 -174.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 175.51 140.31 3.36 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . 0.427 ' O ' ' HD1' ' A' 1608 ' ' TYR . 50.9 m -96.98 143.42 27.85 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 116.994 0.397 . . . . 0.0 110.359 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.492 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -40.42 121.28 1.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.176 1.791 . . . . 0.0 111.589 -178.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.518 ' H ' ' HE1' ' A' 1608 ' ' TYR . 96.0 m-20 -151.72 164.06 37.79 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.4 ' HB3' ' N ' ' A' 1532 ' ' CYS . 14.9 m -124.33 22.96 8.42 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.493 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 30.1 mm-40 -72.96 89.44 1.42 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.521 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -109.74 142.71 40.58 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 123.665 0.603 . . . . 0.0 110.453 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' 1604 ' ' LEU . 4.5 mtm -141.15 177.48 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 124.105 0.878 . . . . 0.0 109.533 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.595 ' HD1' HD12 ' A' 1604 ' ' LEU . 63.0 t80 -139.72 101.22 4.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.6 p -138.19 126.89 31.68 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.018 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 65.61 37.52 5.88 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.467 1.107 . . . . 0.0 110.395 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.462 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 47.3 mt-30 66.66 13.55 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.478 1.111 . . . . 0.0 110.959 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' 1627 ' ' SER . 53.8 t -119.7 142.45 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.511 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.939 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.5 mp -87.57 132.49 34.04 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -124.18 133.81 53.46 Favored 'General case' 0 CA--C 1.475 -1.92 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' 1596 ' ' GLN . 78.4 mt -106.27 124.95 50.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' 1623 ' ' LYS . 96.2 t -108.24 95.13 3.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 122.042 0.925 . . . . 0.0 109.146 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.644 ' HB2' ' HB3' ' A' 1624 ' ' SER . 74.5 m-85 -87.08 85.33 7.22 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.992 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 15.0 t70 -95.64 175.96 6.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 24.9 t70 58.51 42.8 20.36 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 122.398 1.094 . . . . 0.0 110.745 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.0 -150.01 8.96 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.967 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.52 ' HB2' ' OD1' ' A' 1589 ' ' ASN . . . -78.16 152.0 78.92 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 38.0 Cg_endo -82.08 138.21 10.07 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 C-N-CA 121.58 1.52 . . . . 0.0 112.652 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.447 ' HB3' ' CZ ' ' A' 1622 ' ' TYR . 23.4 p -91.49 119.56 68.54 Favored Pre-proline 0 N--CA 1.389 -3.476 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 8.9 Cg_endo -96.63 -10.73 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.444 2.096 . . . . 0.0 112.575 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 29.0 t -103.5 -60.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -172.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -65.24 -37.87 88.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.791 0.805 . . . . 0.0 111.517 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -162.68 -159.39 0.56 Allowed 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -123.68 28.29 6.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 118.546 0.612 . . . . 0.0 111.691 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.723 HD22 ' HA ' ' A' 1649 ' ' THR . 7.3 mp -100.84 -167.44 1.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.558 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.705 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 52.4 mttp -103.14 149.97 24.1 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.7 m-85 -71.33 145.65 49.32 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 121.665 0.745 . . . . 0.0 111.444 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.515 ' HG2' HG23 ' A' 1651 ' ' THR . 16.5 ttpt -140.2 145.51 37.52 Favored 'General case' 0 N--CA 1.38 -3.957 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.094 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.644 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 42.3 t -115.06 134.27 55.32 Favored 'General case' 0 C--N 1.264 -3.137 0 O-C-N 123.806 0.691 . . . . 0.0 110.045 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' 1653 ' ' TYR . 0.4 OUTLIER -124.46 89.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.41 1.1 . . . . 0.0 110.111 177.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.55 112.36 22.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.793 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' 1603 ' ' VAL . 8.2 m -90.35 117.67 29.25 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.939 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.3 m-85 -96.59 109.07 21.75 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.114 0.959 . . . . 0.0 109.738 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -102.53 126.51 56.66 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.242 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' 1658 ' ' THR . 16.0 t -52.66 128.04 24.99 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 123.911 0.884 . . . . 0.0 112.738 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.7 t -124.11 144.2 50.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -66.34 2.71 1.13 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.91 -174.03 0.88 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.807 0.443 . . . . 0.0 110.733 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 12.3 t -126.65 95.45 4.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 121.526 -0.734 . . . . 0.0 110.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 57.83 59.84 10.08 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.167 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -130.62 179.61 5.84 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.6 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 1.2 p-10 -112.66 -16.87 12.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.4 t-20 60.36 -75.7 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.585 1.954 . . . . 0.0 111.067 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 37.8 ttpt -171.81 122.69 0.5 Allowed Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.716 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.677 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.8 Cg_exo -86.57 132.43 3.57 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 123.604 2.869 . . . . 0.0 108.718 168.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.64 HG12 ' OG ' ' A' 1655 ' ' SER . 0.4 OUTLIER -129.59 154.57 40.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.409 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.911 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 78.9 t80 -94.39 111.61 23.36 Favored 'General case' 0 N--CA 1.404 -2.753 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -89.25 -53.69 8.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.34 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 80.9 p -150.31 150.19 31.14 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.405 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.911 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -108.47 142.64 38.56 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.464 ' N ' HD13 ' A' 1645 ' ' LEU . 10.9 t70 -109.17 110.88 22.22 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.76 7.35 37.34 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.274 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.86 -38.78 12.72 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.723 ' HA ' HD22 ' A' 1620 ' ' LEU . 2.3 t -135.44 18.77 3.36 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.062 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 94.9 m 50.25 52.46 14.71 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.653 1.216 . . . . 0.0 112.408 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.515 HG23 ' HG2' ' A' 1623 ' ' LYS . 28.4 m -108.63 113.34 26.24 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.72 -174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.2 mm? -78.43 101.32 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.272 1.829 . . . . 0.0 109.953 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.713 ' HA ' HG23 ' A' 1625 ' ' VAL . 76.1 m-85 -85.47 120.62 27.13 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.632 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -118.87 142.08 48.06 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.64 ' OG ' HG12 ' A' 1641 ' ' VAL . 3.6 p -113.13 119.06 36.51 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.6 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.0 t-105 -118.34 127.79 54.03 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -171.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.55 ' HB3' ' HB ' ' A' 1631 ' ' THR . 65.6 m-70 -96.06 106.85 19.08 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' 1659 ' ' PRO . 12.9 t -135.86 139.73 31.44 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-O 121.525 0.679 . . . . 0.0 112.158 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.526 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 33.5 Cg_exo -69.87 -10.89 29.57 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 124.544 3.496 . . . . 0.0 111.107 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' 1545 ' ' LEU . 1.6 mp -79.09 -21.88 46.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.87 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.03 -6.07 59.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 80.1 m -88.27 120.26 29.47 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.412 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.54 136.33 45.82 Favored 'General case' 0 N--CA 1.409 -2.499 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' 1664 ' ' LYS . 72.2 mmtt -68.37 -15.67 63.65 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -90.03 114.25 26.1 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' 1670 ' ' HIS . 44.0 mt-10 -93.83 136.35 23.96 Favored Pre-proline 0 C--N 1.28 -2.45 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.022 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' 1666 ' ' GLU . 9.7 Cg_exo -72.37 -177.03 2.47 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 123.688 2.926 . . . . 0.0 112.937 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' 1668 ' ' ARG . 72.7 mtt180 -55.02 -49.7 70.89 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.885 0.85 . . . . 0.0 108.771 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -106.95 100.78 10.26 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.569 ' CB ' ' HB3' ' A' 1666 ' ' GLU . 7.3 p80 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.288 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 25.8 tptp -137.9 134.66 35.28 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 49.7 m -89.37 128.32 35.9 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.99 ' HB3' ' H ' ' A' 1535 ' ' THR . 46.9 t30 -76.19 87.86 3.05 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' 1597 ' ' LEU . 4.9 tt -72.38 86.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 170.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -109.6 163.0 13.88 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.1 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -99.23 20.81 12.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 123.856 0.862 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -120.1 21.57 11.76 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.293 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.569 ' SG ' ' HD2' ' A' 1549 ' ' LYS . 3.2 p 48.52 46.75 20.81 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.996 0.903 . . . . 0.0 112.095 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.608 ' HB2' HD22 ' A' 1542 ' ' LEU . 3.6 pt20 -143.93 140.49 29.72 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.059 -1.428 . . . . 0.0 107.506 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' 1598 ' ' MET . 9.5 p -138.58 126.73 29.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.99 ' H ' ' HB3' ' A' 1527 ' ' ASN . 6.3 m -90.26 126.99 36.03 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -58.9 119.54 38.59 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.49 -14.58 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.551 2.167 . . . . 0.0 112.998 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -95.27 -42.01 8.75 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.784 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.1 p -113.02 -10.63 13.47 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.621 0.724 . . . . 0.0 112.649 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.07 10.23 80.95 Favored Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.158 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -79.91 118.33 21.57 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.877 0.37 . . . . 0.0 110.993 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.6 mt -71.43 138.11 48.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-O 122.331 1.063 . . . . 0.0 111.592 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.1 m-85 -107.37 146.07 32.08 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -146.11 151.9 38.42 Favored 'General case' 0 N--CA 1.383 -3.79 0 CA-C-N 118.829 0.74 . . . . 0.0 109.75 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.564 ' CD2' HD11 ' A' 1660 ' ' LEU . 44.7 mt -120.71 21.1 11.6 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.48 -24.93 68.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.299 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 24.3 t -83.06 -14.36 53.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.114 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' 1637 ' ' ASN . 55.6 mt -95.63 2.28 54.04 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.813 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.569 ' HD2' ' SG ' ' A' 1532 ' ' CYS . 58.5 mtpt -79.64 93.62 5.54 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -136.44 148.58 47.81 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.839 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.06 -25.25 40.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.952 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.53 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 16.8 p -53.56 -60.19 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.767 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.476 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 94.8 174.56 38.15 Favored Glycine 0 N--CA 1.413 -2.87 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.917 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -127.36 172.8 10.32 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.224 -0.488 . . . . 0.0 110.676 -173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.439 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.2 p -151.49 149.5 29.31 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 124.629 1.172 . . . . 0.0 111.254 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 77.9 t -138.43 93.5 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 124.099 0.96 . . . . 0.0 108.801 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.449 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -45.17 123.22 3.82 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 123.217 0.607 . . . . 0.0 112.004 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' 1564 ' ' ILE . 40.5 t80 -97.88 147.38 24.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 25.3 m -70.91 13.96 0.17 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -104.69 -73.38 0.68 Allowed 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.458 -0.776 . . . . 0.0 111.789 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.481 ' HE2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -154.18 -0.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.08 -164.37 12.48 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -123.05 179.48 4.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.974 0.91 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' 1558 ' ' TYR . 43.0 mt -124.51 118.01 52.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 71.1 m-85 -78.86 142.26 36.99 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.963 0.411 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.553 HG12 HG22 ' A' 1581 ' ' VAL . 30.4 mt -131.18 138.04 54.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.365 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.67 136.2 11.99 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.432 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 39.9 mm -109.55 97.04 5.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 117.854 0.827 . . . . 0.0 110.439 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.412 ' O ' ' HE3' ' A' 1549 ' ' LYS . 50.4 t 64.23 12.88 7.48 Favored 'General case' 0 C--N 1.371 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 111.209 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.85 158.31 28.22 Favored Glycine 0 N--CA 1.426 -1.998 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.623 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -78.64 125.97 7.33 Favored Glycine 0 N--CA 1.417 -2.614 0 CA-C-O 121.513 0.507 . . . . 0.0 111.84 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.476 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.6 OUTLIER -108.26 164.59 12.18 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.08 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' 1552 ' ' SER . 32.8 pttt -92.07 -8.94 44.45 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.638 0.732 . . . . 0.0 109.998 174.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 6.4 m-20 -89.07 -22.97 22.65 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.36 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.8 t -137.94 142.82 37.42 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.54 151.48 38.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 123.401 2.734 . . . . 0.0 114.893 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 50.0 m -74.53 113.99 12.42 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.532 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 115.53 -10.84 19.16 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.537 HG12 ' SG ' ' A' 1575 ' ' CYS . 67.8 t -117.13 123.0 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -88.94 -38.25 6.94 Favored Glycine 0 C--N 1.293 -1.83 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.956 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.2 t -138.22 138.04 43.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' 1579 ' ' VAL . 24.4 p -154.27 136.69 15.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' 1587 ' ' LYS . 51.0 m-85 -64.59 149.57 48.58 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -95.31 -17.37 37.1 Favored Glycine 0 C--N 1.285 -2.255 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.567 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.607 HD12 HG23 ' A' 1586 ' ' THR . 0.4 OUTLIER -71.37 -67.84 0.49 Allowed 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 121.386 0.612 . . . . 0.0 109.403 -177.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.607 HG23 HD12 ' A' 1585 ' ' LEU . 7.6 p -110.42 22.55 15.35 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' 1583 ' ' PHE . 46.9 mmtm 46.8 59.67 3.82 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.508 1.123 . . . . 0.0 112.431 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 13.4 mm -96.89 101.26 12.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.655 -175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 16.8 t30 -49.93 109.13 0.26 Allowed 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.029 0.919 . . . . 0.0 109.493 171.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.804 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -100.46 9.37 42.68 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.481 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.26 122.42 0.6 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 66.2 m -75.86 146.42 39.84 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.532 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.44 124.65 1.62 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.609 2.364 . . . . 0.0 112.559 -178.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.435 ' H ' ' HE1' ' A' 1608 ' ' TYR . 74.5 m-20 -152.73 167.84 27.64 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.1 m -132.39 18.92 4.37 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.422 ' H ' ' HB3' ' A' 1594 ' ' ASN . 22.3 mm-40 -69.82 94.71 0.84 Allowed 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.83 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.843 HD11 ' HB3' ' A' 1604 ' ' LEU . 54.1 tp -110.03 134.51 52.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 124.023 0.827 . . . . 0.0 110.711 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' 1604 ' ' LEU . 3.0 mpp? -129.54 176.9 7.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.782 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.581 ' HD1' HD12 ' A' 1604 ' ' LEU . 69.6 t80 -140.25 98.31 3.41 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 3.1 p -135.84 127.61 45.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.889 -172.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 65.4 37.78 6.05 Favored 'General case' 0 C--O 1.249 1.032 0 C-N-CA 123.836 0.855 . . . . 0.0 110.288 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.407 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 51.1 mt-30 63.53 13.98 7.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.16 1.384 . . . . 0.0 110.599 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' 1627 ' ' SER . 37.1 t -120.55 135.08 61.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.098 -177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 1.051 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.33 136.57 40.83 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.17 125.28 44.18 Favored 'General case' 0 C--N 1.27 -2.851 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.391 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.421 ' HG ' ' HE1' ' A' 1628 ' ' PHE . 50.1 mt -105.79 123.91 48.71 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.743 HG22 HG12 ' A' 1625 ' ' VAL . 99.2 t -111.91 100.91 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 121.653 0.739 . . . . 0.0 109.133 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.55 ' HE2' HD12 ' A' 1626 ' ' ILE . 95.4 m-85 -91.47 92.08 8.38 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.5 p-10 -100.67 171.39 7.73 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.012 0.434 . . . . 0.0 112.101 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.54 56.97 5.16 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 125.205 1.565 . . . . 0.0 110.99 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.11 -143.92 10.1 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.241 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -78.53 161.18 70.63 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.529 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.9 Cg_endo -69.83 131.38 21.01 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.063 1.842 . . . . 0.0 111.661 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' 1620 ' ' LEU . 41.3 t -96.1 112.74 60.56 Favored Pre-proline 0 C--N 1.297 -1.674 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.887 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -100.36 3.59 0.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.374 2.716 . . . . 0.0 112.605 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 45.4 m -63.09 -62.94 1.37 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.05 -66.16 0.83 Allowed 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 120.804 0.335 . . . . 0.0 110.46 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' 1648 ' ' GLN . 34.8 m-80 -97.87 165.75 11.79 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -102.95 34.07 3.01 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 121.129 0.49 . . . . 0.0 112.198 -170.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' 1614 ' ' CYS . 6.4 mp -89.92 -172.79 3.65 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.85 156.76 16.71 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.544 ' CE2' HG21 ' A' 1588 ' ' ILE . 36.4 m-85 -71.34 145.9 49.15 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.225 0.328 . . . . 0.0 110.154 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.665 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 62.3 pttt -146.98 158.23 43.86 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 50.3 m -125.11 143.55 50.87 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.038 0.447 . . . . 0.0 111.434 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.743 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -130.8 91.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 C-N-CA 124.625 1.17 . . . . 0.0 110.132 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 50.8 mt -86.27 110.0 19.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.32 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.641 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -90.97 118.39 30.32 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.98 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 1.051 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.0 m-85 -97.79 108.38 21.08 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.078 0.942 . . . . 0.0 109.655 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 44.3 t -103.08 129.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.158 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 10.4 t -52.37 126.16 18.31 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 124.278 0.986 . . . . 0.0 111.799 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 2.6 t -126.83 144.54 50.94 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -62.7 2.69 0.27 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.708 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 27.6 m-20 -75.43 -175.71 2.89 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.57 95.55 3.51 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.945 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.643 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 75.65 60.95 3.05 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.464 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' 1659 ' ' PRO . . . -140.37 -178.74 5.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.465 0.706 . . . . 0.0 109.175 -176.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' 1548 ' ' LEU . 1.9 p-10 -119.59 -15.58 8.97 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.5 t-20 64.28 -77.93 0.03 OUTLIER 'General case' 0 C--O 1.244 0.781 0 C-N-CA 125.987 1.715 . . . . 0.0 111.762 177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' 1640 ' ' PRO . 38.5 ttpt -172.82 131.46 0.63 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.576 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 6.1 Cg_exo -91.11 132.2 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.02 3.147 . . . . 0.0 110.282 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.516 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.1 t -122.57 149.9 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.576 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 53.1 t80 -90.62 115.17 27.52 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -93.04 -54.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.305 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 67.5 m -147.63 155.7 42.05 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.714 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.6 HD23 HD13 ' A' 1652 ' ' LEU . 3.2 tm? -127.46 132.92 49.95 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' 1651 ' ' THR . 8.6 t70 -96.52 113.96 25.58 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.512 ' HG2' HD12 ' A' 1645 ' ' LEU . 47.0 mttp -93.44 3.62 55.28 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-O 121.325 0.583 . . . . 0.0 111.125 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . 0.501 ' HA ' ' ND2' ' A' 1618 ' ' ASN . 30.1 tt0 -92.67 -38.51 11.81 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' 1651 ' ' THR . 3.1 t -131.91 18.23 4.62 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.606 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 68.9 m 49.51 58.47 5.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.554 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 20.3 m -105.79 112.14 25.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.014 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.6 HD13 HD23 ' A' 1645 ' ' LEU . 2.4 mm? -78.39 103.04 8.08 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.193 1.397 . . . . 0.0 110.235 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.65 ' HA ' HG23 ' A' 1625 ' ' VAL . 86.2 m-85 -86.74 119.52 27.06 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.558 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 82.9 m-85 -113.94 141.16 47.73 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.534 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.516 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.5 p -108.82 118.17 36.09 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.607 ' CD1' ' HB ' ' A' 1658 ' ' THR . 5.2 t-105 -121.29 116.48 24.94 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.54 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.0 m-70 -91.45 105.16 17.56 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.666 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 14.9 t -128.51 138.35 32.88 Favored Pre-proline 0 N--CA 1.423 -1.783 0 CA-C-O 121.556 0.693 . . . . 0.0 110.824 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.708 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.2 Cg_exo -68.81 -18.03 41.79 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 C-N-CA 124.531 3.488 . . . . 0.0 112.287 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.666 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.1 pp -78.42 -19.63 52.83 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.105 0.478 . . . . 0.0 111.266 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.45 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.07 -1.54 48.89 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.404 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' 1659 ' ' PRO . 98.9 m -93.28 133.94 35.99 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.954 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -110.96 137.42 48.61 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 91.3 mttt -66.11 -33.78 76.56 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 123.93 0.768 . . . . 0.0 111.041 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.57 144.17 26.49 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.77 149.9 67.0 Favored Pre-proline 0 C--N 1.279 -2.499 0 C-N-CA 119.874 -0.731 . . . . 0.0 112.716 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.3 -162.6 0.16 Allowed 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 123.94 3.093 . . . . 0.0 110.043 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -51.52 -54.61 25.43 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -141.08 134.88 30.37 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 C--N 1.299 -1.589 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.6 177.432 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.448 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.739 ' HB2' HG23 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' 1596 ' ' GLN . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.503 ' NE2' ' HB3' ' A' 1530 ' ' ASP . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' 1528 ' ' ILE . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' 1619 ' ' ALA . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.446 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.448 ' HG3' ' HG2' ' A' 1525 ' ' LYS . 23.5 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' 1524 ' ' MET . 74.4 mmtt -118.78 175.58 5.68 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.784 -0.572 . . . . 0.0 110.652 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 20.4 t -108.84 -167.23 1.19 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.739 ' HB2' HG23 ' A' 1534 ' ' VAL . 5.3 m-20 -96.53 142.7 28.3 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.214 0.53 . . . . 0.0 111.051 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' 1598 ' ' MET . 6.8 tt -130.1 79.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 C-N-CA 128.817 2.847 . . . . 0.0 103.975 172.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' 1533 ' ' GLN . 42.9 tt0 -110.45 155.59 22.01 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.457 -168.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . 0.503 ' HB3' ' NE2' ' A' 1596 ' ' GLN . 4.7 p-10 -113.42 18.04 18.0 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.453 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 10.6 t-20 -106.38 21.16 17.86 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 9.0 t 61.95 40.27 12.57 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.436 1.095 . . . . 0.0 108.368 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' 1529 ' ' GLN . 3.8 pt20 -147.98 158.21 43.93 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.075 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' 1527 ' ' ASN . 5.6 p -154.01 128.52 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.23 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 21.6 m -95.3 126.19 40.44 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 121.52 -0.737 . . . . 0.0 109.177 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.427 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 52.9 t-20 -64.71 121.69 74.66 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.31 -7.86 17.04 Favored 'Trans proline' 0 CA--C 1.551 1.365 0 C-N-CA 122.386 2.057 . . . . 0.0 112.487 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -91.74 -38.44 12.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.251 -0.28 . . . . 0.0 111.497 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 72.0 p -121.99 -14.68 7.97 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.78 10.02 83.2 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 78.7 t60 -77.34 114.67 16.41 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.331 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.71 133.82 39.39 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.372 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.637 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -109.2 143.07 39.11 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -146.92 137.45 23.67 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' 1660 ' ' LEU . 36.7 mt -116.76 7.23 13.37 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.491 0.132 . . . . 0.0 111.242 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 45.4 m-80 -62.48 -19.32 63.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 47.9 m -73.17 -14.1 61.29 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.236 -0.29 . . . . 0.0 111.703 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.12 0.68 54.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.273 -0.267 . . . . 0.0 110.925 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' 1568 ' ' ILE . 54.3 mtmt -80.69 92.91 6.07 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 12.5 m120 -127.0 159.9 32.7 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.02 -30.68 27.93 Favored 'General case' 0 C--N 1.267 -2.999 0 O-C-N 123.924 0.765 . . . . 0.0 110.589 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 15.6 t -54.39 -60.87 2.76 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.818 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.544 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.4 173.24 32.46 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 119.625 -1.274 . . . . 0.0 113.512 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 66.2 m-85 -124.72 172.54 9.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.132 -172.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.521 ' HB2' HD13 ' A' 1563 ' ' LEU . 4.1 p -156.06 152.6 28.24 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 124.676 1.191 . . . . 0.0 111.564 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' 1640 ' ' PRO . 67.9 t -145.59 93.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -45.43 126.39 6.52 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.465 ' HD1' HD11 ' A' 1564 ' ' ILE . 62.5 t80 -87.6 154.39 20.64 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 19.9 m -66.12 -12.56 56.52 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -89.05 -90.25 0.14 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.555 ' HG2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.44 9.44 1.83 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -140.89 -176.37 15.31 Favored Glycine 0 N--CA 1.421 -2.353 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 4.2 pp -121.58 177.38 5.25 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 123.864 0.866 . . . . 0.0 108.844 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.651 HG21 ' HZ ' ' A' 1654 ' ' PHE . 60.7 mt -120.79 117.72 54.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 78.8 m-85 -79.86 142.6 35.08 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 60.8 mt -132.07 136.99 55.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.739 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.6 129.89 8.07 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' 1549 ' ' LYS . 45.8 mm -98.15 98.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 117.677 0.739 . . . . 0.0 110.174 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 28.1 p 54.7 18.39 2.07 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.036 1.334 . . . . 0.0 113.037 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.93 175.99 32.79 Favored Glycine 0 N--CA 1.424 -2.105 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.575 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -95.92 144.4 17.24 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.08 -173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.544 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -129.25 164.79 22.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.895 0.379 . . . . 0.0 111.585 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -89.15 -11.5 43.67 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.639 0.733 . . . . 0.0 109.366 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.564 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 5.9 m-20 -89.61 -23.11 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.901 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.4 t -137.3 141.36 33.73 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' 1582 ' ' CYS . 1.5 Cg_endo -53.59 145.17 49.07 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.542 2.828 . . . . 0.0 115.863 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 13.3 t -63.23 119.58 9.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.981 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 105.05 -5.57 42.36 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.7 t -117.48 123.71 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.73 -38.69 7.41 Favored Glycine 0 N--CA 1.428 -1.854 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.86 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 53.0 t -138.37 139.44 41.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' 1576 ' ' PRO . 24.5 p -152.83 139.65 19.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' 1587 ' ' LYS . 87.4 m-85 -68.41 142.31 55.44 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -89.03 -19.96 48.48 Favored Glycine 0 C--N 1.278 -2.694 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.929 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.555 HD21 ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -51.52 -59.46 4.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.263 1.025 . . . . 0.0 109.209 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.55 HG23 HD12 ' A' 1585 ' ' LEU . 68.1 p -130.18 18.79 5.43 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.522 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 59.3 69.4 0.72 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.885 0.85 . . . . 0.0 111.132 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 17.5 mt -103.85 98.87 7.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.67 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 20.6 t30 -46.79 107.85 0.12 Allowed 'General case' 0 C--O 1.207 -1.143 0 CA-C-O 122.09 0.948 . . . . 0.0 111.089 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.95 11.92 37.48 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -175.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 164.76 121.63 0.57 Allowed Glycine 0 C--N 1.296 -1.68 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 64.4 m -78.91 147.08 33.19 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.443 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -39.23 122.36 1.25 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.071 2.148 . . . . 0.0 111.899 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' 1596 ' ' GLN . 83.8 m-20 -154.77 165.98 34.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 18.0 m -126.84 21.18 6.97 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.503 ' NE2' ' HB3' ' A' 1530 ' ' ASP . 29.9 mm-40 -69.4 91.77 0.57 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.334 1.454 . . . . 0.0 110.345 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.846 HD11 ' HB3' ' A' 1604 ' ' LEU . 51.2 tp -109.4 140.14 43.49 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.552 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' 1528 ' ' ILE . 13.0 mtm -137.89 172.12 13.41 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.437 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.588 ' HD1' HD12 ' A' 1604 ' ' LEU . 47.7 t80 -135.11 103.56 5.59 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -136.01 119.43 23.53 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.549 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.78 46.0 12.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.976 1.31 . . . . 0.0 110.884 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.539 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 50.2 mt-30 67.48 14.08 9.5 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.896 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' 1627 ' ' SER . 38.1 t -122.64 126.79 74.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.412 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.901 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.1 mp -75.85 127.73 33.62 Favored 'General case' 0 C--O 1.198 -1.651 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.5 tt0 -128.96 125.2 36.95 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.518 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.55 124.83 43.54 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.807 HG22 HG12 ' A' 1625 ' ' VAL . 96.4 t -109.28 98.45 7.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 122.122 0.963 . . . . 0.0 109.619 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.584 ' HE2' HD12 ' A' 1626 ' ' ILE . 97.4 m-85 -88.27 91.83 8.93 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 7.8 p-10 -96.18 172.91 7.68 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.119 0.485 . . . . 0.0 111.719 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.2 t70 51.74 56.89 7.17 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 125.81 1.644 . . . . 0.0 111.653 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.53 -144.39 7.32 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.173 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.63 156.27 61.89 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 46.2 Cg_endo -77.96 142.51 19.82 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 121.382 1.388 . . . . 0.0 112.546 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' 1619 ' ' ALA . 13.5 p -91.62 117.67 67.92 Favored Pre-proline 0 N--CA 1.387 -3.617 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -100.32 1.93 0.77 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.738 2.292 . . . . 0.0 110.8 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.5 t -90.18 -64.22 1.17 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -172.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.93 -20.21 13.26 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.51 0.671 . . . . 0.0 112.334 -168.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -155.15 -167.69 2.64 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -126.6 25.56 6.44 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' 1649 ' ' THR . 7.2 mp -91.81 -166.58 1.59 Allowed 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 91.4 mttt -100.19 156.65 17.09 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.52 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 71.4 m-85 -76.17 154.35 35.45 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.343 0.592 . . . . 0.0 110.319 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.654 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.5 pttt -150.05 160.21 43.81 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 172.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 35.8 t -128.51 142.08 51.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-O 120.788 0.328 . . . . 0.0 110.37 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.807 HG12 HG22 ' A' 1607 ' ' VAL . 0.6 OUTLIER -129.62 89.71 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.17 0.986 . . . . 0.0 110.102 177.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.584 HD12 ' HE2' ' A' 1608 ' ' TYR . 51.0 mt -86.77 107.52 16.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.695 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.3 m -90.67 115.22 27.6 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.263 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.901 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.0 m-85 -93.66 114.98 27.42 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 124.204 1.002 . . . . 0.0 110.291 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -108.36 129.75 62.18 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.327 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.831 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.8 t -56.34 133.1 52.56 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 123.719 0.637 . . . . 0.0 112.322 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.8 t -130.5 142.2 50.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.9 t60 -71.85 3.83 3.87 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.434 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -68.48 -171.31 0.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.46 0.704 . . . . 0.0 110.252 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 37.2 t -123.99 108.61 12.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 45.46 59.8 4.53 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 124.215 0.947 . . . . 0.0 113.961 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.469 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -119.03 177.93 4.69 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.903 0.859 . . . . 0.0 112.923 -174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -100.23 -41.58 7.03 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.4 t-20 63.13 -68.16 0.08 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.278 1.831 . . . . 0.0 111.498 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -173.06 113.4 0.36 Allowed Pre-proline 0 C--N 1.278 -2.524 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.357 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.641 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.8 Cg_endo -90.42 120.62 0.8 Allowed 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 122.357 2.038 . . . . 0.0 109.059 166.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 10.3 t -108.56 123.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 124.146 0.978 . . . . 0.0 109.127 -173.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.868 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.0 t80 -79.29 101.43 8.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.34 -53.29 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.248 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 52.8 p -156.97 159.0 37.62 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.51 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.868 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -115.87 142.48 46.71 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 174.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.3 t70 -106.12 115.94 31.08 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 74.2 mttt -93.24 5.79 50.3 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.694 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -93.52 -37.6 11.83 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.661 ' HA ' HD22 ' A' 1620 ' ' LEU . 3.6 t -135.12 18.72 3.43 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.679 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 99.0 m 48.92 57.15 6.73 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.57 1.176 . . . . 0.0 112.665 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 27.9 m -110.01 114.75 28.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.804 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' 1583 ' ' PHE . 3.4 mm? -80.11 102.64 9.48 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.253 1.421 . . . . 0.0 110.75 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.631 ' HA ' HG23 ' A' 1625 ' ' VAL . 84.3 m-85 -86.88 117.44 25.61 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.141 0.496 . . . . 0.0 111.086 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.651 ' HZ ' HG21 ' A' 1564 ' ' ILE . 76.9 m-85 -118.13 141.94 47.96 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.541 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 39.7 m -116.29 118.33 32.46 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.732 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -118.98 125.38 49.26 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 17.5 m170 -90.13 101.55 14.27 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.7 t -126.8 138.72 33.16 Favored Pre-proline 0 N--CA 1.422 -1.847 0 CA-C-O 121.65 0.738 . . . . 0.0 111.541 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' 1658 ' ' THR . 32.1 Cg_exo -69.76 -10.97 29.88 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.172 3.248 . . . . 0.0 111.579 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.8 mp -78.31 -21.7 49.24 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.793 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -85.12 -4.11 59.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.753 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 81.8 m -86.58 131.87 34.05 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.293 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -101.74 162.46 12.89 Favored 'General case' 0 N--CA 1.386 -3.626 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.16 -42.39 69.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.5 149.96 22.67 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.436 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.6 163.6 28.06 Favored Pre-proline 0 C--N 1.274 -2.703 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' 1670 ' ' HIS . 8.4 Cg_endo -53.29 150.95 24.07 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.689 1.593 . . . . 0.0 110.385 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -60.41 -29.66 69.12 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.498 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 40.3 m80 -120.91 82.79 1.97 Allowed 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.446 ' HB3' ' HG2' ' A' 1667 ' ' PRO . 11.4 p80 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.465 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' 1600 ' ' VAL . 75.6 mmtt -129.35 179.83 5.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' 1599 ' ' TYR . 6.3 m -94.49 112.77 24.54 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . . . . . . . . . 23.3 t30 -146.88 112.64 5.69 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.719 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.476 ' CG2' ' H ' ' A' 1535 ' ' THR . 7.5 tp -145.53 82.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.436 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' 1530 ' ' ASP . 27.8 pt20 -62.68 163.19 9.5 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.502 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' 1529 ' ' GLN . 29.1 t70 167.4 -68.85 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.318 1.447 . . . . 0.0 110.219 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.56 71.57 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' 1545 ' ' LEU . 1.8 p 49.13 47.33 22.1 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.3 pt20 -147.48 150.01 33.77 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.553 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.7 p -148.38 126.19 3.12 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' 1542 ' ' LEU . 92.9 m -91.85 126.41 36.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 50.7 t30 -67.7 119.39 65.83 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.3 -7.13 19.18 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 123.418 2.745 . . . . 0.0 113.513 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -93.34 -37.05 12.22 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.161 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 65.0 p -112.28 -31.99 6.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.401 0.62 . . . . 0.0 112.267 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 89.75 10.74 64.67 Favored Glycine 1 N--CA 1.395 -4.093 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -173.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . 0.503 ' CG ' ' HG3' ' A' 1663 ' ' GLU . 15.3 t60 -74.46 113.51 11.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.12 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.2 tm? -78.79 127.59 32.26 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.668 0.747 . . . . 0.0 109.359 174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.751 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.6 m-85 -102.11 150.39 23.31 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -156.22 134.83 11.67 Favored 'General case' 0 N--CA 1.424 -1.749 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.884 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' 1660 ' ' LEU . 59.9 mt -108.36 14.14 25.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' 1549 ' ' LYS . 0.8 OUTLIER -66.48 -23.56 66.28 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.624 0.726 . . . . 0.0 109.335 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 13.2 m -70.53 -15.01 62.74 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.804 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.424 HD12 HD22 ' A' 1545 ' ' LEU . 69.5 mt -105.91 1.23 26.53 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 122.266 -0.271 . . . . 0.0 111.614 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' 1546 ' ' ASN . 19.6 ptpt -90.54 104.33 16.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.406 1.098 . . . . 0.0 110.086 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.88 -166.97 2.19 Favored 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.359 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.55 -28.42 8.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.67 0.606 . . . . 0.0 111.445 -174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 91.5 p -52.71 -51.61 59.66 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 123.434 0.459 . . . . 0.0 110.778 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.488 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.78 170.36 35.57 Favored Glycine 0 N--CA 1.416 -2.673 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.683 174.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -123.07 166.48 15.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.506 -0.847 . . . . 0.0 110.069 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' 1563 ' ' LEU . 14.5 m -147.85 150.74 34.71 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 124.324 1.015 . . . . 0.0 108.328 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' 1640 ' ' PRO . 53.4 t -146.03 94.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 124.356 1.062 . . . . 0.0 108.805 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -39.01 126.62 1.61 Allowed 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.809 0.844 . . . . 0.0 112.472 174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.504 ' CD1' HD11 ' A' 1564 ' ' ILE . 36.9 t80 -94.57 158.45 15.53 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.7 m -58.72 -28.97 66.33 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.922 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 46.0 mt-10 -85.27 -92.73 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.922 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.2 mptp? -125.33 -5.13 7.22 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -141.38 -149.28 5.2 Favored Glycine 0 CA--C 1.479 -2.216 0 C-N-CA 119.041 -1.552 . . . . 0.0 112.205 -174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' 1555 ' ' SER . 4.1 pp -135.15 179.97 5.99 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.504 HD11 ' CD1' ' A' 1558 ' ' TYR . 55.7 mt -125.31 121.76 61.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 95.5 m-85 -82.24 149.48 27.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.467 HG12 HG22 ' A' 1581 ' ' VAL . 36.9 mt -135.48 138.63 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.302 0.572 . . . . 0.0 111.786 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.84 Favored Glycine 0 N--CA 1.425 -2.078 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.512 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 36.4 mm -107.4 97.05 5.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 117.679 0.74 . . . . 0.0 110.65 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 44.8 t 61.59 16.15 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.529 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.4 156.35 26.91 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.11 137.99 18.6 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.488 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.5 t -125.05 166.36 16.52 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 122.953 0.501 . . . . 0.0 110.357 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 16.9 pttp -84.59 -13.83 50.56 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 5.8 m-20 -82.12 -24.46 35.12 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.531 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.466 ' H ' HG23 ' A' 1572 ' ' THR . 20.3 m -137.19 142.05 36.54 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.515 ' HG2' HG21 ' A' 1579 ' ' VAL . 2.1 Cg_endo -49.11 143.15 19.13 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.55 2.833 . . . . 0.0 113.484 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 44.6 m -64.04 112.63 3.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 113.21 -5.83 25.18 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -174.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' 1576 ' ' PRO . 42.7 t -117.28 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.49 -36.74 11.68 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.776 HG12 ' HB3' ' A' 1590 ' ' ALA . 44.5 t -138.66 137.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.476 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.3 p -151.48 136.74 17.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.123 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.701 ' O ' ' HA ' ' A' 1587 ' ' LYS . 53.3 m-85 -61.42 152.15 30.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -102.01 -14.25 29.4 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' 1585 ' ' LEU . 0.2 OUTLIER -73.42 -71.19 0.33 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 71.4 p -104.88 10.25 34.43 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' 1583 ' ' PHE . 11.3 mptt 57.08 68.97 0.79 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.161 0.985 . . . . 0.0 112.954 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 14.4 mt -104.58 102.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.339 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 17.1 t30 -47.65 110.81 0.35 Allowed 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 121.889 0.852 . . . . 0.0 110.683 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.776 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.6 9.54 42.98 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.127 -176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.56 129.22 1.01 Allowed Glycine 0 C--N 1.302 -1.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.777 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . 0.418 ' O ' ' HD1' ' A' 1608 ' ' TYR . 71.3 p -77.06 148.27 36.22 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.473 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.415 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.266 0.0 OUTLIER -39.6 122.66 1.4 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 127.054 2.142 . . . . 0.0 111.979 176.973 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.439 ' H ' ' HE1' ' A' 1608 ' ' TYR . 82.3 m-20 -148.59 164.26 34.81 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.123 0.487 . . . . 0.0 109.773 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 9.1 p -125.39 14.83 8.28 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.169 175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' 1594 ' ' ASN . 27.8 mm-40 -69.52 88.12 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.364 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' 1604 ' ' LEU . 52.7 tp -105.04 145.17 30.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' 1604 ' ' LEU . 24.0 mtm -140.92 169.57 17.37 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.978 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.72 ' HB3' ' HB2' ' A' 1526 ' ' SER . 43.7 t80 -130.0 94.64 3.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . 0.454 HG23 ' HD2' ' A' 1525 ' ' LYS . 1.5 p -122.98 114.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.435 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.63 48.52 3.33 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.039 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.624 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 73.5 mt-30 65.03 8.38 4.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.32 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' 1627 ' ' SER . 39.6 t -120.99 135.22 61.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 123.295 0.638 . . . . 0.0 110.11 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.984 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.8 mp -76.03 148.3 38.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.35 132.47 37.66 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.343 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.497 ' HG ' ' HE2' ' A' 1628 ' ' PHE . 61.3 mt -118.98 124.63 47.47 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 170.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1625 ' ' VAL . 58.9 t -113.5 96.81 4.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-O 121.806 0.812 . . . . 0.0 108.945 177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.576 ' HE2' HD12 ' A' 1626 ' ' ILE . 96.5 m-85 -83.68 95.83 8.5 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.454 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 6.8 p-10 -97.52 -179.38 4.45 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.652 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 32.5 t70 48.26 61.05 3.22 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 125.759 1.623 . . . . 0.0 112.149 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.61 -140.25 7.83 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -82.25 157.59 67.92 Favored Pre-proline 0 C--N 1.279 -2.497 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' 1621 ' ' LYS . 36.2 Cg_endo -83.59 142.94 10.62 Favored 'Trans proline' 0 N--CA 1.44 -1.676 0 C-N-CA 121.495 1.463 . . . . 0.0 111.992 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.422 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 24.7 p -95.76 114.36 63.87 Favored Pre-proline 0 N--CA 1.389 -3.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 30.3 Cg_endo -97.16 -0.04 1.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.863 2.376 . . . . 0.0 112.498 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 33.7 t -123.46 -51.12 1.86 Allowed 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.818 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -58.02 -46.94 84.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 0.0 110.321 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' 1647 ' ' LYS . 8.1 t-20 -158.57 -144.56 0.12 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -126.49 18.81 7.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 118.131 0.423 . . . . 0.0 110.948 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' 1649 ' ' THR . 6.4 mp -98.98 -169.22 1.74 Allowed 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.88 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' 1613 ' ' PRO . 33.2 mtmt -99.54 151.48 21.1 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.429 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 72.1 m-85 -70.52 147.39 49.4 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.51 0.506 . . . . 0.0 110.289 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 61.9 pttt -146.51 155.42 42.51 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 52.6 m -124.76 128.19 48.38 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 123.645 0.591 . . . . 0.0 110.273 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.593 HG22 HG22 ' A' 1607 ' ' VAL . 96.1 t -117.39 95.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 CA-C-O 122.004 0.906 . . . . 0.0 108.662 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' 1608 ' ' TYR . 54.4 mt -89.0 112.76 24.59 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.56 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.439 ' HB3' HG11 ' A' 1603 ' ' VAL . 17.9 m -91.08 120.78 32.32 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.37 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.984 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.4 m-85 -97.6 107.13 19.57 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-O 121.913 0.863 . . . . 0.0 110.099 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.6 t -101.98 123.51 55.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 112.982 -1.917 . . . . 0.0 110.107 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.1 t -47.91 121.51 4.24 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 124.739 1.274 . . . . 0.0 112.771 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 12.1 t -126.66 143.36 51.25 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 70.3 t60 -68.03 2.76 1.9 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.775 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -69.23 -169.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.146 0.578 . . . . 0.0 110.207 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 38.0 t -127.58 101.75 6.55 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.602 -0.686 . . . . 0.0 110.607 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 48.9 60.18 6.22 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 123.787 0.679 . . . . 0.0 113.729 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.422 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -130.15 179.03 6.12 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.293 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.45 ' HA ' ' HE1' ' A' 1656 ' ' TRP . 23.8 p-10 -103.84 -23.91 13.34 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 28.2 t-20 61.87 -72.76 0.04 OUTLIER 'General case' 0 C--O 1.243 0.754 0 C-N-CA 126.136 1.774 . . . . 0.0 110.244 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -172.33 106.78 0.35 Allowed Pre-proline 0 C--N 1.271 -2.839 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.749 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.5 Cg_exo -77.64 134.72 13.91 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.785 2.324 . . . . 0.0 110.267 173.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.4 t -117.18 129.96 72.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.865 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 76.1 t80 -76.22 109.57 10.01 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 168.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -88.66 -52.85 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.208 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 20.6 t -152.26 159.34 43.54 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.958 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.865 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.3 tm? -125.25 135.45 52.55 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' 1653 ' ' TYR . 14.4 t70 -106.82 114.69 28.93 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' 1618 ' ' ASN . 25.5 mtpt -94.31 9.52 37.82 Favored 'General case' 0 C--N 1.268 -2.95 0 C-N-CA 124.115 0.966 . . . . 0.0 109.716 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.95 -37.31 11.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.497 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -135.67 18.25 3.31 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.219 179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' 1646 ' ' ASP . 84.2 m 48.36 62.53 2.48 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.737 1.215 . . . . 0.0 113.279 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.497 ' OG1' HG23 ' A' 1649 ' ' THR . 17.9 m -112.18 114.28 27.0 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.099 -177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.585 HD13 HD23 ' A' 1645 ' ' LEU . 2.5 mm? -77.97 109.41 12.0 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.525 1.13 . . . . 0.0 108.318 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.483 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 79.9 m-85 -95.25 119.71 34.22 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.402 ' CD1' HG11 ' A' 1556 ' ' VAL . 81.8 m-85 -118.35 139.04 51.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.549 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 2.4 p -108.8 118.94 38.11 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.765 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.8 t-105 -118.45 123.93 46.39 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.512 ' HB3' ' HB ' ' A' 1631 ' ' THR . 33.0 m170 -89.6 98.95 12.06 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.765 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 7.6 t -121.45 135.22 24.88 Favored Pre-proline 0 N--CA 1.418 -2.053 0 CA-C-O 122.075 0.94 . . . . 0.0 110.987 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.775 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 52.7 Cg_exo -68.12 -21.28 42.8 Favored 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 124.406 3.404 . . . . 0.0 113.048 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.2 pp -78.9 -16.59 56.82 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.488 -176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -81.99 -3.39 54.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.6 m -90.21 115.41 27.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.222 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.503 ' HG3' ' CG ' ' A' 1541 ' ' HIS . 36.8 tt0 -77.75 114.9 17.07 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 171.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -62.08 -29.02 70.02 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.584 -173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.5 119.6 24.9 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.47 128.86 49.36 Favored Pre-proline 0 C--N 1.29 -2.009 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.187 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 83.0 Cg_endo -76.17 -176.11 2.88 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.959 2.439 . . . . 0.0 111.789 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -66.38 -27.43 67.86 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 120.935 0.398 . . . . 0.0 111.735 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.4 m80 -137.17 105.9 5.88 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.636 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 28.6 t-80 . . . . . 0 C--N 1.31 -1.11 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.226 0.536 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -90.76 -175.42 4.38 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 41.2 m -116.89 -171.18 1.97 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.816 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.551 ' HB2' ' HB ' ' A' 1535 ' ' THR . 16.3 m120 -85.14 85.64 7.45 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' 1596 ' ' GLN . 8.2 tt -73.82 101.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.011 176.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -115.09 153.71 30.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -82.11 12.08 4.6 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.778 1.231 . . . . 0.0 111.341 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.628 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 2.9 m-20 -95.95 19.15 11.96 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . . . . . . . . . 11.2 m 60.98 39.96 15.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.628 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 3.9 pt20 -143.57 156.72 44.68 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.683 -171.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' 1527 ' ' ASN . 4.0 p -145.86 128.5 9.4 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.23 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' 1527 ' ' ASN . 41.5 m -92.19 126.63 37.35 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.565 HD21 ' HG3' ' A' 1667 ' ' PRO . 55.2 t-20 -62.9 124.57 84.06 Favored Pre-proline 0 N--CA 1.472 0.672 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.197 177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.54 -7.44 21.29 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.604 2.203 . . . . 0.0 112.594 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.33 -26.1 14.27 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.68 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 75.9 p -125.94 -21.39 4.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.493 0.663 . . . . 0.0 112.659 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 80.38 7.43 88.55 Favored Glycine 0 N--CA 1.415 -2.729 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 34.1 m170 -80.19 117.93 21.43 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.414 0.626 . . . . 0.0 112.273 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -71.92 138.94 48.49 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.485 1.514 . . . . 0.0 111.475 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.738 ' HB3' HD21 ' A' 1604 ' ' LEU . 93.7 m-85 -109.93 158.32 18.34 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 124.905 1.282 . . . . 0.0 109.308 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.23 128.46 15.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 118.271 0.487 . . . . 0.0 112.018 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.578 HD23 ' CD1' ' A' 1660 ' ' LEU . 92.8 mt -109.83 6.15 23.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.291 0.369 . . . . 0.0 111.285 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.625 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 54.4 m-80 -66.66 -23.14 66.1 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.913 0.863 . . . . 0.0 109.446 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 20.0 m -61.57 -22.96 65.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.109 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.412 HD12 HD22 ' A' 1545 ' ' LEU . 59.9 mt -105.65 12.98 30.49 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.343 -0.223 . . . . 0.0 111.474 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.625 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 40.2 mtmt -91.84 97.86 11.24 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.983 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 32.7 p30 -126.76 158.99 35.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 9.5 t70 -67.47 -37.87 83.55 Favored 'General case' 0 C--N 1.265 -3.084 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.343 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 4.8 m -52.45 -56.47 14.87 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 125.292 1.437 . . . . 0.0 111.891 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.538 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 91.8 -179.68 41.49 Favored Glycine 0 N--CA 1.412 -2.918 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.396 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 75.2 m-85 -126.59 176.75 6.97 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.456 -174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.433 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -155.68 152.36 28.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.356 1.063 . . . . 0.0 111.391 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' 1640 ' ' PRO . 69.2 t -146.89 94.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 124.628 1.171 . . . . 0.0 107.95 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.34 132.28 16.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.428 ' H ' ' HA ' ' A' 1563 ' ' LEU . 77.7 t80 -94.16 154.12 17.74 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 8.4 m -52.08 -23.68 5.67 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' 1561 ' ' LYS . 43.2 mt-10 -92.67 -91.68 0.17 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' 1560 ' ' GLU . 1.3 mptp? -120.92 -23.53 5.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -126.15 -153.76 8.47 Favored Glycine 0 CA--C 1.478 -2.279 0 C-N-CA 119.214 -1.469 . . . . 0.0 111.668 -171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.8 pp -134.48 176.28 8.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.299 0.571 . . . . 0.0 110.022 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.487 HG21 ' HZ ' ' A' 1654 ' ' PHE . 49.8 mt -119.11 116.66 51.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 61.5 m-85 -79.77 151.69 30.22 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 47.2 mt -136.04 139.81 45.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.804 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.77 132.31 8.38 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.291 -2.323 . . . . 0.0 107.291 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' 1549 ' ' LYS . 44.0 mm -100.18 97.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 117.77 0.785 . . . . 0.0 111.39 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' 1595 ' ' SER . 23.5 t 61.76 11.69 4.19 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.831 0.852 . . . . 0.0 111.494 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.92 177.56 32.12 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.652 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -85.82 140.79 18.2 Favored Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 121.324 -0.465 . . . . 0.0 112.67 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.538 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.3 t -129.76 165.77 21.24 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 123.607 0.763 . . . . 0.0 109.156 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -89.46 -12.23 40.74 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 10.3 m-20 -81.34 -24.4 37.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.864 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' 1572 ' ' THR . 52.1 m -137.33 144.98 47.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.34 149.21 9.57 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.392 2.728 . . . . 0.0 113.247 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 8.9 t -68.35 109.14 3.5 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 116.58 -4.53 19.44 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.532 HG11 ' HB3' ' A' 1582 ' ' CYS . 60.1 t -116.17 118.78 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -82.04 -42.19 8.97 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' 1590 ' ' ALA . 35.1 t -136.56 140.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.532 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.1 p -152.0 135.75 16.29 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.302 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.698 ' HB3' ' HG ' ' A' 1585 ' ' LEU . 89.3 m-85 -67.65 122.23 17.61 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -72.64 -10.71 76.51 Favored Glycine 0 C--N 1.275 -2.811 0 C-N-CA 123.44 0.543 . . . . 0.0 113.502 -172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.698 ' HG ' ' HB3' ' A' 1583 ' ' PHE . 5.6 mt -49.6 -53.08 25.97 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.385 1.474 . . . . 0.0 109.435 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 5.7 t -148.37 23.83 1.02 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.145 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . . . . . . . . . 12.7 mptt 59.23 58.81 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.41 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 52.3 mt -88.68 101.87 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.325 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 23.7 t30 -51.07 106.44 0.13 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.072 0.939 . . . . 0.0 111.116 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 12.2 33.79 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.887 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.29 120.8 0.54 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 68.3 m -76.22 148.64 37.53 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.09 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER -38.72 121.52 1.06 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.429 1.892 . . . . 0.0 112.054 179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.476 ' H ' ' HE1' ' A' 1608 ' ' TYR . 87.3 m-20 -145.73 156.98 43.97 Favored 'General case' 0 CA--C 1.48 -1.747 0 CA-C-O 121.537 0.684 . . . . 0.0 110.508 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.57 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 4.2 p -114.71 9.8 16.49 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.589 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.636 ' HB3' HD11 ' A' 1528 ' ' ILE . 25.9 mm-40 -79.28 86.17 5.06 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.164 -174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' 1604 ' ' LEU . 67.4 tp -103.18 138.32 40.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.785 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' 1604 ' ' LEU . 16.2 mtm -137.19 169.81 17.15 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.698 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.719 ' HD1' HD12 ' A' 1604 ' ' LEU . 56.8 t80 -125.69 100.5 6.46 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -134.97 125.19 44.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.812 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 64.74 36.71 7.92 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.314 1.045 . . . . 0.0 109.412 -174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.513 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 42.5 mt-30 57.95 20.78 7.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.761 1.224 . . . . 0.0 111.799 -177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' 1627 ' ' SER . 14.1 t -121.77 134.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.622 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.864 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.9 mp -75.62 138.88 41.7 Favored 'General case' 0 C--O 1.193 -1.871 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.646 ' OE1' ' HB ' ' A' 1625 ' ' VAL . 4.6 tt0 -147.84 130.57 16.02 Favored 'General case' 0 C--N 1.272 -2.774 0 C-N-CA 118.617 -1.233 . . . . 0.0 112.076 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' 1597 ' ' LEU . 94.3 mt -102.88 125.98 49.85 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.178 178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.718 HG22 HG12 ' A' 1625 ' ' VAL . 94.6 t -106.54 94.66 3.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' 1624 ' ' SER . 68.1 m-85 -82.95 94.36 7.72 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.559 176.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -94.7 170.77 9.22 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-O 120.956 0.408 . . . . 0.0 111.96 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.59 60.21 2.48 Favored 'General case' 0 CA--C 1.499 -1.009 0 O-C-N 125.48 1.738 . . . . 0.0 114.315 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -80.75 -136.41 1.77 Allowed Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.037 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -79.38 157.64 74.97 Favored Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -67.62 122.66 9.87 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.804 1.67 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.402 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 29.7 t -87.29 110.63 35.2 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 124.538 1.135 . . . . 0.0 110.77 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 16.9 Cg_exo -70.03 -23.59 29.37 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 123.838 3.025 . . . . 0.0 112.574 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 15.0 m -61.28 -49.35 77.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.706 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 6.4 mmtt -92.36 -27.72 17.36 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.414 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 66.9 t30 74.92 -41.06 0.46 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.382 1.873 . . . . 0.0 112.009 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -77.46 -33.18 54.76 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.362 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' 1649 ' ' THR . 5.0 mp -112.68 176.15 5.14 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.72 -175.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.71 170.24 8.1 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.895 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.56 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 80.5 m-85 -74.03 149.66 41.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.031 0.443 . . . . 0.0 110.534 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' 1651 ' ' THR . 30.0 ttpt -146.16 144.92 30.26 Favored 'General case' 1 N--CA 1.371 -4.406 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 34.5 t -119.34 139.25 52.27 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 123.653 0.596 . . . . 0.0 110.1 -174.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.74 HG23 ' HA ' ' A' 1653 ' ' TYR . 1.4 m -131.71 91.08 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.398 1.094 . . . . 0.0 110.684 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' 1605 ' ' GLN . 48.9 mt -87.02 111.03 21.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.687 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.729 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.568 ' HB3' HG11 ' A' 1603 ' ' VAL . 20.3 m -90.0 117.21 28.63 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.864 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 96.7 m-85 -97.1 107.45 19.98 Favored 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 124.594 1.157 . . . . 0.0 109.611 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.1 t -102.79 124.26 56.7 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.598 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.721 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.0 t -46.99 126.78 9.4 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 124.706 1.202 . . . . 0.0 113.188 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.9 t -130.56 144.07 51.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 34.0 m170 -64.78 2.39 0.7 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.641 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 12.0 m-20 -69.95 -163.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 122.87 0.468 . . . . 0.0 111.289 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -131.0 99.72 4.99 Favored 'General case' 0 CA--C 1.552 1.05 0 O-C-N 121.643 -0.66 . . . . 0.0 111.025 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.505 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 44.38 60.25 3.74 Favored Glycine 0 C--N 1.367 2.27 0 C-N-CA 123.611 0.624 . . . . 0.0 113.619 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -132.49 179.92 5.84 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.354 0.662 . . . . 0.0 109.461 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -104.16 -21.95 13.48 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 23.9 t-20 65.65 -69.36 0.11 Allowed 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.553 1.541 . . . . 0.0 111.291 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -171.79 106.88 0.37 Allowed Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.142 -175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.803 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.2 Cg_endo -86.61 120.88 1.8 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.559 2.173 . . . . 0.0 109.771 171.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.8 t -117.83 133.19 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.2 t80 -79.79 108.34 13.28 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -83.66 -53.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.041 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 59.4 p -157.28 160.22 38.37 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.882 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.702 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -111.25 136.73 49.92 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' 1651 ' ' THR . 13.8 t70 -94.09 110.94 22.62 Favored 'General case' 0 CA--C 1.452 -2.816 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.19 8.97 33.12 Favored 'General case' 0 C--N 1.247 -3.87 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.612 -171.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -93.74 -37.25 11.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.579 HG23 ' OG1' ' A' 1651 ' ' THR . 1.8 t -134.58 18.9 3.59 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 74.2 m 54.23 47.31 23.39 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.226 1.012 . . . . 0.0 111.145 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 21.0 m -101.25 109.93 21.87 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.768 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.583 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.7 mm? -73.67 99.09 3.02 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 126.024 1.729 . . . . 0.0 110.252 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.74 ' HA ' HG23 ' A' 1625 ' ' VAL . 61.9 m-85 -83.72 118.75 24.09 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.376 0.608 . . . . 0.0 110.574 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 71.0 m-85 -114.12 140.33 48.59 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.834 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -109.03 118.93 38.07 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.719 ' CD1' ' HB ' ' A' 1658 ' ' THR . 7.4 t-105 -124.49 131.67 53.49 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -173.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 71.3 m-70 -99.94 104.59 16.23 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.719 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 8.9 t -126.73 136.28 28.52 Favored Pre-proline 0 C--N 1.297 -1.697 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.447 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 48.1 Cg_exo -67.35 -22.96 45.04 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 124.582 3.521 . . . . 0.0 113.111 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.578 ' CD1' HD23 ' A' 1545 ' ' LEU . 3.7 pp -79.4 -15.46 57.82 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.421 ' N ' HD12 ' A' 1660 ' ' LEU . . . -82.24 -3.21 54.68 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' 1659 ' ' PRO . 82.7 m -91.32 126.62 36.46 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.128 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' 1665 ' ' GLU . 28.8 tt0 -88.79 153.04 21.4 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 174.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.22 -26.91 66.83 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.81 0.814 . . . . 0.0 109.649 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' 1663 ' ' GLU . 66.6 mm-40 -116.49 179.15 4.08 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -129.11 152.16 78.89 Favored Pre-proline 0 C--N 1.286 -2.18 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.174 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 38.8 Cg_exo -67.42 -163.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 123.274 2.649 . . . . 0.0 110.858 171.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -66.23 -42.51 88.57 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -135.78 89.56 2.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 122.134 -0.354 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.658 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 46.2 t-80 . . . . . 0 C--N 1.303 -1.422 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.19 176.79 8.4 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 24.8 m -78.02 110.71 13.2 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.985 ' HB3' ' H ' ' A' 1535 ' ' THR . 51.0 t30 -67.32 85.04 0.16 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.964 HG12 ' HG2' ' A' 1598 ' ' MET . 9.7 mt -71.95 82.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.44 156.99 17.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 122.171 -0.331 . . . . 0.0 110.277 -176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -85.67 5.76 30.6 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.059 0.943 . . . . 0.0 112.05 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.6 m120 -109.46 19.21 19.55 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.21 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 4.1 t 60.73 41.83 14.4 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 122.008 0.908 . . . . 0.0 108.886 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.675 ' HB2' HD11 ' A' 1542 ' ' LEU . 4.1 pt20 -142.87 144.38 32.46 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.296 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' 1543 ' ' PHE . 8.9 p -142.8 126.02 14.07 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.511 0 CA-C-O 121.056 0.455 . . . . 0.0 109.793 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.985 ' H ' ' HB3' ' A' 1527 ' ' ASN . 19.8 m -92.73 127.01 38.08 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 57.6 t-20 -62.09 121.21 64.34 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.01 -13.55 35.92 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.336 2.024 . . . . 0.0 113.573 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.34 -32.62 12.29 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.581 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 69.1 p -115.69 -23.6 8.63 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.747 0.784 . . . . 0.0 112.393 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 82.21 8.05 86.93 Favored Glycine 0 N--CA 1.407 -3.237 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.793 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -79.66 121.67 25.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.467 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' 1533 ' ' GLN . 17.4 tp -72.38 141.41 48.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.917 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.617 ' HB3' HD21 ' A' 1604 ' ' LEU . 96.2 m-85 -110.42 146.89 35.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 2.8 t70 -138.85 134.3 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 123.168 0.293 . . . . 0.0 110.603 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 85.4 mt -117.97 12.92 13.85 Favored 'General case' 0 N--CA 1.434 -1.229 0 O-C-N 123.391 0.432 . . . . 0.0 110.874 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 38.4 m-80 -65.99 -15.08 62.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.44 0.638 . . . . 0.0 111.061 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' 1660 ' ' LEU . 14.9 m -66.42 -29.38 69.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.863 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.87 -17.0 42.34 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.726 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.568 ' HG3' ' HA ' ' A' 1546 ' ' ASN . 44.6 mtmt -59.21 98.2 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.726 0.641 . . . . 0.0 109.796 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 61.5 t30 -148.39 147.23 28.98 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' 1572 ' ' THR . 25.8 t70 -73.38 -23.13 60.14 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.292 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.491 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 9.3 t -55.75 -51.09 68.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 91.66 166.51 40.05 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.968 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.5 m-85 -118.45 171.8 7.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.866 -0.667 . . . . 0.0 110.523 -176.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' 1563 ' ' LEU . 1.5 p -151.28 143.57 24.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.412 0.685 . . . . 0.0 111.388 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' 1640 ' ' PRO . 97.2 t -136.99 94.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 C-N-CA 124.378 1.071 . . . . 0.0 109.475 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.476 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.93 123.56 3.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' 1564 ' ' ILE . 57.9 t80 -92.02 166.22 12.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 17.5 m -76.38 12.55 1.18 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -113.18 -82.79 0.6 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.665 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.509 ' HG2' ' HG ' ' A' 1585 ' ' LEU . 0.0 OUTLIER -142.65 -12.44 0.78 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -143.78 -174.1 15.78 Favored Glycine 0 N--CA 1.412 -2.932 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.607 HD21 ' CD1' ' A' 1565 ' ' TYR . 0.0 OUTLIER -106.32 179.38 4.29 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-O 121.592 0.71 . . . . 0.0 112.119 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' 1583 ' ' PHE . 51.0 mt -117.5 115.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.976 1.31 . . . . 0.0 107.787 173.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.607 ' CD1' HD21 ' A' 1563 ' ' LEU . 55.4 m-85 -78.17 149.59 33.72 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.098 0.475 . . . . 0.0 110.457 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 43.0 mt -132.3 137.17 55.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.281 -176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -121.34 130.1 8.02 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 170.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.553 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.4 mm -103.7 98.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 117.123 0.462 . . . . 0.0 110.723 -175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 59.4 m 61.42 12.73 4.53 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.605 0.762 . . . . 0.0 112.024 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -154.96 166.39 32.47 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -81.8 142.71 22.79 Favored Glycine 0 N--CA 1.428 -1.894 0 O-C-N 123.809 0.358 . . . . 0.0 113.036 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.3 OUTLIER -126.01 165.03 19.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 123.712 0.805 . . . . 0.0 109.283 176.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' 1552 ' ' SER . 43.1 pttt -86.3 -16.03 38.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.525 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 95.5 m-20 -84.66 -23.03 29.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 36.1 m -133.15 142.54 44.82 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.419 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.96 146.43 68.72 Favored 'Trans proline' 0 CA--C 1.517 -0.335 0 C-N-CA 123.327 2.685 . . . . 0.0 113.56 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 37.3 m -66.4 110.31 3.05 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.55 -10.06 14.54 Favored Glycine 0 C--N 1.309 -0.928 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.6 t -115.3 119.64 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.44 -38.84 9.43 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.264 -0.97 . . . . 0.0 110.697 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.814 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.8 t -136.27 136.13 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.537 ' HB3' HG11 ' A' 1579 ' ' VAL . 19.8 p -150.55 138.83 20.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.213 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' 1564 ' ' ILE . 29.1 m-85 -64.59 142.4 58.44 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -84.04 -42.8 7.42 Favored Glycine 0 C--N 1.285 -2.253 0 C-N-CA 121.337 -0.458 . . . . 0.0 114.024 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.509 ' HG ' ' HG2' ' A' 1561 ' ' LYS . 0.3 OUTLIER -63.68 -56.33 16.53 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.35 0.595 . . . . 0.0 110.245 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 7.6 p -111.28 15.13 21.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' 1583 ' ' PHE . 45.1 mmtm 48.47 58.63 5.02 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.824 1.249 . . . . 0.0 113.36 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 33.3 mt -103.88 103.19 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.948 -177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 17.9 t30 -52.58 108.15 0.28 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.995 0.902 . . . . 0.0 110.281 173.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.814 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -99.78 13.47 33.62 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -175.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.36 120.6 0.53 Allowed Glycine 0 C--N 1.296 -1.684 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.4 m -78.14 148.62 34.06 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.863 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -38.41 125.54 1.35 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 126.419 1.887 . . . . 0.0 111.777 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.617 HD21 ' HB2' ' A' 1596 ' ' GLN . 51.7 t30 -155.4 158.21 38.27 Favored 'General case' 0 N--CA 1.421 -1.875 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 20.0 m -130.97 11.37 5.1 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 124.273 0.983 . . . . 0.0 109.537 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.617 ' HB2' HD21 ' A' 1594 ' ' ASN . 28.8 mm-40 -72.63 94.39 1.72 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 120.915 0.388 . . . . 0.0 110.989 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.2 tp -95.87 139.8 31.56 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.964 ' HG2' HG12 ' A' 1528 ' ' ILE . 38.1 mtm -136.43 174.36 10.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.199 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.557 ' HD1' HD12 ' A' 1604 ' ' LEU . 35.9 t80 -140.55 92.92 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.8 p -122.23 114.95 44.65 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.677 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 34.2 t70 55.41 56.44 6.33 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 125.454 1.502 . . . . 0.0 111.216 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.543 ' NE2' ' HG3' ' A' 1667 ' ' PRO . 15.3 mm100 66.74 6.61 4.65 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 114.09 -1.414 . . . . 0.0 113.145 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.588 HG11 ' HB3' ' A' 1627 ' ' SER . 55.6 t -116.79 125.36 73.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.192 0.52 . . . . 0.0 111.518 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.938 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.9 mp -75.2 131.17 40.23 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -136.73 131.04 32.91 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.062 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' 1597 ' ' LEU . 91.0 mt -112.28 125.05 53.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1625 ' ' VAL . 64.4 t -110.76 93.87 2.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 121.557 0.694 . . . . 0.0 109.539 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.819 ' HB2' ' HB3' ' A' 1624 ' ' SER . 94.2 m-85 -79.14 96.71 5.93 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' 1623 ' ' LYS . 8.5 p-10 -101.52 174.91 5.76 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.453 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 17.4 t70 47.01 61.2 2.97 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 125.465 1.728 . . . . 0.0 111.416 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -82.13 -134.11 1.86 Allowed Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.92 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -81.12 160.56 65.42 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 12.1 Cg_endo -67.04 130.5 23.04 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.474 1.45 . . . . 0.0 109.454 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' 1616 ' ' SER . 34.1 t -85.98 108.48 17.18 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.554 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' 1613 ' ' PRO . 9.4 Cg_exo -72.83 -18.87 24.34 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.224 2.616 . . . . 0.0 111.654 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . 0.494 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.4 m -62.7 -59.38 4.98 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.424 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -101.32 -4.31 27.26 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 57.6 t30 71.65 -62.97 0.44 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.55 1.94 . . . . 0.0 113.836 172.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.85 68.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -172.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' 1649 ' ' THR . 5.2 mp -107.81 177.71 4.74 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.158 -173.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.81 163.95 13.26 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.38 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 73.6 m-85 -74.33 150.19 40.26 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 123.609 0.568 . . . . 0.0 110.673 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.963 ' HB2' HG23 ' A' 1651 ' ' THR . 51.7 mtmt -132.83 165.01 25.57 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.9 t -135.04 120.75 19.5 Favored 'General case' 1 C--N 1.235 -4.374 0 O-C-N 124.335 1.022 . . . . 0.0 109.306 -178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.696 HG22 HG22 ' A' 1607 ' ' VAL . 54.1 t -119.64 94.01 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE1' ' A' 1608 ' ' TYR . 49.0 mt -91.71 108.84 20.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 114.442 -1.253 . . . . 0.0 107.9 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.588 ' HB3' HG11 ' A' 1603 ' ' VAL . 11.7 m -91.13 116.7 29.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.647 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.938 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.9 m-85 -94.42 115.62 27.84 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 121.98 0.895 . . . . 0.0 110.257 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 40.9 t -110.8 125.78 68.12 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.116 0 CA-C-N 113.162 -1.835 . . . . 0.0 110.302 -175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 11.8 t -53.66 123.8 13.3 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.536 1.134 . . . . 0.0 111.966 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -126.53 144.73 50.78 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 11.6 t60 -67.65 1.62 2.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.507 1.123 . . . . 0.0 111.673 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.43 -169.5 0.54 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.59 0.756 . . . . 0.0 110.903 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 28.2 t -129.53 105.4 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 121.902 -0.499 . . . . 0.0 110.208 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' 1660 ' ' LEU . . . 46.38 60.67 4.55 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 124.174 0.921 . . . . 0.0 113.38 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.445 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.54 176.74 5.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.167 -0.516 . . . . 0.0 110.267 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.502 ' ND2' ' HD3' ' A' 1640 ' ' PRO . 2.0 p-10 -117.75 -20.31 8.94 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.538 ' OD1' HG21 ' A' 1631 ' ' THR . 10.3 m120 67.44 -80.46 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.318 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.322 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -173.0 110.57 0.34 Allowed Pre-proline 0 C--N 1.268 -2.944 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.789 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -73.64 125.74 10.28 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.788 1.659 . . . . 0.0 109.908 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' 1655 ' ' SER . 20.5 t -103.85 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 123.892 0.877 . . . . 0.0 110.369 -172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.68 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 89.5 t80 -80.35 107.79 13.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 170.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -53.08 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.342 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 28.9 p -147.07 140.31 25.37 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.703 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.68 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.2 tm? -95.6 131.5 41.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 169.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.479 ' HB2' ' HE1' ' A' 1653 ' ' TYR . 11.5 t70 -91.61 106.36 18.43 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.494 ' HG2' HD12 ' A' 1645 ' ' LEU . 31.4 mtpt -88.9 9.91 23.16 Favored 'General case' 0 C--N 1.256 -3.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.044 -170.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -45.78 7.58 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 176.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.708 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.0 t -124.57 19.1 8.78 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.3 m 54.59 42.26 31.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.745 1.218 . . . . 0.0 112.222 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.963 HG23 ' HB2' ' A' 1623 ' ' LYS . 3.3 m -99.76 120.39 39.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.069 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.594 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 1.9 mm? -78.18 104.94 9.08 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 125.31 1.444 . . . . 0.0 109.068 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' 1646 ' ' ASP . 56.3 m-85 -89.49 117.51 28.45 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.21 0.528 . . . . 0.0 110.893 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -113.28 139.88 48.45 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.704 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' 1641 ' ' VAL . 27.8 m -108.2 119.16 38.69 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.614 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.7 t-105 -123.47 127.22 48.07 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.552 ' HB3' ' HB ' ' A' 1631 ' ' THR . 38.5 m80 -94.36 114.33 26.36 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 13.1 t -136.76 136.26 21.33 Favored Pre-proline 0 N--CA 1.406 -2.672 0 CA-C-O 121.88 0.848 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' 1658 ' ' THR . 51.2 Cg_exo -67.64 -11.15 31.13 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.454 3.436 . . . . 0.0 111.565 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' 1545 ' ' LEU . 4.7 mp -78.46 -21.68 48.71 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.116 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -83.94 -4.45 58.72 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.114 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' 1659 ' ' PRO . 83.1 m -90.83 120.35 31.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.908 176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -76.86 158.9 30.47 Favored 'General case' 0 N--CA 1.41 -2.467 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' 1664 ' ' LYS . 27.8 mmmt -59.99 -47.98 83.57 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -101.44 153.92 19.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' 1670 ' ' HIS . 53.2 mt-10 -92.56 139.99 23.86 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.543 ' HG3' ' NE2' ' A' 1602 ' ' GLN . 62.0 Cg_endo -78.78 -164.65 0.29 Allowed 'Trans proline' 0 C--N 1.325 -0.706 0 C-N-CA 123.06 2.507 . . . . 0.0 112.141 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -47.42 -54.12 12.17 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.426 1.09 . . . . 0.0 111.27 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -128.73 99.05 5.19 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.688 ' HB3' ' HB3' ' A' 1666 ' ' GLU . 24.7 p80 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 118.625 -0.702 . . . . 0.0 111.642 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.543 ' HB2' ' O ' ' A' 1537 ' ' PRO . 60.3 mtt . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -131.39 172.5 12.11 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.8 m -71.36 115.85 11.01 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.907 ' HB3' ' H ' ' A' 1535 ' ' THR . 52.8 t30 -80.5 85.22 5.96 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.627 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.922 HG12 ' HG2' ' A' 1598 ' ' MET . 6.3 mt -72.31 79.54 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.37 140.59 46.96 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 121.786 0.803 . . . . 0.0 109.958 -177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -85.83 35.83 0.64 Allowed 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.386 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 35.5 t-20 -115.51 17.67 16.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.509 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 10.5 m 64.21 33.85 11.38 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.833 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 3.9 pt20 -141.5 155.23 45.83 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.258 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' 1599 ' ' TYR . 7.5 p -147.81 129.25 5.98 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 O-C-N 123.375 0.422 . . . . 0.0 110.13 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.907 ' H ' ' HB3' ' A' 1527 ' ' ASN . 5.2 m -92.06 126.29 37.09 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.536 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 53.1 t-20 -57.61 121.87 52.0 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 124.0 0.92 . . . . 0.0 110.453 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' 1524 ' ' MET . 19.8 Cg_endo -60.9 -11.76 19.39 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.214 2.609 . . . . 0.0 113.372 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -106.09 -32.26 8.34 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.201 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . 0.573 HG21 ' HA ' ' A' 1667 ' ' PRO . 72.2 p -120.56 -13.51 8.77 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.925 -172.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.37 10.51 82.12 Favored Glycine 0 N--CA 1.422 -2.238 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.505 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -79.29 118.37 21.15 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.152 0.501 . . . . 0.0 111.795 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -71.83 135.82 46.78 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.513 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' 1604 ' ' LEU . 89.9 m-85 -114.65 153.51 30.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 125.384 1.474 . . . . 0.0 108.144 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.99 137.29 23.49 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.539 HD23 ' CD1' ' A' 1660 ' ' LEU . 85.7 mt -114.02 7.72 16.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.196 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' 1549 ' ' LYS . 42.1 m-80 -66.51 -15.95 63.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.978 0.894 . . . . 0.0 110.085 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 40.7 m -71.42 -20.33 62.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.217 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.24 14.51 31.72 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.277 0.56 . . . . 0.0 109.642 175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' 1546 ' ' ASN . 13.4 mmmt -85.84 91.18 8.26 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.7 m120 -128.75 -176.33 3.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -104.6 -28.86 11.0 Favored 'General case' 0 C--N 1.279 -2.479 0 O-C-N 123.838 0.711 . . . . 0.0 111.006 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.526 ' HA ' ' HE2' ' A' 1573 ' ' LYS . 23.0 t -54.21 -60.84 2.8 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.421 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 99.76 169.21 29.87 Favored Glycine 0 N--CA 1.41 -3.056 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.209 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 71.1 m-85 -118.14 162.99 17.3 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.887 -172.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.548 ' HB3' HD13 ' A' 1563 ' ' LEU . 15.8 m -148.06 148.09 30.28 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.0 t -140.74 92.91 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.38 122.75 5.68 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.795 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.44 ' H ' ' HA ' ' A' 1563 ' ' LEU . 59.9 t80 -90.27 158.6 17.1 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.1 m -60.96 -16.17 39.77 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -90.61 -84.51 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.468 ' N ' ' HD3' ' A' 1561 ' ' LYS . 0.0 OUTLIER -150.68 10.17 0.63 Allowed 'General case' 0 C--O 1.241 0.606 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -174.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -152.1 -179.42 27.71 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.548 HD13 ' HB3' ' A' 1555 ' ' SER . 4.3 pp -119.97 -178.82 3.74 Favored 'General case' 0 C--N 1.274 -2.701 0 C-N-CA 123.547 0.739 . . . . 0.0 110.201 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.437 HD13 HD12 ' A' 1652 ' ' LEU . 41.8 mt -125.33 117.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.43 ' CE1' HD11 ' A' 1563 ' ' LEU . 92.3 m-85 -80.38 143.11 33.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.564 HG12 HG22 ' A' 1581 ' ' VAL . 35.9 mt -131.26 140.39 48.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.519 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.74 129.76 7.99 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.473 HD12 ' HZ ' ' A' 1628 ' ' PHE . 38.6 mm -100.24 97.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 117.947 0.873 . . . . 0.0 110.618 -174.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' 1595 ' ' SER . 13.9 t 62.13 16.12 8.02 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.099 0.874 . . . . 0.0 110.563 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -157.32 166.17 33.59 Favored Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -91.97 144.54 17.2 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.475 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.5 OUTLIER -125.43 166.08 17.25 Favored 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 123.44 0.696 . . . . 0.0 109.706 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' 1552 ' ' SER . 27.8 pttt -88.31 -8.08 55.71 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.363 0.602 . . . . 0.0 109.896 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 37.3 m-20 -90.44 -22.98 21.14 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.346 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' 1579 ' ' VAL . 6.7 t -137.08 142.07 36.85 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.442 ' HB2' ' CG2' ' A' 1579 ' ' VAL . 51.1 Cg_exo -52.27 151.72 16.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.529 2.819 . . . . 0.0 115.9 -175.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 67.0 m -73.23 116.27 13.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 109.02 -6.52 32.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -174.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' 1589 ' ' ASN . 54.2 t -116.16 123.74 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 114.733 -0.733 . . . . 0.0 109.187 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -84.1 -39.92 8.96 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.257 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.669 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.1 t -143.32 143.17 24.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' 1589 ' ' ASN . 24.1 p -154.59 136.49 14.55 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' A' 1587 ' ' LYS . 60.3 m-85 -62.99 141.1 58.89 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.1 -16.93 49.12 Favored Glycine 0 C--N 1.271 -3.072 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.249 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.32 -65.89 0.53 Allowed 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 124.165 0.986 . . . . 0.0 110.469 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 68.2 p -125.88 17.06 7.98 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.462 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.668 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.26 13.3 mptt 59.59 65.68 1.12 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.304 -179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 20.7 mt -104.88 98.32 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.274 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' A' 1582 ' ' CYS . 1.3 p-10 -59.25 112.83 1.87 Allowed 'General case' 0 C--O 1.187 -2.215 0 CA-C-O 122.868 1.318 . . . . 0.0 113.589 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -87.61 8.25 26.07 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.149 -174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 177.76 149.64 8.06 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 83.9 p -92.19 148.65 21.99 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.455 ' HB2' ' C ' ' A' 1578 ' ' GLY . 0.0 OUTLIER -43.09 123.42 2.83 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.176 1.39 . . . . 0.0 111.173 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.578 ' HB2' ' HD1' ' A' 1608 ' ' TYR . 80.6 m-20 -146.95 164.38 33.15 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.612 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.401 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 6.0 m -123.58 14.65 9.49 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' 1594 ' ' ASN . 25.9 mm-40 -73.66 83.2 1.57 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.377 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' 1604 ' ' LEU . 55.5 tp -101.7 140.69 35.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.922 ' HG2' HG12 ' A' 1528 ' ' ILE . 33.9 mtm -136.98 173.44 11.69 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.671 ' CZ ' ' HA ' ' A' 1602 ' ' GLN . 86.5 t80 -140.52 106.73 5.23 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.1 p -137.63 121.43 21.91 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.015 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 9.5 t70 62.83 48.56 4.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 110.686 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.671 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 45.0 mt-30 65.04 11.57 7.22 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.27 1.028 . . . . 0.0 112.922 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . . . . . . . . . 48.5 t -122.89 126.49 73.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.927 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.981 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.3 mp -75.46 132.34 40.74 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 175.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.9 tt0 -133.97 126.84 31.14 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.656 -174.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' 1597 ' ' LEU . 90.1 mt -110.1 125.37 52.91 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1625 ' ' VAL . 81.7 t -111.16 98.12 6.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.578 ' HD1' ' HB2' ' A' 1594 ' ' ASN . 29.2 m-85 -86.68 91.87 8.75 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 5.6 p-10 -98.57 171.78 7.92 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.919 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 15.4 t70 57.4 61.63 2.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 124.977 1.423 . . . . 0.0 110.532 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -89.97 -137.44 6.69 Favored Glycine 0 N--CA 1.42 -2.419 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.341 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.556 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -77.25 163.79 62.53 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.556 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 38.1 Cg_endo -71.0 132.57 21.57 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 121.837 1.692 . . . . 0.0 111.276 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' 1616 ' ' SER . 49.8 t -95.7 109.55 46.62 Favored Pre-proline 0 N--CA 1.406 -2.638 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' 1613 ' ' PRO . 36.7 Cg_endo -96.42 0.02 1.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.682 2.255 . . . . 0.0 110.471 175.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . 0.435 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 19.1 m -58.37 -62.45 1.84 Allowed 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 125.3 1.44 . . . . 0.0 113.108 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -131.34 -69.36 0.63 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -100.64 159.62 15.02 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -97.63 35.85 1.6 Allowed 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.761 0.791 . . . . 0.0 111.248 -169.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.477 ' H ' ' HG ' ' A' 1620 ' ' LEU . 0.9 OUTLIER -92.45 -168.15 1.91 Allowed 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.914 177.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.32 152.4 22.29 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.368 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' 1650 ' ' CYS . 68.3 m-85 -67.95 152.78 45.01 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.336 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 13.8 ptpt -141.46 157.25 45.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 171.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 48.2 m -125.38 127.51 46.69 Favored 'General case' 0 C--N 1.272 -2.79 0 O-C-N 123.6 0.563 . . . . 0.0 109.687 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.683 HG22 HG22 ' A' 1607 ' ' VAL . 70.0 t -114.54 96.27 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' 1605 ' ' GLN . 44.9 mt -89.57 108.94 19.82 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.891 -177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . . . . . . . . . 16.9 m -91.94 109.94 21.29 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.732 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.981 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.5 m-85 -90.08 110.59 21.59 Favored 'General case' 0 CA--C 1.479 -1.755 0 CA-C-O 122.221 1.01 . . . . 0.0 110.101 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 42.7 t -104.51 130.83 54.75 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.277 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 12.2 t -54.02 124.9 16.91 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 124.323 1.015 . . . . 0.0 111.086 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.57 144.35 50.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.525 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.2 2.55 0.35 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -173.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 2.1 m-20 -73.9 -174.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.893 0.315 . . . . 0.0 110.2 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 21.1 t -133.71 98.38 4.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . . . . . . . . . . . 71.54 60.57 4.27 Favored Glycine 0 N--CA 1.427 -1.927 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.856 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -144.48 179.96 6.93 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.428 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -115.46 -13.07 11.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' 1657 ' ' HIS . 25.3 t-20 58.69 -75.42 0.02 OUTLIER 'General case' 0 C--O 1.247 0.946 0 C-N-CA 126.631 1.972 . . . . 0.0 111.919 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' 1641 ' ' VAL . 37.7 ttpt -171.86 120.82 0.47 Allowed Pre-proline 0 C--N 1.276 -2.623 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.237 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.727 ' HB2' HG22 ' A' 1556 ' ' VAL . 2.1 Cg_endo -81.18 122.34 4.17 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.624 2.216 . . . . 0.0 108.747 166.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.459 HG22 ' HE3' ' A' 1639 ' ' LYS . 1.7 t -117.4 131.2 70.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.817 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 70.2 t80 -70.69 110.8 5.71 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 2.2 p -89.48 -52.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.048 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.3 p -155.91 161.56 40.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.086 0.469 . . . . 0.0 112.093 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.817 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -122.26 133.24 54.7 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.4 t70 -91.81 109.37 20.7 Favored 'General case' 0 CA--C 1.449 -2.924 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -89.52 2.81 54.1 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.114 -168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -95.21 -45.33 7.22 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . . . . . . . . . 67.7 p -116.32 18.39 15.25 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.323 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' 1622 ' ' TYR . 56.8 m 47.59 48.68 16.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.281 -1.781 . . . . 0.0 111.496 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 54.9 m -98.6 109.54 22.28 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.016 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.541 HD13 HD23 ' A' 1645 ' ' LEU . 2.6 mm? -75.11 108.85 8.13 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 124.723 1.209 . . . . 0.0 108.755 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -94.05 120.27 34.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.2 138.95 49.79 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 4.5 p -108.71 119.28 39.06 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.635 ' CD1' ' HB ' ' A' 1658 ' ' THR . 4.1 t-105 -118.16 114.98 23.87 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 1638 ' ' ASN . 33.9 m170 -89.14 104.57 17.1 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.665 ' OG1' ' HG ' ' A' 1660 ' ' LEU . 15.2 t -130.92 136.61 29.18 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 109.61 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.788 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 21.4 Cg_exo -71.01 -15.77 32.38 Favored 'Trans proline' 0 CA--C 1.502 -1.082 0 C-N-CA 123.822 3.014 . . . . 0.0 112.058 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.665 ' HG ' ' OG1' ' A' 1658 ' ' THR . 4.0 pp -78.5 -18.27 55.03 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.71 0.767 . . . . 0.0 111.284 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.78 -2.53 51.1 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.147 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' 1659 ' ' PRO . 78.4 m -90.9 122.55 33.69 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -69.98 142.05 52.9 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -53.14 -49.28 66.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.578 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -104.93 178.29 4.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 12.9 pt-20 -81.89 136.38 47.7 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 118.015 -1.474 . . . . 0.0 111.177 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.725 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 26.2 Cg_exo -67.14 -172.43 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.154 2.569 . . . . 0.0 112.14 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -73.87 -34.62 64.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.47 -174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -123.05 85.13 2.37 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.827 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.725 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 72.1 t60 . . . . . 0 C--N 1.31 -1.15 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 66.0 mttp 64.45 -175.4 0.17 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.769 0.827 . . . . 0.0 110.367 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 15.5 m -85.14 158.46 20.39 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' 1598 ' ' MET . 46.3 t-20 -75.5 124.59 27.44 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' 1598 ' ' MET . 50.0 mt -123.35 94.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 128.133 2.573 . . . . 0.0 106.631 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' 1533 ' ' GLN . 50.4 tt0 -114.43 155.8 25.68 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . 0.457 ' HB2' ' NE2' ' A' 1596 ' ' GLN . 20.1 t70 -123.99 80.79 1.85 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.663 -172.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.868 ' HB3' ' HG2' ' A' 1533 ' ' GLN . 63.9 t30 -166.95 20.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 8.4 t 60.92 31.07 19.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 122.739 1.257 . . . . 0.0 109.115 -174.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.868 ' HG2' ' HB3' ' A' 1531 ' ' ASN . 4.0 pt20 -138.37 152.11 48.13 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' 1598 ' ' MET . 9.3 p -148.25 144.14 18.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . . . . . . . . . 7.2 m -112.4 130.13 56.07 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.618 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -62.3 120.35 57.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.53 -3.73 11.66 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 113.225 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.76 -30.71 12.27 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 122.037 -0.414 . . . . 0.0 111.276 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 73.7 p -119.12 -29.52 5.21 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.64 11.69 70.73 Favored Glycine 0 N--CA 1.404 -3.468 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.12 111.29 8.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.934 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.87 135.07 41.56 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.128 0.971 . . . . 0.0 109.89 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.7 m-85 -109.86 145.53 36.63 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . 0.401 ' O ' HD21 ' A' 1660 ' ' LEU . 13.9 t70 -147.59 112.47 5.42 Favored 'General case' 0 CA--C 1.483 -1.596 0 CA-C-N 118.303 0.502 . . . . 0.0 112.03 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.727 HD23 HD22 ' A' 1660 ' ' LEU . 53.9 mt -94.94 6.84 47.89 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' 1532 ' ' CYS . 32.5 m-80 -64.03 -17.8 63.71 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.732 0.777 . . . . 0.0 110.67 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 9.0 m -69.99 -21.06 63.26 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.46 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' 1637 ' ' ASN . 88.4 mt -96.32 6.78 48.04 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.575 0.35 . . . . 0.0 111.02 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' 1568 ' ' ILE . 51.4 mtpt -79.71 91.87 5.33 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 122.092 0.949 . . . . 0.0 108.763 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -123.95 131.9 53.64 Favored 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.391 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' 1572 ' ' THR . 7.2 m-20 -71.4 -23.97 61.97 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.286 -1.324 . . . . 0.0 109.968 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . 0.517 ' HA ' ' HE3' ' A' 1573 ' ' LYS . 40.8 p -53.87 -48.95 69.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.561 0.696 . . . . 0.0 109.721 177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 93.46 163.86 36.9 Favored Glycine 0 CA--C 1.476 -2.347 0 CA-C-N 114.959 -1.019 . . . . 0.0 113.467 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.639 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.2 m-85 -118.88 169.61 9.73 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.158 -0.521 . . . . 0.0 109.679 -175.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' 1563 ' ' LEU . 19.6 p -148.07 153.24 38.65 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.492 0.495 . . . . 0.0 110.906 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' 1654 ' ' PHE . 53.3 t -141.88 93.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.492 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -48.43 123.04 6.02 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.232 0.539 . . . . 0.0 111.111 174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.458 ' H ' ' HA ' ' A' 1563 ' ' LEU . 47.8 t80 -87.89 161.87 17.24 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 6.6 m -75.03 7.33 3.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -112.28 -80.25 0.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.229 -0.988 . . . . 0.0 113.377 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.73 ' HE2' HD21 ' A' 1585 ' ' LEU . 0.0 OUTLIER -151.64 16.19 0.69 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' 1585 ' ' LEU . . . -158.04 -172.74 25.57 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' 1565 ' ' TYR . 4.0 pp -124.11 -177.09 3.66 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 123.902 0.881 . . . . 0.0 110.494 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.479 ' N ' HD12 ' A' 1563 ' ' LEU . 17.8 mt -129.78 120.39 49.95 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.411 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.506 ' CE1' HD11 ' A' 1563 ' ' LEU . 85.1 m-85 -82.32 148.99 28.0 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 58.0 mt -131.56 142.74 42.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.058 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -125.65 137.52 10.32 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' A' 1549 ' ' LYS . 42.0 mm -107.35 97.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 117.781 0.791 . . . . 0.0 110.759 -175.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 35.6 m 61.12 10.35 2.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.843 0.857 . . . . 0.0 111.537 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . 0.441 ' HA2' ' CZ2' ' A' 1593 ' ' TRP . . . -154.89 157.34 27.54 Favored Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -70.9 145.1 39.29 Favored Glycine 0 N--CA 1.416 -2.666 0 O-C-N 124.353 0.678 . . . . 0.0 112.986 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' 1551 ' ' ASP . 0.7 OUTLIER -129.72 165.4 21.96 Favored 'General case' 0 N--CA 1.409 -2.478 0 C-N-CA 124.153 0.981 . . . . 0.0 108.983 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' 1552 ' ' SER . 15.0 pttp -89.5 -12.14 40.9 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.415 ' HB3' ' CG ' ' A' 1565 ' ' TYR . 93.7 m-20 -83.57 -23.1 32.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.996 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 62.8 m -135.12 144.11 48.7 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.0 152.55 10.1 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.258 2.639 . . . . 0.0 114.002 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 47.4 m -67.16 114.21 5.73 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' 1593 ' ' TRP . . . 111.12 -8.55 29.13 Favored Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -174.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' 1582 ' ' CYS . 55.7 t -112.98 122.3 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -85.96 -41.78 7.0 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.82 HG12 ' HB3' ' A' 1590 ' ' ALA . 39.4 t -136.95 138.38 45.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.545 ' HB3' HG11 ' A' 1579 ' ' VAL . 28.8 p -149.27 136.47 19.95 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.054 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' 1587 ' ' LYS . 78.8 m-85 -61.29 143.71 55.19 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' 1587 ' ' LYS . . . -93.12 -19.34 36.52 Favored Glycine 0 C--N 1.274 -2.866 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.736 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' 1561 ' ' LYS . 14.0 tp -60.02 -61.26 2.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 123.26 0.624 . . . . 0.0 110.845 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -123.28 16.95 9.85 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.486 0.66 . . . . 0.0 111.103 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' 1583 ' ' PHE . 15.0 mmmm 57.48 66.77 1.07 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.731 1.213 . . . . 0.0 113.014 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.53 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 25.8 mt -104.36 104.82 17.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.012 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 20.0 t30 -50.04 108.03 0.19 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 122.23 1.014 . . . . 0.0 111.252 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.8 11.24 34.31 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.062 -176.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.15 120.07 0.52 Allowed Glycine 0 C--N 1.295 -1.718 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 59.5 m -78.11 149.66 33.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.441 ' CZ2' ' HA2' ' A' 1570 ' ' GLY 0.262 0.0 OUTLIER -39.23 123.39 1.38 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 127.574 2.349 . . . . 0.0 112.603 179.834 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.416 ' HB3' ' H ' ' A' 1596 ' ' GLN . 82.0 m-20 -145.07 164.2 31.95 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 69.2 m -122.8 14.21 10.01 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.457 ' NE2' ' HB2' ' A' 1530 ' ' ASP . 20.7 mm-40 -74.74 91.68 2.41 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.834 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' 1604 ' ' LEU . 57.5 tp -107.17 136.68 46.59 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.456 0.646 . . . . 0.0 109.804 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' 1528 ' ' ILE . 29.6 mtm -126.57 168.94 13.61 Favored 'General case' 0 C--N 1.266 -3.027 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.501 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.548 ' HD1' HD12 ' A' 1604 ' ' LEU . 39.9 t80 -138.87 99.43 3.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -129.88 117.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.208 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.28 56.42 6.44 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 125.666 1.586 . . . . 0.0 111.95 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.486 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 27.7 mt-30 62.68 13.55 6.46 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.347 1.459 . . . . 0.0 113.011 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' 1627 ' ' SER . 54.5 t -123.66 126.09 72.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.101 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.953 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.2 mp -75.49 135.38 40.66 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.495 HE21 ' HB2' ' A' 1605 ' ' GLN . 5.5 tt0 -136.5 126.84 26.57 Favored 'General case' 0 C--N 1.273 -2.729 0 C-N-CA 118.566 -1.254 . . . . 0.0 111.69 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' 1625 ' ' VAL . 86.7 mt -107.01 125.32 50.86 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1625 ' ' VAL . 93.0 t -113.2 96.22 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.519 ' HH ' ' HA ' ' A' 1568 ' ' ILE . 82.5 m-85 -79.79 100.95 8.2 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.6 p-10 -101.59 173.13 6.56 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.059 0.457 . . . . 0.0 112.221 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 23.1 t70 46.27 61.53 2.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.778 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -81.96 -134.26 1.83 Allowed Glycine 0 C--N 1.301 -1.398 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -83.44 163.38 50.12 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 28.9 Cg_endo -70.64 131.94 20.95 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.597 1.532 . . . . 0.0 110.767 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . . . . . . . . . 40.8 t -94.37 114.87 64.41 Favored Pre-proline 0 C--N 1.293 -1.852 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.2 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' 1613 ' ' PRO . 57.5 Cg_endo -102.67 2.5 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.458 2.772 . . . . 0.0 111.847 175.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 20.4 t -59.81 -63.05 1.44 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.724 0.809 . . . . 0.0 111.937 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' 1647 ' ' LYS . 31.5 mmmt -134.47 -65.9 0.63 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -89.52 175.29 7.35 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -115.46 34.85 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.171 0.51 . . . . 0.0 112.278 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . . . . . . . . . 6.2 mp -89.02 -167.17 1.8 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.75 159.37 15.24 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.453 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 58.0 m-85 -70.09 149.18 47.9 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.717 0.636 . . . . 0.0 110.284 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 11.8 ptpt -141.32 152.64 44.61 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 173.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' 1652 ' ' LEU . 43.3 t -121.89 127.84 50.91 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.829 HG22 HG22 ' A' 1607 ' ' VAL . 92.6 t -120.59 100.34 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.464 0 CA-C-O 121.873 0.844 . . . . 0.0 108.777 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.472 HD12 ' HE2' ' A' 1608 ' ' TYR . 47.5 mt -96.01 115.45 35.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.452 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.554 ' HB2' HG11 ' A' 1603 ' ' VAL . 28.3 p -90.96 117.85 29.88 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.143 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.953 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 91.2 m-85 -93.98 109.1 20.85 Favored 'General case' 0 CA--C 1.481 -1.71 0 CA-C-O 122.18 0.99 . . . . 0.0 109.301 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.9 t -103.46 132.47 49.7 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.465 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.918 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' 1662 ' ' CYS . 0.9 OUTLIER -55.02 124.19 16.0 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.029 0.932 . . . . 0.0 112.131 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.2 t -121.47 143.98 48.95 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -66.02 1.94 1.28 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.848 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.1 m-20 -70.72 -167.92 0.23 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.941 0.896 . . . . 0.0 109.093 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 8.7 t -133.86 103.34 5.8 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.975 -1.078 . . . . 0.0 112.027 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 55.77 52.98 44.98 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.642 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.41 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -120.52 -179.16 3.89 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 124.251 1.02 . . . . 0.0 108.569 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.537 ' HB3' HD22 ' A' 1548 ' ' LEU . 2.3 p-10 -122.94 -20.16 5.89 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 5.1 m-20 64.29 -75.17 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 125.285 1.434 . . . . 0.0 112.922 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -171.23 129.9 0.74 Allowed Pre-proline 0 C--N 1.278 -2.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.46 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.62 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 9.2 Cg_endo -89.41 129.47 1.88 Allowed 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.673 2.249 . . . . 0.0 109.546 166.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.471 HG12 ' OG ' ' A' 1655 ' ' SER . 0.3 OUTLIER -130.02 158.9 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.688 -177.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.593 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 90.2 t80 -98.42 132.92 43.48 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -115.24 -52.43 4.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.931 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 29.0 p -151.3 149.09 28.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.871 -0.731 . . . . 0.0 112.329 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.593 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -109.88 138.92 45.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.1 t70 -100.72 114.76 28.78 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' 1617 ' ' LYS . 80.0 mttt -89.62 1.64 55.74 Favored 'General case' 0 C--N 1.258 -3.407 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.909 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -87.2 -42.04 13.28 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.527 HG23 ' OG1' ' A' 1651 ' ' THR . 3.5 t -133.42 18.23 3.99 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.227 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 86.2 m 51.72 55.22 9.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.579 1.181 . . . . 0.0 112.146 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 73.0 m -104.42 112.4 25.44 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.835 -175.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.586 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -75.74 104.07 6.12 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.752 1.221 . . . . 0.0 109.478 177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.51 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 73.6 m-85 -90.53 114.2 26.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.912 177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.447 ' HZ ' HG21 ' A' 1564 ' ' ILE . 44.3 m-85 -113.92 148.52 36.66 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.107 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.471 ' OG ' HG12 ' A' 1641 ' ' VAL . 5.6 p -119.62 127.03 52.55 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.62 ' CE3' ' HB3' ' A' 1640 ' ' PRO . 4.1 t-105 -123.29 119.12 29.21 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.545 ' HB3' ' HB ' ' A' 1631 ' ' THR . 14.7 m170 -93.24 104.87 17.01 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.506 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 9.4 t -127.43 137.04 29.86 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-O 121.451 0.643 . . . . 0.0 109.944 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.848 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 29.7 Cg_exo -70.18 -15.69 35.59 Favored 'Trans proline' 0 CA--C 1.493 -1.558 0 C-N-CA 124.088 3.192 . . . . 0.0 110.586 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.727 HD22 HD23 ' A' 1545 ' ' LEU 0.331 2.2 tt -78.23 -23.41 47.44 Favored 'General case' 1 N--CA 1.353 -5.301 0 CA-C-N 113.629 -1.623 . . . . 0.0 106.818 -175.939 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' 1628 ' ' PHE . . . -83.55 -6.94 59.59 Favored 'General case' 0 CA--C 1.485 -1.543 0 CA-C-O 121.665 0.745 . . . . 0.0 109.116 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' 1630 ' ' CYS . 3.9 t -94.59 138.06 32.93 Favored 'General case' 0 N--CA 1.396 -3.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.302 -175.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -88.62 115.3 26.05 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -83.26 -15.37 50.55 Favored 'General case' 0 C--N 1.265 -3.072 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.8 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -71.15 122.41 20.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.68 138.05 73.83 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.052 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.05 173.07 1.98 Allowed 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 124.044 3.163 . . . . 0.0 115.283 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -56.87 -34.73 68.13 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.047 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 53.7 t60 -126.57 87.77 2.72 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--N 1.294 -1.831 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.518 -179.69 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.33 157.03 16.68 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.037 0.446 . . . . 0.0 110.004 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 13.9 m -95.22 -173.4 2.92 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.826 ' HB3' ' H ' ' A' 1535 ' ' THR . 7.6 t30 -81.38 73.25 8.43 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.032 0.444 . . . . 0.0 111.149 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.634 ' HB ' ' HG3' ' A' 1598 ' ' MET . 6.7 tt -72.32 84.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.054 0.931 . . . . 0.0 109.314 173.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -134.92 159.4 41.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -87.06 29.84 0.8 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -101.78 6.7 41.8 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.807 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 12.2 t 59.05 40.03 22.61 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.652 1.215 . . . . 0.0 109.275 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.427 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.8 pt20 -145.05 145.18 31.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.841 -177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' 1527 ' ' ASN . 11.6 p -141.34 126.31 17.99 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 CA-C-O 121.337 0.589 . . . . 0.0 110.798 -176.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.826 ' H ' ' HB3' ' A' 1527 ' ' ASN . 38.5 m -92.2 127.18 37.58 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.406 ' HB2' ' HE1' ' A' 1543 ' ' PHE . 58.7 t-20 -64.96 122.32 78.8 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.41 -7.84 15.3 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.51 2.14 . . . . 0.0 113.248 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -98.82 -42.93 6.96 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.627 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 77.9 p -104.88 -17.0 14.71 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.594 0.711 . . . . 0.0 111.249 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.69 12.52 80.64 Favored Glycine 0 N--CA 1.411 -3.002 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -77.99 114.91 17.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.932 0.396 . . . . 0.0 111.18 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -76.06 133.52 40.3 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.255 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.602 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.0 m-85 -109.8 150.86 27.76 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.12 134.91 33.5 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.725 0.239 . . . . 0.0 110.579 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.611 ' HA ' HD23 ' A' 1660 ' ' LEU . 66.1 mt -118.84 10.12 12.22 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -66.08 -22.76 66.43 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -174.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 51.0 m -71.01 -14.8 62.47 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.915 0.388 . . . . 0.0 111.248 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.74 2.87 54.32 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.281 -0.262 . . . . 0.0 110.976 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -84.42 98.97 10.36 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -147.06 153.39 39.93 Favored 'General case' 0 N--CA 1.404 -2.756 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.01 -22.38 58.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 124.238 1.015 . . . . 0.0 111.247 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 7.1 t -55.56 -46.71 77.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 124.002 0.814 . . . . 0.0 109.489 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.498 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 82.69 172.96 48.91 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.764 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 45.5 m-85 -126.82 174.89 8.43 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.549 -0.825 . . . . 0.0 110.728 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' 1563 ' ' LEU . 2.7 p -153.93 148.69 26.47 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 124.21 1.004 . . . . 0.0 111.555 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' 1640 ' ' PRO . 75.0 t -136.26 93.32 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -50.96 123.05 8.41 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.968 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.478 ' H ' ' HA ' ' A' 1563 ' ' LEU . 3.1 t80 -89.96 140.84 29.23 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 20.5 t -57.01 -17.37 9.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.431 ' H ' ' HD1' ' A' 1558 ' ' TYR . 48.8 mt-10 -69.43 -78.11 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.67 22.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 110.902 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -153.66 -163.53 11.9 Favored Glycine 0 N--CA 1.419 -2.471 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' 1557 ' ' ALA . 3.6 pp -142.81 177.16 8.52 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 117.248 0.524 . . . . 0.0 110.333 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.511 HG21 ' HZ ' ' A' 1654 ' ' PHE . 15.5 mt -122.82 119.22 57.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.599 ' HB3' ' HB3' ' A' 1574 ' ' ASN . 88.2 m-85 -80.63 147.37 30.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.495 HG12 HG22 ' A' 1581 ' ' VAL . 32.9 mt -133.83 142.7 40.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.34 0.59 . . . . 0.0 112.366 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -123.89 144.32 15.41 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' 1608 ' ' TYR . 44.6 mm -113.07 98.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 117.689 0.744 . . . . 0.0 110.025 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . . . . . . . . . 26.6 p 53.47 21.16 2.32 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 124.791 1.236 . . . . 0.0 112.191 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -156.36 167.57 33.48 Favored Glycine 0 N--CA 1.419 -2.492 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.33 -174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.85 141.12 21.51 Favored Glycine 0 N--CA 1.422 -2.283 0 O-C-N 123.888 0.404 . . . . 0.0 112.166 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.498 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 1.6 t -129.51 165.69 21.16 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 123.396 0.678 . . . . 0.0 109.889 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 -12.93 35.32 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 8.9 m-20 -84.24 -24.23 30.08 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.466 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.401 ' H ' HG23 ' A' 1572 ' ' THR . 66.7 m -137.39 144.59 45.97 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.37 150.22 27.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.249 2.632 . . . . 0.0 113.494 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 64.3 m -62.71 120.56 11.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 106.81 -12.02 41.76 Favored Glycine 0 C--N 1.31 -0.89 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' 1582 ' ' CYS . 71.6 t -112.54 120.25 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.37 -38.73 8.16 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.137 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.8 t -136.25 140.13 44.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' 1579 ' ' VAL . 31.4 p -151.58 136.66 17.41 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.858 0.361 . . . . 0.0 111.596 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.554 ' CZ ' HD11 ' A' 1652 ' ' LEU . 76.5 m-85 -63.88 142.34 58.44 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -88.76 -19.69 50.48 Favored Glycine 0 C--N 1.278 -2.681 0 CA-C-N 115.78 -0.645 . . . . 0.0 113.299 -171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 52.3 mt -56.52 -69.38 0.15 Allowed 'General case' 0 N--CA 1.4 -2.947 0 CA-C-O 121.682 0.753 . . . . 0.0 111.096 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 58.9 p -123.85 19.25 9.35 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.275 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' 1583 ' ' PHE . 32.0 mmtp 59.81 68.89 0.74 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.972 0.891 . . . . 0.0 113.067 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 21.1 mt -104.31 98.03 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.242 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 0.9 OUTLIER -44.05 99.52 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.756 0 CA-C-O 122.56 1.172 . . . . 0.0 111.13 174.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.786 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -95.43 11.6 32.3 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 111.29 -174.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 166.03 132.91 1.43 Allowed Glycine 0 C--N 1.282 -2.436 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' 1608 ' ' TYR . 51.1 m -94.68 156.15 16.54 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.435 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.19 122.29 1.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.485 1.514 . . . . 0.0 113.282 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' 1608 ' ' TYR . 15.1 m120 -145.11 157.46 44.09 Favored 'General case' 0 CA--C 1.474 -1.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . . . . . . . . . 13.5 m -128.02 13.29 6.76 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -69.02 94.67 0.66 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.808 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.717 HD11 ' HB3' ' A' 1604 ' ' LEU . 56.5 tp -108.41 131.38 54.83 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 123.688 0.618 . . . . 0.0 111.343 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.634 ' HG3' ' HB ' ' A' 1528 ' ' ILE . 3.2 mpp? -129.69 174.53 9.61 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.06 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.596 ' HD1' HD12 ' A' 1604 ' ' LEU . 60.4 t80 -133.85 90.22 2.67 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.0 p -124.07 122.1 63.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.343 -172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 2.7 m-20 64.9 38.61 6.39 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 124.274 1.03 . . . . 0.0 111.272 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.481 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 53.8 mt-30 66.97 14.0 9.68 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.844 0.857 . . . . 0.0 111.131 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' 1627 ' ' SER . 37.6 t -120.38 129.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.193 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.6 mp -75.19 134.33 41.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' 1605 ' ' GLN . 6.8 tt0 -139.02 130.53 27.19 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.725 -174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.7 mt -107.57 124.84 50.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.786 HG22 HG12 ' A' 1625 ' ' VAL . 50.7 t -108.53 96.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.658 ' HB2' ' HB3' ' A' 1624 ' ' SER . 97.1 m-85 -80.65 89.17 5.71 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.219 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 28.7 t70 -96.04 169.17 10.16 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.463 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 16.1 t70 54.02 61.41 3.07 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.724 1.21 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -87.05 -142.22 7.21 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.167 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' 1589 ' ' ASN . . . -84.95 165.68 35.77 Favored Pre-proline 0 N--CA 1.425 -1.709 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' 1615 ' ' PRO . 4.6 Cg_endo -63.61 135.68 50.31 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 121.113 1.209 . . . . 0.0 109.687 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.509 ' HA ' ' CE2' ' A' 1622 ' ' TYR . 10.7 t -90.06 105.49 11.44 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 123.247 0.619 . . . . 0.0 110.226 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' 1613 ' ' PRO . 6.2 Cg_exo -82.15 -4.15 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.176 2.584 . . . . 0.0 111.382 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . 0.406 ' HB3' ' SG ' ' A' 1614 ' ' CYS . 17.3 t -69.66 -50.68 41.72 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 31.9 mmmt -112.18 -7.34 14.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.624 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 25.2 t-20 74.32 -54.29 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.403 1.881 . . . . 0.0 113.793 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.39 90.1 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' 1649 ' ' THR . 5.3 mp -106.79 -177.46 3.37 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.25 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -103.17 165.92 10.74 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.543 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 44.9 m-85 -80.96 152.61 27.93 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.456 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 64.1 pttt -151.6 159.06 44.23 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 172.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 40.6 t -128.9 144.49 51.19 Favored 'General case' 0 C--N 1.256 -3.488 0 O-C-N 123.489 0.493 . . . . 0.0 110.405 -172.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.786 HG12 HG22 ' A' 1607 ' ' VAL . 0.4 OUTLIER -132.96 90.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-O 122.203 1.001 . . . . 0.0 109.871 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.629 HD12 ' HE2' ' A' 1608 ' ' TYR . 55.7 mt -86.36 109.17 18.49 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.132 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.666 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.7 m -90.61 115.93 28.11 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.701 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.94 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 93.9 m-85 -94.71 111.97 23.73 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-O 122.284 1.04 . . . . 0.0 109.906 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 41.7 t -107.31 127.26 63.27 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 CA-C-N 112.821 -1.99 . . . . 0.0 109.255 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' 1658 ' ' THR . 14.7 t -51.53 130.47 27.87 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 124.174 0.989 . . . . 0.0 111.964 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 11.1 t -128.26 143.0 50.98 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.85 1.74 0.84 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 124.827 1.251 . . . . 0.0 112.757 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 4.4 m-20 -71.38 -172.85 0.8 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 18.1 t -133.54 100.35 4.77 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.644 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 59.9 60.92 7.81 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.436 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -128.07 174.04 9.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.864 0.364 . . . . 0.0 110.046 -176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.8 p-10 -107.86 -19.12 13.63 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . . . . . . . . . 24.1 t-20 61.42 -75.32 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.656 1.983 . . . . 0.0 111.508 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -172.17 121.83 0.47 Allowed Pre-proline 0 C--N 1.273 -2.719 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.44 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.567 ' HB3' ' CE3' ' A' 1656 ' ' TRP . 11.7 Cg_endo -92.36 120.65 0.5 Allowed 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 122.503 2.136 . . . . 0.0 109.825 166.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . . . . . . . . . 2.6 t -115.96 137.61 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.594 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 50.3 t80 -79.32 113.24 17.3 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -91.15 -54.02 8.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' 1653 ' ' TYR . 35.6 t -150.89 144.41 24.98 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.235 -173.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.594 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.4 tm? -106.3 133.06 51.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 170.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' 1651 ' ' THR . 10.5 t70 -94.42 108.6 20.51 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.436 ' HG2' HD12 ' A' 1645 ' ' LEU . 25.6 mtpt -89.0 7.09 36.59 Favored 'General case' 0 C--N 1.257 -3.426 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.549 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -94.18 -39.68 10.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' 1620 ' ' LEU . 5.1 t -130.21 18.91 5.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' 1617 ' ' LYS . 77.6 m 53.29 54.64 9.91 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.426 1.09 . . . . 0.0 111.403 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 16.0 m -107.15 113.25 26.57 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.684 -174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.554 HD11 ' CZ ' ' A' 1583 ' ' PHE . 2.8 mm? -78.5 98.02 5.93 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 124.2 1.0 . . . . 0.0 109.893 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.726 ' HA ' HG23 ' A' 1625 ' ' VAL . 63.1 m-85 -84.91 119.58 25.52 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.052 0.453 . . . . 0.0 110.207 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' A' 1564 ' ' ILE . 78.1 m-85 -114.85 141.52 47.8 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . . . . . . . . . 2.6 p -108.61 118.28 36.38 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.8 t-105 -119.26 126.92 52.64 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.575 ' HB3' ' HB ' ' A' 1631 ' ' THR . 59.9 m-70 -95.55 109.85 22.01 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 14.2 t -135.93 137.59 25.6 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.125 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.485 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 39.0 Cg_exo -68.7 -11.0 30.72 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.653 3.569 . . . . 0.0 111.13 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.34 -22.52 47.91 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.633 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -87.46 -4.06 59.0 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.491 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 83.9 m -84.78 124.84 32.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.17 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -106.24 139.42 40.77 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -94.2 -18.87 21.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -84.59 165.82 17.67 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.81 134.54 10.06 Favored Pre-proline 0 N--CA 1.412 -2.342 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.056 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 45.1 Cg_endo -87.56 -163.08 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 123.465 2.777 . . . . 0.0 109.801 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . 0.709 ' HG3' ' HD2' ' A' 1669 ' ' HIS . 24.1 ptt180 -64.82 -21.03 66.71 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . 0.709 ' HD2' ' HG3' ' A' 1668 ' ' ARG . 40.3 m-70 -131.14 102.52 6.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.702 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 43.4 t60 . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' 1537 ' ' PRO . 91.6 mmm . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 68.1 mttm -119.15 -175.86 3.01 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 15.1 m -70.29 105.05 2.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' 1534 ' ' VAL . 14.7 m120 -79.99 80.73 6.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.135 -173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.576 ' HB ' ' HG2' ' A' 1598 ' ' MET . 5.6 tt -72.66 107.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.242 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -126.36 153.85 44.35 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -79.73 19.62 0.65 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.333 0.653 . . . . 0.0 112.399 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -102.88 12.71 35.79 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' 1545 ' ' LEU . 17.5 t 62.52 45.36 6.33 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-O 122.573 1.178 . . . . 0.0 108.319 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' 1542 ' ' LEU . 2.8 pt20 -143.7 153.21 42.23 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 114.017 -1.447 . . . . 0.0 108.45 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' 1527 ' ' ASN . 2.9 p -143.19 128.77 16.19 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.574 ' H ' ' HB2' ' A' 1527 ' ' ASN . 21.1 m -91.79 126.82 37.01 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' 1537 ' ' PRO . 53.6 t-20 -59.88 122.79 68.24 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' 1526 ' ' SER . 11.7 Cg_endo -56.82 -20.25 34.87 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.555 2.837 . . . . 0.0 113.448 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -99.91 -37.66 8.94 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 121.643 -0.661 . . . . 0.0 112.487 -175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 74.5 p -112.28 -20.42 11.86 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.509 0.671 . . . . 0.0 111.912 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.35 8.14 87.63 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.282 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -76.13 115.8 16.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.234 0.54 . . . . 0.0 110.75 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' 1535 ' ' THR . 3.4 tm? -69.43 135.48 50.3 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 124.535 1.134 . . . . 0.0 110.578 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.755 ' HB3' HD21 ' A' 1604 ' ' LEU . 83.0 m-85 -109.51 152.66 25.15 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 125.067 1.347 . . . . 0.0 108.564 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.21 133.98 18.95 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.201 0.313 . . . . 0.0 110.988 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' 1532 ' ' CYS . 94.0 mt -114.84 9.67 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.519 ' HA ' ' HG3' ' A' 1549 ' ' LYS . 47.8 m-80 -66.32 -20.47 66.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.184 0.516 . . . . 0.0 110.818 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 14.6 m -65.03 -22.97 67.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.672 175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.441 HD12 HD22 ' A' 1545 ' ' LEU . 60.0 mt -99.01 8.82 44.63 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.204 0.526 . . . . 0.0 110.834 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' 1568 ' ' ILE . 56.0 mtpt -84.58 88.58 7.34 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -130.28 142.63 50.53 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-O 121.877 0.846 . . . . 0.0 110.6 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -61.29 -37.26 82.57 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.596 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 16.3 p -52.13 -56.33 15.18 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.328 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 95.57 176.46 37.1 Favored Glycine 0 N--CA 1.411 -3.008 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.171 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 82.0 m-85 -125.87 164.5 20.6 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.012 -1.094 . . . . 0.0 110.488 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' 1565 ' ' TYR . 4.4 p -147.55 152.85 38.66 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 124.274 1.03 . . . . 0.0 110.608 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' 1640 ' ' PRO . 71.1 t -145.98 94.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . . . . . . . . . . . -42.18 122.17 2.08 Favored 'General case' 0 C--O 1.25 1.099 0 CA-C-O 121.888 0.851 . . . . 0.0 112.794 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' 1564 ' ' ILE . 34.8 t80 -92.92 154.26 18.3 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.884 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 9.7 m -62.56 -31.69 72.53 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -73.97 -90.76 0.02 OUTLIER 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.64 30.76 0.66 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.513 0.673 . . . . 0.0 112.761 -174.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -158.13 -168.94 21.12 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.57 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -126.3 175.79 7.57 Favored 'General case' 0 C--N 1.275 -2.674 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.618 HD13 HD12 ' A' 1652 ' ' LEU . 43.0 mt -123.66 115.6 45.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.537 ' HB2' ' SG ' ' A' 1575 ' ' CYS . 95.9 m-85 -79.48 149.68 31.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.511 HG12 HG22 ' A' 1581 ' ' VAL . 53.5 mt -133.49 136.29 54.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.257 0.551 . . . . 0.0 111.349 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -118.95 129.39 8.09 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' 1549 ' ' LYS . 40.2 mm -98.74 97.83 6.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 117.34 0.57 . . . . 0.0 110.121 -174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' 1595 ' ' SER . 64.5 m 62.36 11.52 4.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 0.0 112.428 177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.42 169.67 33.34 Favored Glycine 0 N--CA 1.428 -1.848 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.724 -174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -81.7 138.65 19.17 Favored Glycine 0 N--CA 1.425 -2.083 0 CA-C-N 115.247 -0.477 . . . . 0.0 113.075 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.463 HG23 ' H ' ' A' 1575 ' ' CYS . 0.9 OUTLIER -127.51 165.87 19.06 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 123.676 0.79 . . . . 0.0 109.271 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -87.96 -8.33 55.85 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' 1565 ' ' TYR . 0.9 OUTLIER -88.05 -25.05 23.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.492 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' 1565 ' ' TYR . 52.8 m -137.87 143.3 39.45 Favored Pre-proline 0 CA--C 1.502 -0.883 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.51 148.0 55.28 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.175 2.583 . . . . 0.0 113.415 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 65.2 m -65.24 114.46 4.73 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . . . . . . . . . . . 117.64 -14.48 13.01 Favored Glycine 0 C--N 1.304 -1.197 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' 1582 ' ' CYS . 73.6 t -113.29 119.61 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 C-N-CA 124.15 0.98 . . . . 0.0 108.462 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -87.42 -39.04 7.42 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.862 HG12 ' HB3' ' A' 1590 ' ' ALA . 30.3 t -136.33 138.65 46.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.565 ' HB3' HG11 ' A' 1579 ' ' VAL . 29.5 p -151.25 136.29 17.43 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.757 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' A' 1588 ' ' ILE . 95.6 m-85 -67.01 128.99 38.43 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -76.07 -0.06 64.25 Favored Glycine 0 C--N 1.279 -2.635 0 C-N-CA 123.919 0.771 . . . . 0.0 112.918 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.09 -44.26 71.08 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 12.5 t -168.81 31.45 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.132 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . . . . . . . . 0.277 1.0 OUTLIER 61.12 63.08 1.29 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.189 0.995 . . . . 0.0 112.061 -176.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' 1583 ' ' PHE . 50.3 mt -92.12 97.63 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-N 113.697 -1.592 . . . . 0.0 106.901 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 27.9 t30 -49.47 109.02 0.23 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.282 1.039 . . . . 0.0 111.519 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.862 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -98.39 13.17 32.53 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.801 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 158.75 124.93 0.79 Allowed Glycine 0 C--N 1.296 -1.685 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 65.4 m -82.07 154.58 25.53 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.862 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.02 121.96 1.15 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.217 1.807 . . . . 0.0 113.347 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' 1596 ' ' GLN . 94.6 m-20 -146.23 163.01 36.81 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.486 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 31.1 m -126.03 21.95 7.4 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.417 ' H ' ' HB3' ' A' 1594 ' ' ASN . 24.4 mm-40 -75.03 83.74 2.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.984 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' 1604 ' ' LEU . 63.6 tp -101.03 140.35 35.45 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.036 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.576 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 22.2 mtm -138.85 164.55 29.35 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.45 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.699 ' HD1' HD12 ' A' 1604 ' ' LEU . 33.2 t80 -125.96 102.07 7.1 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 1.7 p -136.35 120.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.093 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.78 37.34 7.44 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 124.647 1.179 . . . . 0.0 111.265 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' 1667 ' ' PRO . 99.0 mt-30 65.22 17.23 10.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.264 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' 1627 ' ' SER . 22.2 t -120.52 129.99 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.336 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.815 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 10.7 mp -75.86 137.59 40.55 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -139.47 132.38 29.33 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 117.982 -1.487 . . . . 0.0 111.339 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.32 124.86 51.64 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.697 HG22 HG12 ' A' 1625 ' ' VAL . 88.1 t -108.8 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' 1624 ' ' SER . 29.0 m-85 -87.29 95.93 10.16 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 8.5 t70 -95.34 -173.67 2.98 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 33.5 t70 43.62 61.21 2.34 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 126.015 1.726 . . . . 0.0 111.877 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -84.0 -144.3 6.1 Favored Glycine 0 C--N 1.292 -1.877 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.399 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -80.21 164.58 51.65 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' 1615 ' ' PRO . 11.2 Cg_endo -70.76 123.48 9.81 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 C-N-CA 121.293 1.329 . . . . 0.0 110.196 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' 1619 ' ' ALA . 23.4 t -95.96 106.29 27.06 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' 1613 ' ' PRO . 61.1 Cg_endo -104.8 3.86 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.899 2.399 . . . . 0.0 109.626 170.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 38.0 m -88.44 -62.23 1.53 Allowed 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.778 -1.556 . . . . 0.0 113.177 -170.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.697 ' HG3' HD11 ' A' 1645 ' ' LEU . 72.5 mmtt -84.44 -41.79 16.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.713 0.768 . . . . 0.0 109.891 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.93 -157.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.05 40.1 3.23 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 118.872 0.76 . . . . 0.0 111.421 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' 1649 ' ' THR . 7.5 mp -102.17 -166.18 1.26 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.615 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -100.78 154.29 18.75 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.536 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 55.8 m-85 -74.06 148.89 41.5 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.519 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 22.2 pttm -145.93 159.81 42.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' 1608 ' ' TYR . 38.7 t -130.66 138.56 50.12 Favored 'General case' 0 C--N 1.267 -2.995 0 O-C-N 123.568 0.543 . . . . 0.0 110.543 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.697 HG12 HG22 ' A' 1607 ' ' VAL . 0.3 OUTLIER -129.12 89.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 122.186 0.993 . . . . 0.0 110.447 178.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.54 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 33.1 mt -87.03 108.13 17.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.612 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.6 ' HB3' HG11 ' A' 1603 ' ' VAL . 66.2 m -90.48 117.14 28.94 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.483 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 87.8 m-85 -93.64 108.69 20.38 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 124.615 1.166 . . . . 0.0 109.574 -178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 45.9 t -106.55 126.07 62.36 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.331 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.967 -174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . . . . . . . . . 9.9 t -51.05 124.98 12.55 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.773 1.229 . . . . 0.0 113.522 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 1659 ' ' PRO . 12.7 t -126.67 143.48 51.22 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 46.2 m80 -63.35 2.33 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.845 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.7 m-20 -73.27 -162.95 0.13 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.742 0.817 . . . . 0.0 109.766 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 33.3 t -133.44 107.94 8.36 Favored 'General case' 0 CA--C 1.553 1.091 0 O-C-N 121.352 -0.842 . . . . 0.0 111.774 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' 1659 ' ' PRO . . . 41.49 52.74 4.4 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 124.51 1.052 . . . . 0.0 114.282 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.421 ' H ' ' HD2' ' A' 1659 ' ' PRO . . . -119.44 178.98 4.34 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.393 -175.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -97.25 -27.34 14.56 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' 1657 ' ' HIS . 46.0 t30 60.16 -66.77 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 126.856 2.062 . . . . 0.0 112.295 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -170.79 106.35 0.41 Allowed Pre-proline 0 C--N 1.267 -2.998 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.331 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.811 ' HB2' HG22 ' A' 1556 ' ' VAL . 3.4 Cg_exo -83.77 121.0 2.8 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.959 2.439 . . . . 0.0 109.697 169.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.505 ' HB ' ' OG ' ' A' 1655 ' ' SER . 4.0 t -118.03 131.34 71.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.906 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.7 t80 -80.17 106.94 12.57 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.5 p -82.88 -54.15 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.452 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 23.5 t -152.82 151.4 30.39 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.8 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.906 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.0 tm? -114.22 139.23 49.56 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' 1651 ' ' THR . 15.2 t70 -102.31 106.3 17.07 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' 1617 ' ' LYS . 80.5 mttt -85.43 2.82 42.86 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.224 -173.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.76 -38.04 11.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.612 ' HA ' HD22 ' A' 1620 ' ' LEU . 82.0 p -125.9 9.57 7.56 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.897 -174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 71.4 m 55.57 50.48 14.43 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.067 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 90.5 m -106.78 114.84 29.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.341 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.65 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 3.0 mm? -79.46 102.22 8.64 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 125.555 1.542 . . . . 0.0 110.721 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.597 ' HA ' HG23 ' A' 1625 ' ' VAL . 78.8 m-85 -87.7 118.98 27.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.57 ' HZ ' HG21 ' A' 1564 ' ' ILE . 70.6 m-85 -115.89 141.67 47.79 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.679 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.505 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 1.9 p -112.62 118.29 34.64 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.721 ' CD1' ' HB ' ' A' 1658 ' ' THR . 6.7 t-105 -121.79 121.51 37.39 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' 1638 ' ' ASN . 80.8 m-70 -92.15 99.31 12.13 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.721 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 11.1 t -121.33 137.23 26.58 Favored Pre-proline 0 N--CA 1.427 -1.616 0 CA-C-O 121.868 0.842 . . . . 0.0 110.93 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.845 ' HG3' ' HB2' ' A' 1633 ' ' ASP . 34.4 Cg_exo -70.16 -20.69 32.64 Favored 'Trans proline' 0 CA--C 1.494 -1.519 0 C-N-CA 124.209 3.272 . . . . 0.0 113.256 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.64 HD11 ' CD2' ' A' 1545 ' ' LEU . 4.0 pp -79.03 -16.74 56.43 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.086 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' 1660 ' ' LEU . . . -81.69 -1.71 47.84 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.583 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . . . . . . . . . 89.9 m -73.34 133.67 43.9 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.14 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.591 ' HG3' ' H ' ' A' 1665 ' ' GLU . 8.5 tp10 -128.54 162.15 27.92 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.448 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.06 -9.98 58.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.422 0.63 . . . . 0.0 110.633 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . 0.591 ' H ' ' HG3' ' A' 1663 ' ' GLU . 43.4 mt-10 -77.77 145.99 36.12 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.23 138.71 30.44 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.564 ' HA ' ' OE1' ' A' 1602 ' ' GLN . 70.2 Cg_endo -68.65 -177.99 1.75 Allowed 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.179 2.586 . . . . 0.0 113.171 -176.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -55.54 -49.73 71.87 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.135 0.493 . . . . 0.0 110.08 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -115.37 104.1 11.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . . . . . . . . . 32.9 p-80 . . . . . 0 C--N 1.294 -1.833 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.241 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.61 ' SD ' ' HA ' ' A' 1537 ' ' PRO . 53.6 ttm . . . . . 0 C--O 1.235 0.318 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -95.38 161.82 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.783 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' 1537 ' ' PRO . 19.1 m -62.39 119.47 9.17 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 173.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.938 ' HB3' ' H ' ' A' 1535 ' ' THR . 3.7 t-20 -66.51 81.61 0.1 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' 1597 ' ' LEU . 9.8 tt -72.27 81.41 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 122.665 1.222 . . . . 0.0 109.217 171.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -93.28 163.92 13.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.712 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -107.74 16.79 23.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.648 1.213 . . . . 0.0 109.338 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.543 ' HB2' ' HG2' ' A' 1533 ' ' GLN . 3.2 m-20 -105.71 21.2 17.66 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.851 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.536 ' HB2' ' ND2' ' A' 1546 ' ' ASN . 18.6 m 61.3 34.95 18.32 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.96 0.904 . . . . 0.0 109.311 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' A' 1531 ' ' ASN . 4.0 pt20 -144.77 155.7 43.66 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -173.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' 1527 ' ' ASN . 7.5 p -147.0 130.73 9.46 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 CA-C-O 120.975 0.417 . . . . 0.0 110.234 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.938 ' H ' ' HB3' ' A' 1527 ' ' ASN . 40.4 m -94.11 126.9 39.61 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -61.23 122.84 72.84 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.22 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . 0.61 ' HA ' ' SD ' ' A' 1524 ' ' MET . 24.8 Cg_endo -63.14 -12.69 31.27 Favored 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.954 1.769 . . . . 0.0 113.218 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -100.23 -30.13 12.08 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 121.738 -0.602 . . . . 0.0 112.443 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 66.7 p -118.83 -21.94 7.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.977 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.1 7.91 87.96 Favored Glycine 0 N--CA 1.403 -3.519 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.206 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -72.0 113.86 9.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.845 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' 1533 ' ' GLN . 3.4 tm? -74.63 135.42 41.98 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.472 0.709 . . . . 0.0 109.491 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -111.95 143.03 43.61 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 124.885 1.274 . . . . 0.0 108.512 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 20.9 t70 -130.03 134.06 47.16 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.58 ' HA ' HD13 ' A' 1660 ' ' LEU . 65.5 mt -113.35 0.97 14.96 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.044 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' 1532 ' ' CYS . 50.0 m-80 -65.84 -21.15 66.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.619 0.723 . . . . 0.0 109.416 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 21.4 m -64.26 -13.53 50.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.787 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . 0.58 HD12 HG21 ' A' 1568 ' ' ILE . 96.0 mt -75.48 -20.17 58.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 122.164 -0.335 . . . . 0.0 111.522 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 64.71 -42.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 57.4 m-80 71.35 1.06 3.69 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.68 -8.7 57.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.044 0.926 . . . . 0.0 110.441 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 -46.63 9.31 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.503 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 86.47 161.76 36.16 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.094 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -126.59 160.51 30.46 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.332 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' 1563 ' ' LEU . 11.8 p -149.66 147.23 27.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.531 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' 1642 ' ' PHE . 95.1 t -141.97 93.94 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' 1563 ' ' LEU . . . -44.29 122.19 2.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.745 0.783 . . . . 0.0 112.011 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.543 ' H ' ' HA ' ' A' 1563 ' ' LEU . 34.0 t80 -92.71 148.29 22.17 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.991 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 3.7 m -52.78 -34.49 53.54 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.241 1.416 . . . . 0.0 114.548 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . 0.671 ' HB3' ' HD3' ' A' 1561 ' ' LYS . 53.6 mt-10 -74.58 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' 1560 ' ' GLU . 0.0 OUTLIER -143.24 17.66 1.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -151.3 -167.97 15.37 Favored Glycine 0 CA--C 1.483 -1.915 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' 1558 ' ' TYR . 3.8 pp -124.28 177.01 6.08 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 123.6 0.76 . . . . 0.0 109.351 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.562 HD13 HD12 ' A' 1652 ' ' LEU . 47.8 mt -122.35 119.76 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 81.8 m-85 -83.51 138.36 33.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.478 HG12 HG22 ' A' 1581 ' ' VAL . 55.3 mt -132.48 141.06 46.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -124.32 129.06 7.02 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.58 HG21 HD12 ' A' 1548 ' ' LEU . 36.4 mm -104.7 95.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 122.611 -0.347 . . . . 0.0 110.78 -172.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' 1595 ' ' SER . 8.8 t 56.06 24.01 7.4 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.975 0.893 . . . . 0.0 110.364 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.26 161.22 30.32 Favored Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . . . . . . . . . . . -89.55 139.11 14.98 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.769 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 165.48 18.55 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 120.817 0.341 . . . . 0.0 111.409 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -89.43 -11.49 42.93 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.696 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 4.6 m-20 -84.72 -24.23 28.97 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.443 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.5 ' SG ' HG12 ' A' 1579 ' ' VAL . 4.0 t -136.85 147.33 58.75 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -63.69 152.23 81.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.351 2.034 . . . . 0.0 113.896 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 33.1 p -62.05 128.93 38.46 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.262 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.523 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 89.33 0.34 80.08 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.34 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.5 HG12 ' SG ' ' A' 1575 ' ' CYS . 54.5 t -118.05 123.34 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -86.55 -40.81 7.12 Favored Glycine 0 N--CA 1.427 -1.933 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.007 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.822 HG12 ' HB3' ' A' 1590 ' ' ALA . 54.9 t -136.05 140.05 44.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' 1588 ' ' ILE . 25.9 p -156.98 136.57 12.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' A' 1587 ' ' LYS . 68.6 m-85 -64.84 154.26 37.7 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 122.131 -0.356 . . . . 0.0 110.386 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -100.91 -12.25 37.63 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.809 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . 0.627 HD12 HG23 ' A' 1586 ' ' THR . 0.3 OUTLIER -69.4 -64.37 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -178.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . 0.627 HG23 HD12 ' A' 1585 ' ' LEU . 5.2 p -118.88 23.46 11.41 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.055 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' 1583 ' ' PHE 0.275 1.0 OUTLIER 44.4 66.77 0.79 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.513 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' 1622 ' ' TYR . 14.7 mm -103.63 106.4 20.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.155 -175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . . . . . . . . . 16.8 t30 -50.67 113.56 0.93 Allowed 'General case' 0 C--O 1.199 -1.577 0 CA-C-O 122.025 0.917 . . . . 0.0 109.533 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.822 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -107.32 16.3 24.11 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.078 -174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 162.2 116.82 0.4 Allowed Glycine 0 C--N 1.296 -1.64 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 57.2 m -75.66 140.38 42.51 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.523 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.26 0.1 OUTLIER -39.49 133.16 1.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.334 2.654 . . . . 0.0 112.72 -177.162 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.502 ' H ' ' HE2' ' A' 1608 ' ' TYR . 45.2 p30 -152.17 166.2 32.45 Favored 'General case' 0 CA--C 1.482 -1.636 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.721 ' HA ' ' SG ' ' A' 1569 ' ' CYS . 15.0 m -120.18 6.1 10.76 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.911 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.859 ' HA ' HE21 ' A' 1596 ' ' GLN . 0.0 OUTLIER -78.29 91.77 4.45 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.282 -174.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' 1528 ' ' ILE . 65.0 tp -101.35 138.01 38.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.657 ' HG2' ' HB ' ' A' 1528 ' ' ILE . 38.2 mtm -129.45 175.11 9.03 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.73 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.574 ' HD1' HD12 ' A' 1604 ' ' LEU . 59.2 t80 -139.74 103.28 4.63 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.4 p -137.96 122.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.748 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.3 -173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.86 42.98 4.15 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.335 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . . . . . . . . . 15.5 mm100 66.36 13.57 9.28 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.744 1.218 . . . . 0.0 112.191 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' 1627 ' ' SER . 45.6 t -123.77 131.0 73.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.931 -177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 7.4 mp -75.42 132.99 41.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.507 HE21 ' HB2' ' A' 1605 ' ' GLN . 4.2 tt0 -136.57 131.04 33.26 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.616 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.14 123.07 46.91 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1625 ' ' VAL . 58.1 t -107.3 93.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.502 ' HE2' ' H ' ' A' 1594 ' ' ASN . 82.1 m-85 -77.27 96.64 4.62 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.47 ' OD1' ' HD3' ' A' 1623 ' ' LYS . 25.9 t70 -100.37 171.74 7.58 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 25.0 t70 48.59 61.58 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 124.977 1.423 . . . . 0.0 111.125 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -83.52 -139.61 3.86 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.701 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . . . . . . . . . . . -85.71 159.35 55.33 Favored Pre-proline 0 C--N 1.276 -2.591 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.601 ' O ' ' HD3' ' A' 1615 ' ' PRO . 35.7 Cg_endo -78.14 144.31 20.89 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 121.552 1.501 . . . . 0.0 111.586 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' 1619 ' ' ALA . 96.4 m -90.02 107.98 22.93 Favored Pre-proline 0 N--CA 1.418 -2.066 0 C-N-CA 125.169 1.387 . . . . 0.0 111.233 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' 1613 ' ' PRO . 47.3 Cg_endo -104.73 6.31 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.097 2.532 . . . . 0.0 108.907 167.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . . . . . . . . . 19.8 m -87.14 -62.9 1.4 Allowed 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.767 -173.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . . . . . . . . . 61.0 mttm -122.61 -65.33 1.11 Allowed 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . 0.621 ' HB2' ' SG ' ' A' 1650 ' ' CYS . 19.0 m120 -92.67 -179.89 5.3 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' 1614 ' ' CYS . . . -118.6 23.22 11.62 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' 1649 ' ' THR . 6.0 mp -99.13 -171.6 2.12 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' 1621 ' ' LYS . 33.3 mtmt -95.41 145.15 25.36 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' 1588 ' ' ILE . 50.9 m-85 -66.57 146.11 54.87 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.638 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' 1609 ' ' ASP . 14.6 pttm -149.31 161.89 41.14 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . . . . . . . . . 33.7 t -134.39 141.42 46.84 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.506 HG22 HG22 ' A' 1607 ' ' VAL . 78.8 t -125.12 98.99 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.51 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.596 HG23 ' CD2' ' A' 1654 ' ' PHE . 70.0 mt -88.57 111.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.602 ' HB3' HG11 ' A' 1603 ' ' VAL . 19.0 m -94.08 115.33 27.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.874 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.923 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 92.5 m-85 -88.59 111.57 22.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.418 1.104 . . . . 0.0 110.03 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' 1657 ' ' HIS . 54.5 t -109.6 121.34 62.42 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.13 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.655 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.7 t -51.35 132.11 28.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 14.8 t -131.77 143.74 50.44 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.436 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 66.3 m80 -64.77 1.77 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.78 -170.23 0.67 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 122.484 0.314 . . . . 0.0 110.562 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 11.1 t -124.42 103.08 7.99 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.474 ' HA2' HD21 ' A' 1660 ' ' LEU . . . 50.65 60.14 7.2 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.569 0.543 . . . . 0.0 113.374 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . 0.497 ' H ' ' CD ' ' A' 1659 ' ' PRO . . . -122.32 179.46 4.55 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.881 0.472 . . . . 0.0 111.647 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.537 ' HA ' ' NE1' ' A' 1656 ' ' TRP . 15.5 p-10 -110.23 -24.0 10.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.662 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 24.7 t-20 63.96 -63.39 0.15 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.22 1.808 . . . . 0.0 113.386 173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . 0.462 ' HG2' HG22 ' A' 1641 ' ' VAL . 40.0 ttmt -169.53 107.28 0.47 Allowed Pre-proline 0 C--N 1.265 -3.104 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.951 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.415 ' HB3' ' HZ ' ' A' 1654 ' ' PHE . 22.9 Cg_exo -76.57 120.94 5.75 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.094 2.529 . . . . 0.0 108.702 169.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.606 ' HB ' ' OG ' ' A' 1655 ' ' SER . 3.9 t -123.57 114.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.158 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.534 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 88.3 t80 -81.78 104.13 11.95 Favored 'General case' 0 N--CA 1.411 -2.409 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 170.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.42 -54.17 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.447 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.767 -174.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 70.4 m -150.16 148.6 29.14 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.129 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.54 HD23 HD13 ' A' 1652 ' ' LEU . 3.3 tm? -108.43 136.28 48.31 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 171.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' 1651 ' ' THR . 20.2 t70 -95.95 109.3 21.7 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . . . . . . . . . 77.1 mttt -89.21 11.56 18.41 Favored 'General case' 0 C--N 1.251 -3.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.801 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -94.59 -41.54 9.26 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.568 ' HA ' HD22 ' A' 1620 ' ' LEU . 6.7 t -135.14 20.26 3.44 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' 1618 ' ' ASN . 99.0 m 60.45 42.39 14.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.276 0.63 . . . . 0.0 111.698 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.538 ' OG1' HG23 ' A' 1649 ' ' THR . 28.0 m -95.98 110.95 23.08 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.496 0.665 . . . . 0.0 112.023 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.562 HD12 HD13 ' A' 1564 ' ' ILE . 2.2 mm? -72.9 99.92 2.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 125.011 1.324 . . . . 0.0 109.124 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' 1646 ' ' ASP . 65.3 m-85 -86.06 113.23 21.96 Favored 'General case' 0 CA--C 1.481 -1.7 0 CA-C-O 121.47 0.652 . . . . 0.0 109.996 176.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.667 ' HE2' ' HE3' ' A' 1656 ' ' TRP . 19.0 t80 -117.68 149.06 41.35 Favored 'General case' 0 N--CA 1.392 -3.331 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.303 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 3.0 p -128.3 125.27 38.47 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.024 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.873 ' CD1' ' HB ' ' A' 1658 ' ' THR . 3.8 t-105 -119.1 122.38 41.95 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.662 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 54.3 m170 -88.07 103.3 15.6 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.873 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 10.8 t -130.81 139.79 36.69 Favored Pre-proline 0 N--CA 1.41 -2.459 0 C-N-CA 119.114 -1.034 . . . . 0.0 112.634 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.554 ' HA ' ' SG ' ' A' 1662 ' ' CYS . 32.3 Cg_exo -69.25 -10.7 29.66 Favored 'Trans proline' 0 C--N 1.326 -0.64 0 C-N-CA 124.404 3.403 . . . . 0.0 111.169 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.782 ' HG ' ' OG1' ' A' 1658 ' ' THR . 8.4 mt -77.95 -20.57 52.47 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' 1658 ' ' THR . . . -86.25 -7.24 58.67 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.727 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 78.4 m -86.02 122.97 30.8 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.945 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' 1665 ' ' GLU . 39.4 tt0 -87.83 130.06 35.0 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.887 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 62.8 mttm -78.75 -12.12 60.01 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.382 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . 0.521 ' H ' ' HG2' ' A' 1663 ' ' GLU . 33.3 mt-10 -116.02 178.55 4.28 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 124.905 1.282 . . . . 0.0 107.648 -176.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -140.86 133.83 14.55 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 118.252 0.478 . . . . 0.0 111.455 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 86.8 Cg_endo -74.26 -178.38 3.9 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.373 2.715 . . . . 0.0 114.418 -176.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -53.87 -33.34 56.1 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.449 1.5 . . . . 0.0 112.883 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 18.0 t60 -127.38 92.79 3.57 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.453 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 45.0 t-80 . . . . . 0 C--N 1.291 -1.937 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1524 ' ' MET . . . . . 0.594 ' HB2' HG21 ' A' 1535 ' ' THR . 1.1 mpt? . . . . . 0 CA--C 1.513 -0.465 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1525 ' ' LYS . . . . . 0.445 ' HD2' ' HB ' ' A' 1528 ' ' ILE . 37.0 ttpt -160.47 151.89 19.45 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1526 ' ' SER . . . . . . . . . . . . . 23.8 m -88.49 -162.08 0.81 Allowed 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.696 0.623 . . . . 0.0 109.495 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1527 ' ' ASN . . . . . 0.708 ' HB2' ' H ' ' A' 1599 ' ' TYR . 5.0 p-10 -74.94 85.37 2.26 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 122.458 1.123 . . . . 0.0 110.762 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1528 ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' 1525 ' ' LYS . 42.6 mm -137.36 154.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1529 ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -60.03 165.69 3.19 Favored 'General case' 0 C--O 1.256 1.431 0 C-N-CA 124.438 1.095 . . . . 0.0 112.294 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1530 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.32 -93.2 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.147 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1531 ' ' ASN . . . . . 0.656 ' HA ' ' HB2' ' A' 1595 ' ' SER . 22.7 t-20 -161.33 76.56 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1532 ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' 1569 ' ' CYS . 2.1 p 49.92 36.76 12.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 122.45 1.119 . . . . 0.0 112.897 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1533 ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' 1542 ' ' LEU . 3.6 pt20 -150.48 143.75 24.94 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.826 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.4 p -138.57 150.28 24.02 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.194 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1535 ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' 1524 ' ' MET . 26.0 m -116.21 128.94 56.04 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1536 ' ' ASN . . . . . 0.429 ' HB2' ' HE2' ' A' 1543 ' ' PHE . 55.0 t-20 -63.72 122.57 77.44 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1537 ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.65 -14.55 40.71 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.461 2.108 . . . . 0.0 113.376 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1538 ' ' ALA . . . . . . . . . . . . . . . -96.62 -27.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.804 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1539 ' ' THR . . . . . . . . . . . . . 76.3 p -121.67 -20.5 6.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.716 0.77 . . . . 0.0 112.671 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.0 10.71 86.12 Favored Glycine 0 N--CA 1.414 -2.791 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1541 ' ' HIS . . . . . . . . . . . . . 32.0 m170 -80.32 121.12 25.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.647 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1542 ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' 1533 ' ' GLN . 3.3 tm? -75.44 139.54 42.35 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 124.857 1.263 . . . . 0.0 109.892 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1543 ' ' PHE . . . . . 0.683 ' HB3' HD21 ' A' 1604 ' ' LEU . 97.3 m-85 -116.2 141.37 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1544 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -139.58 134.71 32.52 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.35 -172.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1545 ' ' LEU . . . . . 0.645 ' HA ' HD23 ' A' 1660 ' ' LEU . 50.7 mt -115.32 11.65 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 123.325 0.391 . . . . 0.0 110.078 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1546 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -65.44 -21.76 66.69 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.795 0.331 . . . . 0.0 111.837 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1547 ' ' SER . . . . . . . . . . . . . 18.1 m -74.51 -13.51 60.69 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.959 0.409 . . . . 0.0 111.224 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1548 ' ' LEU . . . . . . . . . . . . . 94.1 mt -91.88 7.36 42.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 121.941 -0.475 . . . . 0.0 110.782 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1549 ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' 1568 ' ' ILE . 50.9 mtmt -83.58 96.81 8.76 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1550 ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -129.69 137.26 50.51 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.426 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1551 ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' 1571 ' ' GLY . 4.3 p30 -74.06 -21.61 59.87 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.169 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1552 ' ' SER . . . . . . . . . . . . . 9.8 m -55.5 -59.45 4.81 Favored 'General case' 0 N--CA 1.395 -3.182 0 C-N-CA 123.931 0.893 . . . . 0.0 109.048 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' 1572 ' ' THR . . . 98.77 163.24 30.12 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.051 -1.071 . . . . 0.0 113.595 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1554 ' ' TYR . . . . . 0.555 ' HB2' ' HB ' ' A' 1566 ' ' ILE . 77.7 m-85 -115.23 170.32 8.47 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.855 -0.673 . . . . 0.0 110.399 -173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1555 ' ' SER . . . . . 0.469 ' HB2' HD13 ' A' 1563 ' ' LEU . 3.7 p -152.31 146.92 25.76 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 123.562 0.745 . . . . 0.0 111.18 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1556 ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' 1640 ' ' PRO . 78.0 t -139.87 94.53 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 124.526 1.13 . . . . 0.0 108.285 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1557 ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' 1563 ' ' LEU . . . -50.37 126.75 15.78 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.982 175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1558 ' ' TYR . . . . . 0.426 ' HD1' HD11 ' A' 1564 ' ' ILE . 69.8 t80 -87.84 152.06 22.38 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1559 ' ' SER . . . . . . . . . . . . . 2.3 m -53.15 -24.07 9.75 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.454 1.501 . . . . 0.0 114.436 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1560 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -86.07 -80.7 0.22 Allowed 'General case' 0 C--N 1.335 -0.046 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1561 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.78 -14.39 0.64 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1562 ' ' GLY . . . . . . . . . . . . . . . -136.42 -178.74 16.02 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1563 ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' 1557 ' ' ALA . 3.1 pp -110.62 174.42 5.87 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 123.389 0.676 . . . . 0.0 111.102 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1564 ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' 1563 ' ' LEU . 52.6 mt -123.75 120.6 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 124.812 1.245 . . . . 0.0 107.936 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1565 ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' 1574 ' ' ASN . 74.7 m-85 -82.71 145.96 29.3 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1566 ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' 1554 ' ' TYR . 46.9 mt -131.28 139.42 50.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.063 0.459 . . . . 0.0 111.565 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1567 ' ' GLY . . . . . . . . . . . . . . . -120.71 129.64 7.94 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 170.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1568 ' ' ILE . . . . . 0.471 ' HA ' ' OH ' ' A' 1608 ' ' TYR . 44.0 mm -103.22 97.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 117.721 0.76 . . . . 0.0 110.859 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1569 ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' 1532 ' ' CYS . 45.6 t 62.37 13.53 6.11 Favored 'General case' 0 C--N 1.36 1.059 0 CA-C-O 121.8 0.809 . . . . 0.0 111.397 175.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1570 ' ' GLY . . . . . . . . . . . . . . . -155.46 160.55 29.96 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1571 ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' 1551 ' ' ASP . . . -86.38 136.15 13.89 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 121.504 -0.379 . . . . 0.0 112.868 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1572 ' ' THR . . . . . 0.448 ' OG1' ' HA3' ' A' 1553 ' ' GLY . 0.1 OUTLIER -112.92 165.12 12.63 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.6 0.76 . . . . 0.0 110.884 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1573 ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -89.97 -15.17 32.5 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.31 0.576 . . . . 0.0 109.964 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1574 ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' 1565 ' ' TYR . 96.3 m-20 -89.73 -21.31 22.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.033 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1575 ' ' CYS . . . . . 0.437 ' SG ' HG12 ' A' 1579 ' ' VAL . 7.9 t -136.38 142.09 38.26 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1576 ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' 1575 ' ' CYS . 64.2 Cg_exo -56.5 151.93 43.15 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.566 2.844 . . . . 0.0 115.965 -174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1577 ' ' SER . . . . . . . . . . . . . 19.5 m -68.95 124.0 22.55 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1578 ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' 1593 ' ' TRP . . . 100.18 -3.51 56.86 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1579 ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' 1582 ' ' CYS . 53.8 t -117.92 125.65 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1580 ' ' GLY . . . . . . . . . . . . . . . -90.73 -36.7 6.72 Favored Glycine 0 C--O 1.21 -1.379 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.086 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1581 ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' 1590 ' ' ALA . 41.3 t -141.1 138.63 33.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1582 ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' 1579 ' ' VAL . 26.5 p -152.72 136.91 16.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1583 ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' 1587 ' ' LYS . 57.6 m-85 -62.97 143.83 57.37 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1584 ' ' GLY . . . . . . . . . . . . . . . -92.62 -17.67 44.29 Favored Glycine 0 C--N 1.286 -2.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.833 -173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1585 ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.67 -73.54 0.13 Allowed 'General case' 0 N--CA 1.404 -2.774 0 CA-C-O 121.617 0.722 . . . . 0.0 111.156 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1586 ' ' THR . . . . . . . . . . . . . 69.4 p -111.37 16.95 20.6 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.501 -174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1587 ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' A' 1583 ' ' PHE . 34.2 mmtp 54.92 68.69 0.82 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.241 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' 1583 ' ' PHE . 15.9 mt -105.16 99.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.984 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1589 ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' 1612 ' ' ALA . 18.9 t30 -49.41 108.26 0.19 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.205 1.002 . . . . 0.0 110.358 173.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1590 ' ' ALA . . . . . 0.811 ' HB3' HG12 ' A' 1581 ' ' VAL . . . -97.27 9.82 41.2 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.042 -174.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1591 ' ' GLY . . . . . . . . . . . . . . . 163.52 126.67 0.83 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1592 ' ' SER . . . . . . . . . . . . . 72.0 m -77.39 147.62 35.96 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1593 ' ' TRP . . . . . 0.539 ' HB2' ' C ' ' A' 1578 ' ' GLY 0.305 0.7 OUTLIER -40.85 122.16 1.65 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 128.576 2.75 . . . . 0.0 110.816 176.907 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A 1594 ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' 1596 ' ' GLN . 93.9 m-20 -150.53 169.47 21.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.99 0.424 . . . . 0.0 110.373 -178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1595 ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' 1531 ' ' ASN . 16.7 p -124.38 19.9 8.86 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1596 ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' 1594 ' ' ASN . 29.7 mm-40 -75.04 89.67 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.625 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1597 ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' 1604 ' ' LEU . 58.2 tp -109.61 140.9 42.89 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1598 ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' 1604 ' ' LEU . 5.2 mtm -136.89 178.42 7.09 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.844 176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1599 ' ' TYR . . . . . 0.708 ' H ' ' HB2' ' A' 1527 ' ' ASN . 47.9 t80 -139.94 97.78 3.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1600 ' ' VAL . . . . . . . . . . . . . 2.5 p -133.82 124.13 46.57 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.75 -173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1601 ' ' ASP . . . . . . . . . . . . . 33.1 m-20 65.92 38.53 4.96 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 124.935 1.294 . . . . 0.0 111.565 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1602 ' ' GLN . . . . . 0.445 ' HA ' ' CZ ' ' A' 1599 ' ' TYR . 54.4 mt-30 65.22 14.87 9.69 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.639 1.176 . . . . 0.0 110.441 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1603 ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' 1627 ' ' SER . 26.4 t -120.27 128.1 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.807 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' 1628 ' ' PHE . 6.8 mp -75.47 137.11 40.72 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1605 ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' 1626 ' ' ILE . 6.8 tt0 -138.37 125.04 20.86 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 118.05 -1.46 . . . . 0.0 111.495 -175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1606 ' ' LEU . . . . . . . . . . . . . 82.5 mt -99.42 124.56 44.67 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.747 HG22 HG12 ' A' 1625 ' ' VAL . 83.9 t -107.27 95.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1608 ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' 1568 ' ' ILE . 32.9 m-85 -83.36 92.31 7.51 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1609 ' ' ASP . . . . . 0.648 ' HA ' ' HB2' ' A' 1623 ' ' LYS . 10.7 p-10 -99.11 173.96 6.56 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 120.928 0.394 . . . . 0.0 111.499 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1610 ' ' ASP . . . . . . . . . . . . . 19.1 t70 54.46 56.65 6.6 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 125.112 1.508 . . . . 0.0 111.326 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1611 ' ' GLY . . . . . . . . . . . . . . . -85.52 -136.74 4.0 Favored Glycine 0 C--O 1.244 0.776 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.024 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1612 ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' 1613 ' ' PRO . . . -85.5 160.75 53.15 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1613 ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' 1612 ' ' ALA . 18.5 Cg_endo -67.65 129.89 20.91 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.757 1.638 . . . . 0.0 111.13 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1614 ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' 1615 ' ' PRO . 30.1 t -85.71 110.22 28.29 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.162 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1615 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1614 ' ' CYS . 3.6 Cg_exo -78.49 -13.28 15.03 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.974 2.449 . . . . 0.0 112.071 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1616 ' ' SER . . . . . 0.404 ' HB2' ' SG ' ' A' 1614 ' ' CYS . 18.9 m -66.18 -57.31 7.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.478 0.656 . . . . 0.0 110.948 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1617 ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' 1647 ' ' LYS . 72.3 mmtt -104.19 -0.04 28.93 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.957 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1618 ' ' ASN . . . . . . . . . . . . . 55.8 t30 73.16 -60.22 0.54 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.659 1.584 . . . . 0.0 114.548 169.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1619 ' ' ALA . . . . . . . . . . . . . . . -67.08 -27.25 67.21 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1620 ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' 1649 ' ' THR . 4.7 mp -113.7 178.37 4.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 118.419 -1.313 . . . . 0.0 112.419 -173.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1621 ' ' LYS . . . . . . . . . . . . . 96.2 mttt -104.36 170.31 7.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1622 ' ' TYR . . . . . 0.51 ' CB ' ' HA ' ' A' 1590 ' ' ALA . 61.8 m-85 -80.58 150.15 29.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1623 ' ' LYS . . . . . 0.648 ' HB2' ' HA ' ' A' 1609 ' ' ASP . 63.9 pttt -151.01 158.06 43.66 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1624 ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' 1608 ' ' TYR . 55.3 m -124.08 144.3 49.95 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-O 121.202 0.525 . . . . 0.0 111.216 -173.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1625 ' ' VAL . . . . . 0.747 HG12 HG22 ' A' 1607 ' ' VAL . 0.7 OUTLIER -130.07 91.85 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-O 122.479 1.133 . . . . 0.0 110.001 177.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1626 ' ' ILE . . . . . 0.552 ' HA ' ' HB2' ' A' 1654 ' ' PHE . 49.6 mt -86.18 110.05 19.46 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.804 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1627 ' ' SER . . . . . 0.612 ' HB3' HG11 ' A' 1603 ' ' VAL . 14.5 m -90.26 114.13 26.1 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1628 ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' 1604 ' ' LEU . 90.3 m-85 -94.13 114.7 26.89 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.07 0.938 . . . . 0.0 109.571 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1629 ' ' VAL . . . . . . . . . . . . . 38.8 t -109.74 129.73 64.1 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.312 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1630 ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' 1658 ' ' THR . 19.4 t -54.22 127.93 29.0 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 123.809 0.844 . . . . 0.0 111.755 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1631 ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' 1657 ' ' HIS . 13.2 t -125.06 144.69 50.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.479 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1632 ' ' HIS . . . . . . . . . . . . . 39.7 m80 -62.47 0.94 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.947 1.299 . . . . 0.0 113.844 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1633 ' ' ASP . . . . . 0.411 ' HB2' ' HG3' ' A' 1659 ' ' PRO . 5.8 m-20 -78.09 -172.59 2.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.025 0.53 . . . . 0.0 109.644 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1634 ' ' SER . . . . . . . . . . . . . 23.3 t -134.68 119.44 18.29 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1635 ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' 1660 ' ' LEU . . . 53.21 42.1 62.43 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1636 ' ' ALA . . . . . . . . . . . . . . . -120.8 178.22 4.79 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1637 ' ' ASN . . . . . 0.547 ' HB2' ' CZ2' ' A' 1656 ' ' TRP . 2.5 p-10 -117.48 -10.85 10.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1638 ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' 1657 ' ' HIS . 25.8 t-20 59.43 -80.83 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 126.272 1.829 . . . . 0.0 109.72 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1639 ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.93 123.01 0.4 Allowed Pre-proline 0 C--N 1.282 -2.34 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.119 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1640 ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' 1556 ' ' VAL . 1.9 Cg_endo -81.73 129.49 6.39 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1641 ' ' VAL . . . . . 0.475 ' HB ' ' OG ' ' A' 1655 ' ' SER . 2.4 t -115.97 132.6 64.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1642 ' ' PHE . . . . . 0.621 ' HZ ' ' HB2' ' A' 1645 ' ' LEU . 87.1 t80 -77.91 115.4 17.62 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1643 ' ' VAL . . . . . . . . . . . . . 1.4 p -88.96 -52.53 10.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1644 ' ' SER . . . . . . . . . . . . . 32.9 t -160.04 153.72 22.65 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.33 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1645 ' ' LEU . . . . . 0.621 ' HB2' ' HZ ' ' A' 1642 ' ' PHE . 3.5 tm? -103.79 141.44 36.1 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 174.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1646 ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' 1651 ' ' THR . 12.2 t70 -97.95 108.45 21.16 Favored 'General case' 0 CA--C 1.462 -2.411 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1647 ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' 1617 ' ' LYS . 84.4 mttt -86.89 9.12 20.26 Favored 'General case' 0 C--N 1.26 -3.298 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.619 -173.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1648 ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.18 -39.38 10.59 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1649 ' ' THR . . . . . 0.588 HG23 ' OG1' ' A' 1651 ' ' THR . 2.2 t -134.04 19.06 3.76 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1650 ' ' CYS . . . . . . . . . . . . . 79.5 m 55.3 48.21 19.75 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 122.17 0.986 . . . . 0.0 110.929 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1651 ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' 1646 ' ' ASP . 25.6 m -102.04 113.28 26.38 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.516 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1652 ' ' LEU . . . . . 0.41 ' HG ' ' HB1' ' A' 1590 ' ' ALA . 2.1 mm? -75.5 100.8 4.63 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 125.353 1.461 . . . . 0.0 110.063 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1653 ' ' TYR . . . . . 0.718 ' HA ' HG23 ' A' 1625 ' ' VAL . 57.9 m-85 -84.31 119.47 25.11 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.224 0.535 . . . . 0.0 110.388 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1654 ' ' PHE . . . . . 0.552 ' HB2' ' HA ' ' A' 1626 ' ' ILE . 78.0 m-85 -114.88 142.35 46.7 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.47 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1655 ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' 1641 ' ' VAL . 4.8 p -109.42 118.67 37.26 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1656 ' ' TRP . . . . . 0.547 ' CZ2' ' HB2' ' A' 1637 ' ' ASN . 4.5 t-105 -119.58 122.55 41.83 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1657 ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' 1638 ' ' ASN . 89.8 m-70 -90.42 103.69 16.35 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1658 ' ' THR . . . . . 0.525 ' HB ' ' CD1' ' A' 1656 ' ' TRP . 15.3 t -134.24 138.11 29.6 Favored Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.572 -0.705 . . . . 0.0 111.723 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1659 ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' 1660 ' ' LEU . 22.8 Cg_exo -70.77 -10.72 28.31 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.322 3.348 . . . . 0.0 110.764 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1660 ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' 1545 ' ' LEU . 2.4 mp -78.44 -21.29 49.38 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.67 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1661 ' ' ALA . . . . . . . . . . . . . . . -86.36 -5.66 59.12 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.374 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1662 ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' 1659 ' ' PRO . 70.2 m -86.02 127.86 34.74 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.886 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1663 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.99 149.07 43.62 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1664 ' ' LYS . . . . . . . . . . . . . 60.2 mttm -55.44 -45.89 76.78 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.479 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1665 ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -102.04 177.04 5.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 171.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1666 ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' 1667 ' ' PRO . 40.7 mt-10 -77.59 139.1 62.84 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.948 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1667 ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' 1670 ' ' HIS . 14.7 Cg_exo -71.61 -168.62 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.344 2.696 . . . . 0.0 111.856 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1668 ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.83 -35.58 77.13 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1669 ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -140.63 114.41 8.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1670 ' ' HIS . . . . . 0.643 ' HB2' ' HD2' ' A' 1667 ' ' PRO . 51.7 t-80 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.431 . . . . . . . . 1 1 . 1 stop_ save_